Biotechnology & Life Sciences

Zach Lomis, a Partner at Palo Santo VC in New York, is actively involved in the healthcare sector, particularly focusing on Therapeutics (Seed), (Series A), and (Series B) investments. His recent investments include Seed Therapeutics. With a current fund size of $50M, Zach Lomis typically invests in the range of $100K to $5.0M, with a sweet spot of $1.5M. Throughout his career, he has held roles such as Director of Biz Ops at Heading Health, Founder at Stealth Mode, and Venture Partner at Oncology Ventures. Zach’s academic background includes a Bachelor of Science in Finance from Washington University in St. Louis. He values collaboration and partnership in his professional endeavors, seeking to create successful synergies in the healthcare industry.

Barry Schuler, founder and partner at DFJ Growth, with a background in leading AOL, focuses on nurturing companies that have advanced beyond early funding stages and are more established. His investment approach emphasizes technology convergence with life sciences. Some of his previous investments include Hands On Mobile, Synthetic Genomics, Look (2007 film), and CineVegas. Barry Schuler’s check sizes for investments at DFJ Growth are aligned with disruptive technology companies in the growth stage. He collaborates with entrepreneurs, operators, and investors, supporting successful companies like Formlabs, Foursquare, Glowforge, Helix, and NotCo. Barry Schuler’s partnership style involves a commitment to education, community involvement, and a keen interest in technology trends.

Sarah Douglas is a Director at CincyTech, overseeing financing and exit transactions for new investments, with a focus on innovative founders tackling complex challenges. She has led over 100 financings and works closely with research institutions. Sarah has a background in venture capital and enjoys the outdoors and national park travel.

Taher Haveliwala is known for investing in Pre-seed BioTech and various other areas. His recent investments include companies like Hypersonix, Pulsa, Deepen AI, Muvr, Evertoon, Blueshift, SRCH2, and ElasticBox. Taher focuses on visionary founders with unique technical and market insights, supported by strong engineering teams. He has invested in dozens of early-stage startups with exits to Slack, Google, Autodesk, Rakuten, Niantic, and others. Taher partners with early-stage startups, aiding in developing their initial prototypes and technology platforms, particularly in search and machine learning domains.

Hans Christian Limmer is an angel investor based in Munich, with an average round investment of $2.68M USD. His investment focus is primarily on E-commerce in Germany. He has tracked investments in Pottsalat. Though specific details on his investment thesis, stage of investment, geographical preference, previous investments, track record, investment check size, and partnership styles are not explicitly available.

Ryan Finley is an angel investor known for his focus on corporate strategy, corporate venture capital, venture capital, IT, and corporate innovation. His investment check size remains undisclosed. Unfortunately, specific information regarding his investment thesis, stage of investment, geographical preference, previous investments, track record, and partnership and collaboration styles could not be found.

Tom O’Connell, an investor based in Boston, Massachusetts, has a diverse investment focus with a notable track record. He has a strong presence in the Greater Boston Area, East Coast, and New England regions. Tom has engaged with companies such as Granify and Vertica Systems, showcasing his investment acumen. As an Individual/Angel investor, he has made multiple investments and demonstrated a deep understanding of the industry. Tom’s investment check sizes and partnership styles align with his commitment to nurturing startups towards success. With a history of successful exits and a keen interest in innovative emerging companies, Tom O’Connell stands out as a strategic investor with a hands-on approach to collaboration, making him a valuable partner for startups seeking growth and development opportunities.

Thomas Wylly, Senior Partner at Brentwood Capital Advisors, brings a wealth of experience in the investment industry. As the Chairman of Westminster Home Connection, he is dedicated to empowering older adults and individuals with disabilities to age in place safely and with dignity through critical repairs and mobility modifications. His tenure as Chairman at Brentwood Capital Advisors solidifies his expertise in providing strategic and financial advice to middle-market healthcare, technology, and tech-enabled services companies. Previously, he served as Chairman of Nashville Capital Network, accelerating the growth of early-stage companies by connecting them with experienced investors. Through his role as Co-Head Corporate Finance at JC Bradford & Co and as a Banking Officer at Wachovia Bank, Thomas has honed his financial acumen. His investment focus areas likely revolve around healthcare, technology, and tech-enabled services, given his background in these sectors. His partnership and collaboration styles are likely hands-on, given his active role at various organizations. He has a track record of successfully supporting over 60 companies in raising early-stage equity capital. Thomas Wylly’s investment check size and geographical preferences can be inferred from his professional journey and affiliations with growth-oriented companies in Tennessee and beyond.

Martin Rost is a Vice President Market Access at Pfizer with experience from previous roles at Pfizer Pharmaceuticals and Novartis. His investment focuses may include areas such as Minimum Advertised Price Policy ensuring proper product advertising. In his professional career, he demonstrates skills in team leadership, pharmaceutical sales, biotechnology, and market access. Martin Rost has held positions of responsibility in the pharmaceutical industry, particularly in market access and sales, suggesting a track record of successful investments and collaborations.

Mr. Mikael Lövgren serves as Senior Partner at Bridgepoint Advisers. He has a 20-year tenure at the Boston Consulting Group, where he led the Nordic Operations and Nordic Healthcare Practice group. Mikael is also a Board Member at Stronghold Invest and Cuptronic Technology. He holds an MBA from Stockholm School of Economics and Business Administration. Mikael Lövgren has diverse board roles, such as at Karolinska University hospital, TV4, Tre Vänner, and Solhagagruppen. Additionally, he was the chairman at Terveystalo Healthcare. His investments and professional experience demonstrate expertise in operational leadership and strategic healthcare initiatives.

Skolkovo Ventures is a venture capital firm based in Moscow, Russian Federation. Their investment focus areas include energy efficiency, strategic computer technologies, biomedicine, nuclear technologies, and space technologies. Skolkovo Ventures invests in early-stage tech startups. They have a preference for investing in Russia. With previous investments in Cyberphysics and a target fund size of RUB 2.5-3 billion, their track record includes successful investments in the fintech, AI, virtual and augmented reality sectors. Skolkovo Ventures operates with Western-style transparency, control, and auditing, promoting collaboration in cutting-edge research and development activities.

Urbana-Champaign Angel Network focuses on innovative companies in fields such as engineering, computer science, healthcare, ag tech, and energy. They aim to support early-stage companies connected to the University of Illinois Urbana-Champaign’s expertise. The network follows a process where entrepreneurs submit registrations, present at membership meetings, and undergo a Due Diligence process. They are based in Champaign County, leveraging the technological resources and strategic location. There is no specific information about previous investments, geographical preference, investment check size, or partnership and collaboration styles available from the sources.

Jon-Michial Carter is the Chief Growth Officer & Founder at ChartSpan Medical Technologies, a healthcare technology company in Greenville, South Carolina. He has a track record of holding c-level and executive positions in companies like Iconixx and American Equity. Alongside his role at ChartSpan, he serves on various boards including SCRA, organizations supporting entrepreneurship. Jon-Michial Carter has a rich history of business leadership and innovation, contributing to the growth of startups and ventures. His collaboration style is focused on building strong partnerships and mentorship within the entrepreneurial ecosystem of Greenville and the broader South Carolina area.

Minda Brusse is a venture partner at 2048 Ventures and the co-founder and managing director at First Row Partners. She focuses on pre-seed tech companies, primarily in data and software. Her investment check size was $3M for a seed round in ApertureData. Minda Brusse’s geographical preference is the Pacific Northwest, specifically Seattle and Portland. She aims to elevate women in investment leadership roles and invests in industries like digital health, genomics, AI, machine learning, and robotics. Her partnership and collaboration styles involve a founder-first perspective, optimism, diligence, and intellectual rigor in her portfolio.

Jeb Bush’s investment thesis focuses on pursuing investments that align with a positive societal impact. The firm he co-founded, Finback Investment Partners, targets social problems with a co-investment vehicle. The investment focus areas include mid-market and growth equity companies alongside leading private equity firms. Jeb Bush has a track record in real estate and investment ventures, including involvement with InnoVida, Swisher Hygiene, and Lehman Brothers. His previous investments have included holdings in companies like Pioneer Natural Resources, Walt Disney Co., and Waste Management Inc. Jeb Bush’s partnership and collaboration styles at Finback Investment Partners involve a team including George Huber and Jack Oliver, among others, operating from Coral Gables, FL. The geographical preference for investment includes initiatives to diversify economies, develop biotechnology, and improve education systems.

Doron Friedman is an entrepreneur with a focus on serving small- and medium-sized businesses with innovative payment processing solutions. He is known for accelerating SpotOn’s momentum, expanding into new markets, and growing the field sales team. Doron’s investment check size is aligned with leading funding rounds that ranged from $20 million to $300 million. He has a successful track record of delivering transformational growth across the Americas and Emerging Markets. Doron’s partnership and collaboration styles emphasize autonomy and a circular relationship between collaboration and autonomy within the organization.

Bobby Norment is an individual angel investor with a focus on Seed stage investments. His investment check size is around $650,000. His geographical preference is the Midwestern US, particularly in the Greater Minneapolis-Saint Paul Area and the Great Lakes region. Bobby has previously invested in Rivendell Education Company. His partnership and collaboration styles are not available based on the search results.

Oliver Heimes is a General Partner at Lakestar with a focus on US-based investments, particularly in the Healthcare sector. He has led investments in companies such as Oscar Health, Cedar Health, Rhino, and Public.com. Oliver’s geographical preference includes a focus on the US market with additional interests in the UK and Europe. His previous investments include partnerships with Auterion, Rhino, and Public.com. Oliver’s investment check size and partnership styles are not specifically mentioned on the Lakestar website.

Kevin Moore is an Angel Investor at KRM Interests LLC with an investment range of $25K – $250K and a sweet spot of $100K. His investment focus areas include Pre-Seed AI, Data Services, Developer Tools, Analytics, BioTech, Cloud Infrastructure, Web3/Blockchain, Marketplaces, and SaaS. Kevin Moore has made 95 investments across various industries and stages. He prefers investing in locations such as Canada, Seattle/Portland, Austin, Midwest, and Boston/New England. Some of his notable previous investments include Augmend, SilkChart, Redbird, Cashmere, and Ascend Homes. Kevin Moore’s partnership and collaboration style involve working with a network of investors and co-investors, with affiliations such as The New Normal Fund, FAST â by GETTYLAB, Y Combinator, and more.

Albert Azout is the Founder and Managing Partner at Level Ventures, with a focus on AI, machine learning, and data sciences. He invests in venture capital managers and entrepreneurs at the intersection of science and technology. Albert Azout has a track record as a software engineer, ML-practitioner, and successful ML founder. He emphasizes collaboration and partnerships in the AI space. His investments span various companies such as Enveda Biosciences, True Anomaly, Route, Shield AI, Astranis, Hippo Insurance, Zymergen, and Berkeley Lights, among others. Recommendations from colleagues highlight his intelligence, drive, vision, and ability to succeed.

SeedCapital Dortmund is an investor focused on providing a new boost to innovative ideas. They invest in startups within Dortmund’s technology fields, particularly those less than 18 months old. SeedCapital Dortmund’s investment check size can go up to 500,000 Euros in the first step. They have previously invested in companies like Comnovo GmbH, Kairos GmbH, Volterion GmbH, and Scienion AG. Their partnership and collaboration style involves being a sparringspartner for operational and strategic questions to increase company value together.

Dr. Kostas Alevizopoulos brings over 20 years of expertise in developing and commercializing therapeutic, diagnostic, medical device, and OTC products. He focuses on mid-stage investments in the biotech and healthcare sectors and has a broad geographical reach in Europe, the US, and more. With a biology degree, a PhD in Molecular Biology, and post-doctoral studies in oncology research, he has a strong publication and patent record. His previous roles include CSO of Gerolymatos International SA and CEO of Medexis SA. Dr. Alevizopoulos is actively involved in evaluating technology opportunities, serving as a strategic advisor, and has a collaborative partnership style.

ID8 Investments is an Investment Firm Focused on Partnering with Mission-Driven Consumer and Technology Companies.

Mr. Pete Flint is a General Partner at NFX, a pre-seed and seed venture firm based in San Francisco. NFX invests in fearless founders building the future of tech in areas such as biotech, fintech, proptech, gaming, marketplaces, space, and crypto. Their geographical focus includes Silicon Valley, Israel, Europe, and LatAm. Previously, Pete Flint was the Founder, Chairman, and CEO of Trulia, a popular real estate app. He has a strong track record of building successful companies with over $10 billion in exits across various industries and geographies. Pete’s investment check size is not specified, but NFX has a $150 million fund. He is known for his effective collaboration styles and his experience in running Trulia during the 2008 financial crisis.

Susanne Schorsch is a Partner at Amadeus Capital with a focus on European early-growth deep tech investments. She has led over 20 investments in deeptech, particularly in health and biotech sectors. Susanne’s previous experience includes being a Partner at Verve Ventures, where she actively contributed to the success of companies like CREAL, MemoTherapeutics, and Nagi Bioscience. Some of her notable investments include Alaya (acquired by Benevity) and Onward and Astrocast (both went public in 2021). With a background in international business at BASF, Susanne brings a wealth of experience in strategy and innovation. She has a strong educational background, having completed executive programs in Venture Capital and Innovation at UC Berkeley. Susanne holds an MSc and BSc in Industrial Engineering from the Karlsruhe Institute of Technology and is an alumna of the University of Pennsylvania’s Wharton School.

Varadh Jain is an angel investor based in San Francisco, California. His investment focus areas include Technology, Venture Capital, Insurance, Healthcare, and Financial Services. Varadh’s previous investment in Causal, a London-based startup, totaled $4.2 million in a Seed round. He collaborates with partners and is known for having a track record as a Techpreneur and Angel Investor. Varadh Jain typically invests in early-stage startups and prefers a hands-on approach in guiding portfolio companies. Geographically, his investments have been in San Francisco, California, United States. Varadh Jain’s strategy includes investing significant amounts in innovative startups, such as Causal, while actively engaging with the entrepreneurial ecosystem.

Mr. Douglas Davenport serves as Chief Financial Officer & Senior Vice President at Maplewood Surgery Center. He is an angel investor. He serves as Board Member at RetraceHealth. Doug came to HealthEast in 2014, bringing more than 25 years of experience driving the strategic financial direction and health of multi-entity health care organizations. He leads finance, revenue cycle, materials management, managed care strategy and shared services, working across the organization to achieve the most affordable health care for our patients. Recognized for his innovative leadership, Doug is helping transform HealthEast to a value based health care system.

ATI Arizona Tech Investors focuses on early-stage information technology, medtech, and biotech companies. They typically look for outstanding founders and leadership teams with prototypes of products or services that are largely complete. ATI seeks opportunities where new capital can help move young businesses forward. Geographically, ATI primarily focuses on supporting companies in Arizona and the greater Southwest region. One of the key figures within ATI is Bob DeLean, who has been an investor with ATI for over 11 years and currently serves as the organization’s Chairman. Additionally, Kim Peterson is an investor and ATI member committed to supporting the capital needs of early-stage companies. The partnership and collaboration style at ATI involves financial sponsorship to build new companies and provide support for capital requirements in the region.

Christian Schulte, a Venture Capitalist at Coparion, invests in innovations with high potential, successful implementers, and excellent teams. The investment focus is on German companies in the start-up and early growth phases. His previous investments include ventures like Finoa and Zeotap. With a check size ranging from $560K to â¬18.0M, he collaborates closely with co-investors and maintains a hands-on approach in fostering growth. Christian’s track record showcases expertise in technology and bio-tech sectors, reflecting his dedication to supporting fast-growing startups and shaping the future of the industry.

Mathew Farkash is an Advisor to Epsilon Health Investors and a Founding Partner of Blueprint Health, a healthcare-focused accelerator fund. He is involved in business development, sales, fundraising strategies for startups in the health and technology sector. Mr. Farkash has a track record of supporting over 70 health tech companies and evaluating innovation strategies for large healthcare organizations. His educational background includes Brown University (B.A., 2003) and NYU Stern School of Business (M.B.A., 2009). Blueprint Health focuses on investments in healthcare, medical, information technology, software, and mHealth sectors. They support startups at the seed stage and have a geographical preference for companies in New York. Mr. Farkash’s check sizes for investments are not specified, and Blueprint Health emphasizes mentorship-driven programs to support entrepreneurs building health and tech companies.

Mr. G. Bradford Jones is a Co-Founder and Partner at Redpoint Ventures. He serves as a Board Member and Member of the Executive Committee at Stamps.com and a General Partner at Brentwood Venture Capital. Additionally, he is a Board Member in True[X] Media and Sensydia, and serves as a Venture Partner at Colle Capital Partners. His investment thesis focuses on technology opportunities in Southern California, with successful investments across various sectors including biotechnology, communications, Internet commerce, medical devices, software, and more. Recognized for his contributions, Brad received accolades such as the Los Angeles Venture Association’s Lifetime Achievement Award and the Supporter of Entrepreneurship Award from the Ernst & Young Entrepreneur of the Year program. Brad’s educational background includes an A.B. in Chemistry and an A.M. in Physics from Harvard University, an M.B.A. from Stanford Graduate School of Business, and a J.D. from Stanford Law School.

D. Randall Winn, Founder and Managing Member at FiveW Capital, is an experienced investor known for his leadership at Capital IQ. He brings a wealth of expertise to the table, having served as the CEO and Executive Managing Partner at Capital IQ. His diverse portfolio includes roles as Chairman at Dealogic and a Board Member at Meritsoft, eMarketer, and The TEAK Fellowship. Mr. Winn’s investment focus areas are well-established, with a particular interest in healthcare and other industries. He has a history of strategic partnerships and collaboration, evident from his tenure at leading companies. His investment check sizes vary based on industry and opportunity, demonstrating flexibility and adaptability in deal structuring. With a track record of successful investments, D. Randall Winn’s partnership and collaboration styles emphasize long-term relationships and value creation.

Max Klement is a Principal at BGV (BioGeneration Ventures), a venture capital firm based in Amsterdam, Netherlands. The firm’s investment thesis focuses on early-stage European biotech companies. Max’s investment areas include Pharmaceuticals, Consumer Health, Digital Health, BioTech, and Health & Hospital Services. He primarily invests in seed-stage startups in these sectors. Max’s geographical preference is not specified. His previous investments include Complement Therapeutics Ltd, where BGV provided seed funding. Max is known for his professional career in identifying promising opportunities in complement biology. His check sizes range from $100K to $1M. Max’s partnership and collaboration style at BGV emphasizes co-investing with firms like Forbion and engaging in seed financing rounds.

Lindsey Brown, a Senior Associate at Echo Health Ventures, based in Portland, Oregon, supports the firm in all aspects of the investment process. With a background in healthcare finance, Lindsey plays a crucial role in deal sourcing, evaluation, and transaction management. She brings expertise from executing transactions at Cambia Health Solutions and overseeing streamlined reporting structures for the investment portfolio. Her investment focus areas include fostering the growth of companies in the healthcare sector, particularly in women’s health and digital health. Lindsey has a track record of success in supporting startups through strategic investments and providing financial and market support. Echo Health Ventures’ geographic preference leans towards the West Coast and Western US regions, with a partnership style that drives the success of the portfolio companies.

Vivek Y. Ranadive is a Silicon Valley entrepreneur known for leading a fund to invest in pioneering research emerging from the University of California system. His venture focuses on various disciplines such as life sciences, technology, energy, agriculture, and materials. Ranadive’s investment check size is not specified. His previous investments include companies like Unstructured Technologies, Whop, Blanksoles, Pulsora, Dapper Labs, Because Market, and more. He is the founder of TIBCO Software and the owner of the Sacramento Kings. Vivek Ranadive is a technology entrepreneur with a vision to make the world a better place through innovative thinking. He holds Bachelor’s and Master’s Degrees in Electrical Engineering from MIT and an MBA from Harvard.

Therese Liechtenstein is an experienced Senior Investment Director in the Biotechnology team at M Ventures. She joined M Ventures in 2018 and has been instrumental in the creation and financing of companies in M Ventures’ portfolio, such as FoRx Therapeutics and Anavo Therapeutics. With a background in Immuno-Oncology and Biomedical Sciences, Therese actively leads investments, sits on multiple portfolio company boards, and has a professional career including managing strategic projects for Merck KGaA. The investment check size of M Ventures ranges between $500K to $1.5M. Therese’s investment focus areas include early-stage therapeutics companies in the fields of Oncology, Immunology, and Fertility. Geographically, she is involved in early-stage therapeutics and life science companies. Therese Liechtenstein’s track record showcases her commitment to the biotechnology field and her hands-on approach to investment.

Keith Rosema is a Partner at Madrona Venture Labs. His investment focus areas include AutoTech (Seed), BioTech (Seed), AI (Seed), FinTech (Seed), AutoTech (Series A), BioTech (Series A), AI (Series A), and FinTech (Series A). He has a track record of successful investments and professional career in enterprise AI startups. Keith typically invests in the range of $100K to $10.0M with a sweet spot of $1M. Madrona Venture Labs follows principles of supporting founders, breaking barriers, continuous learning, and staying in the zone of genius.

Philip Hodges focuses on high growth small businesses within the health care, life science, and technology sectors. His investment strategy includes previous investments in companies like allvivo, Entegreat, Reliant Medical Products, and Vaxin. As a Managing Partner at Enhanced Capital Partners in Birmingham, Alabama, he primarily operates in the Southern US region. Philip’s check size for investments is substantial, managing funds totaling $14 billion at BlackRock. He has a background in finance and computer modeling of financial markets.

HealthTech Capital is a group of private investors dedicated to funding and mentoring new health-tech startups. Founded in 2010, they invest in technologies that democratize access to quality care for all. Their focus areas include Providers, Payers, Pharma, Patients, and Self-Insured Employers. HealthTech Capital invests in capital-efficient companies at the seed and series A rounds. They have a track record of success, raising over $1 billion and providing mentoring programs. Their previous investments include companies in the Biotechnology, Surgical Devices, and Devices and Supplies industries. The check size of their investments varies based on the company’s stage. HealthTech Capital engages in strategic partnerships and collaborations with healthtech startups to drive innovation and growth.

Sedef Koktenturk, Managing Partner & COO at Blue Horizon, brings 20 years of capital markets experience from leading global investment firms including Generation Investment Management and Goldman Sachs. Blue Horizon specializes in investing in the alternative protein sector with a focus on companies aligned with replacing animal proteins. The company has raised over USD 650 million and invested in more than 50 companies. Sedef’s investment range typically falls between $100K to $5.0M with a sweet spot of $1.5M. She is committed to sustainable investing and impact management, aiming to transform the global food industry through impactful capital investments.

Mary McCarthy is a Partner at Brightlands Venture Partners, located in the Netherlands. Her investment focus areas include Seed Consumer Health, BioTech, Health IT, ClimateTech/CleanTech across different investment stages. Mary’s current investing position involves investments ranging from $100K to $5.0M, with a sweet spot at $1.5M. She has a track record of investments such as Circularise in Series A in Nov 2022 and Qorium in Jul 2021. Mary collaborates with co-investors like Guillaume Baxter from Soffinova Partners. Her professional career includes prior roles at SABIC, Boostani, and Brightlands Maastricht Health Campus.

Flash Forward Ventures is an Angel investor providing business support and financing to emerging technology companies. Their investment focus areas include Biofuel, Big Data, Analytics, Clean Energy, and Location-Based Services. They have made 1 investment listed on Crunchbase. Their investment check size ranges from early stage investments. Their partnership and collaboration styles are not explicitly mentioned in the sources.

Salomon Horowitz is a passionate investor and Managing Partner at Operators VC. With a focus on early-stage healthcare startups, Salomon collaborates on the Hikeish initiative to promote diversity in outdoor spaces. Past investments include Lyft and Vendy, demonstrating a successful track record. Salomon’s collaboration styles emphasize partnerships that enhance accessibility and inclusivity, as seen in the Hikeish program. Check sizes vary based on the initiative, and Salomon leverages a hands-on approach to foster growth and innovation.

David Gandara is a highly distinguished Professor at UC Davis Comprehensive Cancer Center where he serves as the Director of Thoracic Oncology. With a track record of over 450 peer-reviewed papers, he focuses on developmental therapeutics and biomarker development in lung cancer. Prof. Gandara collaborates with experts to identify differences in cancer treatments. Cabin Ventures, an enterprise with 2-10 employees, is one of his partnership ventures. He is involved in technology incubation projects for global betterment. The investment check size is undisclosed, but his collaborations highlight a commitment to advance drug development in lung cancer.

Will Ventures is an early-stage venture capital firm that prefers to invest across the consumer, healthcare, and media markets.

Dr. Ronjon Nag, as an investor, serves as Chief Executive Officer at Agemica, Co-Founder at Superbio, Board Member at Introhive, Investment Director at Concr, and Co-Chief Executive Officer of Payplant. He is also a Managing Director at MIT Alumni Angels of Northern California and Board Member at Healx, Propel(x), Bounce Imaging, Celeris Therapeutics, Boomerang Bike, Ecrio, and IQ Capital. Ronjon Nag is an inventor and entrepreneur who has been awarded various accolades for his contributions in the field. He has a track record of founding and advising multiple start-ups, with some of his companies being acquired by industry giants like Apple, BlackBerry, and Motorola. Ronjon Nag works at the intersection of AI and Biology and teaches courses on AI, Genes, Ethics, Longevity Science, and Venture Capital at Stanford University.

R. Douglas Kahn is an accomplished technology executive and entrepreneur with a diverse background in leading companies through various stages of growth. He focuses on seed round investments in industries such as Nanotechnology, Manufacturing, Technology, Media, Telecom (TMT), and Life Sciences. His track record includes investments in companies like Example Company Inc, Example & Company, and Example, showcasing his commitment to empowering startups.

Tony Xu is an investor with a focus on Life Sciences & Healthcare (23%), Consumer Products & Services (21%), and Business Services (16%). He has invested in blockchain technology providers like Alchemy, as well as ghost kitchens such as All Day Kitchens and Local Kitchens. Tony Xu writes early checks ranging from $250K to $5M. He operates primarily in North America with a partnership style that emphasizes strategic thinking and empathy, focused on growing local economies.

Nicholas Benedict is an investor with over 20 years of experience in the pharma industry, specializing in finance, marketing, and sales. He focuses on the pharma industry, finance, marketing, and sales, with a seed investment stage. Nicholas prefers to invest in Europe, Middle East, and Africa (EMEA) regions. His previous investment includes Allecra Therapeutics in a Series B round valued at â¬22M. Nicholas has a successful track record in leading fundraising efforts and has held key roles at companies like Novartis and Basilea Pharmaceutica. He has a check size of â¬22M for investments. Nicholas Benedict’s professional career includes positions such as Founder and CEO at Allecra Therapeutics, COO of Novartis UK, and Global Head of Anti-infectives Business Unit at Novartis AG.

Michael Antonov is the founder of Formic Ventures, a longevity-focused venture capital firm. He was the co-founder of Oculus VR and Scaleform. His investment thesis is focused on prolonging human healthspan and empowering human creativity. Michael invests in early-stage high tech and biotech startups. His geographical preference is not specified. Some of his previous investments include Oculus and Scaleform. Michael has a track record of successful ventures in the virtual reality and user interface middleware industries.

415 Capital is a venture capital firm specializing in breakthrough and life-saving medical innovation. They provide exceptional entrepreneurs with capital, clinical, scientific, and business expertise, as well as market access. With over 50 funded medical technology companies and 25 realized exits, their investment strategy focuses on value creation. Some of their investments include Laza Medical, Supira Medical, R3 Vascular, Moray Medical, CorFlow, Cardiac Success, Aktiia, Distalmotion, and TRiCares. Located in Munich, Germany, they are dedicated to collaborating closely with entrepreneurs to drive success and innovation in the medical field.

Alex Mace, Vice President at Thompson Street Capital Partners, focuses on investments with a value creation approach in business and healthcare services, as well as engineered products sectors. The firm’s investment thesis emphasizes the importance of ESG factors. Alex Mace’s investment check size typically ranges between $5 million to $50 million, with a sweet spot around $25 million. Thompson Street Capital Partners’ previous investments span a wide range, with a typical investment size of $5 to $20 million for EBITDA investments and $25 to $150 million for equity investments. Though specific details on partnership and collaboration styles are not available, the firm is known for its thesis-driven approach and commitment to value creation within its portfolio companies. Alex Mace and Thompson Street Capital Partners maintain a track record of successful investments in line with their strategic focus areas.

Roger Ingold is the founder of RS Investments, a venture capital firm based in San Francisco. The firm focuses on investments in Health Care, Biotechnology, Information Technology, Artificial Intelligence, and Therapeutics. With a total of 7 investments and an average round size of $85M, RS Investments has a track record of 6 exits. One of the popular portfolio startups is Four51. Roger Ingold’s fund was most active in 2000, and the average startup value when receiving investment from RS Investments is highlighted on the (website)[http://www.rsinvestments.com].

Jason Trachewsky is an experienced technical contributor, executive, and leader of R&D teams. He has an investment focus in biological target detection for clinical testing and biomedical research, 3D imaging, manufacturing, and logistics solutions. Jason has a hands-on investment style with a check size typically varying from $15 million to $40 million per round. He has a collaborative partnership style evidenced by his involvement in Series A funding rounds for Pleno Inc., a multi-omics startup, fostering innovation across industries.

Matthew Ocko is a Co-Founder and Co-Managing Partner at Data Collective, with investments spanning computational and synthetic biology, geospatial and space access. His investments focus on funding deep technology companies at the early stage. He has a track record of over 30 years as a tech entrepreneur and VC, with successful investments including Zoom, Fortinet, D-Wave Systems, Uber, AngelList, Xensource, and Facebook. Matthew Ocko’s check size for investments ranges from $1 million to $15 million, with a partnership approach that emphasizes the importance of collaborations for meaningful innovation and driving better healthcare outcomes.

Jerome Hamilton is a General Partner at Brown Venture Group with an investment range of $100K-$5.0M and a sweet spot of $1.5M. His investment focus areas include AutoTech, Logistics, BioTech, and Enterprise at the seed stage. Jerome is located in St. Paul, Minnesota, and the recent media mention highlighted Best Buy investing millions in Brown Venture Group, a firm exclusively backing BIPOC founders.

Carl Byers is an Executive Partner at F-Prime Capital Partners. He focuses on investing in digital health and healthcare sectors. His recent investments include companies like Devoted Health, Doceree, SpectrumAi, Spry, Eleos Health, AmplifyMD, Rialtic, and Notable. Carl’s investment style includes leading rounds of financing and joining the board of directors of companies he invests in. He has led investments in Wellframe, a mobile-enabled care management provider, where he led a Series B round of financing. He primarily invests in Seed and Series A stages. Additionally, Carl Byers has experience in healthcare finance and serves as a key advisor to the senior leadership team. F-Prime Capital’s Investment Check Size is around $400M. In partnerships, Carl collaborates actively with other investors and industry partners to translate innovative ideas into real impact.

Florian Müellershausen, PhD, is a Managing Director at the Novartis Venture Fund in Basel, Switzerland. He focuses on Pharmaceuticals (Series A), Pharmaceuticals (Seed), BioTech (Seed), and BioTech (Series A). Florian aims to invest in the development of novel therapeutics and platforms, medical devices, diagnostics, or drug delivery systems. He prefers the early stage for initial investments, with additional funding as companies progress. Florian anticipates total investments up to USD 30 to 50 million per company over its life. His partnership and collaboration styles are hands-on, leveraging his expertise in drug discovery and biochemistry to guide portfolio companies towards successful acquisitions. Previous investments include Anaveon, Granite Bio, and LoQus23 Therapeutics.

Antoine Boulanger Piette, an Associate at Forbion, has an impressive track record in venture capital investments. With experience in various roles at Forbion, including Analyst and Senior Associate, Antoine has been actively involved in the European venture capital scene. He specializes in Life Sciences and Biomedical Technology companies, focusing on late-stage preclinical and early-stage clinical development programs. Throughout his career, Antoine has contributed to the success of numerous portfolio companies, demonstrating a commitment to responsible investments that positively impact patients’ health and well-being.

Threshold is an early-stage venture capital firm that focuses on conviction investment strategy.

The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.

Laura Seifert focuses on early stage investments in the DACH region. In venture capital, she values partnerships with seasoned investors and emphasizes the importance of the people behind the money. She has a track record of investing in companies like Token, Shift One, and Paloma Health. Laura’s investment check sizes range from â¬500k to â¬60m. She co-founded WeSpace and brings a wealth of entrepreneurial and operational experience to her role, cherishing the industry for its big ideas and inspiring people.

The Yield Lab provides agriculture technology companies with funding, training, mentorship, and networking opportunities.

Nick Wyman is a Partner at Galvanize Ventures with a focus on Pre-seed investments in sectors like Sales & CRM, Hardware, Food and Beverage, Robotics, Developer Tools, Education, Marketplaces, FinTech, AI, and SaaS. He has a background in Entrepreneurial Finance and Management Operations, with previous roles at Galvanize, Foundry Group, and TechStars. Nick Wyman’s recent investments include Pre-seed Robotics. His partnership and collaboration styles are not explicitly mentioned, but his track record demonstrates a depth of experience in various sectors.

Lifeline Ventures is a team of serial entrepreneurs that invest in sectors we know by heart from our years as founders and startup leaders.

Amy Kobe, a Principal at Baird Capital, focuses on sustainability sectors, with an investment thesis centered on proven solutions addressing global sustainability demands, above-market growth, and digitalizing the customer experience. She is part of the Venture team that invests $10-20 million in equity over the life of an investment in healthcare and technology firms. Amy has been involved in investments like AEGIS Energy Risk, Cala Health, ChurnZero, and Greenlight Biosciences. Baird Capital’s investment check size ranges from $10 to $20 million. Amy Kobe’s partnership style involves active support and strategic guidance to address bleeding complication challenges in ventures like Virtual Incision.

Michael Stucky is the Chief Investment Officer at Serpentine Ventures, where he coaches and mentors young entrepreneurs and spin-off companies from ETH Zurich. The investment focus areas include Series B Biotech and other sectors. Serpentine Ventures has a portfolio of 60 companies, including Aegis Rider, MindMetrix, properti, and more. Michael Stucky’s professional career spans various roles, and he emphasizes the importance of choosing the right GP in VC investments. While specific information on check size and partnership styles was not found, the track record showcases his experience and involvement in the startup ecosystem.

Trevor Zimmerman is the Founder and Managing Partner at Blackhorn Ventures. He primarily focuses on investing in companies within the HealthTech and Life Sciences sectors. Blackhorn Ventures, which was founded in 2016, seeks venture capital investments in resource-efficient technologies. Trevor’s previous investments include Aether Bio, and the company’s total funding exceeds 1.5M+. Blackhorn Ventures invests in early-stage ventures and is positioned to invest in resource-efficient technologies. The firm aims to redefine resource productivity and addresses the impact of global consumption on Earth’s resource capacity.

Dieter Manstein is an individual angel investor with a primary focus on seed-stage investments. He has invested in GME Medical Engineering with a check size of â¬750K. His investment focus areas are in dermatology-related procedures for scars, burns, aging skin, and fat removal. Dieter Manstein’s professional career includes roles as a Clinical Consultant and Assistant Professor of Dermatology at Harvard Medical School, and he is the Co-Founder of GME Medical Engineering in Nuremberg, Germany. His partnership and collaboration styles involve co-founding ventures like GME Medical Engineering and R2 Technologies.

Chris Dixon’s investment thesis focuses on forward-thinking ideas, particularly in technology that impacts real-world sectors like transportation and healthcare. He prioritizes addressing billion-dollar markets and is open to investing in smaller markets as well. His professional career includes insights into the startup ecosystem and inspirational quotes for entrepreneurs. Chris Dixon’s involvement in crypto investing at Andreessen Horowitz showcases his commitment to the field despite market challenges. Specific details about his stage of investment, previous investments, investment check size, and partnership styles are not available.

Lars Ingerslev is an individual investor specializing in Seed stage investments. He has a geographical preference for investments in the European Union, particularly in the Nordic Countries and Scandinavia. Lars has previously invested in Ontame io, a company located in Stockholm, Sweden. With a track record that includes investments in Ontame io and a professional career spanning roles such as Senior Project Manager, Lars Ingerslev demonstrates a collaborative and partnership-focused style, evidenced by his role as a Partner at Rocket Padel Danmark. His investment check size and partnership details were not found.

Mr. Alan Hartman serves as Partner at Centerview Partners. He is also an angel investor. He has established himself as a leading advisor in the healthcare industry. Prior to Centerview, Alan spent several years with Merrill Lynch where he was Head of Americas Mergers & Acquisitions. He was twice named one of the ‘Dealmakers of the Year’ by Dealmaker Magazine. Prior to joining Merrill Lynch in 1993, Alan spent four years as a Mergers & Acquisitions attorney at Skadden, Arps, Meagher & Flom in New York. He received a B.S. in economics from the Wharton School of Finance and a J.D. from Harvard Law School.

NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.

Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries.

Nami Zarringhalam is the Co-Founder and Chief Strategy Officer at Truecaller. He is actively involved in the company’s strategy and serves on the board. His professional career includes founding Truecaller after completing his Master’s in Computer Science from KTH Royal Institute of Technology. Nami Zarringhalam’s investment focus areas are aligned with Truecaller and other related ventures. His partnership and collaboration style emphasize building collaborative platforms, as seen in Truecaller’s success. Geographically, he has shown interest in India among other regions, balancing global investments. Despite specific information on the stage of investments and check sizes not available, his track record showcases successful entrepreneurial ventures and strategic insights in the tech industry.

MED Angels invests liberally across healthcare focusing on companies that can yield high potential impact with a focus on disease management.

James Beshara is an Angel investor with a focus on investing in direct-to-consumer (D2C) startups. His criteria for evaluating startups include product quality, founder capability, brand universe, growth potential, and market space. Beshara has made investments in various sectors and stages, such as Health & Hospital Services, Health IT, Consumer Internet, and FinTech. He typically invests in the Seed and Series A stages with an investment range of $100K to $100K per company. Some of his notable investments include Clinikally, Superorder, BOND, Frond, Meez Culinary Solutions, Rye, Kona, and Showplace. Beshara’s track record includes founding Tilt and Magic Mind, emphasizing the importance of creating products people love, growth strategies, and learning from failures.

Nikki Bogopolskaya focuses on investing in health, wealth, and community with a focus on female founders. Her investments include startups such as Amboy Street Ventures, Aplos, Brightland, Character, Esker Beauty, House of Wise, and more. She is skilled at building and scaling revenue and partnerships products and teams, with over a decade of experience in leading high-performing teams. Nikki takes pride in being a connector, brand builder, and data devotee. She is actively involved in teaching yoga, prenatal yoga, and megaformer pilates, alongside making angel investments in health, wealth, and community.

Christian Schweizer, Head of Marketing Intelligence at Kaufman Rossin, focuses on seed and early-stage investments in areas such as technology, hedge funds, private equity, real estate, and broker-dealers. His professional background includes leading global business analytics teams at IBM and product marketing at Dell Computers. Schweizer’s investments align with social impact and spiritual return, with previous investments in mobile technology businesses in Ethiopia. He prefers to work in collaboration styles that value human connection, structured meetings, and sincere preparation. Schweizer’s investment check size falls within the range of CHF 1.4 million to CHF 5.8 million. His geographic preferences and specific partnership styles were not explicitly mentioned in the available information.

Jeffrey Bezos is known for his long-term approach to investments, focusing on companies with strong growth potential and innovative business models. He invests in disruptive technologies like biotech, AI, and neurotechnology. Bezos’ investments span various sectors, including companies such as EverFi, General Assembly, MakerBot, NextDoor, Plenty, Airbnb, Grail, Juno Therapeutics, and more. His investment check size varies, with examples like $112 million in some companies. Bezos values long-term vision, patience, diversification, and investing in passion projects. His leadership style emphasizes teamwork, promoting new leaders, and high-quality decision-making. Bezos has a strategic acquisition history, expanding Amazon’s capabilities through acquisitions like Zappos and Whole Foods.

Zann Ali, a Partner at 2048 Ventures, is a thesis-driven investor focused on early-stage investments in next-generation B2B platforms, including Biotechnology, Health Tech, AI/ML Applications, Robotics, IoT, and AR/VR. He leads pre-seed or seed rounds in North America or the UK. 2048 Ventures has invested in over 200 startups and is supported by top founders, family offices, and venture capital firms. Previous investments include Century Health, accelerating drug development with AI in clinical data. Zann Ali’s investment range is typically between $150K and $600K.

Carl-Johan Dalsgaard, a Venture Partner at HealthCap, based in Stockholm, Sweden, focuses on investments in Therapeutics (Series B), BioTech (Series B), Health IT (Series B), Digital Health (Series B), and Health & Hospital Services (Series B). He typically invests in the range of $100K to $5.0M with a sweet spot at $1.5M. Carl-Johan has a current fund size of â¬1.2B and collaborates with investors like Alex Valcu, Anki Forsberg, Björn Odlander, Carl Kilander, and Eugen Steiner. His track record includes leadership roles in various biotech companies and a successful career in the management of healthcare-related ventures.

Jeff Huber, as an investor, focuses on Material Science, DeepTech, Robotics, Digital Health (Pre-seed), Media/Content, BioTech, Marketplaces, and AI (Pre-seed, Seed, Series A, Series B) sectors. His investment range is $250K to $25.0M with a sweet spot of $10.0M. Jeff has made 21 investments and is a part of networks like Harvard Business School, Google, University of Illinois at Urbana-Champaign, and eBay. Recent investments include Betteromics, Chemify, Arsenal Bio, Manifold Bio, Synapticure, Weta Digital, Cellanome, Aldevron. His experience includes board memberships at Electronic Arts, GRAIL, and Illumina, as well as executive roles at Google and eBay. Jeff Huber holds a BS in Computer Engineering and an MBA in Technology Strategy and Economics.

Ariana Thacker is a chemical engineer turned early-stage investor and the Founding Partner of Conscience VC. Her investment focus areas are science-led companies empowering humanity, with a preference for businesses at the pre-seed and seed stages. She has a track record of 2 exits (1 IPO, 1 acquisition) and has invested in companies like Biolinq, Synchron, and Ginkgo. Ariana typically invests check sizes ranging from $100k to $250k into startups. She values partnership and collaboration, actively seeking out opportunities to partner with early-stage founders who are innovating in the industry.

C-Cap, operated as an angel capital hub in the Cincinnati region, is led by Steve Andrew, an experienced professional. Steve has a background with Angels Partners, focusing on connecting high-tech companies with essential funding particularly in sectors like technology, biotech, cleantech, apps, and more. C-Cap specializes in linking entrepreneurs with angel investors, nurturing emerging trends, and making connections based on stages, industries, and locations. Steve is actively engaged in initiatives to support the startup ecosystem, notably as an Angel Investor and a member of the Keiretsu Forum. With a track record of success in assisting startups, C-Cap maintains a partnership-oriented approach, connecting individuals with business angels and Partners to foster growth and innovation. Steve Andrew’s expertise and collaborative style position C-Cap as a valuable resource for entrepreneurs seeking angel investment opportunities.

Ravi Berry is an Angel investor at Angel Physicians Fund, based in Cincinnati, Ohio. His investment thesis focuses on Therapeutics, Medical Devices, Pharmaceuticals, Marketplaces, BioTech, Digital Health, Health & Hospital Services, and Health IT at both Seed and Series A stages. Ravi’s investment range is $5K – $50K, with a sweet spot at $25K. His previous investments include startups in various healthcare sectors. Collaborates with scouts & angels like Angie Willmott, Anil Verma, Ann Weichert, Arshdeep Tindni, and Clay Willmott.

Altitude Ventures provides early-stage venture capital financing to healthcare services and technology startups that improve healthcare.

Johannes Gebendorfer, a Strategic Projects Lead at bunch, has a background in computer science and information technology. Prior to his current role, he worked with one of Europe’s largest Venture Capital funds, specializing in building a portfolio of FinTech companies. His investment focus areas cover returns related to the German Central Bank, with a strong emphasis on balance sheets, cross-border transactions, and ownership. Johannes Gebendorfer’s professional career showcases his expertise in software engineering, including front-end and back-end development skills. While specific information about his investment thesis, previous investments, check size, and partnership styles is not available, his track record reflects successful work in the Venture Capital sector, particularly in the FinTech industry.

Estelle Botbol is a seasoned investor on the Speedinvest Health team, committed to identifying and supporting early-stage European healthtech and digital health startups. With a focus on the TechBio space, Estelle seeks out exciting companies in Digital Health. Her background includes working at Inkef, specializing in Life Sciences and MedTech. Estelle is known for her collaboration and partnership styles, leveraging her experience to forge strategic alliances. She holds a Master’s degree in Applied Biosciences and Biotechnology from Imperial College London and a Bachelor’s in Microbiology and Immunology from McGill University. Alongside her professional pursuits, Estelle is a talented songwriter, piano composer, and singer in a Funk & Disco band in Paris.

Health Velocity Capital is a health care focused venture and growth capital partnership

Rutger Arnhult is an Angel Investor who is known for his investments in Life Sciences and FinTech sectors across Sweden and the United States.

John Payton, Senior Portfolio Analyst at Frazier Healthcare Partners, focuses on investment in BioTech, Digital Health, Health & Hospital Services, and Health IT. He specializes in seed to Series B stages with an investment range from $100K to $5.0M. His track record includes successful investments in these sectors with a sweet spot of $1.5M. John has worked with investors like Albert Cha, Angel Martin, Danica Elliott, Daniel Estes, and Elizabeth Park.

Francesca Baillieu focuses on Synthetic bio and invests between 1 to 10 million USD in a round aiming for ownership between 10% and 20% depending on the stage. Her investment focus areas include TechBio, Sustainability Tech, and Digital Health. She is involved in screening businesses for the Partner Programme at True, injecting innovative solutions into corporate partners’ strategies. Francesca’s partnership and collaboration styles align with Project A’s operational VC model, offering hands-on support without imposing obligations on the teams backed. Project A has a conviction-driven investment team and an operational value-add team of 140 experts covering engineering, product, sales, marketing, data, brand, communications, and recruiting.

Dalmore Investments is an angel fund based in Minneapolis, focusing on emerging healthcare businesses with high growth potential. Led by Dr. John Blank, the fund is committed to investing in lower volatility infrastructure assets primarily in the UK but also manages assets in Ireland, continental Europe, and Canada. Notable investments include companies like Beyond Lucid Technologies. Dr. John Blank, with over 30 years of experience in healthcare leadership, leads the fund and is dedicated to providing more than just capital. The fund’s collaboration style emphasizes building long-term relationships with aligned interests.

Ger van Jeveren is an investor at Peak Capital III Opportunity Fund with an investment range of $260K to $4.2M and a sweet spot of $2.2M. He focuses on Series B investments in Pharmaceuticals and Digital Health. Previous investments include Photon Ventures Fund 1, Quadrum Investment Fund III and IV, Slingshot Ventures 3, and more. Ger van Jeveren has a background as the founder and previous CEO of Fagron and Arseus, and his partnership and collaboration style revolves around working with a select group of investors like Calin Fabri and David King.

Patrick Schneider-Sikorsky is a Partner at Beast Ventures focusing on seed stage deep tech investments in Europe. He has invested in startups in diagnostics, GovTech, manufacturing, cybersecurity, deep tech, AgTech, security, climate tech/clean tech, bio tech, and AI. One of his notable investments is Nutropy in the pre-seed stage with a round size of $2M. Co-investors include Andrew D Ive from Big Idea Ventures.

WI Harper Group is a venture capital firm that focuses on early and expansion investments in Mainland China, Taiwan and Silicon Valley.

Alexandra Pine is a Ventures Analyst at Plug & Play Ventures, the investment arm of Plug and Play Tech Center. The firm focuses on pre-seed and seed-stage investments globally within various industries, with check sizes typically ranging between $100,000 and $150,000. Alexandra Pine’s preferred investment areas include insurtech, fintech, proptech, digital health, pharma, and enterprise. Plug and Play Ventures has a track record of investing in a diverse range of industries, with a partnership style that prioritizes collaboration, innovation, and access to specialized talent. The firm has a successful history of investing in numerous startups and actively participates in corporate-startup collaborations to drive technological innovation and business growth.

Bauke Anninga is the Investment Director at M Ventures, focusing on the biotechnology team and leading investments in companies like Immunitas, Nucleome, NanoSyrinx, PictorLabs, Multitude, Rewind, Synaffix BV, and Outrun Therapeutics. His professional career showcases successful investments and strategic decisions in the biotechnology sector. The collaboration style at M Ventures involves a team effort with key roles such as Managing Directors, CFO, Head of Business Operations, and various investment-related positions.

Launchpad Venture Group is a Boston, Massachusetts based angel investment group and venture capital firm. They focus on software, IT, e-commerce, media, healthcare, clean-tech, and renewable energy sectors in the United States. They have made 115 investments with 25 exits. The firm provides funding to early-stage technology and life science companies.

Mark Torrance is a seasoned professional with over 20 years of experience in executive leadership, product and engineering strategy. He founded Vinq and served as the CTO of Rocket Fuel Inc., overseeing teams through IPO. Mark is a principal engineer at Facebook, focusing on small business solutions. His investments are diverse, with a focus on compute-related ventures. Mark’s partnership and collaboration style emphasize creative collaboration in the creative process involving multiple entities. Specific investment check sizes were not found.

Danica Reynaud is the CEO and Founder of BriteScan, Inc., a company that develops innovative testing technologies. She holds a Ph.D. in Integrative Biology from the University of California, Berkeley. Danica previously served as the Global Director of Scientific Innovation at NSF International and founded NaturalProductIntegrity.org. Her professional career includes roles such as CEO of AuthenTechnologies LLC and Quality Control Plant Taxonomist at Bionovo, Inc. She has a hands-on approach to her investments, focusing on emerging technologies and innovative solutions. Danica’s check sizes for investments range based on the startup’s needs. She has a collaborative style and has been involved in developing guidelines for validation of botanical authentication methods and co-founding the International Sandalwood Foundation.

Linda Abraham is an Angel Investor who serves as Vice Chairman at APX Labs. She focuses on investments in Seed Round startups within the 3D Technology, SaaS, Technology, Media and Telecom (TMT), and Mobile industries. Some of her relevant investments include providing funding in the seed round for companies like Example company Inc. with an amount of $1,000,000. Linda Abraham is the Founder of Accepted, a premier admissions consultancy and has a track record of advising MBA programs and colleges. She holds an MBA and a BA in Political Science from UCLA.

Ska Sijia Du is a VC Analyst at DTCP with an investment range of $1M – $5.0M and a sweet spot of $2.5M. The current fund size is $350M. Ska Sijia Du’s sector and stage rankings are in SaaS (Series A) and SaaS (Seed). Co-investors include Alexander Helmke, Bart de Jong, Claudius Laskawy, Irit Kahan, and Isabel Eberhardt.

Crowdholding is an angel investor based in Sweden. Per Erlandsson, the key figure behind Crowdholding, has a track record including roles as a Private Investor and Non-Executive Director at companies like Cross Technology Solutions, GeoSignage Sweden, and Sveafastigheter. His professional career spans from being an Interim CFO at Brunswick Real Estate to holding partnership roles at Leimdörfer and Sveafastigheter. Crowdholding’s investment focus areas and specific check size are not available. However, they potentially engage in partnerships with crowds and collaborative communities for innovation and research problem-solving.

Key Ventures is a venture capital investment firm based in Paris, France. The firm focuses on early-stage investing in the technology sector. Their investment thesis is built upon a tripartite foundation: Team, Technology, and Traction. Key Ventures collaborates with Key Opinion Leaders and early adopters to build traction for investments, validating technological choices and accelerating the commercialization process. They have made investments in companies like PEP-Therapy, Inspeere, and Hoplunch within the Drug Discovery, Database Software, and Commercial Services industries. Key Ventures utilizes an active approach in engagement, ensuring a legacy of impact in outpatient spine surgery technology. The firm invests in early-stage tech companies and has a flexible approach, investing individually or as a syndicate depending on the situation. The geographical preference of Key Ventures is global, and their investment check size varies based on the opportunity.

Randolph Seidler, a Venture Partner at Anterra Capital BV, focuses on providing capital and resources to founders to achieve their goals and preserve the culture they’ve built. His investment areas include consumer services, manufacturing, food, and beverage. While his investment check size is significant, as reflected in the $1.25B size of Seidler Equity Partners VIII, his partnership and collaboration style aim to actively drive growth by partnering with exceptional management teams. Randolph Seidler has a track record that demonstrates a commitment to nurturing mid-market businesses and facilitating strategic growth opportunities.

Annie Lamont, Co-Founder and Managing Partner at Oak HC/FT, focuses exclusively on healthcare and fintech entrepreneurs. She has a successful track record with prior investments in companies like athenahealth, Castlight Health, and Devoted Health. Annie has been named the top-ranking investor in healthcare several times and has received multiple lifetime achievement awards for transforming the healthcare industry. Her approach involves investing in companies that improve health outcomes and lower costs. Currently, her active investments include companies like Blend, Carebridge, Devoted, and VillageMD. Annie is known for her strategic insight, commitment, and strong network in the industry.

Gaurav Garg, Founding Partner at Wing Venture Capital, has a focus on data infrastructure and companies reshaping healthcare with AI. Notable investments include Cohesity, Path, Clear Labs, Obsidian Security, Gather, Vevo Therapeutics, and more. With a track record of building successful companies from incubation to public listings, Gaurav’s investments range from early to late-stage tech firms. His partnership style emphasizes hands-on involvement, leveraging decades of experience in tech investing.

Dimitri Panayotopoulos invests in markets such as biopharma, biotechnology, health care, and pharmaceuticals. His previous investments include Legacy Healthcare. With a career at Procter & Gamble and a track record of overseeing P&G’s global brands and business units, Panayotopoulos brings extensive experience to the table. He also serves on the boards of other companies like British American Tobacco Company and JBS Foods International. Collaboration styles of Dimitri Panayotopoulos are not explicitly available from the sources found.

Eli Alroy is a serial investor with over 30 years of experience in hi-tech investments, venture capital investments, and capital markets. His investment focus areas include prevention and personalized medicine, nutrition, mental health and sleep, wellness sustainability, remote and self-care, longevity, and physical activity. Some of his previous investments include companies like Hedonia, Quris, Alike, CalmiGO, MDI Health, Vuze Medical, Antidote, XTrodes, Amai, and Behavidence. Eli Alroy invests in early-stage entrepreneurs with big ideas and a focus on wellness technology. His investments span across a diverse range of sectors seeking to improve health and wellness.

The Columbia Angel Network (CAN) is a non-profit group of Columbia University alumni interested in investing in Columbia-affiliated early-stage ventures.

4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies

Ron Seubert is the founder of RareCyte, Inc., a company that focuses on characterizing and isolating rare cells in the blood, providing tools for cancer and cardiovascular research. He has a significant track record in developing innovative technologies and collaborating with industry experts. Previous investments include RareCyte, with a focus on life science research and diagnostics. Specific partnership and collaboration styles are not explicitly mentioned, but Ron Seubert engages in webinars and collaborations within the industry.

An early-stage venture fund supercharging consumer-powered climate innovation driven by circular and regenerative principles

Ulrike Kalapis is an Investment Manager specializing in venture capital and investments in Life Science & Chemistry startups. She studied medical engineering with a focus on medical imaging and biomedical optics. Her previous investments include startups like implandata Ophthalmic Products, photonics healthcare, and more.

Bio/Med Investor Network is an angel network that prefers to make early-stage investments in the biomedical, medtech, and healthcare-related companies based in the Southeast region of the United States and Georgia.

Philipp Mueller, a key member of the Boehringer Ingelheim Venture Fund team, has a strong focus on immuno-oncology and immuno-modulation investments. He serves on the board of ImCheck Therapeutics and Asgard Therapeutics, contributing to the fund’s portfolio in groundbreaking therapeutic potential in the field of anti-infectives. With a background in Molecular Biology and a PhD in Biochemistry, Philipp has extensive experience in translational immuno-oncology research and infectious diseases. He has built a global collaboration network with academic, biotech, and pharma partners, showing a hands-on partnership approach. Philipp’s career includes leading research and projects in Cancer Immunology and Immune Modulation within the pharmaceutical industry.

Dot Piper is an experienced investor specializing in commercial-stage businesses with strong growth prospects in sectors like healthcare, technology, consumer, and tech-enabled business services. Dot Piper focuses on high-growth companies with proven leadership, offering investments in equity, recapitalizations, and change of control transactions. Geographically, Dot Piper operates within the U.S., Europe, and Asia, with a strong emphasis on hands-on involvement and active guidance at the board level. Previous investments include Integrity Orthopaedics, Apkudo, and Graylog. Dot Piper’s track record showcases success in capital campaign assessments, frontline fundraising, and board development. The investment check size of Dot Piper is not specified, and collaboration styles emphasize personalized one-on-one service and direct interaction with investors.

HLM Venture Partners is a venture capital firm that invests in healthcare technology companies.

North Carolina Biotechnology Center is a biotechnology investor that focuses on emerging life sciences companies in North Carolina. They invest in therapeutics, medical devices, diagnostics, health IT, and ag tech. Their investment check sizes range from $150,000 to $500,000, with strategic growth loans of $350,000 to $500,000. North Carolina Biotechnology Center has an active investment portfolio with over 70 companies. They have a track record in life sciences, offering strategic growth loans and small business research loans to support early-stage companies. The Center has a partnership and collaboration style that involves engaging with VC & Angel Investors and providing career options and networking events for STEM professionals.

Saints Capital is a merchant venture capital firm with offices located in San Francisco and London.

Eli Blee-Goldman is a Co-Founder & General Partner at Character, a VC firm investing up to $1M at seed stage in startups betting on big shifts in customer behavior. The firm, remote-native and located in the USA, collaborates with founders using the sprint method to find and expand product-market fit. Previous investments include Flatiron Health. No specific information found on track record, investment check size, or partnership styles.

Dr. Norm Gitis serves as Managing Partner at Lymo Ventures, actively funding and mentoring startups in medtech, biotech, nanotech, and scientific fields. With a Ph.D. in Mechanical Engineering, he has been a visiting professor at MIT and was a CEO of two highly profitable test instrumentation companies. His investment focus includes med-tech and biotech startups, with a track record of over 150 scientific papers, three books, and two dozen patents. Norm Gitis prefers investments in the later stages, with a keen interest in oncology, cardiology, and diagnostics. While his geographical preferences are not specific, his previous investments reveal a dedication to supporting innovative startups. His investment check size aligns with angel investors, typically under $30,000, showcasing a commitment to nurturing early-stage ventures. Norm Gitis showcases a hands-on partnership style, leveraging his extensive expertise to provide valuable guidance to portfolio companies.

John Pappajohn is a key figure known for his involvement in over 100 startups and 50 IPOs, with a notable investment in the home health care company Caremark. He is a self-made entrepreneur and visionary philanthropist. The Iowa Entrepreneurial Venture Competition, which he supports, awards $100,000 to early-stage Iowa startups. John Pappajohn’s investment focus includes health care and advanced technology ventures. His partnership and collaboration styles are highlighted through the UNI John Pappajohn Entrepreneurial Center’s collaborations in economic development with Iowa CORE. Further details on his investment check size were not available.

Life Science Angels, founded in 2004, is an angel investment group based in Sunnyvale, California, USA. The firm focuses on companies in the healthcare and life sciences sectors, including medical device, pharmaceuticals, biotechnology, and health care. Life Science Angels typically invests in early-stage ventures and seed rounds. They have a track record of 81 total investments with an average round size of $3 million. The portfolio includes companies in the United States and Netherlands. The firm has had 7 successful exits, with key areas of investment in biotechnology, health care, medical device, and pharmaceuticals. Life Science Angels seeks partnerships in the life sciences industry and shows a preference for companies with a higher percentage of exits and a higher IRR compared to other industry verticals.

Dr. Simon Fredriksson, Co-Founder and CEO of Pixelgen Technologies, has a diverse background in life science research and entrepreneurship. His investment focus areas include biotech and proteomics technologies. He has been involved in startups like Genagon Therapeutics and serves as a Partner at Colibri Ventures. Simon’s investments range in size, with a check size typically between $100K – $500K. His involvement spans across companies in the life science and technology sectors, showcasing his commitment to innovation and growth.

Steve Eskenazi is an active investor with a focus on Digital Media, Internet, SaaS, and microcap market with an interest in technology-life sciences convergence. His partnership and collaboration style involves seeking new healthcare technology sales opportunities and consulting roles. He has a background in sales and leadership in fields like National + Regional Sales, Eastern Regional Hospital Sales, Business Development, and PatientSafe solutions. His track record reflects a history of successful sales leadership and client relationship development in various sectors such as technology, healthcare, and life sciences.

David Cleevely is an entrepreneur with a strong focus on HealthTech, High Tech, and related sectors. His investments include companies like Netronome and Cambridge Communication. With a track record of advisory roles in telecommunication policy and entrepreneurship, David has a diverse portfolio in the UK and the USA. He is actively involved in contributing to government reports and servicing on various advisory boards. His investments have ranged from doppel to Cambridge Communication, showcasing his interest in impactful ventures. David’s check size for investments remains undisclosed, but his recent successes include IPOs and significant growth in his portfolio companies.

Threshold is an early-stage venture capital firm that focuses on conviction investment strategy.

Nikolaus Plaitakis is an investor with a focus on AI in life sciences and health. He has invested in startups such as HouseTab. His investments range between $100,000 and $500,000. Nikolaus shows preferences for North America in terms of geographic focus. His partnership and collaboration styles involve knowledge sharing and strategic collaborations with startup founders.

Baigo Capital is a private equity fund focusing on mid-market healthcare companies with an enterprise value up to �200m. Their investments cover traditional LBOs and MBOs, consolidations, corporate disposals, and more. They have previously invested in companies like Vanguard AG and EuroEyes group. Baigo Capital partners with management teams to create market leaders. Their investment check size is within the mid-market range. Baigo Capital collaborates strategically with a focus on the healthcare sector. For more information, you can visit their (website)[http://www.baigo-capital.com/].

Magnus Bergman is a Co-Founder and General Partner at Luminar Ventures, having made over 30 seed investments in the past 10 years. Luminar Ventures focuses on technology in healthcare as a transformation area. One of their portfolio exits was Soundtrap in 2017.

Ron Sheridan focuses his investments on companies within the healthcare industry, targeting control positions in healthcare businesses and partial recapitalizations or buyouts. His investment check size ranges from $15 to $100 million, with a focus on healthcare providers, healthcare outsourced services, and consumer health & products. Sheridan’s geographic focus is on companies headquartered in the United States or Canada. He has a track record of investing in healthcare businesses with a platform EBITDA of $3 to $20 million, and his hands-on approach in creating value post-close sets him apart as a disciplined, thesis-driven investor in the healthcare sector.

Tomas Mora-Morrison is the Co-founder and Owner of Cambio Healthcare Systems. He has a focus on investments in the healthcare sector, with previous investments including AlgoDx in a Seed VC round. His investment check size ranges between $500K to $1.5M per company. Tomas Mora-Morrison has a collaborative partnership style and has invested in companies in the European Union, particularly in the Nordic countries.

Sara Weinheimer, an Angel Investor and General Partner at Mayfair Trading Partners, focuses on early-stage companies in tech, media, and telecom. Sara’s investments range from $25k-$100k per company, with 3-6 investments annually. She prefers tech companies without a technical founder and invests in IT, consumer social, clean tech, and life science sectors. Sara’s partnership style includes managing deal flow, mentoring, advising startups, and serving on boards. Her career spans from Citibank to Goldman Sachs, and she is an LP at Golden Seeds Fund II.

Polaris Partners invests in healthcare and technology companies ,Äãacross all stages from founding to profitable growth.

Han de Groot is a Co-Founder and Partner at Curie Capital. He led MetrixLab from start to public exit as founder, CEO, and Board Member. In 2014, he merged MetrixLab with MacroMill, creating a marketing tech leader with $300M+ in annual revenue, 1800 employees, and 30 offices globally. Han de Groot is an active investor in Life Sciences and founder of VOC Capital Partners and Stadswaarde. He invests in technology-related companies and real estate. His partnership and collaboration style involves investing in companies beyond the ‘eureka’ phase.

Fusion Fund invests in early stage companies with technological and data advantages in industrial, enterprise, and healthcare applications.

Michael Palmer invests in technology and life sciences. The Band of Angels typically invests between $300K and $750K, with the largest investment made being $3.3M. In 2023, the Band invested in 22 companies. Geographically, there was no specific preference mentioned for investments.

Builders VC is an early-stage VC focused on investing where technology meets new business models to modernize antiquated industries.

Min-Sung Sean Kim is a Managing Partner at Digital Health Ventures in Berlin, specializing in digital health investments. He has a strong track record and professional career, having held positions at Allianz X GmbH and XLHealth AG as a Private Equity Investor and Director/Board Member, respectively. Min-Sung’s investment focus includes startups like mySugr, Amwell, Mimihearing, NeuroNation, medbelle, and thryve_health. His partnership and collaboration styles revolve around fostering impactful social change through innovative healthcare startups.

William Bahl, a member at Angel Physicians Fund, is part of a seed stage investor group of physicians and healthcare entrepreneurs exclusively focused on life science and healthcare investments. The fund’s geographical preference is in healthcare startups. Specific details about their investment check size, past investments, track record, and collaboration styles are not available from the search results.

Telegraph Hill Partners is a venture capital firm investing in life sciences, medical device, and healthcare technology companies.

Investitionsbank Berlin (IBB) focuses on promoting investment, innovation, startups, and growth in Berlin. Their Venture Capital fund ‘VC Fonds’ invests in high-growth companies in various tech sectors with initial investments ranging from EUR 0.2M to EUR 1M. They support companies with innovative and scalable products/services, primarily in industries like creative industries, life sciences, and ICT. Potential partners for funding rounds include venture capital firms, industrial companies, or business angels. IBB Ventures emphasizes minority participations in company shares and collaboration with other stakeholders. Past investments and activities are diverse, with a focus on funding history and acquisition trends. Funds are typically in the range of EUR 200,000 to EUR 1 million, with potential upward scaling in subsequent rounds. For collaboration, confidentiality and engagement with other partners play a key role, ensuring mutual growth and success.

Georgia Cavanaugh is a VC Analyst at SteelSky Ventures based in Chicago, Illinois. Her investment focus areas include Consumer Health and Digital Health at both pre-seed and seed stages. Georgia’s investment range is $100K to $5.0M with a sweet spot at $1.5M. She has collaborated with co-investors such as Buffy Alegria, Casey Santiago, Maria Velissaris, Maya Hardigan, and Nichole Jones.

Primer Sazze Partners is a California-based VC that is looking for companies with grand vision and world changing potential.

Maulik Mehta, an Investor and Venture Associate at Arc Ventures, focuses on sectors like AutoTech, Pharmaceuticals, AgTech, Cybersecurity, TransportationTech, and Enterprise Applications. His investment range is $100K to $5.0M, with a sweet spot at $1.5M. Maulik has invested in various seed and series A/B startups in sectors such as AutoTech, Pharmaceuticals, AgTech, Cybersecurity, TransportationTech, Enterprise Applications, BioTech, Consumer Internet, Enterprise, and FinTech. He collaborates with Akbar Dawood, Eric Kohlmann, Irene Susmano, and Joe Korff from Arc Ventures.

Cherrystone Angel Group primarily invests in early-stage companies in New England across various industry verticals, including Life Sciences, Software, Consumer, Industrial Tech, Healthcare, and Fintech sectors. They aim to be active and trusted partners, providing industry expertise and business skills to their portfolio companies. Cherrystone’s investment check size, track record, and partnership collaboration styles are not explicitly mentioned on their website. They are based in Providence, RI, and have upcoming Pitch Night events to support startup ideas.

Irene Chen, as an investor, focuses on healthcare. Her stage of investment is active. Specific details about her previous investments, track record, professional career, investment check size, and partnership and collaboration styles could not be found.

Annegret de Baey is a Venture Partner at Seventure Partners SA, specializing in investments in the microbiome sector. Her investment focus areas include Digital Health (Series A), Health & Hospital Services (Series A), Health IT (Series A). She has a track record of investing in companies like Abalos Therapeutics and Dopavision. Her investment check size ranges from $685K to $27.0M, with a sweet spot of $14.0M. Annegret de Baey has collaborated with co-investors such as Sebastian Pünzeler and Isabelle de Cremoux. She has a geographic preference for investing in Munich, Bavaria, Germany. Annegret brings 20 years of experience in the life science and venture capital sectors to her investment endeavors, leveraging her expertise in Dermatology and Allergology.

Quantum Leap Ventures actively identifies and supports early stage startups building deep technology powered solutions for problems in healthcare, climate & sustainability, finance, and education. They invest in founders with a strong vision and a stellar business acumen. Their investment focus areas include Hitfox, Point Nine Capital, Fyber, Delivery Hero, DNA, LiquidM, GUK, and Mobilike. Quantum Leap Ventures invests early as a business angel and helps mature companies scale. Their investment portfolio consists of Hitfox, Point Nine Capital, Fyber, Delivery Hero, DNA, LiquidM, GUK, and Mobilike.

Dana Sun, a Senior Associate at OCA Ventures, focuses on health technology companies in the digital health sector. She has worked on investments in companies like Regroup Therapy, HealthiPASS, mPulse, and Moving Analytics. Dana’s check sizes typically range from $1M-$3M with follow-on capacity, targeting Seed, Series A, and select Series B stages. Her geographical preference and partnership styles were not specified on the official OCA Ventures website.

Mark Mueller-Eberstein is the CEO and co-founder of CodexDF, specializing in blockchain, cryptocurrencies, IoT, AI, and cloud computing. With two decades of experience connecting business leaders and IT, he is a digital transformation leader and an active investor with expertise in these areas. Mark is bilingual in English and German, a best-selling author, keynote speaker, and advisor to various VCs. He is known for his academic research and speaking engagements internationally. Mark currently resides outside Seattle, Washington, USA.

Christoph Lange, an Angel Investor, has invested in LaundryAngels in the Consumer sector in Germany. His investment check size is in the Angel Round. His professional career includes being a professor and associate chair of radiation oncology and molecular and cell biology at SUNY Downstate Medical Center. He focuses on understanding molecular and cellular responses to ionizing radiation, especially in cancer stem cells. Christoph’s investment focus areas include Devices and Supplies, Food Products, and Specialty. He mainly invests in early-stage tech companies. His geographical preference for investments is in Germany. Christoph’s investments typically range around 800K+, targeting early-stage tech companies.

Parin Shah has actively been doing his investment thesis over the last five years. His experience in a portfolio company has impacted his investment thesis. He has launched a formal investment vehicle called Zed Capital, providing risk capital to bold founders building enduring companies from India. Zed Capital’s portfolio of investments has already exceeded 30 startups including GIVA, The Mom’s Co., MYFITNESS, August Cafe, Wellbeing Nutrition, Zouk, ReshaMandi, SuperBottoms, Anveshan farm, Perfora, and many more. Parin Shah recently started a journey setting up the Foundersâ Office at RENÉE Cosmetics, working with Aashka Goradia Goble, Priyank Shah, and Ashutosh Valani. Among his investments are Landmark Games, Kinxtive, and others.

Dimitri Krainc is a Venture Partner at OrbiMed with a current investing position focused on Digital Health, Health & Hospital Services, and Health IT at both Seed and Series A stages. His investment range varies from $1M to $75.0M, with a sweet spot of $4.0M. The current fund size associated with his investments is $18B. Located in Chicago, Illinois, Dimitri Krainc has collaborated with investors such as Alexandria Huynh, Anat Nursella, Brendan Weber, Carl Gordon, and Charles Steinman.

Chen Lin is a successful investor with a focus on natural resources, biotech, energy, and mining sectors. Her investments mainly target early to mid-stage startups. Chen is known for her expertise in quality assurance and automated testing, gained through roles at Speechcloud and Motorola Solutions. She previously held the position of Software Engineer Intern at Speechcloud, specializing in quality assurance and automated testing. Chen’s investments are driven by a keen interest in natural resources and biotech sectors, aiming for significant growth and returns. She has a strong track record in software engineering, holding a Bachelor of Science in Software Engineering from Neumont College of Computer Science. Her partnership and collaboration styles focus on ensuring the quality and functionality of applications, working collaboratively with dynamic teams to achieve success.

Heartcore is a venture capital firm that invests in founders building category-defining consumer internet brands.

Sebastian Kreuz is an investment manager at Boehringer Ingelheim Venture Fund focusing on strategic opportunities in the infectious diseases space. His geographical preference is to invest worldwide in innovative early-stage therapeutics and digital health companies. He has been involved in previous investments such as Centauri Therapeutics and Quantro Therapeutics. Sebastian’s track record includes roles in research and venture capital law. The investment check size for companies like QUANTRO Therapeutics is significant. His partnership and collaboration styles involve a focus on groundbreaking therapeutic approaches and technologies.

Brian Gill is an experienced Senior Communications and Investor Relations Consultant with previous roles at Gamida Cell, TYME Technologies Inc., and Celgene. His investment focus areas include biotech and medical innovation. With experience in global corporate communications, he brings expertise in fostering investor relations. Brian holds a Bachelor’s of Science with a major in Biology and a minor in Chemistry from West Chester University of Pennsylvania. He also holds Series 7 & Series 63 licenses from FINRA. Brian has been involved in the Value Of Medical Innovation Initiative project.,

PsyMed Ventures invests in transformational technologies that elevate mental health and wellness through it’s fund and angel syndicate.

MEDA Angels is a healthcare-focused angel investor group comprised of accredited investors with diverse backgrounds. They have made 8 investments, with the latest one in MimiVax as part of their Series C. The group is based in Washington, DC, United States.

Peter Frishauf is an Angel Investor known for his leadership in New York City’s entrepreneurial hi-tech digital health scene, founded Medscape in 1995. He has an extensive professional background and is an Advisor at various ventures. His investment focus areas include digital health and healthcare media. His partnership style involves advisory roles and director positions in established companies, showcasing a collaborative approach. The specifics of his investment stage, geographical preferences, previous investments, check size, and partnership styles vary and could be further explored for a comprehensive understanding.

Carl Shepherd is a board member at Edge Retreats, RVshare, and HomeAway. He co-founded HomeAway and has held various positions in companies like TurnKey Vacation Rentals, Hoover’s, Human Code, and Hanley Wood. He has a background in business administration and has an M.B.A. from the University of Texas at Austin.

HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry

GoBeyond is a venture capital firm based in Zurich, focusing on investments in early-stage fintech companies. Their portfolio includes companies in industries like environment, health, education, food, housing, services, medtech, biotech, technology, and luxury sectors.

Sedat Eryilmaz is an angel investor based in Turkey who focuses on investments in biotechnology, manufacturing, and renewable energy sectors, particularly in early-stage ventures. His recent investments include Daxe Games and Wastespresso. Sedat Eryilmaz prefers to invest in companies in Turkey and Europe. He has a track record of supporting startups in these sectors, indicating a specialization in renewable energy. Although specific details about his investment thesis and partnership styles are not readily available, his career showcases a commitment to fostering innovation and sustainability through strategic investments and collaborations in the mentioned industries. Sedat Eryilmaz’s check size for investments is not explicitly mentioned in the search results.

Shumway Capital is a growth focused investment firm that partners with management teams to help accelerate their companies’ growth.

Mission BioCapital is a life science venture capital firm that invests in early-stage companies.

Digitalis is a venture capital firm that that invests in solutions to complex problems in human and animal health.

Virginia Giugliano is an Angel Investor with a portfolio including investments like Fruit Street. She focuses on healthcare startups and has invested in Fruit Street during their Seed round in 2015. Her partnership and collaboration styles are highlighted in her role at Isagenix International, where she serves as an Executive, showing her commitment to supporting and growing businesses. Virginia Giugliano has a significant background in healthcare and brings valuable experience to her investments.

Howard Edelstein is an individual angel investor who serves as the Chairman and CEO at BioCatch. He studied at Stanford University with a background in Electrical Engineering, Information Sciences, BioMedical Engineering, and Real-Time software. Howard has made investments in various companies, with notable investment details including $5 million in Pivit in 2015. His professional career showcases his ability to lead successful turnarounds and create significant shareholder value. Howard’s partnership and collaboration style involve the use of advanced technology like behavioral biometrics to prevent fraud in capital markets. The return on investment for financial institutions using BioCatch’s technology is substantial, paying for itself in as little as 1-3 months and yielding high returns. Howard’s investment check size and partnership approach are geared towards innovative solutions with significant benefits for the financial industry.

DrPano Kroko Churchill is a legendary entrepreneur, Angel, VC, and PE investor focusing on innovation for solving major challenges. His investment emphasis is on Life Sciences. He has invested in startups such as Amrit Advanced Biotech at the Seed stage. Dr. Pano Kroko Churchill’s check size ranges between £150,000 to £1,500,000. His partnership and collaboration styles are individualized to the specific goals of the investment. With a track record in Potomak Ventures, DrPano Kroko Churchill has shown a commitment to supporting startups in the Life Sciences sector.

Long Island Angel Network, based in Stony Brook, NY, is an angel group that provides seed-stage funding for startups in the technology, biotechnology, nanotechnology, medicine, and energy sectors. They focus on early-stage and emerging growth companies, with investments in software and information technology. Long Island Angel Network typically invests between $100,000 and $750,000 per company. Their geographical preference includes locations like New York and North America. With a track record of 10 investments and one exit, including recent investments in Neuvotion and Celmatix, they demonstrate a commitment to supporting innovation and growth. The group follows a collaborative style, emphasizing partnerships to help startups succeed.

Mr. Sachin Garg, an Angel Investor, focuses on investment, asset management, and investor relations in India. He has a background in real estate development projects in the Delhi-NCR region. Mr. Garg is actively involved in early-stage startups in the mobile and internet domains with previous investments in iimjobs.com. He has a professional career spanning from leading roles at Amazon.com in luxury consumer products to consulting at Tata Consultancy Services. Mr. Garg has an MBA from the Yale School of Management and a Bachelor’s in Electronics & Communication Engineering. His investment check size and partnership styles are not detailed in the available information.

Esther Dyson is an angel investor, entrepreneur, and commentator focused on healthcare, open government, digital technology, biotechnology, logistics, and outer space industries. She is the Chairman of EDVentures Holdings and serves as a Board Member at various companies such as Swvl, StartUp Health, Luxoft, Bamf Health, and Yandex. Dyson’s investments range from startups globally, including winners like Evernote, Facebook, and Square. Her check sizes vary depending on the company’s needs. She actively collaborates with other organizations, showcasing a collaborative and systems change approach. Dyson’s professional career includes being a founding chairman of ICANN, and she holds a BA in economics from Harvard University.

Women Angels is an angel investor group that focuses on investing in female-founded startups primarily in technology, software, and healthcare sectors. They have a preference for companies based in Maryland, Virginia, and Washington, DC. Women Angels have made 14 investments, with a track record of 5 portfolio exits. Their check sizes reflect a strategy of making smaller investments across more companies to spread risk. The group meets monthly to consider investment opportunities and companies do not need to be woman-owned to apply for funding. They aim to provide capital, guidance, and mentorship to startups they invest in.

Tom Mucklow is a friendly founder and seed investor based between NYC and London. He focuses on sectors like E-Commerce, SaaS, and Consumer Goods at pre-seed and seed stages. Tom has a background in Chinese Studies from The University of Manchester and has been involved in various roles including Co-Founder of SuperCo. Although no specific previous investments are listed, his check size for investment is known to start from a minimum of $10,000. Tom’s partnership and collaboration styles reflect his experiences in roles like Partner Development Manager, emphasizing on building partnerships and collaborations for growth.

Scott Brun is a Venture Partner at Abingworth with over twenty years of experience in the pharmaceutical industry. He most recently served as AbbVie’s VP Scientific Affairs and Head of AbbVie Ventures, expanding the investment portfolio with over 20 active companies. Scott’s previous roles include leadership positions at Abbott Laboratories. His educational background includes an MD from Johns Hopkins University School of Medicine with a residency at Harvard Medical School. Scott collaborates with Axial Therapeutics and Horizon and has extensive expertise in the venture capital field.

Social Capital is a venture capital investment firm that partners with entrepreneurs at all stages.

Doris Qamar, MBA, C.E.T. is an experienced investor with a background in analytical chemistry and material science. She has a strong track record in the chemicals, biotechnology, medtech, and lifescience sectors. Doris has served as an Angel at York Angel Investors and has held roles in biotechnology business development and finance. She is the Founder and CEO of SPEC Labs, where she helps biotech companies achieve their milestones. Doris holds an MBA from Ivey Business School at Western University and a Bachelors Degree in Chemistry. Her expertise and connections make her a valuable partner for startups seeking growth and support.

Tove Larsson is a General Partner at Norrsken VC, a venture capital firm with a focus on impact entrepreneurs. The firm’s investment thesis revolves around supporting startups in sectors such as climate tech, energy, biotech AI, and health tech. Norrsken VC prefers to invest in early-stage companies and targets a global market. Tove Larsson has a track record of investments in companies like CEEZER, ClimateView, Yapevroc, and others. The fund typically invests between EUR 0.025 million to EUR 0.1 million per company. Norrsken VC’s partnership and collaboration style is centered around impact investing in deep tech.

A pre-seed firm obsessively pursuing the near frontier ,Äì where software, hardware, & wetware intersect.

W. Bruce Lunsford serves as Chairman and Chief Executive Officer at Lunsford Capital, where the investment focus areas include healthcare, technology, entertainment, and real estate. The stage of investment ranges from early to late stages. Geographically, the preference indicates potential investments in diverse companies, although specific regions are not highlighted. Previous investments include participation in financing deals such as the Series A funding for Edumedics. Mr. Lunsford’s track record includes successful involvement in various ventures. The specific investment check sizes are not publicly available. Partnership and collaboration styles emphasize negotiation, accountability, shared values, clear communication, and respecting each collaborator’s roles and responsibilities to ensure productive and sustainable collaborations.

Richard Morrison is an infrastructure investor with a strong focus on private and listed infrastructure investments globally. With over 29 years of experience, Morrison has achieved impressive net returns of 18%+ per annum and manages assets under management (AUM) exceeding USD 24 billion. The firm, established in 1988, is owned by the Morrison team and founders, emphasizing long-term alignment and global collaboration. Morrison’s investment strategy prioritizes wise investments that serve enduring societal needs, across the risk spectrum. The firm offers a suite of global strategies providing access to high conviction infrastructure opportunities. Morrison’s partnership and collaboration styles are characterized by a dedicated team of over 180 professionals across seven global offices who work together to deliver outstanding performance.

Wolfgang Dengler, a Senior Investment Manager at Bayern Kapital, has been an integral part of the team since 2009. He specializes in venture capital for innovative, technology-oriented start-ups in Bavaria. With over twenty years of experience, Wolfgang leads the Growth and Later-Stage team, focusing on B2B software start-ups. His investment thesis revolves around supporting ambitious founding teams with visionary ideas. Wolfgang’s investment check sizes range from EUR 250,000 to EUR 25 million, and he values collaboration and partnership in fostering technological advancements. His track record includes building a portfolio of primarily B2B software start-ups and providing financing and expertise to technology-oriented companies. Wolfgang Dengler’s investment approach aligns with Bayern Kapital’s mission to revolutionize tech sectors through strategic investments and customized financing concepts.

Zorba Lieberman serves as the Chairman at Pleio and Founder, Managing Director at ZL Investments. He has a focus on Enterprise Applications and Life Sciences, with investments primarily in the United States. Zorba Lieberman has invested in Comprehend during a Series A round in 2013. His investment check size ranges from $500K to $1.5M. Unfortunately, no specific information on his partnership and collaboration styles is available at this time.

TechGROWTH Ohio is an organization with a focus on providing capital to professionally managed investment funds to support early-stage technology companies in underserved communities and populations in Ohio. Their investment check sizes can range to over $1 billion annually. TechGROWTH Ohio has a sustained public-private partnership model involving various entrepreneurial services and technology acceleration programs. They have a track record of success, being involved in investments such as OsteoDx and Stirling Ultracold. The organization’s partnership and collaboration styles are highlighted through collaborations with Ohio University, Ohio Innovation Fund, and Ohio SBIR Technology Acceleration Program.

Ashmeet Sidana is the Founder and Chief Engineer of Engineering Capital. The investment focus areas of Engineering Capital include partnerships with great entrepreneurs driven by technical insights. Ashmeet Sidana’s investment thesis includes partnering with startups at the seed stage with a focus on technical insights. Engineering Capital typically invests in rounds such as Pre-Seed, Seed, and Series A in sectors like AI/Devtools. Their check size ranges from $0 to $10M. Geographically, Engineering Capital invests in the USA, particularly emphasizing sectors like Communications and Information Technology, Business services, Cybersecurity, Life Sciences & Healthcare, and Consumer Products & Services. Some of their previous investments include companies like Azure, SignalFx, and Tubi.tv. Ashmeet Sidana’s professional career includes experience in startups like VMware and founding his own software company. Engineering Capital’s collaboration style focuses on partnerships with entrepreneurs driven by technical insights, supported by a team that includes mentors.

Alexander Ruppert is an investor whose investment thesis focuses on seed-stage investments with a geographical preference for the European Union (EU), Europe, Middle East, and Africa (EMEA). His investment focus areas include North America, EU, EA, SEA, and LATAM. He has a track record as an Investment Manager at Heilemann Ventures and has made previous investments like Inkitt with a check size of $1.1M for a seed round investment.

Sean Parker, a renowned entrepreneur, co-founded Napster and served as the first President of Facebook. He focuses on Life Sciences, Global Public Health, Civic Engagement, and the Arts through the Parker Foundation. Parker invests personal funds as an angel investor in promising startups and advocates for complete teams in the startup landscape. Geographically, he has investments in North America, Europe, and East Asia. His investments include companies like Osaro and Thrive Global, with an investment check size varying based on the round. Parker is known for his collaborative efforts, particularly through the Parker Institute for Cancer Immunotherapy, fostering data sharing and industry partnerships to accelerate cancer research.

Steve Jobs is known for his strategic ‘do-nothing’ investment approach, waiting for the next big opportunity. He has a track record of successful investments, with only 4% of listed companies responsible for 100% of the stock market net gain. Notable investments include Apple, facilitated by angel investor Mike Markkula. Jobs’ investment check size and geographical preferences are not explicitly mentioned. His partnership and collaboration styles emphasize innovation and customer focus.

Benny Schnaider, a Co-Founder and angel investor, focuses on early-stage investments in B2B and B2C startups. His investment check sizes vary from seed funding to series A, with a range of $1.5M to $58.1M. Schnaider’s geographical preference seems to be global, with a diverse portfolio that includes companies like DriveNets, Everafter AI, and Matific. His partnership and collaboration style are evident in his involvement with companies offering solutions in AI-driven infrastructure, customer interface platforms, math-learning apps, and more. With a strong background in Silicon Valley companies and over 20 years of experience, he brings strategic consulting expertise to his investments, aiming for growth and success in the startups he supports.

Derek Rapp is the Managing Director at RiverVest Venture Partners, a life sciences venture capital firm investing in early-stage biopharmaceutical companies. His investment focus areas include the diabetes community and product development. Derek has been involved in organizations such as JDRF, Divergence, Inc., Monsanto Company, and Lazard Freres & Co. His previous investments are not specified. Derek’s professional background includes roles at various companies, and he holds an MBA from the Wharton School. RiverVest’s investment check sizes range from 10 to 50 million dollars. Derek’s partnership and collaboration styles are not explicitly mentioned on the website.

Raju Indukuri is an angel investor interested in disruptive innovations in technology and healthcare. He invests in startups to disrupt the healthcare market and has a track record of over 30 years in psychiatry. Raju’s investments range from seed rounds to Series B, with a check size that is undisclosed. His geographical focus spans across global regions such as Europe and Southeast Asia. Previous investments include FalconX and collaborations with KPIT Technologies. Raju’s partnership and collaboration styles involve expanding networks and accessing innovative solutions.

The Sofia Fund, an angel group based in Minneapolis, focuses on early-stage, growth-oriented, gender-diverse companies with women leaders and equity owners. Their portfolio of 23 companies includes notable investments like AbiliTech Medical and Joylux. They invest in sectors such as HealthTech and Life Sciences, with investments at Series A and Seed stages. Some top investments include Tactile Medical, Magnet 360, and Rebiotix.

William Bain is an angel investor affiliated with Alliance of Angels, known for his diverse professional experience. With a track record spanning from executive roles in technology companies to founding non-profits, Bain has demonstrated expertise in technology strategy, innovation, and business growth. Throughout his career, Bain has held key positions such as Vice President of Data Science at Albertsons Companies and General Partner at NewVantage Partners. His educational background includes a Doctor of Philosophy (PhD) in Computer Science from Yale University. As an investor, Bain is part of a network investing in early-stage startups with investment check sizes typically ranging from $250K to $1M. The partnership and collaboration style of Bain involves leveraging an ecosystem to provide specialized services and achieve breakthrough results.

Luc Vincent is an Angel Investor with a focus on AI and visual technologies. His investments include companies leveraging Generative AI technology for disrupting legacy enterprises. He invests in gaming, NFTs, the metaverse, blockchain, biotech, AI videos, natural language processing, robotics, precision medicine, and more. Some of his previous investments include SpotAngels and Threedy.ai. The check size of his investments is not disclosed. Mr. Luc Vincent is known for advising companies like Spotscale and Hayden AI.

Ashwin Kiran is an Angel/Individual investor focusing on markets like Advertising, Guides, Mobile, and Sales. He has made past investments in Drink Up Downtown. The investment check size is undisclosed, and his partnership and collaboration style information were not found.

Hyde Park Angels is an angel group based in Chicago, Illinois that focuses on growing early-stage startups primarily in the Midwest region. The firm follows a thorough diligence process, evaluating companies based on team dynamics, problem/solution fit, evidence of success, and market opportunity. They invest in industries such as industrial technology, information technology, healthcare services, and financial services. Hyde Park Angels predominantly invests at the early stage and Series A, emphasizing wise spending and understanding marketplace insights. The firm has a track record of investing in companies like ParkWhiz, Rheaply, ShipBob, Fee Fighters, 1871, and more. Their investment check sizes vary, and they focus on verticals like Life Sciences & Healthcare, Consumer Products & Services, and Business Services. Hyde Park Angels collaborates with various partners, including Industry Partners, Corporate Sponsors, and Community Partners, to provide additional resources and support to entrepreneurs.

Sanjay Mirchandani is a seasoned investor with a focus on disrupting the data protection industry. His investment thesis revolves around advancing the industry with a platform that integrates leading software, SaaS, and security capabilities to secure, defend, and recover data across environments. Sanjay’s investment focus areas span Food, Agriculture, and Healthcare industries. He typically invests at the Seed stage and has a strong geographical preference for the Asia Pacific & Japan region. Sanjay’s previous investments include Chai Point and Shantani Proteome Analytics. With a career spanning over 25 years, Sanjay has demonstrated exceptional leadership in technology companies like Commvault and VMware. His partnership and collaboration style emphasize assembling great teams, fostering innovation, and clear communication. The check size of his investments is most evident in his Angel investment in BHIVE Workspace in 2016.

Charles Matausch is a VC Investor at XAnge with an investment range of $300K – $10.0M and a sweet spot at $5.0M. His current fund size is â¬600M. His investment focus areas include Developer Tools (Series A), Developer Tools (Seed), Consumer Health (Series A), Consumer Health (Seed), Web3/Blockchain (Series A), Web3/Crypto (Series A), Web3/Blockchain (Seed), BioTech (Series A), Web3/Crypto (Seed), Digital Health (Seed), Digital Health (Series A), Health & Hospital Services (Series A), BioTech (Seed), Health IT (Series A), Health & Hospital Services (Seed), Consumer Internet (Series A), Health IT (Seed), Consumer Internet (Seed), FinTech (Series A), FinTech (Seed). Charles Matausch’s geographical preference is focused on EU.

Asiff Hirji focuses on private equity and venture capital investments. His geographical preference and investment stage are not specified directly. He has previous experience in notable positions such as Operating Partner with Andreessen Horowitz, Senior Advisor with Bain Capital and Advent International, Chief Restructuring Officer of HP, and Partner with TPG Capital. Specific details about his previous investments, investment check size, and partnership/collaboration styles are not available from the sources searched.

Inaki Berenguer is the Managing Partner at LifeX Ventures, investing in visionary entrepreneurs building a longer and better life for People and Planet. He previously co-founded and was the CEO of CoverWallet, a tech startup reinventing insurance for small businesses. Inaki has an extensive track record, having been involved in multiple non-profit organizations, co-founding iPronics Programmable Photonics, and working as a Guest Lecturer at the Massachusetts Institute of Technology. As an angel investor, he has invested in companies such as Appzen, Cabify, UniPaaS, and many others. Inaki’s education includes a Telecom Engineering degree from UPV, Master and PhD degrees in Engineering from Cambridge University, and an MBA from MIT.

Wisconsin Investment Partners LLC is a venture capital firm based in Madison, Wisconsin, founded in 1999. The firm focuses on technology and life science sectors, with investment areas including Health Care, Biotechnology, Medical, Software, and Medical Device. They make seed- and early-stage investments in various industries, contributing to the region’s entrepreneurial economy. Their investment check size offers fractionalized ownership opportunities for as low as $1,000, allowing investors to have security tokens. Wisconsin Investment Partners collaborates with other investors through partnerships, particularly in private equity and debt investments.

Dr. Stelios Papadopoulos is a Co-founder and Chairman of the Board at Exelixis. He also holds the position of Chairman of the Board and Member of the Corporate Governance Committee at Biogen. Additionally, he serves as the Special Board Advisor at Evelo Biosciences and is the Chairman and Director at Regulus Therapeutics. Dr. Papadopoulos retired as Vice Chairman of Cowen & Co. in 2006 after significant experience as an investment banker, focusing on biotechnology and pharmaceutical sectors. His career includes roles as Chairman of PaineWebber Development Corp. and Vice President at Drexel Burnham Lambert. Notably, he has been involved with various organizations and boards, including Joule Unlimited. Throughout his career, Dr. Papadopoulos has maintained an association with NYU as an adjunct associate professor of cell biology.

Dr. Caroline Fichtner focuses on financing and developing technology start-ups in the life sciences field. With a biophysics background and experience in venture capital, she works with the Max Planck Institute for Bioinorganic Chemistry. Her investment thesis revolves around the life sciences sector, but specific details on investment stage, geographical preference, previous investments, and check sizes are not disclosed. Dr. Fichtner’s partnership and collaboration styles are also unspecified at this time.

Robert Adelson is a Managing Partner at Osage University Partners, investing in Biotech, Future of Work, Edtech, and Enterprise sectors primarily in the USA. His check sizes range from $500K to $1M, $1M to $3M, and $3M to $10M.

Boynton Angels is an Angel Group focusing on early-stage venture investments. They have diverse members with experience in various industries like biotech, consumer products, energy, manufacturing, software, real estate, and more. The members have invested in over 25 start-ups individually before joining Boynton Angels. They have a strong background with many members being founders, CEOs, or presidents of companies. Boynton Angels have had at least one exit. They are open to collaboration and can be contacted at info@boyntonangels.com or 508.983.1452.

Félix Charif Schaal is an engineer and adventure capitalist at Modulare Ventures with 15+ angel investments. His investment focus areas include LifeHacks, CleanTech, and AI. Some of his previous investments include NeuroNation.de, FeedR, and HealthUnlocked. Félix has co-founded the Berlin Metropolitan Office and has worked at Telefonica O2 Germany and Bosenet in the past. Additionally, he is known to invest in startups like Zero Carbon Farms and Berry White.

John Steffens is the Founder and Senior Managing Director at Spring Mountain Capital, an investment firm based in New York. The firm focuses on providing capital for enterprise software, digital health, technology-enabled services, and healthcare companies across North America. Their investment preferences include life sciences, cybersecurity, e-Commerce, impact investing, and virtual reality. Previous investments by John Steffens at Spring Mountain Capital are not available. The webpage also mentions his involvement in various organizations and industry connections.

Beat Steffen is a Managing Director at Novartis Venture Fund in Basel, Switzerland. He focuses on investing in life science companies developing biotechnology and biopharmaceutical therapeutics to address unmet patient needs. His previous investments include companies like Rappta, SpliceBio, Vivet Therapeutics, FoRx Therapeutics, and UZH Life Sciences Fund.

Mark Krul is the Partner/Co-Founder of Aglaia Biomedical Ventures BV, an oncology specialist investor focused on early-stage breakthrough inventions. Aglaia invests in oncology and novel tools in contemporary drug development. The target fund size is $80-$100 million, with investments in 10-15 high-potential oncology start-ups. Mark Krul is actively involved as a Founder and Director, supporting early-stage companies in drug development as a board member. His geographical preference spans across the Netherlands, focusing on oncology advancements. Previous investments include boards at MIMETAS, Cristal Therapeutics, and others. Mark Krul holds a Ph.D. in Medical Biology from Utrecht University and has a comprehensive background in anticancer drug development.

Frank Riedel is a Venture Partner at Blue Horizon and has made recent investments in Series B Food and Beverage, Enterprise Applications, and Consumer Internet sectors.

Joe D’Amico is an investor with a focus on equity investments in Virginia’s leading technology, energy, life science, and scalable non-tech startups through a family of seed and early-stage investment funds. His investment ranges cover various sectors such as Biotechnology, Biopharmaceuticals, Medical Devices, IT, Telecommunications, Cybersecurity, Renewable Energy, Transportation Technologies, and more. He has a background in supply chain and procurement, with experience in roles like General Manager of Supply Chain Services at Quest Global and Senior Director of Global Procurement at Baker Hughes. His investment check size is not specified, but he has a track record of meaningful results in challenging environments and seeks a Procurement, Sourcing, or Supply Chain leadership role in medium to large scale companies. He demonstrates a results-oriented approach and collaborates effectively in his roles.

SJF Ventures is a venture capital partnership focusing on the resource efficiency, sustainability, and technology-enhanced services sectors.

T.A. McCann is the Managing Director at Pioneer Square Labs, specializing in various entrepreneurial endeavors and serving as a board member in multiple companies. He provides venture studio and corporate innovation services. T.A. McCann has a diverse track record, including advisory roles at the University of Washington Foster School of Business and mentoring at TechStars. He is known for hosting podcasts and supporting initiatives like the Microsoft Alumni Network. His investments cover a wide range of areas including health, manufacturing, and energy. T.A. McCann is active in the entrepreneurial scene, with a focus on early-stage ventures and engaging with various types of investors in seed rounds. He demonstrates a commitment to building and supporting innovative startups.

ShangPharma Innovation is a global innovation incubator and investment organization focused on biomedical R&D technologies and therapeutics.

Georges Harik is an angel investor and advisor known for focusing on internet applications, machine learning, advertising technologies, and biotechnology. He has invested in companies such as Lambda, Nimble Robotics, Athelas, and Apprente. Georges typically invests at the seed stage and is based in the San Francisco Bay Area and Silicon Valley. His investment check sizes vary based on the stage of the company. As an industry veteran, Georges has a background in machine learning and artificial intelligence, with a Ph.D. in Computer Science from the University of Michigan. His collaboration style involves partnering with startups in a hands-on approach, drawing from his extensive experience at Google as a product management director and software engineer. Georges’ partnerships focus on leveraging his technical expertise and industry connections to support the growth and success of the startups he invests in.

Robert Poulin is a Co-Founder and Executive at Neustar and serves as an Advisor at ICX Media. No specific information was found regarding investment thesis, focus areas, stage of investment, geographical preference, previous investments, track record and professional career, investment check size, or partnership and collaboration styles for Mr. Poulin.

Nils Root, a Partner at Drive Capital, focuses on investing in sectors such as Gig Economy, Human Capital/HRTech, Future of Work, Enterprise Applications, and Enterprise at both the Seed and Series A stages. His investment check size ranges from $10.0M to $30.0M with a sweet spot at $15.0M. Nils Root has a current fund size of $1B and has made investments in companies like Bookbag Video. He has a track record of being a Founder and Producer at Bookbag Video from 2012 to 2019 and has previous experience as the President of Business Builders.

AngelFire Ventures is a prominent venture capital firm that emerged in 2008 to fill funding gaps in Mexico’s early-stage sector. They focus on specialized industries, providing funding and resources for startups in technology, healthcare, education, and more. Their portfolio includes investments in various sectors. The firm plays a vital role in fostering innovation and economic growth in Mexico by offering not just funding but also expertise and mentorship. While specific previous investments are not available, AngelFire Ventures has been active in supporting startups. They aim to make a lasting positive impact on Mexico’s business landscape. The check size strategy emphasizes consistency for negotiation and diversification. Their partnership and collaboration styles are not detailed, but the firm is known for its support in bridging the gap between startups and investors.

Joanne Chang is a healthcare angel investor and advisor with a focus on female and BIPOC founders. Her investments range from $10,000 to $25,000 per company. She holds a joint MBA-MS degree in healthcare, clinical sciences, and general management from Harvard and MIT. Joanne is known for her ownership of Flour Bakery in Boston and Cambridge, Massachusetts. She has a successful track record in the culinary industry, including being the James Beard Foundation Award winner for Outstanding Baker in 2016. Her investments are typically focused on healthcare and consumer sectors, and she has a partnership filled with love, especially in the food industry.

Ari Buchler is a seasoned investor with over 20 years of global experience leading corporate development, legal, software OEM sales, and other corporate functions in both private and public companies. His track record includes being a key member of turn-around teams at companies like Intralinks and Sophos, with over 40 transactions globally. Ari has invested in early-stage startups, as well as private equity and venture funds. He serves as a Board Member at Simeio Solutions, as a Limited Partner at Glilot Capital Partners, and in advisory roles for various companies. His partnership and collaboration style is exemplified through his involvement in securing corporate networks from unauthorized mobile devices through partnerships with companies like Check Point Software Technologies. Ari’s investments are primarily focused on HealthTech, Enterprise Applications, Software, and Cyber Security sectors, with past investments in companies like LinkSquares, Ginger, and others. He is based in Boston, USA, and has a law degree from Columbia University School of Law.

Tom Patton is a seasoned healthcare executive and board member with broad operational, strategic, legal, compliance and transactional experience. He has served in various leadership roles in public and private healthcare companies. Tom’s investment focus areas include healthcare, biotechnology, dementia, and medical devices. He has a track record of success in leading companies to growth and acquisition. Tom has been involved in previous investments in companies like CAS Medical Systems, QDX, Inc., Novametrix Medical Systems, and Wright Medical Technology. His investment check size varies depending on the company’s needs. Tom prefers collaborations and partnerships that emphasize effective communication and relationship dynamics in decision-making processes.

Jack Gill is a Managing Director at Vanguard Ventures, specializing in Life Sciences and Telecommunications. His investments include companies like Saranas, ChaCha, and Novalux. He has a new investment theme related to Health IT startups. Jack Gill focuses on early-stage investments and has a significant track record in the industry. The investment check size ranges depending on the startup’s potential. His partnership and collaboration styles are not explicitly mentioned on the available sources.

Philip Dillon is an experienced individual with over 10 years in mergers and acquisitions, joint ventures, private equity, corporate restructuring, and more. His recent transactions include advising private equity funds, financial institutions, and corporations on significant deals. His career spans from corporate transactions to private equity investments. Although specific previous investments were not found, he is knowledgeable in various sectors, offering expertise and collaboration in commercial filmmaking.

Abhay Jain is an angel investor with a focus on Life Sciences and High Tech sectors. His recent investments include startups like Minus Zero, S3V, and Comofi Medtech. He typically invests in seed rounds with a check size ranging from $25,000 to $50,000. Abhay Jain’s partnership and collaboration styles are demonstrated through board memberships, with a current position at Comofi Medtech. His professional career includes successful investments and involvement in AI and AR-based assistive robots for surgery at Comofi Medtech.

Alexander Khan is an Angel Investor with a focus on early-stage startups in the crypto industry. He invests in categories such as gaming guild and has funded projects like Ampverse. His investment check size is typically less than $1 million. Khan is known for his professional background in accounting and marketing, holding a Bachelor of Arts degree from Cal State Fullerton, College of Business and Economics. His geographical preference and partnership/collaboration styles were not found.

Lars Hedbys, a Partner at Ventac Partners, brings over 30 years of international leadership experience in the life science industry. He focuses on company building, financing, mergers & acquisitions, and IPOs. Lars has led listed companies and founded life science companies, handling pharmaceutical, ATMP, and medical device development. He serves as chairman or board member in various listed and private life science firms. Lars holds an M.Sc. in chemical engineering and a Ph.D. in Applied Biochemistry. His past roles include CEO of Idogen AB and Chairman of Lund Life Science Incubator. Lars Hedbys co-founded Idogen AB, Regenesance BV, IAmPatient AB, and Casigen Pharma Ltd. The investment check size and partnership styles are not publicly available.

Preston Tollinger, a seasoned entrepreneur and investor, is renowned for founding successful startups like CollectiveHealth, Lightside Games, and Cellfire. With a BS in Computer Science from Carnegie Mellon University, his career showcases a deep tech expertise. Notable roles include Chief Technology Officer at Collective Health and co-founder of Lightside Games. In the past, he served as CTO at Cellfire and Motion. His foundational work at CollectiveHealth emphasizes a focus on health technology. Previous ventures reflect a commitment to innovation and growth, positioning him as a key figure in the tech industry. As Chief Product Officer at Chorus Innovations since 2023, his strategic leadership continues to drive impactful investments and collaborations. Preston’s background underscores a diverse portfolio and a visionary approach to fostering startup success.

Presight Capital is a venture capital firm investing in the most ambitious founders across sectors, stages, and geographies.

Mr. Edward Fritzky served as Chairman and Chief Executive Officer at Immunex Corporation. He served as President of Lederle Laboratories, a division of American Cyanamid Company from 1992 to 1994 and Vice President of Lederle Laboratories from 1989 to 1992. Prior to joining Laboratories, he served as an Executive of Searle Pharmaceuticals, Inc., a subsidiary of the Monsanto Company, a Pharmaceutical and Chemical Company in the United States.

Karanpal Singh, the Founder of Hunch Ventures, is a seasoned investor with a focus on seed and early-stage investments. His investment thesis revolves around opportunities in healthcare, hospitality, education, media, retail, and new-age technology sectors. Karanpal has made investments in companies like MyHealthcare, N+1 Capital, India Inc. Group, Roots Ventures, and more. With over 19 portfolio companies and 3 exits, he has a strong track record in managing clinical laboratories and a background in neuroscience. His usual investment check size ranges around $2 million, and he is known for his collaborative and mentorship-driven partnership styles, to uplift projects like easing cervical cancer testing and converting CO2 emissions into valuable compounds.

Julia Dewey is the Managing Director at Rev1 Ventures. Rev1 Ventures focuses on late-seed, pre-Series A, and Series A investments in B2B startups across industries. Some of the previous investments made by Rev1 Ventures include Color Coded Labs, Redi Health, SureImpact, and Rapchat. The investment check size at Rev1 Ventures ranges from $150,000 to $325,000, with a sweet spot at $240,000. Julia Dewey’s investment approach aligns with the fund’s focus on digital health, health & hospital services, and health IT sectors in the pre-seed to Series A stages.

Nyfikna Investerare, a venture capital company based in Sweden, is dedicated to democratizing knowledge about investments and inspiring investors. The firm focuses on fostering collaboration between entrepreneurs and investors to build a supportive community. Nyfikna Investerare has a diverse partnership and collaboration style, working closely with startups to deliver actionable strategies tailored for their success. While specific investment check sizes are not provided, Nyfikna Investerare is actively involved in the health tech category and has a portfolio of investments. The firm has shown interest in sectors like wearable tech, IoT, and Smart Textiles, with investments in companies such as LEIA and Gokind. Additionally, Nyfikna Investerare organizes events and programs like board of directors training to enhance the skills and opportunities for investors and entrepreneurs in the startup ecosystem.

INnovation Angels is an investor focusing on cybersecurity, health tech, and agritech. They target early-stage startups with investments ranging from $25,000 to $50,000. The organization collaborates strategically to fuel growth and innovation.

Samuel Beyer is an investor with a focus on sectors such as Supply Chain Tech, Wellness & Fitness, Pharmaceuticals, TransportationTech, Data Services, eCommerce, BioTech, and AI. He invests in Series A and Series B stages, with an investment range of $100K – $5.0M and a sweet spot of $1.5M. Samuel Beyer shows a preference for geographies such as the United States and Europe. His previous investments include companies in various sectors. He has a significant fund size of $1.1B and is part of General Catalyst. Samuel Beyer’s partnership and collaboration styles involve working with affiliated investors and scouts in the industry.

Klaus Dugi is a Venture Partner at ND Capital, a venture capital firm investing in disruptive technologies across life, physical, and data sciences. With assets under management of approximately $820 million, ND Capital operates in the United States and Europe. Klaus Dugi’s investment focus areas include Therapeutics, Digital Health, BioTech, and Health & Hospital Services at various stages from Pre-seed to Series B. He typically invests between $100,000 to $5 million, with a sweet spot of $1.5 million, from a current fund size of $500 million. Some investors who collaborate with Klaus Dugi include Aditya Rajagopal, Alison Palmer, Aymeric Sallin, Dani Bach, and Eric Moessinger. His recent investments include leading a $20.6 million Series A financing for Vandria. Klaus Dugi plays a crucial role in supporting startups through their development phases and financing rounds.

As a Venture Partner at Nina Capital, Sarah Fisher focuses on investments in the range of $10.0M to $50.0M, with a sweet spot of $25.0M. The current fund size for investments is â¬40M.

CIC backs life sciences and technology companies in Europe’s leading ecosystem, Cambridge. A preferred investor for the university.

Simon Leicht is a dedicated investor with a long-term focus on investments, backed by the renowned family businesses in Germany. He partners with leading early-stage funds for co-investments and has access to world-leading early-stage co-investors. His investment portfolio includes a diverse range of companies in sectors like CBD, B2B platforms, plant-based dairy alternatives, digital spice brands, and clean label plant-based meat replacements. Simon Leicht has expert access to a network of industry-leading companies for investment decisions and works with a team of experienced investment professionals. His team includes Managing Partners like Jan Leicht, and Senior Investment Managers. Additionally, his team has expertise in private markets and venture capital, with specific focuses on FoodTech and consumer investments. Simon Leicht’s operations are supported by professionals with backgrounds in green power generation technologies, financial analysis, and regulatory compliance.

ONSET Ventures provides early-stage venture capital in the areas of IT and medical.

Lucas Nivon is a Venture Partner at Argonautic Ventures with a focus on Pre-seed and Seed investments in Pharmaceuticals and BioTech sectors. His investment range is from $100K to $5.0M, with a sweet spot of $1.5M. Lucas has a professional background as CEO and Co-Founder of Cyrus Biotechnology and as a Translational Investigator at the University of Washington. He holds a PhD in Biophysics from Harvard University and an AB in Biochemistry from Harvard University. Previously, Lucas has also been involved in startups like PedalAnywhere and has experience as a Post-Doctoral Fellow at the University of Washington. His collaborative style is evident through his roles as a Co-Founder and Executive Committee Member at OpenFold and as a Co-Founder at PedalAnywhere. Lucas has a strong academic foundation with a comprehensive track record in the biotechnology sector.

Chuck Gordon is the Co-Founder and CEO of SpareFoot, an Austin-based self-storage finder. SpareFoot focuses on product development and engineering with investments from Insight Venture Partners. Chuck Gordon has led SpareFoot in raising significant venture capital to enhance their offerings in the market. SpareFoot’s previous investments include collaborations with Capital Factory, FLOODGATE, and Silverton Partners. Chuck Gordon has demonstrated a philanthropic partnership approach through initiatives like ‘Supply Memories’ to support at-risk students through charity campaigns. SpareFoot uses social media to engage users and contribute to community causes.

John Evans is an individual angel investor with a seed stage focus. He is based in New York, New York, United States. His educational background includes the University of Pennsylvania, Yale University, and Wharton School of the University of Pennsylvania. John Evans is the CEO of Beam Therapeutics and has one portfolio company. His previous roles include positions at Agios Pharmaceuticals, Infinity Pharmaceuticals, McKinsey & Company, and MedImmune. He has a diverse educational background with degrees from prestigious institutions. John Evans’ investment style is as an individual angel investor focusing on seed stage companies.

Sravish Sridhar is an Angel Investor with a focus on industries like Biotechnology, Digital Health, Insurance, Cloud Infrastructure, and others. His investments range from Pre-seed to Series A stages, with recent investments including BodesWell, American Cricket Enterprises, Talla, and Kato. Sravish Sridhar typically invests in seed round stages and has shown interest in biotech, digital health, insurance, cloud infrastructure, fintech, pharmaceutical, manufacturing, and enterprise software. He has a check size range of $5K to $25K, with a sweet spot around $15K. Some of his past investments include Talla, Evisort, Securicy, Fyle, and Kinvey. Sravish Sridhar’s track record includes founding Kinvey, a mobile developer platform focused on user experience in backend services, competing with large enterprise rivals. His professional career has been dedicated to encouraging innovation, providing flexible pricing options, and expanding the company’s presence into new markets.

Paul Holliman is an active mentor at 500 Global and other startup accelerators, providing assistance with business strategy, fundraising, presentations, and pitch decks. With previous experience as the head of worldwide strategic planning and operations for Walt Disney Studios Motion Pictures, Paul played a crucial role in the global conversion to digital cinema and the introduction of new theatrical distribution formats. He is known to invest personal money in promising companies in exchange for equity. Paul has early stage investments in 32 unicorn companies and his investment focus includes pre-seed robotics and other areas. His investment check size and partnership/collaboration style details are not available publicly.

Liz Marchi is the Founder of Frontier Angel Fund 2, co-founder of Frontier Funds 1 and 2, and Chief Marketing Officer at Two Bear Capital Operations LLC. Liz focuses on investing in tech and healthcare startups, with an investment range of $25,000 to $150,000. She prefers early-stage companies and geographic focus on Montana. Liz has a strong track record in angel investing and collaborates with organizations like the Montana Chamber of Commerce to support entrepreneurship initiatives.

Adam Spector is the Managing Partner of Brandywine Global Investment Management, LLC. He is responsible for the overall management of the firm’s business areas, works with investment teams to achieve client objectives, and serves as the Chair of the Global Management Committee. He holds an M.B.A. from the Wharton School of the University of Pennsylvania and a B.A. in Public Policy and Anthropology from Brown University.

Ingrid Nieweg is an Investment Manager at BOM Brabant Ventures with an investment thesis focusing on sectors like Manufacturing, Logistics, EnergyTech, Food and Beverage, AgTech, ClimateTech/CleanTech, Digital Health, BioTech, Health & Hospital Services, and Health IT. She has a track record in roles such as International Sales Manager and Senior Credit Risk Analyst at reputable organizations like Fisher Investments and ABN AMRO. Her partnership and collaboration approach involves assisting startups in achieving their milestones and seeking cooperation with venture capitalists in fields like climate technologies. Ingrid’s professional career includes a Master’s in Business Administration, a Private Banking Program from INSEAD, and a Bachelor’s in Commercial Economics, among other educational achievements.

Southwest Angel Network is an early-stage impact investor focusing on startups providing solutions to societal and environmental challenges, including climate change mitigation. They invest in companies improving physical and mental health outcomes across the US, particularly supporting under-represented founders. Previous investments include Scriptly Rx and ResilientGrid. SWAN Impact Network emphasizes angel investors enabling entrepreneurs to address pressing issues, with a strong commitment to impact investing education. Partnership and collaboration styles are evident through their diverse sponsors, including Atchley and Associates, TechMatrix, and Goodwin Procter LLP. Contact executives in different regions for investment opportunities.

GSR Ventures focuses on early-stage technology companies developing AI-enabled technology.

Ankush Gera, the Co-Founder and CEO of Junglee Games, focuses on backing purpose-driven businesses and prioritizing good people in his investments. His investment portfolio spans industries like technology, healthcare, and blockchain. Ankush Gera’s geographical preference includes a significant focus on India. Some of his notable investments include The Whole Truth Foods, StockGro, and Fynd. With a background in computer science and bioinformatics, Ankush Gera has successfully led Junglee Games and emphasized bootstrapping in building a unicorn from India. His investment check size ranges across various rounds, and he values partnership with purpose-driven founders in the gaming industry.

Ryan T. Melohn is an Angel/Individual investor with a focus on various markets including Consumer Internet, Biotechnology, Mobile, Digital Media, SaaS, Enterprise Software, and E-Commerce. He has invested in companies like SEEVA Technologies, Via, OrderUp, POSTMATES, Lemonade, and more.

Roman Schumacher is an investor with a focus on healthcare startups. He has made investments in companies like Remberg and Stonly. Schumacher’s investments typically range between â¬100,000 and â¬500,000 per company. With a professional career in the healthcare sector, he brings industry expertise to his portfolio. He favors partnerships and collaborations that bring value to both sides, creating mutually beneficial relationships. Schumacher’s geographical preference appears to be in the EU region. His investment check size varies but typically does not exceed â¬3,000,000 per company. Overall, Roman Schumacher has a track record of successful investments, particularly in healthcare startups.

We empower ambitious teams building tomorrow,Äôs industry-defining platforms.

Michael Greeley, Co-Founder and General Partner at Flare Capital Partners, focuses on healthcare investments in companies like Aspen RxHealth, Author Health, Axuall, Cayaba Care, Circulation, Cohere Health, HealthVerity, Higi, Inbound Health, Iora Health, Oshi Health, RightMove, and Welltok. He holds a BA in chemistry from Williams College and an MBA from Harvard Business School.

Mr. Mike Elconin is an Angel Investor. He is the Chief Executive Officer of Cognionics, a wireless medical device company. He served as Director at MicroPower Technologies. Additionally, Mr. Elconin is an advisor at the von Liebig Center at the School of Engineering at the University of California, San Diego, specializing in technology commercialization in various engineering fields. He is also involved with the Center for the Commercialization of Advanced Technology, focusing on innovative technology commercialization for military applications. As an active angel investor, he has been consulting with California technology startups since 1999 and has a background in founding and leading Software Banc. His career includes political roles in Wisconsin before transitioning into the industry.

Davide Ottolini is an experienced investor with a focus on biotechnology’s impact on longevity, mental health, and regenerative medicine. He cofounded Korify Capital, aiming to invest in innovative companies contributing to preventive healthcare and longer lives. His extensive background includes consulting for prominent pharma companies, enhancing his knowledge of the financial and biotech sectors. Davide Ottolini’s vision at Korify Capital is to support visionary firms in the biotech space, reflecting his dedication to shaping a healthier future through strategic investments.

Chennakeshav Adya provides seed funding to companies in sectors like Technology, Media & Entertainment, Healthcare Systems & Services, Pharma & Life Sciences, Private Equity, Retail, Real Estate, and Banking & Capital Markets. He is known for growing teams and leading them through complexity. While there is limited information on his previous investments, he serves as a board advisor to businesses, offering insights into starting businesses from concept. His investment check size and stage of investment are not explicitly stated on his website. His partnership and collaboration style involve discussions on the art and science of business, highlighting the importance of alliances, joint ventures, and partnerships.

Sudheesh Nair is a growth-stage investor with a focus on areas such as life sciences, healthcare, and manufacturing. He has previously led Nutanix as President, growing revenue from $0 to $1 billion in 7 years. Sudheesh Nair is known for his leadership in data, analytics, ML/AI, and modern platforms. He invests in disruptive technology companies and has a proven track record of scaling businesses rapidly. Sudheesh Nair’s investments typically range in the millions, as seen from ThoughtSpot’s plan to invest $150 million in their operations in India. His partnership and collaboration styles focus on embracing situations and driving compassion in leadership teams.

Logan Green is a Co-Founder of Lyft and serves as Chief Executive Officer & Board Member. He has specialized in investment advice with ongoing management, focuses on charitable giving and high net worth client needs. His previous investments include companies in HealthTech and FinTech sectors primarily in the United States and the United Kingdom. Logan Green’s check size for investments is based on the specific round, and he has a background in sustainable development goals and ESG investing. Logan Green’s partnership and collaboration styles reflect a commitment to culture and values, emphasizing relationships for organizational success.

Michael Sidler is a founding partner at Redalpine Venture Partners, a thesis-driven VC firm with expertise in software and science. Redalpine’s focus areas include AI Middleware, Energy Revolution, Mobility, Health Tech, and more. They invest in disruptive technologies and prefer investments ranging from $300K to $10M. Michael has a track record in the European biotech VC space and follows a collaborative approach in investments.

An accelerated, hands-on investing method that builds companies around game-changing technologies

Björn Odlander, Partner at HealthCap, focuses on investments in the life sciences sector with a keen interest in therapeutics, health IT, biotech, digital health, and health & hospital services. His preferred investment stage is Series B. Björn’s investment check size ranges from $100K to $5.0M, with a sweet spot of $1.5M. Notable previous investments include Oncorena. He collaborates closely with co-investors such as Alex Valcu, Anki Forsberg, Carl-Johan Dalsgaard, Carl Kilander, and Eugen Steiner. Björn Odlander is known for his professional career as a co-founder of HealthCap, a global venture capital fund in life sciences since 1996. HealthCap celebrates 25 years of operations, boasting a strong track record in the industry.

Mindshift Capital focuses on investing in post-seed early-stage companies in the U.S., Europe, and the Middle East. They have a track record of investing in healthtech companies like MDisrupt. Their investment check size, partnership, and collaboration styles are not explicitly mentioned in the available information.

iiM (Innovation in Motion) is an early-stage investment firm headquartered in Merriam, KS. They invest at the Seed and Series A stage across the United States and Canada, focusing on agriculture, animal health, and human health sectors. Their typical investment check size ranges from $150,000 to $300,000, with their largest investment being $530,000. iiM values collaboration and partnerships in venture capital, working closely with companies aligned with their investment focus areas.

Brigitte Linseis is a Senior Investment Manager at Bayern Kapital GmbH. Bayern Kapital invests from the seed to the scale-up phase, with ticket sizes ranging from EUR 250,000 to EUR 25 million. The industries financed include biotechnology and life sciences, medical technology, software and IT, environmental and nanotechnology, materials, and new materials. Brigitte Linseis focuses on seed rounds with investments typically at the seed round A level.

Ray Shealy is a successful operator, investor, and board member involved with healthcare and technology-based companies. He focuses on strategy, innovation, and execution. He has a background in healthcare and technology, with experience as COO at IncludeHealth and CEO at SafeWhite.

Lauren Currie, a VC Scout at Backed VC based in Sweden, has an investment thesis focused on sectors like Entertainment & Sports, Manufacturing, Future of Work, Food and Beverage, Web3/Blockchain, Web3/Crypto, BioTech, SaaS, and FinTech. Her investment check size ranges from $25K to $100K, with a sweet spot of $50K. Lauren has made investments in various startups within these sectors. She is known for her professional career as the CEO of Stride and the Founder of UPFRONT, where she focuses on leadership development and empowering women. Lauren emphasizes building a powerhouse team by investing in team morale and paying attention to individuals’ needs.

Aaron Zucker backs Israeli founders in the sectors of Biotech, Sustainability, and Frontier Technologies. His previous investments and track record details are undisclosed. His professional career indicates he is an Angel Investor.

Keiretsu Forum is a California-based angel group that offers early, seed, and later stage venture, and debt financing investments.

Chris Heid is an Angel Investor with extensive experience in product marketing, business development, and R&D in the life science industry. He has served in various roles at companies like HumanZyme, Fluidigm, Agilent, and Genentech. He holds an MBA from UC Berkeley’s Haas School of Business and has a background in Cell & Molecular Biology and Microbiology.

Based on the information collected: Investment Thesis: Mr. Zachary Gobst, as the Co-Founder and Chief Executive Officer at LeapCure, aims to reduce clinical trial cycle time by two years. Investment Focus Areas: Zachary is primarily focused on health care and clinical trials. Stage of Investment: Zachary’s investments are likely early-stage, particularly in the seed stage companies with less than $10M in revenue. Geographical Preference: Zachary Gobst is based in Los Angeles, California, and his investments may focus on the health care companies in the Greater Los Angeles Area and California, with a broader interest in clinical trials companies in the United States. Previous Investments: Specific previous investments were not provided in the information gathered. Track record and professional career: Zachary Gobst is dedicated to guiding Leapcure toward achieving its vision in the healthcare field, with a focus on reducing clinical trial cycle time. Investment Check Size: The exact check size for investments by Zachary Gobst was not specified in the information found. Partnership and Collaboration Styles: No specific details on partnership and collaboration styles were mentioned in the gathered information. This description provides an overview of Zachary Gobst’s role, focus areas, location, and investment style.

Khayriddin Muradov is a Venture Capital Associate at Edge Case Capital Partners with an investment focus on early-stage and angel investments. The firm targets disruptive technology startups with the potential for rapid growth, including those in biotech, fintech, AI, blockchain, and sustainable energy spaces. Their average initial investment size ranges from $25,000 to $50,000. Edge Case Capital Partners seeks startups led by a great management team and offers support in terms of lead investment, capital, talent, experience, and connections. The firm aims to increase the value of invested companies beyond the equity position granted. Previous investments of Edge Case Capital Partners include companies in Social/Platform Software, Healthcare Technology Systems, and Multimedia and Design Software industries. Though specific information about Khayriddin Muradov’s professional career and partnership styles is not available, the firm emphasizes rigorous research on startups to tap into cutting-edge opportunities.

David Wickham is the Global Head of Quantitative Investment Solutions at Aberdeen Standard Investments. His previous roles include Director & Chief Portfolio Specialist at HSBC Global Asset Management and Senior Portfolio Manager at Invesco Private Capital. David holds a Master’s degree in International Relations from the University of Cambridge and an MBA with Distinction from the University of Oxford. He is known for leading investment strategies and initiatives at reputable financial institutions, focusing on smart-factor, ESG/climate investments, and sustainable index funds. His partnerships and collaboration style emphasize sustained growth through sustainable investments, as seen in the launch of the ASI Sustainable Index funds targeting pension funds and institutional investors.

Andre Hoffmann is the Vice-Chairman of Roche Holding Ltd since 2006, overseeing various external mandates and memberships. His investment focus areas are in pharma and diagnostic solutions. The investment check size details are not available. André Hoffmann’s professional career includes roles at Roche, James Capel and Co., and Nestlé UK Ltd. He has received several awards and honors, and actively participates in various non-profit organizations and memberships. Collaboration styles and partnership approaches are highlighted through his engagement with the Capitals Coalition, Fondation Tour du Valat, and HGIBS Hoffmann Global Institute for Business and Society.

Jonathan Kraft focuses on investing in startups in various sectors, including biotech, medical devices, entertainment software, and accessories. Some notable investments include DraftKings, Stackwell, Scholar Rock, and Evolved by Nature. He has made 18 investments, with a recent investment in Splash Sports as part of their Series A. Jonathan Kraft’s investment check sizes vary, with the latest round at $14.1 million. He has a track record of 5 portfolio exits, with the latest exit being Dave. Jonathan Kraft is actively involved in overseeing the management of New England Patriots, New England Revolution, and The Kraft Group, where he serves as President and Chief Operating Officer.

Pekka Mäki is the Managing Partner of 3TS Capital Partners, a firm that focuses on providing expansion capital and buyout funding for small and medium-sized businesses in growth sectors including Technology & Internet, Media & Communications, and Technology-Enabled Services. 3TS typically invests in the range of â¬300,000 to â¬10 million in the broader TMT sectors. The team becomes active business partners of portfolio companies, targeting exceptional high growth SMEs. Some of their investments include Jentis, Spectrm, Boksi, Autenti, Tosibox, Homecare.com, and Piano Software, Inc.

William Canestaro, Ph.D., Managing Director at Washington Research Foundation/WRF Capital, invests in biotechnology startups in Washington with a focus on long-term success and companies at every stage of growth. His previous investments include 25 investments in 19 Washington-based companies like 2Morrow, A-Alpha Bio, and Icosavax. Dr. Canestaro has a strong professional background in venture capitalism, health economics, and meta-epidemiology. He utilizes his expertise to manage the Foundation’s biotech and engineering VC portfolio, supporting the Washington ecosystem. The investment check size by WRF Capital under his leadership has been significant, leading the biotechnology investment team. Dr. Canestaro is committed to fostering collaboration and partnership within the biotechnology industry.

Sanna Westman, Investment Manager at Creandum, has a focus on digital health and consumer-related services. Some of her previous investments include FirstVet, Careship, Kry, and Epidemic Sound.

Gary Fegel is an angel investor focusing on seed-stage investments in Life Sciences companies in Israel. He left Glencore in 2013 to build a diversified investment portfolio through GMF Capital, which invests in public and private equity across media, technology, and real estate sectors. His recent investments include FlyExclusive and The Motorsport Network. Fegel’s investment check size varies based on deals he undertakes. He held a significant stake at Glencore’s aluminum division before leaving in 2013 to pursue investments through GMF Capital.

Blake Overlock, Principal at LOUD Capital, focuses on alternative investments, particularly in people-centered healthcare, medtech, alternative care models, and healthcare infrastructure and IT. His investment thesis revolves around driving equitable access in healthcare. LOUD Catalyst Health Investment Thesis: Fueling innovations that drive access to quality healthcare. They invest in medtech, alternative care models, and healthcare infrastructure.

Dominik Escher is the Managing Partner at Pureos Bioventures and a founding partner of Pureos Bioventures with a successful track record. He was also a founder and CEO of ESBATech, which was acquired for $589 million by Alcon (Novartis). Pureos Bioventures focuses on investing in private innovative drug development companies, emphasizing the next generation of biological drugs and drug formats to impact patients’ lives positively. The fund aims to build a balanced portfolio of 17-20 pre-clinical and clinical-stage companies. Dominik is known to collaborate with passion for biotech startups, innovation, and the development of new and improved medicines.

Stuart Gardner is an angel investor with approximately 80 investments in his portfolio. He focuses on Pre-Seed and Seed stage companies, particularly in areas such as Hardware, Sales & CRM, Medical Devices, AgTech, Consumer Health, BioTech, ClimateTech/CleanTech, Consumer Internet, and Enterprise. His investment check size ranges from $25K to $50K, with a sweet spot of around $40K. Some of his notable investments include Fundably, MONET, Connect4, Cargofy, BeeReaders, PF Nexus, Unbound, and Den. Stuart Gardner collaborates with co-investors like Marvin Liao, Esther Dyson, Ed Roman, Chris Adelsbach, and Will Neale. He has a diverse portfolio and a track record supporting startups in various sectors.

Christoph Lymbersky focuses on exceptional investment opportunities in the early and growth stage in the areas of artificial intelligence, blockchain, and health technology. He has made investments in companies like WeFunder. His investment check size and partnership styles are not mentioned on the source.

Andera Partners is a private equity firm focused on early- and late-stage venture investments.

Mark Vreeke, a Co-Founder and President of Chemical Angel Network, specializes in matching customer needs with technical capabilities to create new business opportunities. With a background in medical devices and diagnostics and over 100 issued US patents, he has generated over $20B in revenue. Mark has demonstrated expertise in the energy industry, launching innovative products. Chemical Angel Network invests in early-stage hard science companies. Mark Vreeke’s professional career includes notable achievements in energy transportation and glucose fuel cells. The network writes check sizes ranging from $20,000 to $12 million.

XSquared Angels focuses on venture capital acceleration and seed investments in the U.S., particularly in Central Ohio. They have expertise in industries like enterprise software and life sciences. The investment thesis of XSquared Angels revolves around investing in women-led startups, seeking high-potential early-stage companies with at least one woman at the C-level who owns significant equity. They have made investments in hospitality, restaurants, marketplaces, event management, and EdTech. XSquared Angels collaborates with co-investors and partners to support their portfolio companies.

Glen Gaidos is an investor and member at Alliance of Angels with a focus on E-commerce, particularly in the Seed and Series A stages. His investment range typically falls between $500,000 and $1.5 million, with a sweet spot at $1 million. Operating from Seattle/Portland, Glen Gaidos has a current fund size of $100 million. His previous investments include ventures in the E-commerce sector and other areas. Glen’s professional career spans across various roles, including being the CEO and Founder of 3R Technology, a certified IT asset disposition company. He is actively involved in the Alliance of Angels Innovation Fund and SeaChange Fund, demonstrating a strong commitment to supporting early-stage companies and fostering innovation. Glen holds a B.S. in Physics from the University of Washington and has certifications in information destruction and electronics recycling.

Matt Cameron is an Angel Investor with a focus on Commercial Services and Social/Platform Software industries. He has previous investments in companies like StartupHouse and Koozoo. He serves as an Advisor at Switch Automation and has a professional background as the Vice President of Sales at Kahuna and Scripted.com. Matt Cameron’s investment check size, track record, and partnership collaboration styles are not specified on the available profile.

Michael Luciani is the Managing Partner at Climate Capital, specializing in biotech climate solutions. The firm focuses on accelerating the decarbonization of the economy through synthetic biology. Luciani’s investments range from $50,000 to $250,000. He has a track record as a serial entrepreneur and founding partner of Climate Capital, with a focus on clean energy and sustainable solutions. Luciani’s previous investments include ventures in the civic tech space. His partnership and collaboration styles emphasize a diversified team and strong financial performance. He operates in the US and Canada, with a preference for impactful startups in biotech climate solutions.

Cliodhna Adamson is a key figure at Wells Fargo Strategic Capital, known for providing capital solutions across various industries. The investment team, led by Cliodhna, focuses on non-control equity, private credit, and investments in approved Small Business Investment Company (SBIC) funds. With over 30 investment professionals nationwide, the team targets early-stage technology and healthcare companies. Their investment strategy encompasses diversified industries, fund investing, healthcare, and technology, with a typical investment size ranging from $10 million to $50 million. Additionally, the team has a strategic relationship with Centerbridge Partners, specializing in direct lending to non-sponsor North American middle market companies.

Elizabeth Walder is the President and Executive Director of Walder Foundation, a private family foundation with a mission to uplift local communities and elevate Chicago’s contributions to the world. Elizabeth and her husband, Joseph Walder, established organizations focused on science education, Jewish educational resources, and Jewish continuity in Chicago. They founded the Walder Foundation to support science innovation, environmental sustainability, performing arts, Jewish life, and migration/immigrant communities. In partnership and collaboration, the Walder Foundation awarded a generous grant to JCFS Chicago for the HIAS Immigration & Citizenship’s Refugee Resettlement Program. Elizabeth has a track record of supporting immigration causes and aims to support immigrants and refugees to thrive in society.

The AI Institute focuses on Responsible Design, Development, and Deployment of Technologies, Research on Innovative Technologies for Enhanced Learning, Secure and Trustworthy Cyberspace, Smart and Connected Communities, and Smart Health and Biomedical Research in the Era of Artificial Intelligence. They have made previous investments with Boston Dynamics AI Institute. The investment check size is unknown. For collaboration, they engage in cutting-edge AI insights and innovation through collaboration with the brightest minds in the field.

Jumpstart New Jersey Angel Network is a private, member-led angel group investing in early-stage startup technology ventures in New Jersey and the Mid-Atlantic region. They focus on companies with scalability, generating revenue with pre-money valuations typically under $10MM. Check sizes range between $25K to $50K individually, with some members investing over $500K. They invest primarily in technology across industries like HealthTech, Manufacturing, Consumer Packaged Goods, and AgroTech. Jumpstart NJ angels maintain a personal bond with entrepreneurs, investing independently. The network prefers capable and complementary teams, scalability in business models, and seeks companies with high potential returns and disruptive technology. Collaboration involves personal investments and diverse member preferences, with due diligence conducted as a group when considering investments.

Andrew Wald is a VC Investment Intern at Palo Santo VC. He focuses on therapeutics investments at seed, Series A, and Series B stages. His geographical preference focuses on the Midwest. Previous investments include participating in raising $50 million for a fund focused on psychedelic medicine. Wald has a background in finance and capital markets, having worked at energyRe, Barclays, and as a General Manager at Student Agencies, Inc. He holds a JD from Northwestern University Pritzker School of Law, an MBA from Northwestern University – Kellogg School of Management, and a BA in Economics from Cornell University. His investment check size ranges from $100K to $5.0M.

Henri Termeer has a track record of guiding the early careers of many industry leaders in the biotech sector. He is known for his constant vision of working together with smart people to solve healthcare problems. Henri Termeer’s investments typically focus on early-stage ventures in the biotechnology industry. He has made 11 investments, with notable exits such as Amylyx Pharmaceuticals. The check size of his investments is not specified. Henri Termeer’s partnership and collaboration styles are not detailed in the available information.

Shane Skinner, a member at Alliance of Angels, invests in seed and early-stage technology startups primarily in the Pacific Northwest with a focus on SAAS, AI, and Life Sciences. He is known for investing in companies like Record360, where he co-founded the company that raised $1.5 million in seed funding. The investment check size ranges from $500k to $2.5 million per company. Shane Skinner is actively involved in the investment process, participating in due diligence and member meetings to drive the success of his investments.

Venture-Med is an exclusive membership organization of accredited investors focusing on healthcare startups. Their previous investments include a total funding of $28M led by Endeavour Vision and RiverVest Venture Partners. They have a collaborative approach to decision-making with five stances ranging from Telling to Co-creating. The typical investment check size is undisclosed, with a recent funding round on Nov 23, 2021. Partnership and collaboration styles are based on a decision-making framework for leaders and teams, emphasizing input from team members for smoother decisions.

NuFund Venture Group is a prominent angel investor network known for its innovative fund model focused on emerging technology leaders. Their investment focus areas include innovative technologies like AI-driven drug discovery and sports analytics solutions. They have a geographic preference for investments, demonstrated through their investments in alternative sports data and healthcare. NuFund Venture Group typically invests between $250K and $500K per company, and they are recognized for their diverse backgrounds and perspectives, fostering a culture of excellence, respect, innovation, and fun. Their partnership and collaboration styles involve strategic investments and partnerships to support startups in their growth journey.

Matt Badler is a General Partner at Cultivation Capital, focusing on new opportunities and corporate strategy. The investment thesis centers around categories such as Platform Data Management, Health Tech, Software, FinTech, AgriTech, Product Technology, and AdTech. Cultivation Capital invests at the Pre-Seed, Seed, Series A, and Series B stages. Geographically, the focus is on the United States, specifically in St. Louis, Missouri. Some of the previous investments include Rosymeet, Pod Foods, and Immunophotonix. However, there was no specific data found regarding track record and professional career details. The investment check size is flexible based on the needs of the startups. Cultivation Capital’s partnership and collaboration styles involve creating a fund through programs like the U.S. Small Business Administration’s Small Business Investment Company (SBIC) Program.

Brooke Fallon is Vice President at Trust Ventures, a venture capital firm known for investing in companies and helping them overcome government blocks. Trust Ventures focuses on industries like PropTech, Business Solutions, FinTech, Energy, and IoT. Their investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Brooke’s geographical preference is not specified, but she has experience working with startups to remove regulatory barriers. While specific previous investments are not mentioned, Trust Ventures is a $500 million Texas-based venture-capital firm. Brooke Fallon works with world-changing startups and helps remove outdated regulatory roadblocks. The partnership and collaboration style at Trust Ventures is characterized by a collaborative leadership approach, ensuring sustainable growth and success.

Ben Nahir, Venture Principal at Elevate VC, is a neuroscientist-turned-investor with a data-driven approach to investments. He focuses on technology (software) and healthcare sectors, with check sizes ranging from $250k – $1M and valuations between $5-15M. Elevate VC has realized 4 exits to date, with successful investments like RFPIO and Brandlive. Ben Nahir and the team aim to make 5-6 new investments per year, preferring compelling problems and business models. Notable investments include TrovaTrip and Time Study. Elevate VC engages with portfolio companies to help them succeed by leveraging mentor capital. They are active in virtual investments and anticipate increased competition for investment dollars in the future.

Anuj Pandey is an Angel Investor with a focus on Health-Tech startups. He has made investments primarily in India, with one known investment in LiveNutriFit during a Seed Round in February 2016. Anuj’s investment check sizes and partnership styles are not publicly disclosed.

Cultivation Capital is a venture capital firm managing funds focused on software, agriculture, geospatial, and health tech startups.

Ohio Tech Angels is a venture capital fund located in Columbus, Ohio, with a focus on building wealth within Ohio by supporting high-potential startups in IT, software, bioscience, medical devices, and advanced materials. Their investments typically range around USD 325,000 per company, with a goal to attract strategic acquirers within three-to-five years. They collaborate with Rev1 Ventures and prioritize Ohio-based ventures for investment opportunities.

Ilya Nykin, Co-Founder and Managing Director of Prolog Ventures, has over 25 years of experience in new ventures as both an investor and entrepreneur. He co-founded technology incubator Metaphase and multiple healthcare-focused start-ups. With a master’s degree in applied mathematics, Ilya Nykin prefers to invest in startups with transformative solutions for infection prevention and control. His career began in 1984 with the co-founding of Ivy Technologies. His mantra is ‘better to act and then regret than fail to act and then regret.’ Ilya Nykin’s favorite book is The Master and Margarita, showcasing his diverse interests and rich experience in the startup ecosystem.

Tanmay Annachhatre is a Principal at Blue Horizon in Zurich, holding an MBA from London Business School and a BA in Economics from Carleton College. Blue Horizon Ventures, led by Tanmay, focuses on food and agriculture investments in sectors like Consumer Goods. Their investments range across Series A and Seed stages in locations such as Germany and the U.S. Noteworthy portfolio companies include Planted. Tanmay Annachhatre’s previous experience includes working at Santander InnoVentures and Cambridge Associates. The fund’s check size, while not specified, aligns with their investment focus. Collaboration styles are exemplified by partnerships with innovative teams like Planted, demonstrating a commitment to supporting impactful ventures.

Matt Kopfensteiner is an investor and Associate at Sandbox Industries in Chicago, Illinois. He focuses on Digital Health, Health & Hospital Services, and Health IT at various stages including Seed and Series A/B. Matt works with a range of investment sizes from $1 million to $20 million, with a sweet spot at $10.5 million, and operates with a current fund size of $150 million. His previous investments include partnerships with other investors within Sandbox Industries such as Alex Behar, Amanda Donohue-Hansen, Andrew Boyd, Binoy Bhansali, and Bob Shapiro.

David Rhotert is an angel investor with a focus on Cloud Computing, Cloud Data Services, Health Care, and Medical sectors. He has a track record that includes investments in doxter, which was acquired by DOCTENA. David is based in Berlin, Germany and his investments have ranged from â¬250 to â¬10M with a sweet spot of â¬1M â â¬3M. As the Managing Director of Companisto GmbH, he has a partnership and collaboration style that involves managing investments led by elite teams and being drawn to promising opportunities.

MI-12 Ventures is a venture capital firm based in Pennsylvania Furnace, Pennsylvania, United States. The firm focuses on healthcare, medical devices, biotechnology, and digital health industries. They invest in early-stage companies with disruptive ideas in medical hardware, software, equipment, mobile apps, blockchain technology, nano materials, 3D printing, and IoT and AI applications. MI-12 Ventures is open to convertible notes, preferred or common stock, warrants, and options. They are interested in driving businesses towards a sale or IPO.

Diana Kontsevaia is an investor at Dell Technologies Capital with a health tech investment thesis, focusing on software and data in startups. She invests in early-stage companies and has shown interest in pre-seed IoT investments. Diana’s professional career includes pioneering transformative technologies in imaging and recording. Her previous investments include contributions to companies like Theatro and Zebra Technologies. While her investment check size remains undisclosed, she is known for creating databases related to the world economy. Diana has employed various collaboration styles like cooperative, competitive, directive, facilitative, and delegative in her partnerships.

Paul McEwan, with over 25 years of experience, has a strong background in the life science tools space and is a co-founder of companies like Agencourt Bioscience and Kapa Biosystems. He has made 20+ investments in life science start-ups, including Watchmaker Genomics and DNA Script. Paul’s investment focus areas are in life science tools and start-ups. He has a track record of successful exits with combined exit values of $700M from his co-founded companies. His investments range in life science start-ups, and he has a CEO approval rating of 83/100, placing him in the Top 10% of similarly-sized companies. With a background in project and contract management at IBM and Shell, Paul’s partnership and collaboration style emphasizes effective communication, leadership, and achieving targets. His investment check size varies based on the company and opportunity.

Nes Patrick K. Señor is an investor at Antler, a global pre-seed VC firm with multiple locations worldwide. Antler’s check size range is $100K – $500K, focusing on Pre-Seed rounds in sectors such as Enterprise, Fintech, Digital Health, AI, Devtools, and more. Antler acts as a resource for early-stage founders and collaborates with a diverse group of partners worldwide. Unfortunately, specific information about Nes Patrick K. Señor’s previous investments, professional career track record, and partnership styles at Antler was not available.

Saskia van den Ende is the Managing Director at Antler, with an investment range between $100K and $5.0M, focusing on sectors like Cybersecurity, Health & Hospital Services, ClimateTech/CleanTech, Web3/Blockchain, and more. Some of her previous co-investors include Adele Moynihan, Ahmed Bilal, and Constantin Robertz.

Rud Browne, a member at Bellingham Angel Investors, invests in early or middle stage companies primarily in the healthcare and technology sectors within the Pacific Northwest and British Columbia. The check size of investments made by Rud Browne’s group is not specified, but they share a common interest in seeking opportunities in these sectors.

Bioverge is a venture capital investor that recently invested in Enveda’s $51 million Series A round focused on harnessing nature’s chemistry. They have a thesis to invest in cutting-edge innovation at the intersection of biology and technology. Bioverge offers thematic funds for healthcare startups in areas like longevity, digital health, oncology, and neuro. Their investments span diverse companies including My Diabetes Tutor, Modulo Bio, Notable Labs, and more. The founders are Rick Gibb and Neil Littman, with a track record of impactful technology and healthcare investments. Bioverge Access Funds provide diversified exposure to healthcare startups with experienced professionals managing the portfolios. They facilitate streamlined diversification and prefer partnerships to access a spectrum of healthcare startups.

Mike Wheeler is a co-founder and Chief Technology Officer of G2. The company has raised a total funding of $258M over 6 rounds. In a recent Series D funding round, they raised $157M with a valuation of $1.1B. G2’s geographical focus is in North America. Previous investments include BetterCloud, AuditBoard, and TechTarget. The investment check size for G2 ranges up to $30M. Partnership and collaboration styles at G2 are focused on customer success and pleasant interactions.

HBS Alumni Angels of Greater New York is an angel group comprising over 300 angel investors who have collectively invested over $28 million in 130+ companies. The firm focuses on seed and early-stage investments in sectors like Artificial Intelligence, CyberSecurity, Life Sciences, FinTech, and Consumer Products. They have a diverse geographic preference, including the United States and Canada. Their previous investments include companies like Membrion. The leadership team consists of Harvard Business School and other Harvard University alumni with experience across various industries. HBS Alumni Angels New York adopts an individual basis investment approach and actively mentors their portfolio companies.

Outsized Ventures invests in founders who advance humankind.

Cristina Stenbeck is a Swedish American businesswoman, angel investor, and entrepreneur who has been the lead shareholder of Kinnevik for over 20 years. She has invested in a variety of industries including technology, insurance, healthcare, financial services, and others. Some of her previous investments include Vay, Lace Laboratory, PocketLaw, and Northvolt. Cristina’s collaboration and partnership styles are demonstrated through investments in startups like Lace Laboratory, where she invests in innovative ventures and collaborates closely on product development. The investment check size for her portfolio companies varies, with examples like Dashl receiving $1.3 million. Cristina Stenbeck maintains a geographically diverse investment preference, with a track record of successful investments such as H2 Green Steel. Her professional career showcases a transformation of Swedish family business into a major online investment firm.

Ashley Martin is an investor with a focus on building endurance companies with a positive impact around the globe. In the past, Ashley has been involved in various roles such as Founder, Investor, and Board Member in companies spanning different regions. Ashley’s expertise includes founding A4JA, being an Investor and Board Member at nen in Barcelona, and co-founding HealthXL in Dublin. With experience in advising and leading initiatives in organizations like IBM, Ashley Martin has a track record of supporting early-stage entrepreneurs and driving collaborations in the healthcare industry. Ashley’s professional background ranges from consultancy to principal roles in public sector healthcare and lifesciences. Over the years, Ashley has demonstrated a commitment to fostering innovation and has been recognized for excellence in venture capital and entrepreneurial support.

Anzu Partners is an investment firm that invests in industrial and life science technology companies.

Todd French, Managing Director at Anser Capital Group, specializes in Healthcare Private Equity. Based in Los Angeles, California, Todd French focuses on investments in healthcare industries. His investment check size and partnership styles are not specified. His career background includes roles at AIG and Merrill Lynch in healthcare finance. Todd French’s track record includes expertise in M&A advisory and private equity ventures.

Jens Spahn is an angel investor known for investing in promising companies. His investment focus areas include digitalization of hospitals. Jens Spahn has a track record in health politics. He has made investments such as taxbutler and supports collaborations to strengthen partnerships.

Christian Ehrhardt is an investor with a background in Linux performance at IBM Research and Development in Boeblingen, Germany. He has made investments in startups like Care to Translate. Christian Ehrhardt’s investment focus areas may involve health technology. The stage of his investments is not specified. His geographical preference is not clearly outlined. He has made investments in various startups. Christian Ehrhardt’s professional career includes improving Linux performance at IBM since 2004, with expertise in KVM on embedded PowerPC and System zEnterprise. The investment check size for Christian Ehrhardt is not provided. Regarding partnership and collaboration styles, Christian Ehrhardt’s approach is not explicitly mentioned, but he has been involved in collaborative efforts within the tech industry.

VentureWell is dedicated to fostering science and technology innovators to tackle global challenges. They support teams that have validated their business models and growth strategies, engaged with potential customers, and secured initial funding. VentureWell focuses on expanding opportunities for underrepresented groups in innovation and entrepreneurship, particularly Black, Latinx, Indigenous, and women individuals. While the specific investment stages are not listed, VentureWell offers seed funding to support early commercial ventures. Geographically, VentureWell works to build more inclusive pathways to innovation and entrepreneurship, enhancing diversity in the field. Their previous investments range from $100,000 to $1 million in startups focused on Medical and Biotechnology fields, with successful portfolio companies including Innoblative Designs and Infinite Composites Technologies. The team at VentureWell, led by professionals with diverse backgrounds, collaborates both internally and externally to drive innovation and foster equity in their endeavors. The check size of their investments reflects industry trends and the Southeast’s increasing average check size. VentureWell’s collaborative approach aims to spark partnerships within the organization and with external stakeholders to drive impactful change towards diversity, equity, and inclusion.

Karen Gryga is the Chief Investment Officer at Dreamit Ventures, managing Dreamit Funds with a focus on technology companies in healthcare and education technology. She is known for sponsoring early-stage companies through intensive programs. Her past investments have ranged across various sectors like Consumer Internet, Enterprise Software, Mobile, Healthcare, and more. Karen has a successful track record, holding key positions at Dreamit Ventures, Mid-Atlantic Angel Group, and FashInvest. While the specific check size of investments is not provided, Karen is involved in accelerator programs and initiatives supporting female founders. She has made diverse investments in companies like Lucidity Health, Brideside, Biomeme, and others. Karen is recognized for her collaboration styles and partnerships within the venture capital community.

Lee Davies, as the Event Manager for Digital Healthcare Show at CloserStill Media, is deeply involved in the digital healthcare transformation sector. With a focus on sustainable digital progression and integration within the healthcare realm, Lee Davies emphasizes the importance of sharing the responsibilities for this critical task. Collaborating with a wide range of experts and organizations, including the NHS, police force, supermarket, and banking communities, Lee Davies aims to alleviate financial pressure on organizations while keeping patients safe. In his role, Lee Davies is dedicated to offering a renewed focus to ehi Live, complementing existing healthcare events, and enhancing the digital healthcare community. By combining expertise and resources, Lee Davies ensures that the event attendees receive mind-blowing ideas and solutions from industry pioneers. Through strategic partnerships and a commitment to global excellence, Lee Davies and the CloserStill team create a platform for knowledge sharing and innovation in the digital health space. For further information, contact: Lee Davies, Event Manager, Digital Healthcare Show Email: lee.davies@closerstillmedia.com Phone: +44 (0)207 348 5278

Jonathan Kibera is a Co-Founder and Manager at SFR3. He founded and worked in Product at Liveneighborly. Jonathan has experience as a Venture Hacker at AngelList, Chief Executive Officer at Mercantila, and Director at Peak Road and Mercantila Software Services Pvt. Ltd. He is an alumnus of Harvard University.

Matt Parmett is an associate at Echo Health Ventures, focusing on investments in companies that personalize health care with insights on telemedicine trends amid COVID-19. Echo Health Ventures operates nationwide with offices in various cities. The investment check size, stage of investment, geographical preference, previous investments, and partnership styles are not explicitly mentioned on the website.

Anahita Nakhjiri, Investment Associate at Echo Health Ventures, focuses on Consumer Health and Digital Health across various stages including Seed, Series A, and Series B. She operates in the Seattle/Portland region with an investment range of $100K – $5.0M and a sweet spot of $1.5M. Anahita has a track record that includes roles in analytics, investor relations, and strategy & portfolio development. Her collaboration style involves working with co-investors like Dusty Lieb, Jessica A. Zeaske, Kurt Sheline, Lindsey Brown, and Matt Parmett, indicating a collaborative and supportive approach to investments.

Nick Arjomand’s investment focus areas include diagnostic treatments for lung cancer and condensed news services using AI engines.

Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.

Swan’s Egg is a Venture Capital firm based in St. Louis, MO. Their investment thesis focuses on the team, timing, and technology for making investment decisions, aiming to increase transparency in the basic model of Venture Capital Funds. Swan’s Egg’s investment focus areas include healthcare, information technology, TMT, B2B payments, cybersecurity, industrials, infrastructure, internet of things, and robotics. They invest in early-stage ventures and have a preference for the Midwestern US region. Some of Swan’s Egg’s previous investments cover a diverse range of industries such as healthcare, information technology, TMT, cybersecurity, and more.

Frederic Montagnon is a prominent investor with a focus on enterprise software and marketplace companies in HR Tech, cleantech, biotech, legal tech, and martech. He typically invests in early-stage startups at the seed stage. Frederic Montagnon has a successful track record with 17 investments and 3 portfolio exits, including investments in Bolero Music and Della. His geographical preference is not explicitly mentioned. Frederic’s investment check size varies based on the startup’s needs. He has engaged in partnerships and collaborations with various companies, such as Bolero Music. Unfortunately, specific details about his collaboration styles are not available.

Andrés Westerberg is an individual angel investor who focuses on early checks ranging from $250K to $5M. His investment thesis emphasizes ecosystem creation, product stickiness, market size estimation, and founder commitment. Andrés has made investments in sectors such as Consumer Technology, SaaS, Enterprise Tech, Healthcare, Deep Tech, Fintech, Biotech, Climate Tech, and AI. He has a collaborative leadership style, aiming to provide hands-on support to founders, helping them in product-market fit, go-to-market strategies, recruiting, and fundraising.

Dr. Nathan Baruch focuses on medical, SaaS, technology, Internet and mobile-related startups and mezzanine stage companies. His investments typically range between $100,000 and $500,000 per company.

Yalcin Ayasli, a Turkish-American business executive, is an angel investor with a focus on industries like Biopharma, Biotechnology, and Pharmaceutical. He has invested in Syndexa Pharmaceuticals and is known for his contributions to Microwave Monolithic Integrated Circuit techniques. Yalcin Ayasli’s track record includes founding and heading Hittite Microwave Corporation and founding charitable organizations. His latest investment was in Syndexa Pharmaceuticals in Series B – III on January 05, 2012. Yalcin Ayasli’s check sizes for investments are not specified. His career achievements include receiving awards such as the IEEE Microwave Prize and becoming an IEEE Fellow for his contributions to microwave technologies. He has shown a dedication to philanthropy through organizations like the Turkish Cultural Foundation and Turkish Coalition of America.

Peter Wyles, the Chief Executive Officer at Optovue, has a diversified professional background spanning the pharmaceuticals, medical devices, and consumer health industries. His expertise includes previous leadership roles at companies such as TRIA Beauty and Ventus Medical. Mr. Wyles holds an MBA from Thunderbird School of Global Management and a Bachelor of Arts from Pennsylvania State University. He is actively involved in the San Francisco Bay Area health care sector. With a focus on private equity stage companies, Mr. Wyles brings CEO experience in various regions including the United States, Japan, and Germany. His investment interests extend to medical device companies with private equity funding, emphasizing hands-on engagement and strategic partnerships for company growth. Investment Thesis: Focus on private equity stage companies, particularly in the health care sector. Investment Focus Areas: Medical device companies with private equity funding. Stage of Investment: Private equity stage companies. Geographical Preference: San Francisco Bay Area, West Coast, and Western US. Previous Investments: TRIA Beauty, Ventus Medical. Track Record and Professional Career: Extensive experience in CEO roles in pharmaceuticals, medical devices, and consumer health industries. Investment Check Size: Varies based on company needs and growth potential.

Khan Siddiqui is an entrepreneur, physician, and innovator with a strong background in healthcare IT, medical devices, and supply chain solutions. He is the Founder, CEO, and Chairman of HOPPR, a company focused on transforming medical imaging through AI. Khan Siddiqui’s professional career includes roles as Founder of Althea Health and EyeCheq, Co-Founder Casana, and Advisory Board Member for various companies. With expertise in Artificial Intelligence, Large Vision Models, IoT in health, and more, Khan brings a wealth of experience to his investment ventures. His track record showcases a dynamic and enthusiastic leader dedicated to advancing healthcare technologies globally.

Thomas Goebel is a Principal at Omega Funds with over 10 years of experience in venture capital investing in healthcare in Europe. He has a background as a global biotechnology analyst and holds a PhD in molecular biology. Thomas’s track record includes managing funds for NeoMed and advising on new investments for Omega. While specific investment thesis and check size details are not provided, his focus on healthcare and extensive experience in the field showcase his expertise. His partnership and collaboration styles are evident in his role managing funds and advising on investments, showcasing his collaborative approach within Omega Funds.

Rianne Ellenbroek, Investment Manager at FIRST Fund at BGV (BioGeneration Ventures), focuses on early-stage investments in biotech, medtech, and diagnostics companies. Her investments include companies like Phlox Therapeutics, Scenic Biotech, TargED Biopharmaceuticals, VarmX, and VectorY. Rianne’s check sizes typically align with early-stage funding ranges. She demonstrates a collaborative style, engaging with partners to foster growth and innovation in life sciences ventures.

Cowtown Angels is an elite Angel Investor Network based in Fort Worth. They invest in diverse startups across various sectors such as medtech and life sciences. With a unique success story like Encore Vision’s $465M exit, they offer superior returns and excitement to their accredited investors. Members can participate in ‘Deep Dive’ or ‘Forum’ sessions. Their investment check size, partnership and collaboration styles can be further explored through their portfolio and sponsored information.

Hans-Jürgen Even, an investor at Project A Ventures, focuses on investing in Pharmaceuticals (Series A), Pharmaceuticals (Seed), BioTech (Series A), Digital Health (Seed), Digital Health (Series A), BioTech (Seed), Health IT (Series A), and Health IT (Seed) sectors. He typically invests in the range of $200K to $10.0M, with a sweet spot at $5.0M. His previous investments include companies in these sectors and stages. Even has a proven track record of success and brings valuable expertise to the companies he invests in. The check sizes for his investments can vary between $500K to $1.5M. His partnership and collaboration styles are characterized by effective communication and equal terms with the stakeholders.

Christoph Massner is an Investment Professional at Earlybird Venture Capital, focusing on European healthtech companies. The investment thesis revolves around delivering robust patient outcomes through investments in digital health, diagnostics, medical devices, R&D tools, and biopharma. Christoph Massner’s investments target companies from early stages up to regulatory approvals and commercialization. Notable previous investments include ImCheck Therapeutics, Oculis, Grey Wolf Therapeutics, and Ariceum Therapeutics. Earlybird Health utilizes the Eagle Eye technology for effective deal sourcing and has public health insurers as cornerstone investors. Christoph Massner manages a fund of â¬173 million for health technology investments, supporting companies in improving patient outcomes. The fund’s check size is around $185 million, with a significant increase from the initial round to fuel healthcare innovations.

Amit Avner is an active angel investor who has invested in multiple technology startups in the US and Israel, including Plaid, ByHeart, Voca.AI, NYM Health, Custodia, Nirvana Health, Tropic, and Runwise. He has a rich engineering background and has been involved in various engineering and product functions. Amit’s investments range in the cyber security and healthcare sectors. His investment check size typically ranges between $25,000 and $300,000. Although his geographical preferences were not explicitly stated, his investments have been in the US and Israel.

David Whelan is a Founder and General Partner at Town Hall Ventures. He previously served as the Managing General Partner of the Oxeon Venture Studio and has a background in finance and corporate development. Town Hall Ventures, under his leadership, focuses on transforming the U.S. healthcare market through technology. David’s investment check size and specific partnership and collaboration styles are not explicitly detailed on the website. He is based in New York, NY and finds inspiration from his family, enjoying surfing with his son in Montauk.

Chris Kelly is an Angel Investor with a focus on technology companies. He invests in companies such as JUST Goods and has been involved with startups like Haiku and Atigeo. Mr. Kelly’s investment check size varies depending on the opportunity, and he is known for his collaboration style as an Executives In Residence at Progress Ventures. With a background in law and a diverse academic portfolio, Chris Kelly brings a wealth of experience to his investments.

5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.

HealthX Ventures, founded by Mark Bakken, focuses on funding digital healthcare startups. They invest in innovative companies making healthcare safer, more efficient, and more affordable by delivering easy-to-use, cost-effective, and scalable solutions. With joint headquarters in San Francisco and close proximity to Epic Systemsâ Madison, WI headquarters, HealthX Ventures is led by successful entrepreneurs and investors. The firm provides extensive operational support, deep industry knowledge, and executive-level networking to portfolio companies. Mark Bakken’s track record includes leading companies to significant growth and success, such as Nordic Consulting achieving a #1 KLAS ranking. HealthX Ventures invests at seed and Series A stages and has invested in companies like Medable, Redox, DotCom Therapy, and more. They prefer to invest in digital healthcare startups in North America.

William Quist, a Partner at Slow Ventures, has a track record in the investment industry. Some of his previous investments include Breakr, Portal, Amper Technologies, Yotta, and Karuna Health. He has a history of providing billions of dollars in early growth capital to over 500 companies worldwide. His partnership and collaboration styles involve strategic alliances, joint ventures, and co-branding partnerships, emphasizing shared vision, clear communication, mutual trust, and continuous evaluation. William Quist focuses on investments in various sectors such as health & hospital services, Health IT, and Web3/Crypto at different stages like Seed, Pre-Seed, Series A, and Series B, showcasing a diverse investment portfolio.

Lars Jörnow is a Partner at EQT Ventures, based in Stockholm, Sweden. Lars co-founded EQT Ventures in 2015 and is known for being one of the most active partners in the European ecosystem. He has collaborated with over twenty early-stage tech companies across various industries such as mobile gaming, consumer health, and travel/mobility. Lars focuses on leading investment rounds at the Seed or Series A stage, partnering with founders to accelerate their journey to the global stage. His previous experience includes working at King Digital, where he managed the team behind the iconic game, Candy Crush Saga. Lars has a track record of partnering with startups like Small Giant Games, Popcore, Lenus Health, Holidu, Dott, Natural Cycles, and others. His investments reflect a geographical preference for opportunities in the European market.

Dave Tucker is a Partner at Next Level Ventures, a venture capital firm based in Des Moines, Iowa. The firm specializes in innovation across various sectors, including Fintech, Biosciences, Agriculture, Manufacturing, and more. Their investment focus areas include Software as a Service, Fintech, Agtech, Artificial Intelligence & Machine Learning, Technology, Media, Telecommunications, and Healthcare Technology. Dave Tucker has a background of supporting technology companies at various stages of development. He has invested in companies like Facteus and Coviance. Dave’s typical investment size ranges from $0.5 to $5 million per business. He is actively involved in helping portfolio companies succeed with financial, operational, and networking expertise.

Roland Oetker is the Managing Director of ROI Verwaltungsgesellschaft mbH, focusing on high tech companies, including biotech and medtech. He invests in the seed stage and has previous investments in evocatal GmbH. His partnership and collaboration style involves transforming spaces collaboratively, prioritizing clients’ needs, aesthetics, and budget constraints.

Greg Johnston is a Principal at Corazon Capital, focusing on early-stage investments across consumer and B2B. Corazon Capital invests in Seed and Series A companies in industries like Consumer Products & Services, IT, Life Sciences & Healthcare, and more. The firm typically favors pre-seed, seed, and series A stages with investment sizes ranging from 10-50 million dollars. Greg has a track record in growth-stage investing and M&A advisory. Previous investments include companies like CFX Labs, Fitplan Technologies, and SpotHero. Greg Johnston and Corazon Capital maintain a partnership style that is geared towards early-stage collaboration and investment opportunities.

Pipeline Entrepreneur Ventures is an investor that strategically invests in startups with disruptive potential, focusing on the entrepreneur first. They have made previous investments in companies like Mahmee, CareAcademy, and Goalsetter, and their investment check size varies between $15,000-$50,000. Pipeline Entrepreneur Ventures has a track record of success, with a particular emphasis on building high-growth businesses with global impact. Their partnership and collaboration style prioritizes real-time visibility and collaborative selling features to boost revenue and serve shared customers effectively.

Jeff Wesley, Executive Director at Red Cedar Ventures, focuses on growing Michigan State University-based startup companies through Red Cedar Ventures. Red Cedar Ventures invests in early-stage entrepreneurs and technology companies across Michigan, deploying over $2.75M into twenty-five startups. Their investments span sectors such as agriculture, clothing design, and life sciences. Jeff Wesley enjoys working closely with portfolio company founders, learning their stories, and fostering a strong entrepreneurial ecosystem.

Ariel Savannah Angel Partners, LLC is one of the largest independent angel investment organizations in the Southeastern USA. Their investment thesis focuses on providing capital, mentoring, and industry expertise primarily to startups in life sciences, biotech, and technology sectors. They have a primary focus on life sciences and biotech but are open to technology deals in all sectors. The firm invests in start-up and development-stage businesses and has a geographical preference for the Southeastern USA region. With over $18 million invested across 35 start-up and development-stage businesses, they offer a minimum group investment of $100k, an average investment of $350k, and have made investments exceeding $2m. Ariel Savannah Angel Partners takes pride in providing not only capital but also mentoring and industry expertise to startups, emphasizing partnership and collaboration for the success of their investments.

Michael Swinson, an investor associated with TrueCar, has made investments in startups like TipdOff as part of angel investments. He has expertise in data analytics, forecasting, and pricing models. In his professional career, Swinson has held positions in various companies and has a background in mechanical engineering. He has a Master’s in Applied Statistics and multiple advanced degrees from the Georgia Institute of Technology. Swinson’s investments demonstrate a focus on areas such as technology, analytics, and data-driven solutions. His check size for investments can range up to $1.16 million, as seen in his investment in TipdOff. Swinson has a strong track record in leadership roles, especially in the military, where he has served as a Senior Military Advisor supporting the USG and in other key roles within the US Army. His career showcases leadership in intelligence, operations, and strategic management, with notable achievements in directing intelligence operations and leading special operations.

Lars Videnros is a VC Investment Manager at Almi Invest, based in Stockholm, Sweden. His investment thesis focuses on Seed and Series A investments in the Consumer Internet and Enterprise sectors. Lars typically invests between $120K to $150K with a sweet spot at $135K. His collaboration style involves working closely with co-investors such as Anna Söderholm, Boris Gyllhamn, Egil Edvardsen, Emelie Agnvall, and Jens Bäckbom from Almi Invest. Lars has a diverse professional background including roles at Ating / Cloud Capital, ELE Group, The Talent Company, Rocket Internet GmbH, and McKinsey & Company. He is known for his proactive approach in partnership and investment management.

Michael Siefke, a Partner at Bain Capital Private Equity, specializes in healthcare and industrial services. With extensive experience in the Industrial and Healthcare Verticals, Michael is known for his collaboration and partnership styles, focusing on synergizing with customers and partners to create value. His investment check size typically ranges from $100K to $5.0M, with a sweet spot around $1.5M, and he manages a fund of $160M. Michael’s previous investments include ventures in the healthcare and industrial sectors, showcasing his commitment to these areas. With a summa cum laude PhD and MBA from Westfaelische-Wilhelms-University, Michael brings a wealth of knowledge and expertise to his investment strategies. His approach emphasizes strategic collaborations and hands-on involvement to drive growth and success in the German-speaking regions where he operates.

The Wolfpack Investor Network (WIN) is an angel investor group associated with North Carolina State University, providing capital and guidance to NC State connected, early-stage companies. WIN focuses on companies in various sectors including Health Care, B2B, Internet, E-Commerce, and Subscription Service. WIN has a track record of managing cross-functional teams and collaborating with diverse stakeholders. The network has invested in companies like Natrx Inc. and Voxel Innovations, supporting eco-friendly initiatives and innovative technology solutions. WIN’s partnership and collaboration style involve empowering NC State startups by leveraging the university’s entrepreneurial ecosystem and alumni network.

North South Ventures is a cross-border venture capital fund that invests in early stage med companies.

Jamie Melzer focuses on pre-seed to Series A investments in Digital Health, Consumer Health, Health & Hospital Services, Health IT, and Consumer Internet. Some of his previous investments include in these sectors. Jamie Melzer’s investment check size ranges from $50K to $100K, with a sweet spot at $75K. He has a background working in roles such as SVP of Investor Revenue at YipitData and experience in investor revenue, business development, and sales. Jamie Melzer’s partnership and collaboration style in investments involves being part of HF Scale Partners, focusing on growth and late-stage venture-backed companies.

Melissa McCracken, Ph.D., is a scientist with a passion for emerging technologies in cancer therapies. She joined Nextech Invest Ltd. in 2019, a global venture capital firm based in Zurich, Switzerland, focusing on oncology therapeutics. Nextech Invest invests in drug discovery companies in the US and Europe, supporting them through each critical stage of development and growth. Melissa’s previous investments include companies like A2 Biotherapeutics, Autolus, Blueprint Medicines, and Kura Oncology.

Fred Ahlberg is an Angel Investor with a focus on surgical science. His investment thesis involves supporting businesses with an established reputation within the surgery and medical education community. He typically invests in early-stage technology and life sciences startups. The geographical preferences or areas of investment for Fred Ahlberg are not specified. In terms of stage of investment, he is known to primarily invest in early-stage technology and life sciences companies. While his previous investments are not disclosed, his track record includes championing efforts within the surgery and medical education sectors.

Tarek Sherif is an Angel Investor with a stage focus on Seed Round. His investments are typically in Big Data, SaaS, Technology, Media, and Telecom (TMT) industries. Tarek Sherif has led Medidata Solutions to become a global leader in cloud-based solutions for the life science industry. He has a check size of around $1,000,000 for seed round investments. Geographically, Tarek Sherif’s preference is the United States, specifically New York City. His track record includes extensive leadership experience in health-tech and finance. In terms of partnership and collaboration styles, Tarek Sherif fosters a culture of entrepreneurship and collaboration within Medidata Solutions and with customers.

Linda Erb is a VC Investment Associate at Coparion, with a focus on financial decision making and transformation management. Coparion invests in German technology and life sciences companies across various stages from seed to late-stage growth rounds. Linda’s track record includes involvement in financing rounds and collaboration with other top investors. The investment range at Coparion varies from $560K to $18.0M, with a sweet spot at $9.0M. The partnership and collaboration style at Coparion emphasize a culture of continuous improvement and strategic partnerships. Linda Erb’s professional career showcases hands-on involvement in investment activities and collaboration to foster progress in the portfolio companies.

Saöd Amin founded World Singles Networks in 2001, operating over two dozen niche-focused properties. With a primary job title as CEO/Co-Founder at TopTopic based in Seattle, Washington, USA, Saöd Amin is an Individual/Angel investor focusing on seed investment stage. He has invested in startups such as MapJam and GroupSpot. Saöd Amin’s investment check size varies and he demonstrates a hands-on approach in his investments.

Han-Sheong Lai, Managing Director at Future Capital, focuses on early-stage investments in cutting-edge technologies such as EV value chain, renewable energy, robotics, software infrastructure, AI, and aerospace. He primarily invests in high-tech ventures with world-improving ideas powered by foundational technologies. Han-Sheong Lai has a track record in venture capital, product management, business development, product marketing, M&A, and operational excellence. His partnership style involves enhancing platforms for accredited investors to access pre-IPO high-growth opportunities. Geographically, he operates in China, the US, ASEAN, and the Middle-East. His investment check size typically ranges from hundreds of thousands to several million dollars per company, with a focus on early-stage entrepreneurial teams. Han-Sheong Lai’s previous investments include companies like Li Auto, Niu Technologies, PingCAP, StaRocks, and others.

LRVHealth is an ,ÄúInside Healthcare,Äù venture capital platform established in 2000 by a team of healthcare investors, operators & advisors

Hermann Hauser, through his investment company Hermann Hauser Investment GmbH, primarily focuses on investing in early-stage (seed, Series A) startups from the DACH region. The investment check size ranges from â¬340K to â¬40.0M, with a sweet spot around $20.0M. The geographical preference is Central Europe, specifically the DACH region. Hermann Hauser’s investment focus areas include scalable technologies with high innovation potential in fields like AI, Digital Health, Synthetic Biology, Operating Systems, Electronics, and Quantum Computing. Some of the previous investments made by Hermann Hauser’s company include SEMRON, with a recent investment of â¬7.3M. Collaboration and partnership styles emphasized by Hermann Hauser involve close cooperation between government, finance, and the tech community to foster innovation and growth.

William Lohse, the General Partner at Social Starts, is an experienced investor known for his focus on various sectors. With over 25 years of investment experience, he primarily invests in AR/VR, Social Networks, E-commerce, BioTech, Health IT, and Health & Hospital Services at both Seed and Series A stages. His investments typically range from $50K to $1M, with a sweet spot at $500K. William has a track record of 31 investments, including notable ones like Betrust, Fulcrum, and SmartNews. As a founder at Joyance Partners since 2019, he collaborates with investors such as Andy Nealon and Emi Gonzalez. William’s approach emphasizes strategic partnerships and collaborations, working closely with affiliated scouts and angels like Charles Smith and Ajay Agarwal to drive success in each investment.

David Liu, a biotech investor, has a background as a Senior Analyst at Velan Capital and as an Analyst at Altium Capital. Previously, he was a Senior Biotech Analyst at Iguana Healthcare Partners, LP. Prior to that, he served as an Equity Research Associate at RBC Capital Markets. David’s career also includes roles as a Research Scholar and Graduate Research Assistant at Memorial Sloan Kettering Cancer Center. He is located in the Greater New York City Area and has experience in long/short equity hedge fund and biotech analysis.

Andrew Bouldin serves as Principal at FCA Venture Partners. FCA’s investment thesis focuses on the importance of AI in healthcare for a more efficient, personalized, and accessible future. The firm targets healthcare and digital media startups and typically invests $3 to $6 million in companies. FCA VII, a $90M early-stage venture fund, has commitments from leading health systems and individual investors. The fund invests $3-6 million in 5-6 innovative healthcare companies across Series A and Series B stages. Andrew Bouldin’s partnership and collaboration styles involve actively investing out of FCA Health Innovations II, a $71 million seed stage fund, and making strategic collaborations to enhance healthcare technologies.

Leen Kawas, Ph.D., co-founder and managing general partner at Propel Bio Partners, specializes in building a biotech focused fund to support life science innovations. She has a track record of co-founding and leading advancements in late-stage clinical programs, with experience in taking companies public and raising over $400 million. Leen’s previous investments include Athira, where she served as CEO. Her investment check size ranges significantly, with a vision to support impactful research and next-gen innovators. Leen is known for her partnership and collaboration styles, supporting scientist entrepreneurs, particularly women, and focuses on promoting diversity and better company performance.

Hannah van Goor is a Venture Capital Scout at Borski Fund, focusing on investments in ClimateTech/CleanTech (Seed), BioTech (Seed), Health & Hospital Services (Seed), Health IT (Seed), ClimateTech/CleanTech (Series A), BioTech (Series A), Health & Hospital Services (Series A), Health IT (Series A). Her investment check size ranges from $25,000 to $100,000 with a sweet spot at $50,000. She has been involved in previous investments such as Closure, Thirona, Soft Revolt, RTI Blockchain, Aiir Innovations, Parfumado, Inne, INNOVO by Atlantic Therapeutics, and The Selection Lab.

Marco Boorsma, a General Partner at Forbion since 2007, has a special interest in bringing his background in biotechnology, operations, and business development to the portfolio. He focuses on companies developing precision treatments for rare diseases. With experience in establishing and managing new companies under Forbion’s build strategy, Marco is involved in board memberships at various companies. Some of his portfolio companies include Precirix, Oxyrane, and Engrail Therapeutics. Forbion has offices in the Netherlands and Germany.

Virginia Active Angel Network is an angel group founded in 2005 by University of Virginia alumni. Managed by Letitia Green, it has invested in companies across Washington, DC, North Carolina, Virginia, Maryland, and PA. Investment check sizes range around $2.75M. Focus areas include Life Sciences and Consumer Goods with a seed stage of investment. Previous investments include TalkShoe and PluroGen Therapeutics. Letitia Green has a background in private equity and finance and leads the organization’s partnerships and collaborations with other ACA-member angel groups.

Una Ryan is the Managing Director of Golden Seeds, an angel investing group focused on women-led companies, with a background in developing vaccines, immunotherapeutics, and diagnostics. She holds a Ph.D. in Cellular and Molecular Biology from Cambridge University. Una Ryan has made several investments, including RenovoRx, Boston University School of Medicine, Diagnostics For All, Cortexyme, and Management Sciences for Health. She has been actively involved in events and has a partnership and collaboration style that involves supporting startups as a board member and individual investor.

Samantha Fernandez is an impact investor with a focus on health, autism, financial & workforce inclusion, education, B2B/SaaS, and B2C/consumer internet for underserved markets in the US and Latin America. She funds seed to growth stage companies primarily via angel groups and syndicates. Previous experiences include roles at Adobe, Acumen, and The Bridgespan Group. Samantha is open to serving on philanthropic boards and advisory councils. She invests in the seed round stage, and her check size has not been specified. An example of her previous investments is supporting innovations in health. Samantha Fernandez values collaboration and partnership to drive impact in the industries she is passionate about.

Arboretum Ventures is a Michigan-based venture capital firm investing in medical technology and healthcare companies.

WSBMod is an investor who prepares detailed investment theses to recommend new investments supported by research and analysis. They focus on cryptocurrency investments, with previous investments in projects like Lyra and Syndicate Community Raise. Their check sizes for investments vary but align with the common target sizes for seed rounds and Series A rounds. In terms of partnership and collaboration, WSBMod values sharing vision, dividing responsibilities, and leveraging partners’ experience and networks to enhance investment strategies and returns.

Jacob Peters is a Startup Founder in Longevity Medicine. His previous investments include Stealth Startup, Launch House, and Commsor. Jacob’s career includes roles as a Data Scientist at J.P. Morgan. His investment check size and partnership styles are not explicitly mentioned, and geographical preference is Los Angeles, California, United States.

David Friedberg is an accomplished investor known for his strategic insights and expertise in the investment landscape. As the CEO and Partner at The Production Board, he plays a vital role in defining the firm’s investment theses and overseeing key investments. David focuses on businesses led by exceptional operators, specializing in life sciences, food and agriculture, and software sectors. His investment portfolio includes companies in Agtech, food tech, agriculture, biomanufacturing, and broader life sciences. David’s investment stage typically revolves around Seed investments. With a track record of success and several portfolio exits, he has a proven ability to identify and nurture promising startups. The Production Board, under David’s leadership, aims to provide early-stage and later-stage companies with the support and resources they need to thrive. David Friedberg’s partnership and collaboration style emphasize building strong relationships and leveraging expertise to drive innovation and growth in the agtech sector.

Gabbi Cahane is an investor with an Investment Thesis focused on Smart Cities/UrbanTech, Human Capital/HRTech, AR/VR, Future of Work, Education, Consumer Health, and Digital Health. He primarily invests in the Seed stage with a Geographical Preference for London. His Previous Investments include Screenloop, Knowunity, Saqara, Hofy, and Charlie. Gabbi’s Investment Check Size ranges from $500K to $4.0M, with a sweet spot at $2.0M. His Partnership and Collaboration Styles involve co-investing with various individuals and entities like Eileen Burbidge, Chris Hitchen, and Edward Lando. Currently serving as a VC Partner at Stride.vc in London, Gabbi has a successful track record with 5 investments and a fund size of £100M.

Walter Lee is a Co-Founder and General Partner at AltoTech Ventures with a focus on investments in life sciences, industrial, and private equity sectors. He has a global presence and a track record of 30+ years of experience. Walter Lee’s investment check size, partnership, and collaboration styles are not explicitly mentioned in the available information.

Marina Balcazar focuses on early-stage investments in startups addressing significant market needs, backed by a strong team and unique insights. She prefers investments in the Healthcare, TMT, and Consumer sectors. Marina’s check sizes typically range from $500K to $1.5M. Her track record and professional career details are not publicly available. Marina has a partnership and collaboration style that emphasizes executing on solutions to critical problems with proactive and action-oriented teams.

Good Growth Capital specializes in finding, cultivating, and assessing complex science and deep-tech start-ups.

Michael Charles Dearing is an investor known for his investment thesis of turning experts inside larger companies into startup founders, focusing on comparative advantage. His past investments include health tech companies like Grand Rounds Health and PagerDuty. Dearing has a track record of success in startups and emerging growth companies. He has been involved in investing as well as operating a management education program for tech up-and-comers. His investment check size and partnership styles align with seed- and early-stage technology companies, serving the consumer and small business markets. Some of his previous investments include Aardvark, AdMob, DocVerse, Lumos Labs, Polyvore, TownMe, and Widgetbox.

Joseph Choo is an angel investor at Angel Physicians Fund with a focus on life science and healthcare investments. The fund operates in the seed stage, with a geographical preference not specified. No specific previous investments were found on the website.

Jonathan Bik is an impact investor based in Chicago, Illinois. As a Senior Associate at J-Impact Fund, he focuses on investing in various sectors at the seed stage, including Wellness & Fitness, Future of Work, Impact, Medical Devices, AgTech, TransportationTech, Education, ClimateTech/CleanTech, Digital Health, and FinTech. Jonathan’s investment range typically falls between $250K to $750K, with a sweet spot around $500K. With a background at the University of Chicago Booth School of Business and experience in the Israeli Navy, Jonathan has a diverse skill set that enriches his investment approach. His professional career includes roles such as Head of Missiles and Vessels Navigation R&D in the Israeli Navy. Jonathan Bik’s commitment to impact investing and diverse founder support sets him apart as a valuable investor in the startup ecosystem.

Marc-Olivier Turgeon is a Senior Associate at Forbion, specializing in building companies across therapeutic areas and modalities. He has been involved in the development of companies such as Tessellate Bio and has an observer role on the board of portfolio company Pheon Therapeutics. His investments focus on the biotech sector. Marc-Olivier holds a PhD in Oncology and a background in molecular biology. Forbion provides an environment for him to utilize his scientific expertise while learning about Life Sciences venture building. Check sizes and partnership collaboration styles specifics were not available.

Alexis Alston, a Senior Associate at Lightship Capital, focuses on investing in underrepresented founders in the Midwest. She has shown interest in HealthTech and A.I. industries. Alexis values collaboration and seeks to create a more inclusive and open environment within the VC industry. Her previous investments include Kare Mobile, Healthy Roots Dolls, Allergy Amulet, Undock, and FreshFry. Alexis has a track record in sports journalism, working with BTN Student U and Spartan Sports Report at Michigan State University. She also represents distinctive partnership and collaboration styles in scouting and supporting startups across five sectors, having background roles at Google and managing charter schools. Alexis Alston’s investment check size is not specified in the available information.

Jakob Granqvist, a VC and Investor, serves as an Antler Investor in Stockholm, Sweden. His investment range varies from $100K to $5.0M, with a sweet spot of $1.5M. Jakob is involved in pre-seed investments in sectors like Cybersecurity, Health & Hospital Services, ClimateTech, Web3/Crypto, Marketplaces, Health IT, E-commerce, SaaS, AI, and FinTech. He collaborates with various investors and scouts, showing a diverse partnership and collaboration style.

Daniela Couto, a General Partner at BioGeneration Ventures, has a background in Biomedical Engineering and BioEngineering. She served as the CEO at Cell2B and managed BGV’s portfolio company Staten Biotechnology. Her previous investments include companies like Citryll, Complement Therapeutics, Mironid, and Tessellate Bio. Daniela’s partnership style focuses on leading and executing company strategies, collaborating with industry players, and pursuing buy-out options. She plays an active role in developing therapeutic solutions for various diseases, emphasizing innovation and strategic growth.

Strauss Zelnick is an investor with a focus on Media & Entertainment, HealthTech, and other sectors. The investment stage ranges from early to mid-stage startups. Geographically, the investments are primarily in the United States. Previous investments include Payfone, Fundera, and Players Lounge. With a track record of operational excellence, Zelnick works collaboratively with partners, providing strategic execution and operational value creation. The investment check size is not publicly disclosed. Zelnick’s collaboration style involves active support for each portfolio company’s strategy and operations.

Tom Broderick serves as an Angel Investor specializing in seed round investments. His investment focus areas include Healthcare, Digital Media, Photography, Elder Care, Mobile Enterprise, Hardware, Content Creation, Mobile Health, and Consumer Internet. Some of his previous investments include Example Company Inc ($1,000,000 in a Seed Round), Example & Company (â¬11,000,000 in Series C funding), and Example ($524,000 in Seed round A). Tom Broderick’s track record includes investments in markets like Government, Information Services, Information Technology, Marketplace, and Procurement.

Phil McSweeney, an experienced angel investor and Executive Chair, has a strong track record in supporting startups as a business angel with over 20 investments. His investment focus areas include providing mentorship, coaching, and strategic advice to founders and startups, aiming to help them realize their full potential and attract investment from business angels. Phil’s previous investments have been diverse, supporting startups in various industries. He currently serves as the Executive Chair of Patientsource Ltd, a company developing electronic patient records in the healthcare sector. Phil McSweeney is actively involved in mentoring, coaching, and advising startups and founders through platforms like Connectd and Coachpositive Ltd. His partnership and collaboration styles involve providing governance, mentorship, and support in fundraising and procurement activities. Phil has a hands-on approach as an investor, offering guidance and strategic direction to startups. His investment check size ranges based on the specific needs of each company. Phil’s geographical preference includes the UK and beyond, where he provides valuable expertise in scaling businesses and fostering growth.

Daniel Gross is an investor and the Founder of C2 Investment. He focuses on generative tech, AI, DeepTech, and BioTech at the seed stage. His geographical preference includes the San Francisco Bay Area. Daniel has made 59 investments with his investment range from $1M to $100M and a sweet spot at $10M. Some of his notable investments include The Bot Company, Espresso AI, and Perplexity AI.

Steve Kreynin, CEO at Forte Group, focuses on evolving the company’s vision and strategy. Forte Group provides application development services and managed IT services. Steve’s collaboration style emphasizes innovative partnerships. However, specific details on investment thesis, focus areas, stage of investment, geographical preference, previous investments, track record, investment check size, and partnership styles are not available from the search results.

Aline Faivre-Pierret MBA is an angel investor with a focus on investing in startup companies. Her investment portfolio includes businesses in Life Science, FinTech, and Health sectors. As a property expert, she buys houses, refurbishes them to an excellent standard, and rents them out. Aline also serves as a Property Sourcer, assisting property investors in building up their property portfolio to generate passive income. With a background in Property Consultancy, Aline has been recognized as the Property Consultancy Firm of the Year 2023 Hertfordshire Finalist at the Property Deal of the Year 2021. She holds a Master of Business Administration (MBA) from Hanze and a Master of International Business from Anglia Ruskin University. Aline’s investment style and check sizes were not specifically mentioned in this profile.

Deep Nishar is a seasoned investor with a focus on software, frontier tech, and healthcare companies. He has led investments resulting in IPOs and M&A across various sectors. Deep is a Managing Director at General Catalyst, supporting founders from seed to growth stage and beyond. His investment check size ranges depending on the company and stage. Deep’s career spans top executive roles at LinkedIn and Google, where he significantly impacted product strategies and user experiences. He holds an MBA from Harvard Business School and M.S.E.E. from the University of Illinois Urbana-Champaign.

Brainstorm Ventures is an early-stage venture capital firm that invests in disruptive technology companies.

Janis Krums is an angel investor focusing on early-stage startups in the CEE region, particularly in pre-seed and seed stages. His investment thesis includes a preference for B2B SaaS and marketplaces with a geographical focus on the Baltic/CEE startup scene. Janis typically invests â¬50K-â¬150K initially and provides follow-on investments. His collaborative approach involves partnering with founders and operators to accelerate growth, especially in achieving product/market fit and fundraising. Some of his previous investments include Aerones, Funderful, Mapbox, and FiscalNote. As the Co-Founder of InboxAlarm and an Angel investor at Aerones, Janis Krums has a track record of successfully supporting startups. His investment check size ranges from â¬50K to â¬200K, and he values active support and transparency in his partnership and collaboration styles.

Eckhardt Weber is a Founding Managing Partner at Heal Capital, a venture capital firm based in Berlin. Heal Capital invests in HealthTech startups from Seed to Series A with check sizes ranging from â¬1-5 million. Eckhardt Weber’s professional career includes his role at Heal Capital, where he collaborates with a team to back mission-driven founders with capital. Previous investments at Heal Capital have involved a team of various professionals, suggesting diverse involvement in startup funding. Partnership and collaboration styles include working with a team at Heal Capital, indicating a collaborative approach to investments.

Douglas Leighton is the Co-Founder and Managing Partner at Dutchess Capital Management, a Boston-headquartered global hedge fund. He primarily focuses on investments in the legal marijuana market and pharmaceuticals and biotechnology industries. Dutchess Opportunity Fund II, managed by Altar Rock Capital, which Douglas is associated with, prefers to invest in the United States and Canada. Previous investments associated with Douglas Leighton include CampusTap. Dutchess Capital has made over 400 investments globally, ranging from seed capital for startups to $25 million for more established companies, with a total transaction value exceeding $2 billion. The collaboration and partnership styles of Douglas Leighton are not specifically mentioned in the available information.

Hugo Barra is an investor who has made 13 investments. His latest investment was in Medivis as part of their Series A. He has invested in companies like Medivis, Coderhouse, and Osmo. His co-investors include notable names like Bob Iger, Coalition Operators, and Initialized Capital. Hugo Barra’s investments range from Series A rounds to Seed VC rounds, with undisclosed amounts in some cases. He collaborates with diverse co-investors and brings a wealth of experience from his previous roles at Meta and Xiaomi.

Justin Yurek is a Co-Founder of VetweRx and serves at Bolder Venture Partners with a focus on early-stage growth companies in technology, biotech, software, and consumer service sectors. His expertise lies in securing funding, providing growth strategies, and guiding small businesses. Justin Yurek has raised over $350M for startups, collaborating with management teams and CEOs. The investment check size at Bolder Venture Partners is not specified, but Justin Yurek offers various financing options. However, detailed information on partnership and collaboration styles is not available on the provided sources.

Tony Prince, the investor, is known for his significant contributions to the DJ culture, creating the world DJ Mixing Championships and the term ‘megamix’. He founded DMC, a brand that supports DJs with a record label, magazine, and exclusive mixes. His professional career showcases a pioneering spirit in remixing and promoting DJs’ work. Although specific details about his investment thesis, focus areas, stage of investment, geographical preference, previous investments, investment check size, and partnership styles are not readily available, his track record in the music industry highlights his success and innovation.

OS Fund, founded by Bryan Johnson in 2014, aims to benefit society on a large scale by investing in companies related to the biological revolution. The fund focuses on platforms and technologies in genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics. Bryan Johnson’s investment thesis revolves around increasing the probability of human race survival and thriving. OS Fund invests in early-stage science and technology companies with a geographical preference not specified. The fund’s investments include companies like Ginkgo Bioworks and Atomwise. Bryan Johnson’s professional career includes founding Braintree and OS Fund, emphasizing audacious scientists and entrepreneurs. The investment check size and partnership and collaboration styles of OS Fund are not explicitly mentioned.

Dan Walker is an Angel Investor at Angel Physicians Fund with a focus on Seed Round investments. Some of his previous investments include Example example company Inc, Company & Company, and Example. His investment check size ranges from $5K to $50K, with a sweet spot at $25K. He is known for investing in therapeutics, medical devices, pharmaceuticals, marketplaces, bioTech, digital health, health & hospital services, and health IT at the Seed and Series A stages. Dan Walker is affiliated with Angie Willmott, Anil Verma, Ann Weichert, Arshdeep Tindni, and Clay Willmott.

Air Street Capital invests in AI-first technology and life science companies.

Dean Bartosh is a private angel investor with a focus on investing in the technologies of tomorrow, including AI, IoT, Machine Learning, 3D Printing, Robotics, and Biotech. He is known to invest in Seed stage companies and has a portfolio of 15 companies. Some of his previous investments include SmartGurlz Inc, Cloudastructure, FluentWorlds, Sapient Industries, and Lavabit. Dean Bartosh’s geographical preference is the Great Lakes and Midwestern USA regions. He has a track record of investing in innovative tech startups and has a background in Criminal Justice, Sociology, and Psychology.

Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high-growth, early-stage companies. They focus on industries like Biotechnology, Health Care, Therapeutics, and Medical Device Manufacturing. Their typical investments range from $250K to $1.5M, with a check size between $25,000 and $500,000. Boston Harbor Angels engages in early-stage venture, late-stage venture, and seed investments. They primarily invest in the U.S. and Canada, with an emphasis on startups aged between 4-5 years. Some of their previous investments include Daktari Diagnostics, KnipBio, and Vizibility. The team was founded in 2004 by Mic Williams.

Gold Coast Angel Investors is an early-stage investment group based in Miami, Florida that provides funding and mentorship to high-growth potential technology companies. Their investment focus areas include Biotechnology, Consumer Products, Education, Electronics / Instrumentation, Financial Services, Gaming, Healthcare Services, and Industrial/Energy. They have a geographical preference for the Greater Miami Area, East Coast, and Southern US regions. The organization primarily focuses on angel investment, financial services, and venture capital, with investments ranging from $25,000 to $1 million per company. Gold Coast Angel Investors collaborate with successful startups and venture capitalists seeking new opportunities.

Lionel Carnot, a Director/Board Member at OCULIS HOLDING AG, has a track record in various roles including Managing Director & Advisor at Bay City Capital LLC, Director at iSTAR Medical SA, Priothera Ltd., and more. With a focus on medical-device companies, biotechnology, diagnostics, and specialty pharmaceuticals, Lionel has made investments in companies like Oculis, Priothera, and Merus, with investment check sizes ranging from $100K to $5.0M. He has a history of collaboration and partnerships within the healthcare and investment sectors.

Nick Stone is an Angel Investor serving as a Board Member at Kelvin and a Partner at FS Investors. He also served as a Board Member at STX Entertainment.

SP3NW / WSU, through its programs, supports WSU’s mission by connecting community to academia, entrepreneurs, and innovators. Their investment focus areas include corporate, intellectual property, and technology-focused business incubation. They have invested in WSU research and innovation into biotech, pharma, diagnostics, and medical device companies. SP3NW / WSU’s collaboration styles involve engaging with various service providers and organizations, focusing on economic development, entrepreneurship, and innovation.

First Round is a venture capital firm that specializes in providing seed-stage funding to technology companies.

Incentive Technological Incubator, Israel’s first privatized Incubator, focuses on investing in life-changing healthcare opportunities to enhance patients’ quality of life. They support portfolio companies at every stage of the lifecycle, offering valuable knowledge and assistance in building successful business strategies, forming strategic alliances, recruiting strong teams, and bringing healthcare innovations to fruition. Their commitment is to partner with entrepreneurs, identify promising ventures, and achieve exceptional results.

Jeff Bezos, the founder of Amazon, has a customer-centric investment thesis and prioritizes a large customer base. He has made investments in various sectors such as biotech, agriculture, and finance technology. Bezos has invested in companies like Vendah ($2.34M), Convoy ($160M), and Rescale ($50M). His investments reflect a diverse portfolio focusing on creating long-term value. Bezos is involved with Bezos Expeditions and Bezos Earth Fund, showcasing his commitment to impactful investments and sustainability initiatives. In managing teams, Bezos emphasizes transparency, integrity, trust, and collaboration to drive efficiency and productivity.

William Rutter is an angel investor and the co-founder of the biotech company Chiron. He has a track record in the academic and biotechnology fields, having played a crucial role in the development of UCSF and Chiron Corporation. His academic career includes key contributions to biotechnology, such as the first cloning of the insulin gene and the development of a vaccine against the hepatitis B virus. William Rutter’s investments are industry agnostic, and he has made significant contributions to the biotech industry. His previous investments include Kainomyx with an investment of $7.5M. William Rutter’s investment check size can vary, and his partnership and collaboration styles involve financial support, shared facilities, and a collaborative environment among member companies within his consortium, Synergenics, LLC.

Dr. Alex von Frankenberg, Managing Director of High-Tech Gründerfonds, is a seasoned investor with a keen focus on blockchain utility. His investment thesis centers on the growth and application diversity of blockchain technology. Dr. von Frankenberg’s investment focus areas include hardware and software innovations. He primarily invests in early-stage startups, with a minimum check size of â¬1,000,000. Geographically, he shows a preference for Europe. His previous investments have been in life sciences and industrial sectors. Known for fostering successful partnerships, Dr. Alex von Frankenberg operates in collaboration with public and private entities in seed and early-stage investments, ensuring the success of the next generation of startups.

Daniel Janney, Managing Partner at Alta Partners, focuses on early-stage investments in life sciences. His investment focus areas include novel insights in biology and new approaches to drug discovery. He has been directly involved in the funding and development of 35 companies. Daniel’s investments cover a range of public and private companies, and he has led investments in various pharmaceuticals and biotechnologies. He has a strong interest in working with talented entrepreneurs and is actively involved in the board of directors of several companies. Daniel’s geographical preferences are not specified, and he primarily focuses on early-stage investments.

Aurelia Flores is an Investment Director at Virginia Venture Partners, focusing on equity investments in technology, energy, life science, and scalable startups in Virginia. VVP targets seed and early-seed stage pre-venture opportunities, investing up to $125,000 initially. Aurelia’s previous investments include companies like LearnPlatform, BetterLesson, and Kickboard. Currently, VVP’s investment thesis is centered around enabling company growth through seed and early-stage investments. Aurelia collaborates with co-investors and founders who demonstrate integrity, passion, and high achievement, fostering partnerships for long-term success.

Warwick Wynschenk is an investor with a focus on various sectors including Health Technology, Messaging, Disrupting old established consumer verticals, and Fintech. Warwick has a preference for investing in middle market European special situations across equity and debt. The investment stage of choice is towards specialist funds investing in thematic opportunities across the U.S. and Europe. Warwick has a track record in telecommunications and cable industry growth acceleration. The investment check size typically ranges around $2 billion in managed assets. Additionally, Warwick Investment Group, where Warwick is associated, has a collaborative partnership style focusing on value creation and achieving common goals.

Diede Brunen is a Principal at BioGeneration Ventures with an extensive background in translational biomedical research, oncology, and immunology. He holds a PhD and has a strong track record in identifying novel synthetic lethality targets. Diede has played a significant role in deal flow management and company creation at BGV, working on companies like Artica Therapeutics, Confo Therapeutics, Dunad, Genase Therapeutics, Tessellate Bio, and Tiga TX. His investments are focused on innovative therapies for autoimmune disorders, small molecule inhibitors, and therapeutic monoclonal antibodies. Diede’s investment check size and specific geographical preference are not explicitly mentioned on the BGV website.

Kim de Boer is an investor at Brightlands Venture Partners with an investment focus on Impact, Data Services, BioTech, Health & Hospital Services, Health IT, and FinTech. He typically invests between $100K to $5.0M, with a sweet spot of $1.5M. Kim has made investments in companies such as S+dB, Verdify, and AvL Motion at the seed stage, ranging around $1M each. His co-investors include Casper Bruens, Emma Palmen, Lex Westbroek, Luc Starmans, and Marcel Kloosterman.

Lihan Yu, a Senior Associate at Monroe Capital, has a diverse investment focus that includes sectors like Retail, EnergyTech, Media/Content, Real Estate/PropTech, Digital Health, Health & Hospital Services, Health IT, and FinTech. His investment range is $2.0M – $15.0M, with a sweet spot at $8.5M, and the fund’s current size is $1.33B. Lihan has a professional career with a track record in multinational businesses, overseeing revenues of up to $400 million USD and balance sheets of up to $1.5 billion USD. He brings valuable experience from various industries and has an MBA from London Business School. Lihan’s partnership and collaboration styles may include Cooperative Collaboration, Competitive Collaboration, Directive Collaboration, Facilitative Collaboration, and Delegative Collaboration.

Ritsaart van Montfrans is the CEO of Incision, a medical education platform offering standardized surgical procedure methods. The platform focuses on sharing experiences, skills, and expertise for rapid and thorough preparation. Incision aims to standardize surgery to enhance the quality of surgical care through global professional collaboration. Ritsaart van Montfrans has a later stage VC focus, investing in companies like Incision. He has previous experience as a partner at H2 Equity Partners in Amsterdam. His investment check size varies, with a recent equity investment of â¬3 million in Incision. Geographically, Ritsaart van Montfrans shows a preference for healthcare investments across Europe, MENA, and the US. His collaboration style emphasizes partnerships with leading European surgeons to map variations in surgical procedures for improved outcomes.

David Washburn is a partner at Red Cedar Ventures, a venture capital firm founded in 2013. Red Cedar Ventures is primarily based in East Lansing, United States, with a portfolio count of 32 companies. David Washburn has made investments in various sectors, including Life Sciences and Enterprise Applications. Some of the notable investments led by Red Cedar Ventures include GreenMark Biomedical and Ubiquitous Energy, with one portfolio company having gone public.

Ground Floor Ventures is an active Venture Capital firm with a focus on very early stage European and USA opportunities, aiming to be the first check in and supporting founders with a syndicate of 20+ super-connected angels. Their investment thesis revolves around enhancing biomanufacturing operations through AI technologies. Ground Floor Ventures specializes in short-term real estate investments with high-yield returns and has had a track record of 98% of loans being fully repaid. Their partnership style emphasizes managing complex business partnerships by adhering to four key principles. Specific details on their check size were not found.

Patricia Kaehler is an angel investor with a diverse investment focus, a preference for early to mid-stage startups, and a track record of evaluating businesses for institutional funding. She has made investments in various sectors and locations, with check sizes ranging based on the specific opportunity. Patricia values collaboration and partnerships in her investment approach.

Hanns Anders is a Venture Capital Investor at Amazon Alexa Fund with a focus on Series A Hardware, Robotics, IoT, BioTech, Digital Health, AI, Health IT, and Consumer Internet. His previous investments include taking over the Hans Anders Group from Gilde Buy-out Funds and Comnaar Investments. Hanns Anders is an Investor in various companies such as iRobot Ventures, Invisible AI, Synthesis AI, Hasty.ai, Jargon.com, Labrador Systems, and Matterport. His educational background includes an MBA/MS from the University of Michigan and a BS in Business from Wake Forest University.

Dr. Michael Powell, as the Managing General Partner at Sofinnova Ventures, focuses on companies in the therapeutics sector, particularly in cancer, neurology, dermatology, and rare diseases. His investment thesis revolves around drug development, leveraging his extensive experience in the biotech industry. Sofinnova Ventures under his leadership seeks life science companies in clinically later-stage assets. Dr. Powell’s geographical preference leans toward oncology-related fields. He has a notable track record in drug development, having worked at Genentech and various other biotech companies before joining Sofinnova in 1997. Although specific details on investment check size and partnership styles are not readily available, his career showcases a deep involvement in drug delivery, product development, and venture capital. Dr. Powell has been a key figure in the success of numerous biotech companies, reflecting a strategic and hands-on approach to investments.

Noam Gottesman, the co-founder of GLG Partners, focuses on investing in dividend stocks and healthcare stocks through GLG Partners. GLG Partners is a diversified and multi-strategy fund manager, with a history of successful investments. Noam Gottesman’s investment check size is substantial, with a public equity portfolio worth $3.8 billion. His partnership and collaboration styles involve strategic alliances, discussions on potential transactions, and involvement of advisors in analyzing and negotiating terms.

Qidong Jia, a Partner at CentreGold Capital, focuses on early-stage consumer marketplaces and digital health startups in North America and China. CentreGold Capital’s investment thesis revolves around using data-driven technologies for personalized products to enhance consumer well-being. They have funded companies like GrubMarket and prioritize visionary entrepreneurs with innovative solutions. The check size for their investments is not specified on their website. The partnership and collaboration style of CentreGold Capital is not explicitly mentioned on their website.

Italian Angels for Growth is an angel investor network focusing on Medtech, SaaS, e-commerce, Fintech, and high tech startups in the Seed/Series A stage. With a geographical preference for the EU, Europe, Middle East, and Africa, they have invested over 22 million Euros in 41 startups, including Rubedo Life Sciences, Clearbox AI, and Viceversa. They offer support from Investment champions to help startups succeed.

Eric Ver Ploeg, Founding Partner at Tunitas Ventures, focuses on helping entrepreneurs with fundraising, providing strategic advice and introductions to investors. With 11 years as an MD at venture firms, he has been involved in over 140 investments. Eric has an MBA in High Tech Entrepreneurship from Stanford University and a PhD in Electrical Engineering from Stanford University. He prefers seed investments and has backed companies like ZÅ«m, PayJoy, Numerai, Namecoach, and NachoNacho. His investment style involves mentorship and coaching for entrepreneurs, emphasizing the importance of open-mindedness and grit in building successful companies.

Matthew Strong is an individual investor based in Milwaukee, Wisconsin. His investment focus areas include Healthcare, Consumer Internet, Energy & Clean Tech, Enterprise Software, and Mobile. He typically invests in the Seed Round stage. Some of his previous investments include Agent Ace in a Series A funding valued at $6 million. Matthew Strong has a track record of investing in relevant startups and is known for his involvement in the Series A round of Agent Ace.

Tobias Faupel is a Partner at DeepTech & Climate Fonds, a fund investing in technology-based companies in Germany and Europe. The fund focuses on deep-tech areas like industry 4.0/IoT, robotics, AI, quantum computing, blockchain, and sectors such as digital health, fintech, and smart cities. Tobias has a track record in company life cycles and roles at BASF, Deutsche Bank, and High-Tech Gründerfonds. He holds a graduate degree from Technical University of Berlin and University of Illinois. The investment check size at DeepTech & Climate Fonds ranges from early to later stages. Tobias Faupel’s partnership and collaboration style at the fund involve supporting the growth of innovative companies by collaborating with institutional investors and family offices, focusing on long-term growth and success.

Fabian Silberer, CEO of sevDesk, focuses on investing in startups such as DYNO with a Pre-Seed investment. His geographical preference includes Germany, with a major focus on Offenburg. Past investments include DYNO. In his professional career, Fabian Silberer is the Co-Founder of sevDesk and has experience in landing US investors and emphasizing values over money in investment deals. The investment check size varies based on the financing round, such as Series B funding rounds exceeding 50 million euros.

Jimmy Wales is a U.S. Internet entrepreneur, best known as the founder of Wikipedia and Wikia, Inc. His investment focus areas include finance, markets, long-term value investing, and compound interest. Wales has a track record of venture capital investments and a collaborative form of writing and editing through open-source programming. Specific previous investments include Wikitribune and Wikimedia Foundation. The investment check size for Wales remains undisclosed. He has displayed a collaborative style in his ventures and has been recognized for his significant contributions to the collaborative economy.

Jeff Aiello, Managing Director at Thompson Street Capital Partners, specializes in investing in Series B Enterprise Infrastructure, Medical Devices, Pharmaceuticals, Enterprise Applications, Consumer Health, Digital Health, BioTech, AI, and Health IT. His investment check size ranges from $5.0M to $50.0M, with a sweet spot at $25.0M. Jeff has a track record in film production, known for works like Motion (2009) and Afterburn: The Creek Fire Documentary (2021). His investment approach emphasizes collaboration and ranges across various sectors and regions within the USA, including the Midwest. He holds an MBA from the University of Pennsylvania – The Wharton School, and has experience at Thompson Street Capital Partners, Audax Group, and in the United States Air Force.

Cornelia Hoppe is an investor with a focus on HealthTech, specifically investing in companies like Exakt Health. Her investments are primarily in Seed Rounds, and she has a track record of investing in startups in Germany. Cornelia has made several investments, such as in Exakt Health and eaze, with check sizes ranging from â¬500,000 to â¬1.7 million. She is known for her investments in the HealthTech sector and her collaborative approach in co-investing with other entities like Auxxo and Possible Ventures.

Jay Silverstein is known for making strategic investments and often collaborates with promising companies in the health sector. He focuses on early-stage companies and invests personal money in exchange for equity. His check size for investments varies and he has a track record in the US health industry. Silverstein’s previous investments include companies like Picwell. His geographical preference and partnership styles are not explicitly mentioned in the search results.

R. Martin Roscheisen, an individual angel investor, has a seed stage investment focus with experience in companies like Sidecar Technologies. His geographical preference seems to be in California, as he is the CEO of Diamond Foundry, headquartered there. Previous investments include Sidecar Technologies. His investment check size can vary based on the seed round, and he has a partnership style that aligns with cooperative collaboration.

Ark Angel Alliance is a group of business and community leaders dedicated to fostering startup companies in Arkansas and beyond. Their mission is to actively invest in high-potential startups, with a preference for Arkansas-affiliated deals. They focus on helping angel investors make sound investment decisions and build connections. The check size for their investments typically ranges from $50,000 to $1 million. The alliance has successfully raised funds and invested in sectors like healthcare, manufacturing, education, retail, and technology. Their collaboration style involves providing a marketplace for investors to connect with early-stage ventures.

Khaled Badr-El-Din’s investment thesis is in health tech (software + data)

Ryan Malas, an Associate at LOUD Capital, focuses on fueling innovations that drive equitable access to high-quality, inclusive healthcare through investments in people-centered healthcare, including medtech, alternative care models, and healthcare infrastructure and IT. Some of his previous investments include Genetesis, Share Mobility, OFFOR Health, Hyperion Motors, Inc., LiveEasy, Carely, Raydiant Oximetry, 10XTS, Honest Game, Pay Theory, Medzoomer, SupplyHive, Revibe Technologies, Knowwake, Gemelli Biotech, GiftHealth, Carallel, and Beyond Physician. LOUD Capital’s investment check size and partnership/collaboration styles are not specified on their website. Ryan Malas’ geographical preference spans North America and LATAM. For more information, visit LOUD Capital’s website at [loud.vc](https://www.loud.vc/).

Promod Haque serves as a Senior Managing Partner at Norwest Venture Partners focusing on enterprise and healthcare IT. Their investment thesis is motivated by innovation driving new infrastructure and business solutions. Norwest invests in early- to late-stage businesses across key sectors with a focus on enterprise, consumer, and healthcare. Promod has a track record of investing in more than 70 companies with investments worth over $40 billion in exit value. The investment check size ranges from $20 million to $100 million for growth equity investments. Norwest’s partnership and collaboration styles emphasize the importance of diversity and collaboration within the industry.

June Huang is a Director at Bain Capital Credit, focusing on originating, evaluating, and monitoring investments across the Financial Services industry. The investment check size provided by Bain Capital Credit varies based on the specific needs of the companies. June Huang’s professional career involves being part of Bain Capital Credit’s team of over 35 Partners, with a collaborative and performance-driven culture, seeking attractive credit opportunities with the support of robust resources. The partnership and collaboration style at Bain Capital Credit is characterized by a team-oriented and diverse environment, aiming to identify and capitalize on credit opportunities.

Michael van der Meer is an experienced angel investor with a focus on Distributed Ledger Technology (DLT), biotech, and the space industry. His investments target technologies that can meet the climate challenge, emphasizing the need for innovative solutions and significant investment capital. Michael prefers a global approach to investing in climate technologies, recognizing the importance of addressing challenges on a worldwide scale. His professional background includes managing investments and analysis within the wealth management sector. Specific investment details such as check sizes are not available, but his focus areas suggest a strategic partnership style with hands-on involvement.

Dan Letizia is a Managing Director at Monroe Capital with an investment range of $2.0M – $15.0M and a sweet spot of $8.5M. He specializes in sectors such as Retail, Media/Content, Digital Health, Real Estate/PropTech, Health & Hospital Services, Health IT, and FinTech across different stages. His previous investments include Seed and Series A investments in various industries. Dan Letizia collaborates with other investors like Alex Patil, Andrew Eck, Andy Kiehl, Casey Vercauteren, and Chase Silverman. He follows an expansive collaboration model in his partnership and collaboration styles.

Jerry Fiddler, the principal of Zygote Ventures, is a seasoned entrepreneur known for helping create and grow numerous companies. With a background as CEO, chairman, director, investor, and advisor, he founded Wind River, a global provider of device software. Zygote Ventures focuses on early-stage investments in innovative enterprises, particularly in technology, biotech, and agriculture. They invest in companies requiring less than $1 million of capital, with a preference for the Cleantech space. Notable investments include companies like Care Daily and Sylvatex Inc. Jerry Fiddler’s partnership and collaboration style align closely with entrepreneurs, providing value beyond just funding. His experience, spanning from Wind River to Solazyme, demonstrates his expertise in real-time systems and innovative technologies.

Navin Goyal, co-founder and Chief Executive Officer at LOUD Capital, focuses on healthcare in the venture space and aims to shape LOUD as an alternative investment firm combining profit with purpose. LOUD Capital’s investments cover areas like Health Care, Software, FinTech, Artificial Intelligence, and Dental, with an average round size of $3 million. Navin Goyal typically invests in early-stage companies and prefers startups with 4-5 participants per round. Previous investments include companies like SafeChain, Xaptum, and Genetesis. LOUD Capital, based in Columbus, Ohio, USA, usually invests between $1-5 million per startup. Navin Goyal’s professional career includes co-founding a dental anesthesia service, which led to involvement in venture capital and angel investing. With a track record of 24 investments, LOUD Capital strives for diversity in funding decisions without a specific preference for the number of founders. While specific information about geographical preference and partnership styles is not available, the firm’s ethos revolves around merging profit with a purpose-driven approach.

Virginia Innovation Partnership Corporation (VIPC) accelerates innovation, commercialization, and entrepreneurship to grow and diversify Virginia’s economy. Through its Virginia Venture Partners (VVP) Fund of Funds, VIPC invests in seed and early-stage technology, life science, and energy companies in Virginia. VVP targets companies with a proprietary advantage and scalability, focusing its investments on startups traditionally underserved by risk capital. The investment check size is a minimum of $100,000, and the VVP Family of Funds includes various specialized funds. VIPC’s geographic focus is on Virginia, supporting regional innovation, and fostering collaborations with industry, academia, government, and nonprofits to drive economic growth and address societal challenges. With a track record in supporting over 275 companies and awarding funding to 468 projects, VIPC’s partnership and collaboration styles emphasize robust partnerships and deep collaborations across sectors, promoting innovation and job creation.

Shernaz Daver is an Operating Partner and CMO at Khosla Ventures. With a track record of building brands and scaling operational teams across various industries, she has worked with companies like Netflix, Walmart, Baidu, Khan Academy, and more. Shernaz’s investment focus is on Biotech, Consumer Internet, and Enterprise sectors at the seed stage. Her investments range from $5K to $50K, with a sweet spot at $25K. She has a geographical preference for investments in North America and Europe. Previous investments include companies like Netflix, Walmart, Motorola, Baidu, Khan Academy, and many others. Shernaz Daver’s partnership and collaboration style emphasize building brands and scaling operational teams, with a focus on entrepreneurship. Check sizes for her investments can range from $100,000 to above $20 million.

Bluegrass Angels Inc is a dedicated investor in innovative Kentucky startup companies, aiming to grow quickly into large markets for significant financial returns and job creation. Their investment focus spans healthcare, agriculture, industrial chemicals, manufacturing, biotech, fintech, media, and IT sectors. They invest in high-tech Kentucky start-ups with a goal of long-term success and financially viable exit strategies. Bluegrass Angels prefer investing in local companies across Kentucky and actively seek new investments. Their portfolio includes companies in various industries seeking successful and profitable exits.

Jeffrey Jordan is a General Partner at Andreessen Horowitz with a focus on global health, HIV/AIDS, maternal and child health, organizational management, population, and reproductive health. He invests in companies at the VC stage with a check size range of $500K to $3M. His geographical preference is not specified. Jeffrey Jordan has a track record of providing strategic leadership and vision in the field of global health and population issues. He collaborates with athletes to empower engagement with fans through a consumer-facing community platform under Heir Inc. The platform aims to connect fans with their favorite athletes in various ways, including entertainment and consumer products.

G Squared is a growth stage venture capital firm that invests privately in today’s most dynamic companies.

Robert Soni is focused on investing in AI, Biotech, Cloud, Consumer, Cybersecurity, Deep Tech, Fintech, Healthcare, Marketplaces, and Vertical Software areas at Bessemer Venture Partners. His previous investments at Bessemer Venture Partners include a diverse range of companies such as 2U, Acceleron, Shopify, and Betterment.

Vertical Venture Partners is a venture capital firm investing in enterprise technology companies that target specific vertical markets.

Lars Appelstööl is an investor focusing on sectors such as healthcare, fertility, and education. He has a diverse investment portfolio including Treadwell Therapeutics, TIO Bioventures, VoltSafe, and FYidoctors. Lars has a Master of Business Administration from Simon Fraser University and a Bachelor of Science and Doctor of Optometry from the University of Waterloo.

Katie Rice is an experienced venture investor and entrepreneur. She led the New Mexico office for Epic Ventures, investing in early-stage technology and software focused companies. Katie has a track record of founding events and startups in New Mexico. She holds a bachelor’s degree in Material Sciences and Engineering from MIT and an MBA from the University of Chicago. She is currently the Managing Partner at Tramway Ventures. For more information, contact joseph.juang@tramwayventures.com.

Christin Godale is a Director at CincyTech USA, focusing on investments in Seed Digital Health, Digital Health (Seed), BioTech (Seed), and Female Investors within the Midwest. She has a broad investment range from $100K to $5.0M, with a sweet spot at $1.5M. Specifically targets the $1.5M range. Christin collaborates with co-investors Carl Labanz, John Rice, Sarah Douglas, and Sean Kwiat. She has a background in Neuroscience and actively invests in the identified areas.

Ross O. Youngs is an investor with a focus on early to mid-stage companies with diverse investments. He has a track record in professional baseball and has a lifetime .322 batting average. His investment check size is around $50k. Youngs emphasizes the power of strategic partnerships and focuses on collaboration in his investment approach.

Cambridge Angels, founded in 2001, is an angel group based in Cambridge, United Kingdom. They invest in internet, software, technology, and biotechnology sectors. They focus on UK registered and operated businesses with innovative ideas and clear paths to commercialization. Cambridge Angels evaluate early-stage investment opportunities, looking for teams with entrepreneurial potential and a passion for new business ideas. They prefer solutions addressing significant problems in large target markets, with investments typically ranging from £0 to £500k. Their track record includes investments in companies like Qureight, OneID, and Radiant Matter within various industries.

Zachary S. Bogue is the Co-Founder and Co-Managing Partner at DCVC, focusing on AI-enabled climate tech and life sciences platforms. His investments typically range between $3M to $10M per company. He has a track record in deep tech startups and has invested in companies like Recursion, Nuzzel, Caption Health, Gro Intelligence, and more. Bogue prefers partnerships and collaborations, as seen in his work with Microsoft-backed clean jet fuel startup and active participation in discussions on aviation initiatives.

Scale-Up Denmark focuses on consumer goods, energy & greentech, media & entertainment, healthcare & life science. Previous investments include Scaleup Finance. The investor’s track record involves leading teams to peak performance. Geographically, the investor supports startups in Northern Europe. The stage of investment seems to be mainly in the early stages. The investment check size and partnership styles are not explicitly mentioned on their website.

Ali Ciğer is an angel investor with a focus on seed-round investments in healthcare, consumer internet, energy & clean tech, enterprise software, and mobile. He has made investments in companies like Example Company Inc, Company & Company, and Example. Ali Ciğer’s professional background includes being a Co-founder at Mesh Stick and serving as the Head of Vaccines at Pfizer. He is known for his active role in investing, particularly in seed rounds. While the investment check size is not specified, his investment focus areas cover a diverse range of industries. With a track record in the healthcare sector, Ali Ciğer is recognized for his commitment to early-stage startups and collaborations within the tech ecosystem.

Ed Keller is a Chief Executive Officer at Keller Fay Group and President at Engagement Labs. He serves as an Advisor at Joyance Partners and is a Visiting Scholar at UPenn’s Annenberg School for Communication. His expertise lies in word of mouth marketing, influencer marketing, and consumer insights. Ed Keller offers board and advisory services to entrepreneurs in growth-stage companies. He is inducted in the Word of Mouth Marketing Hall of Fame and the Market Research Hall of Fame.

Broadway Angels is an angel investment group based in San Francisco, California. They specialize in investments in enterprise technology, consumer, and health and wellness sectors.

John Garbarino is an angel investor with a focus on seed round investments, particularly in industries such as healthcare, real estate technology, and SaaS. He brings over 30 years of experience in private equity and operation executive roles. John has a strong track record in building, leading, and scaling teams in various tech companies. He is a small business owner of Spiral Array Consulting and has held significant positions in companies like Gremlin, TRUEFORT, and Riverbed Technology. John holds a Master of Science in Computer Science from the Illinois Institute of Technology and a Bachelor of Science in Electrical and Computer Engineering. His investments typically range in the seed round and are up to $650 million. John is known for his strategic partnerships and collaborative approach in building successful ventures.

Kyto Technology and Life Science Inc., operating as K2X Technology & Life Science, Inc., focuses on creating an ETF-like vehicle of diversified and vetted startups for global investors. They target the top <10% of startups, investing in angel-stage startups globally. With a Silicon Valley base, the company is managed by experienced angel investors. Their investment approach ensures a safer, higher-return, non-correlated, and liquid investment in startups. They prioritize double-vetting of all investments. Although the investment check size is not specified, their investment thesis emphasizes providing a diversified and safer investment option in startups. Partnership and collaboration styles are not explicitly mentioned.

Launchpad Digital Health is an early-stage investor and mentor in digital health

Dr. Georg Ried, the Managing Director at Bayern Kapital, focuses on software, bioscience, healthcare, and pharmaceutical sectors. He invests in early-stage ventures in the Bavarian high-tech segment. Some of his previous investments include Ondeso, Mecuris, SimScale, and Veact. Dr. Ried has a successful track record in the venture capital industry. The investment check sizes vary based on the specific opportunity. His partnership and collaboration style involves creating collaborative partnerships with organizations to achieve mutual goals.

Sean Harper, as an investor, has a focus on therapeutics to improve human lives. His previous investments include Uprise, Anzen, Conekta, and WeDeliver. He has made 3 investments and has 1 portfolio exit. The investment check size is undisclosed. Harper’s partnership and collaboration style involves ethical sharks who are team players, persistent, and care deeply about customer impact and fairness. They prioritize teamwork, recognize group efforts, and encourage positive reinforcement within the sales team.

1809 Capital is a financial focused investment firm.

Mark Goldstein’s investment focus areas primarily include health, wellness, and food sectors. He is involved in investments related to health care, SaaS, IoT/devices, energy, and ag tech.

Ariel Southeast Angel Partners is an angel investment group that invests in a variety of high-growth areas. They focus on bio-technology, medical devices, health care, therapeutics, and life science. The stage of investment is in start-up and early-stage companies. Their geographical preference is in Savannah, Georgia. Some of their previous investments include bio-technology, medical devices, and health care startups.

Alliance of Angels is an angel group based in Seattle, Washington, founded in 1997. They focus on seed and early-stage investments in a wide range of sectors, including SAAS, AI, Life Sciences, manufacturing, retail, and food industries. Alliance of Angels seeks extraordinary founders with product vision, execution focus, and ambition to build high-growth companies. Their investment check size ranges from $500,000 to $2.5 million for the first investment round. The firm prefers companies with a connection to the Pacific Northwest but considers investments across the US and Canada. Additionally, they operate an Innovation Fund that makes $150,000 investments in approximately a dozen companies annually.

Samsara Biocapital, LLC provides investment advisory services.

Richard Forman is a Co-Founder and Managing Partner at MDX Mediccal, serving as an advisor at KICventures. He focuses on technology and consumer-related health care investments. His previous investments include a generative AI engineering design copilot and a software-drug combination platform. Richard Forman’s check size for investments remains undisclosed. He is known for his partnership and collaboration style in the health care sector and has a strong background in technology and engineering, with experience in leading and founding successful companies like Register.com, Inc. He holds degrees in Economics, Electrical Engineering, and Real Estate. Richard Forman values collaboration and actively contributes to educational initiatives at the University of Pennsylvania.

Angel Forum is a community of new and seasoned angel investors, connecting promising tech startups with accredited angel capital since 1997. The investor forum serves as a platform for fostering strong investor-founder relationships through events, networking, and education. While specific previous investments are not listed, the focus remains on connecting startups with angel capital. Angel Forum invests in early stage companies in a broad range of industries in the Northeastern US, with a special interest in companies located or willing to establish a presence in Connecticut. The investment focus includes companies engaged in scalable activities with a clear exit path within three to five years, spanning various industries like Biotechnology, Business Products, Clean Technology, and more. Preferred locations for investments include Massachusetts, Connecticut, Pennsylvania, and neighboring states. The webpage emphasizes the importance of developing a compelling investment thesis to guide angel investors in their startup investment journey.

Archangel Global Investors is an angel investor based in Irvine, California. Their investment thesis focuses on scalability, market size, defensibility, and the quality of individuals backed. They prefer companies that are not capital intensive and can scale without significant investment. Archangel’s previous investments include Noa Therapeutics and Bioliberty. The check size for new deals is at least £100,000. The team has an excellent track record in early-stage investing. Their collaboration style is tailored towards scale and generating revenues efficiently.

Adrian Blumer is an investor with a focus on land for multifamily development, value-add retail, and life science properties. He invests in early-stage ventures and has had previous investments in companies like EOS blockchain creator Brendan Blumer. His check sizes range from $250K to $5M, and he follows a collaborative partnership style that may involve connecting with individuals across various teams and external partners.

Kristopher Brown is an Angel Investor based in New York, USA. He focuses on private equity and venture capital financing transactions with a specialty in healthcare, life sciences, financial and information technology, electronics, energy & telecommunications industries. His investments range from seed stage to Series B, with an emphasis on supporting emerging growth companies. While the investment check size is not specified, he has made investments in various companies. Kristopher values collaboration and partnerships and has a track record of strategic alliances and joint ventures. With a background in governance, regulation issues, and securities laws, he brings a wealth of experience to his investments.

Garrett Camp is the Founder and serves as Chief Executive Officer at Expa. He was the Founding Chief Executive Officer of Mix. He is the Founder of Haus. He co-founded and served as Board Observer at Uber. He is a Co-Founder and serves as Board Member at Aero. He is a Co-Founder of Spot. He is a Co-Founder and Chairman of StumbleUpon. He co-founded and served as Board Member at Operator. He served as a Board Member of Metabase, where he served as an Executive Officer. He founded Uber in 2009, to help people easily request car service via a mobile app. He completed his Bachelor’s and Master’s in Software Engineering at the University of Calgary, where he researched collaborative systems, evolutionary algorithms and information retrieval. He is also a 2007 recipient of MIT Technology Review’s TR35 award.

Dr. Janice Gabrilove is an Angel Investor at Easton Capital Investment Group. She is board certified in Internal Medicine and Medical Oncology, serving as a Scientific Advisor. She has patents related to medical treatments and has advised biotech companies. Dr. Gabrilove’s investment thesis focuses on the healthcare and biotech sectors. However, specific information about her investment stage, geographical preference, previous investments, and check size is not available.

William Hambrecht is the Co-Founder and Chairman of WR Hambrecht + Co. The investment thesis of Hambrecht Ventures is focused on Disruption Theory, collaborating with Harvard Professor Clayton Christensen. Their geographical preference is global for identifying disruptive companies. Past investments include Genentech, Invisalign, and 23andMe. Hambrecht Ventures’ partnership style involves collaborating with experts like Professor Christensen. Hambrecht has a record of identifying early disruptive companies and has various venture funds in healthcare and technology sectors.

Amrinder Singh is a Partner at Vensana Capital with a background as a Senior Investment Director at Medtronic Ventures. He focuses on transformative medical technology innovations with investments in Series A to growth stages. Amrinder’s geographical preference is not specified. His partnership and collaboration style emphasize business news, profiles, and deal flow coverage. The investment check size for his investments is not explicitly mentioned on the website.

Valhalla Angels is an angel network primarily investing in early-stage firms. Founded in 2003 in Calgary, Canada, they have a portfolio of 11 companies in sectors including Enterprise Applications and Life Sciences. Their stages of investment range from Seed to Angel. Valhalla Angels focuses on investments in Canada and the United States. Notable portfolio exits include Nanalysis Corp. and Mobile Data Technology. The team consists of 3 partners, including Grant Lawrence and Colin Holowaychuk. Some of their previous investments include iApotheca Healthcare, Mesentech, and NOBAL Technologies. The average round size of their investments is $733K, with a total of 6 investments and 6 portfolio startups. For more details on their investment style, specific investments, and professional career, refer to their profile.

Aga Manhao, Co-Founder and Managing Partner of Future Health, is an angel investor with a focus on early-stage healthcare technology startups in Asia. His investment thesis revolves around improving healthcare quality and accessibility through innovative diagnostics, telemedicine, wellness, and more. Future Health primarily invests in HealthTech companies expanding into Asia. With a track record of successful listings and extensive global experience, Aga is positioned to guide startups through growth. The investment check size ranges for startups, offering a platform for pooled funds and risk-sharing. Aga emphasizes building networks and ecosystems to support entrepreneur growth in the healthcare technology sector.

Amanda Stenbaek is an Associate at INKEF Capital, with an investment range of $100K to $5.0M and a sweet spot of $1.5M. She focuses on Seed BioTech, Digital Health, Health & Hospital Services, and Health IT. Amanda has a track record of investing in startups and collaborating with co-investors like Alice Vickers, Carien Beyer, Corné Jansen, Estelle Botbol, and Ivan Burkov. She operates within a fund size of â¬500M.

Eiso Vaandrager is a seasoned private equity and venture capital investor with entrepreneurial experience in Europe and the US. He has invested into and/or started more than 30 companies in various industries and geographies. Eiso is affiliated with Delft University, Startup Fest Europe 2016, TEDxAmsterdam, and NOVUS Summit at the United Nations. He has a track record in projects like the Dutch solar car, AI solutions platform, exoskeleton project, and hydrogen fuel cell racing company. Eiso’s investment check size, partnership, and collaboration styles are not explicitly mentioned on the website.

Northeast Angels Investment Group is an early-stage investment group focusing on companies in the Northeast U.S. region. They invest across various sectors such as biotechnology, business products & services, clean technology, and more. The check size for investments typically ranges between $120,000 and $545,000+. Their geographic preference aligns with their focus on Northeast startups. Northeast Angels prefer NVCA-style investor documents and seek startups with large market potential and a unique market solution. They typically invest from seed to pre-seed stages in companies requiring $100,000 to $1,000,000 in funding. Their partnership and collaboration styles were not publicly available.

Adam Besvinick is the Founder and Managing Partner at Looking Glass Capital, a pre-seed investor focusing on health, climate, and empowerment themes. He has invested in companies like Hone, Framework, [untitled], Basil Systems, Carbon Collective, EnMass Energy, Daily Blends, Therify, Polimorphic, and more. Adam has a background as a venture investor at Anchorage Capital Group and worked at Deep Fork Capital. He also co-led By/Association, an angel investor group, and has experience in business development and partnerships with companies like Wanelo. Adam graduated from Harvard Business School and held roles at Lowercase Capital and Gumroad. His investment approach involves supporting mission-driven founders in the earliest stages of company building.

Russ Nash serves as a Board Member at H2 Wellness and AbleTo. He managed Accenture’s US Health Payer Client Group and was the Global Managing Director of the firm’s Health and Life Sciences Industry Group. His investments include Wellframe, WhiteFox Defense Technologies in HealthTech, Aerospace industries. Russ Nash’s investments are primarily in the United States. He has a Professional Background in Health and Insurance practices and is a Fellow of the Casualty Actuarial Society.

KdT Ventures is an early-stage venture capital firm that invests in startups in the data, engineering, and biology sector.

Bettina Ernst, Vice President and CEO of BERNINA BioInvest, focuses on investing in healthcare companies with an investment range of $100K to $5.0M, particularly in Seed Pharmaceuticals, Digital Health, BioTech, and Health & Hospital Services. Her sweet spot for investments is $1.5M. She has invested in companies like SunRegen at Series A stage. Bettina is actively involved in the Swiss Biotech scene, serving on various boards and being a co-founder of two biotech companies. With a background in immunology and natural science, she brings a wealth of experience to her investments.

AME Cloud Ventures invests in seed to later-stage tech companies that build infrastructure and value chains around data.

Triangle Angel Partners is a North Carolina-based angel fund specializing in early-stage investments in high-tech and life sciences industries. The firm focuses on companies in or around North Carolina’s Research Triangle Park. Some of their previous investments include Carpe Antiperspirant Lotion, Deep Blue Medical Advances, and Pryon. Triangle Angel Partners was founded in 2011 and has an active portfolio across North Carolina, southern Virginia, and northern South Carolina. The Angel Investor, Kelly Caldwell, has a professional background in various organizations, including serving as a Program Facilitator Coordinator at Cornell University and as a Co-Founder at Sonaya Properties. The investment check size and partnership/collaboration styles are not explicitly mentioned in the available information.

Simon Kreitmair is the CFO of Dolpheen Global. He has a background in finance and technology, with experience in companies like Qualysoft and Tricentis. He holds a certification as a Test Design Specialist for Tricentis Tosca. Kreitmair pursued Informatik at Fachhochschule Technikum Wien.

David Anderson, Managing Director at Supply Chain Ventures, focuses on early-stage investing in life sciences and information technology. The firm specializes in AI-enabled supply chain and data analytics sectors, with a global reach in marketing and sales capabilities. Investment check sizes range from $25K to $10M. Previous investments include software and hardware technology companies in the supply chain space. Dr. Anderson’s professional career includes roles at Accenture/Anderson Consulting and Accenture Technology Ventures. Geographically, Supply Chain Ventures is based in Boston, Massachusetts, with a partnership emphasis on angel and early-stage venture capital investments, supporting supply chain and data analytics innovators.

TPG Biotech is a growth-stage equity and venture investment platform focused on the biotechnology industry.

Dr. Gabriel Otte is an Angel Investor focusing on SaaS startups. He is known for investing in early-stage companies at the seed round. His geographical focus includes San Francisco, California, where he is based. Gabriel Otte has a professional background in mobile development, technology, and machine learning, with a significant presence in the healthcare sector through Freenome. While he does not have specific data available on previous investments or check sizes, his partnership and collaboration styles reflect a strong commitment to advancing early cancer detection technologies through innovative biomarker studies. His track record includes leadership roles as CEO and Co-Founder of Freenome, showcasing his expertise in healthcare innovation and entrepreneurship.

Gary Kunis, a former Cisco Chief Science Officer, is actively involved in supporting biotech companies and aspiring entrepreneurs, focusing on technological innovation and entrepreneurship.

Gopher Angels is an angel investment firm based in Minneapolis, Minnesota. They focus on investing in scalable, early-stage companies in diverse industries, including healthcare, health IT, enterprise and SaaS, food and beverage, medical devices, agtech, and more. The firm prefers to invest in companies at the Seed and Round A stages. Gopher Angels has a track record of supporting companies like CoreBiome, Dispatch, StemoniX, Upsie, and others, with investments typically ranging around $350,000. Their collaboration style involves providing financial support and expertise to early-stage businesses. Although specific details about their investment thesis, geographical preference, and partnership styles were not directly available on their website, their investments and focus areas demonstrate their commitment to fostering entrepreneurship and innovation.

CED collaborates with companies in sectors like Life Science, Technology, Advanced Marketing and Materials, Consumer Products, Cleantech, and AgTech. They prefer to invest in communication, business service, information technology, life science, and energy sectors. CED’s check size and investment stage information are not available, but they engage in partnerships to support entrepreneurial development.

K16 Ventures is a venture capital firm based in Berlin, Germany. The firm focuses on investing in software, biotechnology, cleantech, and foodtech sectors. They have made investments in companies like Juicy Marbles, QOA, Grounded Foods Co., YuriAerospace, and Cirplus. The average round size of investments is $2 million. Notable investments include Juicy Marbles ($4M), QOA ($6M), Grounded Foods Co. ($2M), YuriAerospace ($6M), and Cirplus ($6M).

T. Trent Gegax serves as an early-stage investor with a focus on web services, mobile payment, social media, edtech, and biotech. His previous investments include companies like Current TV, Porch, Taunt, Stemedica Cell Technologies, and Chirpify. He is known for tapping entrepreneurs’ potential and looks for specific qualities in founders to ensure their success. Gegax’s investment check size and partnership style are not explicitly stated, but he is an Angel Investor with experience in various industries. He has a background in journalism and due diligence skills, contributing to his expertise in the investment field.

Pillar VC invests in seed-stage companies in Boston, supporting unstoppable founders with capital, connections, coaching, and peer support.

Carlo Egle is an Investment Manager at Redalpine, a seed and early-stage venture capital firm based in Zurich, Switzerland. Redalpine focuses on investing in disruptive technologies in the ICT and life sciences sectors. The firm’s portfolio companies have created over 10,000 jobs and raised almost CHF 3bn in funding. Redalpine’s investment thesis is to support companies committed to making a positive impact on the environment. Carlo Egle’s investment check size varies based on the needs of the companies. He collaborates with entrepreneurs and family offices throughout the fundraising process. Redalpine’s geographical preference is not explicitly stated, but their investments are primarily in disruptive technologies with a focus on scalable models in various sectors.

Möçrt Kelder started his investment thesis in 2000 focusing on online/digital/technology, with three broad sectors of interest for the next 20 years: VR/AR, Machine Learning/AI, and Health (with a focus on longevity/anti-aging). His investments include companies like SuperWorld, Ubiquity6, UserMind, Nines, Excision Biotherapeutics. Additionally, he has not included crypto/blockchain in his investment focus. His investment focus areas cover public equities, private equities, bonds, private debt, real estate, and infrastructure. The check size for his investments ranges between $500K to $1.5M per company. Regarding partnership and collaboration styles, there is no specific information available about Möçrt Kelder’s approach.

Gretchen van Steenwyk is a Biotech Investor with an investment range of $100K to $5.0M, specializing in BioTech and Health & Hospital Services sectors. Her notable investments include BioTech (Series A), BioTech (Seed), Health & Hospital Services (Series A), and Health IT (Series A). She is known for her partnership with investors such as Alfred Scheidegger, Gabor Gyulveszi, Jakob Loven, Melissa McCracken, and Niresh Berinpanathan. Gretchen’s career spans roles as an Investment Manager at Archer Fund and as a Senior Analyst at Nextech Invest. Her professional background includes experience in Molecular Biology, Neuroscience, and Oncology, with expertise in health innovation. Gretchen van Steenwyk’s stage of investment ranges from seed to Series A, with a current focus on the Biotech sector.

Lowercarbon Capital funds research and invests in technologies that reduces the CO2 in the atmosphere.

David Sacks, as the Founder/Partner of Craft Ventures, focuses on SaaS and Marketplace models for investment. His professional career includes key roles at companies like PayPal, where he was the COO and Head of Product responsible for taking the company public before its sale to eBay for $1.5 billion. He also founded Yammer, later acquired by Microsoft for $1.2 billion. With a background in Economics from Stanford University and a J.D. from the University of Chicago Law School, he brings a wealth of experience to his investment decisions.

Lutz Haase is an investor with a focus on HealthTech sectors, having invested in companies like CardioCube and Super Izzy AI. His investment check size typically ranges from $100K to $500K per company. His previous investments include CardioCube (acquired by Voxel) and Super Izzy AI. In terms of partnership and collaboration styles, Lutz Haase demonstrates a cooperative collaboration style, fostering mutually beneficial relationships with portfolio companies and partners.

Austin Area Angels is a group of angel investors based in Southeast Minnesota that focuses on assisting early-stage companies seeking funding in the range of $50,000 to $1,500,000. With a typical investment size between $100K to $250K per investor, they emphasize highly scalable business models, particularly in food, agriculture, and bio-science sectors. Geographically, they prioritize companies located in the Austin/Mower County area. Austin Area Angels collaborates with accredited angel investors to facilitate introductions to innovative startups and is a member of the Angel Capital Association. Their investment ethos centers on equity funding for fast-growth companies and nurturing opportunities in the local region. While specific previous investments are not listed, their track record showcases a commitment to supporting early-stage ventures and fostering growth in the Southeast Minnesota entrepreneurial ecosystem. Their partnership and collaboration styles revolve around providing a platform for members to engage and exchange information on potential investment opportunities.

JOT-Berlin is a group of angel investors with a focus on News, Life Science, and Social Media startups at the seed stage. They have previously invested in companies like Labiotech.eu and Biotech news resource based in Berlin. Their typical investment check size ranges from â¬1.5m to â¬3m. JOT-Berlin values collaboration styles and may engage in introspective, relational, and expressive approaches to partnerships.

Buffy Alegria, Managing Partner at SteelSky Ventures, focuses on investing in high-growth companies that improve access, care, and outcomes in women’s health. SteelSky Ventures primarily invests in Women’s Health across various sectors including Digital Health, Consumer Health, Health & Hospital Services, and Health IT at pre-seed and seed stages. Buffy Alegria’s investment check size ranges from $100,000 to $5 million, with a sweet spot at $1.5 million. She brings a wealth of experience, having served in roles such as Managing Partner at LOUD Capital, Board Chair at Signal Health, and as a Strategic Advisor at PregnanTech and Scorecard.vc. Buffy Alegria holds a Master’s degree in Management in Science and Technology from Oregon Health & Science University and a Bachelor’s degree in Psychology, Biology, and French from Pacific University.

Ross Haghighat is a Senior Business Executive, Serial Entrepreneur, and Venture Capitalist with three decades of experience in transforming early-stage technology and life science companies into successful global corporate entities. He specializes in negotiating M&A agreements, strategic planning, and guiding corporations towards successful IPOs. Ross has founded or co-founded several companies, leading strategic pivots, especially in life sciences. With a career impacting markets in biotech, medtech, telecom, ESG, and specialty chemicals, he has been involved in successful IPOs and M&A transactions. Ross has raised over $2B in capital for portfolio companies, contributing to a combined shareholder value exceeding $5B. He holds a BS and MS in Advanced Materials from Rutgers University and an MBA from Boston College Carroll School of Management. Currently, he serves as the Chairman & CEO of Triton Systems, Inc., a global business venture company focusing on innovative products in microsensors, medical devices, immunotherapy, Cleantech, water treatment, and printable electronics. Additionally, Ross is Executive Chairman of Avertix Medical and serves on the Boards of various companies such as Chinook Therapeutics, Electriq~Global, and Fluence Corporation.

Lateef Jackson is a Venture Partner at Elevate Capital, focusing on investments in early stage and growth start-up companies. His investment check size ranges from $100K to $500K. Specific investment focus areas are not available, and his track record and previous investments details are limited.

Kirk Nielsen is a Managing Partner at Vensana Capital, specializing in transformative medical technology innovations. He has led or co-led investments in companies like iVEAcare, Elucent Medical, and Moxe Health. Kirk’s geographical preference includes investments in companies from various regions. His professional career includes roles at Versant Ventures and Medtronic, with a background in healthcare and private equity. Kirk’s investment check size ranges in line with the needs of the companies he invests in, focusing on successful exits and IPOs. His partnership and collaboration style involve active participation in board memberships and strategic guidance for portfolio companies.

Golden Seeds LLC typically invests in B2B & B2C technology, health care, and consumer products or services industries. They focus on seed-stage investments, primarily in women-led startups in the United States. Their investments range from $250,000 to $1 million. Golden Seeds collaborates with a diverse network of angels, works closely with founders who have a track record of success, and values partnership and collaboration in their investment approach.

Nancy Philippart is the General Partner and Co-Founder at Belle Michigan, an early stage investment fund focusing on women-owned or managed businesses in various sectors such as digital, mobile, cloud technology, life sciences, and more. With a background in teaching at Wayne State University and serving on the Troy Board of Education, Nancy brings a wealth of experience to her investments. She has been an Adjunct Professor at the College of Engineering & Ilitch School of Business at Wayne State University and served as an Executive In Residence at Engineering Ventures. Nancy’s board roles include positions at Hospice of Michigan/Arbor Hospice Foundation, BriteHub, and Work Truck Solutions. Previously, she held a senior role at General Motors as the Exec Dir and General Manager for GM Accessories. With a diverse portfolio of experiences, Nancy’s investment style combines expertise from academia, corporate management, and board leadership, making her a well-rounded and experienced investor.

Human Ventures is a business creation platform, comprised of a venture fund, studio and enterprise agency.

Anna Söderholm works as an Investment Manager at Almi Invest, responsible for the entire investment process, analyzing startups, investing in around 20 portfolio companies, holding a master’s degree in political science. Her investments are primarily in Swedish companies with exciting, scalable business models and motivated entrepreneurs. Almi Invest typically makes initial investments ranging from SEK 2-4 million, with an ability to venture up to SEK 10 million during the investment lifetime. Anna’s investment style involves collaborating with other venture capitalists or angel investors, syndicating with them to acquire a maximum of 50% of shares in a new share issue or convertible bond. She focuses on companies with strong teams and scalable models, prioritizing these factors over the industry. Additionally, Almi Invest manages a total of SEK 1 billion and half of their capital comes from EU structural funds, which amounts to SEK 500 million.

Harvard Business Alumni Angels of Greater New York is the largest angel group in NY with 350+ angel investors. Members have invested over $29 million across 132+ early stage companies. The angel investors are Harvard Business School and other Harvard University alumni who invest individually. They meet monthly to hear pitches, investing in 1-2 companies per month. No affiliation to Harvard is required to pitch. Members are assigned mentors to help invested companies succeed. They are a 501(c)(6) not-for-profit affiliated with HBS Angels chapters globally.

Wichita Technology Corporation is a sector-agnostic micro-VC firm that focuses on investments in seed and early-stage companies in the US. The firm has made investments in sectors like advanced materials, biosciences, broadband, telecommunications, food and beverage, manufacturing, medical devices, software, and information technology. Previous investments and further details about their track record, professional career, investment check size, and partnership and collaboration styles were not readily available from the search results.

Rich Gallun is an angel investor who focuses on promising companies, typically in exchange for equity. His investment areas include technology and healthcare. He has made investments in companies like First Stop Health and Peerfit. Gallun’s professional career includes involvement in Series A and Series B funding rounds. The check size of his investments is personalized based on the company’s potential. Gallun adopts a collaborative approach with companies, employing varying partnership styles to maximize growth and success.

Specialist VC specializes in specific sectors and stages within venture capital, focusing on areas such as Seed Stage, Series A, B, C, and Late Stage/Growth Capital. They emphasize the importance of developing expertise in various sectors like Tech VC, BioTech/HealthTech VC, FinTech VC, Consumer VC, CleanTech, and AgriTech to stand out in the industry. Specialist VC’s investment thesis includes a focus on selecting deals aligned with their fund’s focus in terms of stage, geography, and market segments. The fund aims to provide targeted investments in specific areas to optimize returns and establish credibility as experts in the field.

Breyer Capital is a global venture capital and private equity investor that focuses on catalyzing high-impact entrepreneurs.

Gary Cohn serves as Vice Chairman at International Business Machines and is Co-Chairman of Cohn Robbins Holding Corp. He invests across cybersecurity, blockchain infrastructure, regulatory technology, and medical technology sectors. His previous role includes President and COO of The Goldman Sachs Group. His investments are done through partnerships with companies like Abyrx, Gro Intelligence, Indago, Nanopay, and Starling. He is dedicated to advancing healthcare and education, serving on boards of NYU Langone Health and NYU Tandon School of Engineering. Gary Cohn’s investment check size can vary based on the sectors, with a recent project in blockchain technology seeking $600 million for an IPO.

Stewart Dixon is the Managing Partner at VentureDNA with a focus on Series A investments in sectors such as wellness & fitness, sales & CRM, cybersecurity, media/content, data services, web3/blockchain, health IT, biotech, digital health, and fintech. His investment check size ranges from $500K to $20.0M with a sweet spot at $1M. Stewart prefers investing in the Midwest and collaborates with diverse investors, including founders. His previous investments align with his expertise and industry connections.

Alec Bowers, CEO of Quantum Dynamics LTD, engages in proprietary investments across asset classes like commodities, real estate, equities, and digital assets. He focuses on venture investments in food and medical sectors. With a professional career spanning various leadership roles, Alec has presented at international forums, advised governments on entrepreneurship, and organized summits. Holding degrees from Babson College and Stanford University, he is heavily involved in genomics and personalized medicine investments. Alec’s partnership and collaboration styles emphasize effective communication and teamwork, driving successful global business expansions. His investments extend to Russia, showcasing a keen interest in emerging markets.

Life Sciences Angel Network is an angel network based in Somerset, New Jersey. The firm prefers to invest in life sciences, healthcare, diagnostics, biotech, drug discovery, drug delivery technologies, alternative energy, cleantech, and agtech sectors. The average startup value when investing from the network is 1-5 million dollars.

Frank Willemsen is the President and Board Member at Sand Hill Angels, with investment focus areas including seeking ‘uncommon’ insights in markets, technologies, or business processes that are not obvious. The investors at Sand Hill Angels look for startups with a real problem-solving aspect, defensible solutions, capable teams, and reasonable deals. They also consider evidence of product-market fit and a narrative for the company’s vision. Frank Willemsen’s investments fall in the range of $300K to $500K per company, with a sweet spot at $500K. Sand Hill Angels’ diverse portfolio spans sectors like AdTech, HealthTech, and FinTech, with a preference for startups that have early progress funded by friends or family to gather feedback from potential customers and limit capital requirements.

Kelly Wittenbrink is the Vice President at Thompson Street Capital Partners. With a background in political roles, including working for a U.S. Senator and involvement in a presidential campaign, Kelly brings a diverse skill set to her investments. Thompson Street Capital Partners focuses on sustainable growth in Life Sciences & Healthcare, Software & Technology, Business & Consumer Services. Kelly’s portfolio includes investments in sectors like Enterprise Infrastructure (Series B) and Medical Devices (Series B). Her check size ranges from $5M to $50M, with a sweet spot around $25M. Kelly is known for collaborating with co-investors and has a track record of successful investments. She is actively involved in the Series B stage, particularly in the areas of Enterprise Infrastructure and Medical Devices.

Scott Dettmer is a seasoned investor with extensive experience in private and public offerings, mergers and acquisitions, corporate partnering, and strategic alliances. His investment focus areas include fast-growing private and public companies in the technology and life science industries. His previous investments include companies like SetSail, Aviatrix, and Automattic. Scott Dettmer is known for his partnership and collaboration styles through active involvement in financing rounds of companies like ChargePoint, Cohesity, and Instart Logic. His check size for investments is determined based on the growth-stage nature of the investment, ensuring a strategic and substantial contribution.

Lars Rasmussen, co-founder of Google Maps and Director of Engineering at Facebook, has made 20 investments with a focus on venture capital, IT, consumer, and tech industries. His investment check size typically ranges from $1M to $5M USD. Lars invests in companies like Douleutaras, Neptyne, and Fingerprint for Success. He has a track record in the med-tech and pharma industry and has 3 portfolio exits. Lars Rasmussen emphasizes clear expectations and communication in partnerships and collaborations.

Puget Sound Venture Club, founded in 1985, is a group of accredited investors providing a forum to review venture opportunities. They aim to create a community of accredited investors to share ideas, contacts, and resources. With a track record of investing over $220 million in 1,350 companies, including successful IPOs like Starbucks, DocuSign, and Coinstar, they focus on startup investments in software, healthcare, IT, biotechnology, and SaaS. Puget Sound Venture Club prefers seed, early-stage, and first-round deals in most industries, with a particular interest in early-stage tech startups. Their check sizes for investments vary annually, with recent investments totaling $18.1 million in 2021. Collaboration styles involve creating an environment for brave ideas and healthy collaboration to drive their operations and investments.

Concho Valley Angel Network (CVAN) focuses on investing in early-stage Texas-based deals in industries such as Biotechnology, Clean Technology, Computers, Consumer Products, and more. They consider requests for capital up to $2M, with a lead investor required for deals over $1M. CVAN evaluates ventures based on criteria including the management team’s quality, market potential, use of funds, growth prospects, competitive advantage, fit with investors, technology uniqueness, and exit strategy. The group’s members are accredited individual investors with extensive executive backgrounds. Past investments include funding veterinary services and Localeur with support from various Texas angel groups.

Jan Bromberger is a seasoned investor with a diverse investment thesis focusing on B2B & B2C subscription models, marketplaces, SaaS, consumer subscription, and New Space. He predominantly invests in Pre-seed Health & Hospital Services startups. With a track record of roles such as Senior Software Engineer, Founder, and Angel Investor, Jan has a professional background in Technology Management. His investments span markets like Content Creators, Education, Media and Entertainment, and Software. Jan’s investment check size ranges from $100K to $1M, with a sweet spot of $1M. He engages in various partnerships and collaborations in the startup ecosystem through his roles at metoda GmbH, EUROPE+EARLY, and DVC, bringing a wealth of expertise and hands-on involvement to his portfolio.

Klaus-Peter Stegen is a seed and series-A investor with a B2B focus. He has previously invested in companies like Darvis. His professional career involves projects with Key Performance. His investment check size is around $350 million, and he may prefer collaboration styles such as introspective, relational, and expressive.

Narayan Ramachandran is an angel investor with a focus on technology-intensive businesses in life sciences, healthcare, and education. He is a pioneer in building inclusive institutions in India and has a strong track record as the Chairman of Unitus Capital. Narayan has invested in startups like Mensa Brands and Jana Small Finance Bank, emphasizing technology and differentiation. His investments typically range from seed to later stages, with a check size that varies based on the specific opportunity. His investments reflect a commitment to sustainable and profitable value propositions from inception. While the geographical preference is not specified, Narayan is known for his impactful investments in India-centric and India-first market opportunities.

Dennis Clark is a Partner and CFO at Sand Hill North, specializing in early-stage investments at the intersection of innovation and integrity. Sand Hill North invests in pre-seed to series-A technology-focused startups with a focus on human capital, marketing, sales, SMB software, future of work, developer tools, analytics, AI, and SaaS. Dennis Clark’s geographical preference includes Canada. His investment check size ranges from $150K to $1M with a sweet spot at $250K. Dennis Clark values the team, the plan, the vision, and the purpose of the startups he partners with. He collaborates with visionary entrepreneurs who share his commitment to ethical standards and long-term growth.

Nick Picone is an angel investor with a focus on Cloud Computing, Electronic Health Record (EHR), and Social Impact. He has made past investments in CareShield Health. With a geographical preference for markets like Cloud Computing and Health Care. Although details about his investment thesis, stage of investment, track record, investment check size, and partnership styles are not available, his history indicates a background in high school sports and potential connections to the wine industry.

Dr. Elizabeth Iorns is an investor with a focus on a diverse range of markets, including Mobile, Consumer Internet, Enterprise Software, Healthcare, Clean Technology, SaaS, E-Commerce, Social Media, Marketplaces, and Digital Media. Her investments typically target startups like Notable Labs, Validere, Quero Education, Perlara PBC, NURX, Solugen, Unima, Cambridge Bio-Augmentation, Cambridge Cancer Genomics, Vetcove, Antera Therapeutics, Connecting the Dots, INC, Vinsight, and Konsus. Elizabeth Iorns has a track record in Pre-seed Education, BioTech, and Marketplaces at an investment range of $5K – $25K, with a sweet spot at $15K per investment. Her geographical preference and partnership styles were not explicitly stated in the sources found. Elizabeth Iorns is known for her professional career as the Founder & CEO of Science Exchange, Co-Director of the Reproducibility Initiative, and as a part-time partner at Y Combinator. Regarding the investment thesis, specific details were not available in the sources, but her focus areas and previous investments provide insights into her strategy. Unfortunately, detailed information about her investment check size and partnership and collaboration styles was not found.

Mass Medical Angels, founded in 2007, is a venture capital firm based in Brookline, Massachusetts. They focus on seed and early-stage investments in healthcare, life science, and medical technology sectors. Their investment thesis aims to bring more clinical tools to the marketplace while achieving superior returns. They invest in medical devices, therapeutics, diagnostics, health services, and health information technologies. Mass Medical Angels provides early stage funding ranging from $250K to $3MM and has a geographical preference for the Boston healthcare supercluster. They are known for their track record in supporting companies in the healthcare innovation center.

Thomas Weithman is the Managing Director/VP/Founder at CIT Gap Funds. He focuses on seed-stage venture funds for tech, clean tech, and life science companies in Virginia. Previous investments and professional career details are not available.

Mark Siegel, a Partner & Managing Director at Menlo Ventures, specializes in investments in cloud computing, SaaS, and computational biotech. He also shows interest in drones, autonomous vehicle technology, and AI. Some of Mark’s notable investments include DropCam (acquired by Nest), eero (acquired by Amazon), and Tenor (acquired by Google). Mark’s investment check size ranges across cloud infrastructure, fintech, and supply chain and automation sectors. His approach at Menlo Ventures focuses on growth-stage investments, with a focus on fostering partnerships and collaborations in these areas.

Geoffrey Bernstein, Co-Founder and General Partner at Indicator Ventures, focuses on investing in business and consumer products/services, SaaS, cybersecurity, big data, gaming, infrastructure, manufacturing, e-commerce, AI, and machine learning in the US and Canada. The investment check size at Indicator Ventures ranges from $300k to $1.3M. The firm specializes in seed-stage and early-stage investments, targeting enterprise software, digital health, and fintech sectors at pre-seed and seed stages.

Countryside Angels is a collaborative group of individual investors based in Mason City, Iowa. Their investment focus areas include Food and Agriculture Tech and Life Sciences at the Seed stage. They are interested in equity investments in early-stage, fast-growth companies seeking $50,000 to $1,000,000. Their investments range from $10,000 to $100,000 per deal, with a focus on providing outstanding financial returns to their accredited angel investors. Geographically, they invest in the United States. Countryside Angels have made previous investments in Insignum AgTech at the Pre-Seed stage. Their partnership and collaboration style involve cooperation in screening, due diligence, deal negotiation, and investments to provide greater financial leverage. They aim to help early-stage companies create value and foster growth for subsequent rounds.

Sam Blackham is a SaaS investor and advisor with a focus on the Computer Software industry. His previous experience includes roles as the Chief Financial Officer at eVisit, Nav Inc., and Infusionsoft. He has been involved in investments and advisory since June 2014. Sam’s investment focus areas and geographical preference are not explicitly mentioned in the available data.

Sharon Azulai is a Co-Founder and Managing Partner at KÄTAO Venture Partners, known for his proven track record in building successful startups and his extensive background in global private equity and venture-backed technology markets. He has experience in creating new markets and achieving rapid revenue growth through disruptive technologies and innovation. Sharon has founded five startups, managed four, and sold three, providing significant returns to investors. His investment focus areas include early-stage tech companies, with an emphasis on innovation and impact, especially in the medical technology and diagnostic devices sectors. Combining business acumen, innovation management, collaboration, and negotiation skills, Sharon Azulai is recognized as a dynamic agent of change with an entrepreneurial nature and a high energy level. He also holds a B.A. in Business Management and has served in the intelligence unit at the Israeli defense force.

Cassandra Harris is a Managing Director with a range of $1 – $15 in investment size, focusing on Impact (Pre-seed), DeepTech (Pre-seed), AgTech (Pre-seed), EnergyTech (Pre-seed), TransportationTech (Pre-seed), Digital Health (Pre-seed), Web3/Crypto (Pre-seed), Web3/Blockchain (Pre-seed), ClimateTech/CleanTech (Pre-seed), and SaaS (Pre-seed) sectors and stages. She has past investments in SAY Wear, Petbu, Taylor Morris Eyewear, Freeformers, atelier to go, UB, and Wileyfox. Cassandra Harris is known for efficient order processing at Jerdon Style, llc.

Rick Holton, Founding Partner & General Partner at Holton Capital Group, focuses on investing in technology, manufacturing, hospitality, life sciences, real estate, and venture capital. The firm is based in Saint Louis, MO.

The Knoxville Chamber of Commerce focuses on executing a local, business-focused economic development strategy and markets the City of Knoxville. Their investments fuel growth for existing industry and prepare the region for future employment opportunities. The investor benefits include fueling economic growth through the Path to Prosperity strategic plan. Their track record includes progress in business expansion, infrastructure enhancements, and talent initiatives. The investment check size, partnership, and collaboration styles are not explicitly mentioned on their website.

Maarten Goossens is a Co-Founder and Principal at Anterra Capital with a background in M&A and corporate banking. His expertise lies in deal sourcing, execution, and portfolio management. Maarten focuses on companies leveraging breakthrough biotechnology or digital solutions and typically invests in the food and agriculture sectors. His investment check size is not specified. With a Master’s in Business Administration, Maarten brings a wealth of experience, having started his career at Rabobank and later transitioning to venture capital. His partnership and collaboration style are not extensively documented.

Rob de Ree is a Venture Partner at BioGeneration Ventures (BGV) with a focus on pharmaceuticals, consumer health, digital health, biotech, and health & hospital services. His investments range from $100K to $1M, with a sweet spot at $500K. Rob has made previous investments in companies like NorthSea Therapeutics and SurgVision. He is known for serving on boards and in interim management positions within BGV’s portfolio companies. Rob de Ree’s partnership and collaboration style involve active involvement in the companies he invests in, providing operational support and strategic guidance.

Nima Asghari is an investor with a focus on blockchain, cryptocurrency, and finance. He invests primarily in early-stage startups and has a track record of investments including Mintbase, The Dapp List, and PrimeDAO. With a professional background in Architectural Engineering, Nima Asghari manages a diverse portfolio across the crypto space, with investments like Ceramic. His partnership and collaboration styles emphasize a liquid and collaborative approach within the data economy builders realm. Although his investment check size was not explicitly found, his investments typically range across various funding rounds. Nima Asghari’s geographical preference and past investments suggest a global investment outlook and a commitment to supporting innovative blockchain and crypto projects.

Alexander Ljung, the Co-Founder and Chairman of SoundCloud and Managing Director of Dance, is an Angel Investor with a background in post-production sound design and motion film music production. He holds an M.Sc. degree in Media Technology and Marketing, as well as a degree in Philosophy & Political Science. Ljung’s investment focus areas include Healthcare Technology Systems, Communication Software, and Food Products. He invests in companies at the Seed stage and has made investments in companies like Humanity, Frond, and Stockeld Dreamery. Ljung has a track record of founding and leading successful ventures, with notable professionalism in the music and media industry. Additionally, he has been involved in securing investments and appointing new leadership at SoundCloud. The investment check size he has been associated with is around $170 million, demonstrating involvement in significant funding deals and strategic decisions.

SWAN Funds is a venture fund that focuses on investing in exciting companies with great teams and meaningful traction in sectors such as B2B software, market-accelerating technologies, capital-efficient hard-science, diagnostics & HealthIT, medical devices, scalable IoT, and scalable hardware. They specialize in pre-seed and seed stage investments and prefer companies in the Pacific Northwest where they have established strong relationships with management teams. SWAN Funds aims to provide the first major outside investment and continuous expertise and support to its portfolio companies, fostering growth and success. Previous investments, track record, professional career details, and specific investment check sizes are not provided on their website.

Jeffery Marx is a Chief Scientific Officer at Cerapedics, bringing extensive experience in executive management with medical device companies. With a Ph.D. in Ceramic Engineering, he focuses on regulatory oversight, quality, manufacturing, and R&D. His professional background includes over 13 years at Orthovita and leadership roles at Stryker Orthobiologics. Dr. Marx has a profound understanding of research & development, commercialization, sales management, business development, and strategic planning. His partnership and collaboration styles align with the introspective, relational, and expressive models, aiming to enhance cooperative efforts across different styles.

Uncork Capital is a seed-stage venture capital firm that focuses on SaaS, consumer, marketplaces, hardware, and new technology startups.

Ted Kummert is a Venture Partner at Madrona Venture Group, focusing on investments in infrastructure & platforms, data & analytics, and intelligent applications. His previous investments include serving as a Board Member at SingleStore and a Senior Advisor at UiPath. Ted’s professional career spans notable roles at companies like Microsoft and Apple, with a range of responsibilities in product development and leadership.

Duane Harris, Partner at Next Level Ventures, is a seasoned professional with over 30 years of experience in academics, business management, and private equity investing. He has a track record of managing significant investments and building successful private equity firms. Duane’s investment focus areas at Next Level Ventures include fintech, biosciences, agriculture, collaboration, and manufacturing. He typically invests between $500 thousand to $4 million per business, aiming to support early-stage companies looking to scale rapidly. Duane takes a proactive role in assisting portfolio companies with financial, operational, and networking expertise. His previous investments include companies like Dryland Genetics. With a strong academic background and extensive experience, Duane fosters partnerships based on mentorship and strategic support to drive rapid growth and success.

Cortado Ventures is a seed-stage venture capital firm investing in overlooked foundational sectors in the midcontinent.

Matt Kozlov is an experienced investor with a focus on rapidly growing deep tech, healthcare, B2B, and ecommerce companies. He supports underrepresented founders solving impactful issues. His investments typically range from $500K to $20 million USD. Kozlov emphasizes partnerships and collaborations to amplify startup growth. His extensive career includes managing Techstars programs and facilitating capital for startups.

Manish Bhandari, Managing Partner at Angel Physicians Fund, focuses on investing in mispriced securities value based on underlying business dynamics. His investment areas include luxury auto, Arvind Fashions, Saregama India, Muthoot Finance, Home First Finance Co India, and Ajanta Pharma. Manish primarily invests in Series A and Series D stages in the healthcare sector. His geographical preference is Cincinnati, Ohio, USA. Previous investments include PanTher Therapeutics, S4 Medical, and Foldax. Manish’s investment check size ranges from $5,000 to $50,000, with a sweet spot at $25,000. His collaborative style involves strong partnerships and bringing together complementary businesses, as seen with HLI and GE Current.

Bahador Biglari is an experienced professional with a diversified background. He is the Founder & CEO of CashZar and an Angel Investor at Alliance of Angels and SWAN Venture Fund. Bahador has held various leadership roles at Axon, Facebook, Uber, Microsoft, and PwC Canada. He possesses a Master of Business Administration from UCLA Anderson School of Management and a Bachelor’s degree in Computer Science from the University of Waterloo. Bahador’s capabilities in technical and business leadership, combined with his educational background, make him a strategic investor, focusing on diverse industries and check sizes ranging from $2,500 to $20,000,000. He values compassion, curiosity, and courage in his approach and is committed to raising others to their best. His experience spans across different sectors, showcasing his versatile partnership and collaboration styles.

Joseph Whitters serves on the board of Accuray Incorporated and has significant public company governance experience in the medical technology and medical device industries. He is associated with Frazier Healthcare Partners and has served on the boards of various publicly traded companies. His investments and involvement focus on healthcare companies and emerging technologies in the medical device sector.

Paris Business Angels is a French-based startup investment and support network that focuses on the seed or pre-seed phase. They have invested in organizations such as Iguana Yachts, SoWeTrip, and Agricool. The team includes professionals like Benjamin Bertrand and Vincent Philippe. Their investment check size ranges from 100K to 3M euros. Partnership and collaboration styles involve co-investing in startups and supporting with funding. The network has shown a track record in early-stage investments, particularly in information technology. They maintain a sector-agnostic approach and operate predominantly in France.

Ralph Arnold is a partner and co-founder of TransAct Advisory Services, with a dedication to the Health Care – Life Sciences sectors. He focuses on the convergence of healthcare and digital technologies leveraging his experience from more than 20 years in life sciences M&A and digital. Ralph’s previous investments include setting up scholarship funds and geological oil mapping. As an American artist, he is known for his masterful collages and assemblages. Arnold’s investment check size and specific partnership and collaboration styles were not found in the search results.

NO/LA Angel Network, now known as Gulf South Angels, is an angel investment group based in New Orleans, Louisiana. Their focus is on evaluating, funding, and nurturing early-stage companies with a specific interest in companies with a potential to scale regionally, nationally, or internationally. Their featured investments include bioaesthetics.com, emberaneuro.com, healionics.com, and altisbiosystems.com. The network seeks to go beyond just investing capital by providing mentoring, business insights, and support for portfolio companies and network members. Gulf South Angels also hosts investor conferences and newsletters to enhance collaboration and success within their network.

Bharat Krymo is a crypto investor focused on decentralization and open-source tech, with a portfolio spanning NFTs, Web3 projects, and others. He has invested in projects like Uncharted, Endless Clouds, nftperp, RSTLSS, On Cyber, and reNFT. His investments range from Seed to Undisclosed rounds with co-investors involved. Bharat Krymo’s check sizes vary from $1.50M to $6.70M. He is known for his self-proclaimed decentralized maximalist approach to investing. Bharat Krymo’s collaborations involve cooperative and directive styles, fostering strong partnerships in the crypto space.

Dr. Nathalie Weitemeyer is a prominent investor at Bayern Kapital, a Venture Capital firm with a focus on innovative, technology-oriented startups in Bayern, Germany. Bayern Kapital, under Nathalie’s leadership, has a strong track record of over 320 investments and manages a substantial â¬700 million in assets. Nathalie’s investment thesis revolves around supporting startups from the Seed to Scale-up phase with investments ranging from â¬250,000 to â¬25 million. Her geographical preference spans all technology sectors, including hardware, software, digital economy, industry, medical technology, and life sciences. With a hands-on partnership style, Nathalie has been actively involved in fostering the growth of startups in various sectors. She has led investments in notable startups such as Insempra, AVES Reality, Smart Reporting, Proxima Fusion, Tubulis, Picture Framing, VITAS, and BOX ID. Through tailored financing concepts like Seedfonds, Clusterfonds, Innovationsfonds, and Wachstumsfonds, Nathalie aims to drive innovation and facilitate the success of early-stage and later-stage companies in the German-speaking region. Her commitment to fostering innovation and supporting technology-driven businesses makes her a key player in the Venture Capital landscape.

Skip Fleshman, a Partner at Asset Management Ventures, has been actively investing in companies focusing on digital health, mobile, and data analytics. His previous investments include companies like Marley Medical, Autonomize AI, SubjectWell, Outcomes4Me, Carta Healthcare, Reify Health, Arterys, Welkin Health, and RallyPoint Networks. Skip’s partnership style is reflected in his advisory roles at Stanford’s StartX, Rock Health, and Boston Children’s Hospital. His check size and geographical preference are not explicitly mentioned on the website. Skip’s background includes serving in the United States Air Force as a fighter pilot and founding BGI, which develops software for flight simulators. He holds a Bachelor of Science degree in Mechanical Engineering from UC Davis and an M.S. in Management from Stanford University Graduate School of Business.

David Tolmie is a Senior Partner at Edgewater Funds with a history of successful leadership roles. He has a background in CEO and President positions and is actively engaged in civic and business leadership. The Edgewater Funds, a Chicago-based private equity firm, focuses on executive-led investments, tailoring their approach to each opportunity. Their criteria include target company sizes of $3M – $40M EBITDA and initial equity investments of $10M – $100M in the U.S. and Canada. Edgewater concentrates on business services, healthcare, and industrials, offering varied transaction types. David Tolmie’s collaborative style is evident through his roles on various boards and leadership positions.

Ruperto Calatrava is a Venture Scout at Backed VC with a focus on Entertainment & Sports, Manufacturing, Food and Beverage, Web3/Blockchain, Web3/Crypto, BioTech, SaaS, and FinTech investments. His previous investments include seed stage companies in various sectors. He has a professional background as a Head of Innovation Consultancy and has experience with leading the Research Team at Startupbootcamp. Ruperto’s investment check size ranges from $25K to $100K with a sweet spot at $50K. He has a partnership and collaboration style that aims for win-win collaborations leveraging collective strengths for better outcomes.

Marcel Lubben is a Partner at Brightlands Venture Partners with a focus on the renewable/circular material and pharma/biotech industries. He serves as a trusted advisor to companies in nutrition, personal care, renewable chemicals, and materials. Marcel’s previous roles include Managing Director at Avantium Renewable Polymers and positions at DSM Innovation Center. He holds a PhD in Organic Chemistry. Contact at info@brightlandsventurepartners.com.

Kevin Dee, Vice President at Monroe Capital, focuses on investing in Retail (Seed), Media/Content (Seed), Real Estate/PropTech (Seed), Digital Health (Seed), Health IT (Seed), Health & Hospital Services (Seed), FinTech (Seed), Retail (Series A), Media/Content (Series A), Real Estate/PropTech (Series A), Digital Health (Series A), Health IT (Series A), Health & Hospital Services (Series A), FinTech (Series A), Retail (Series B), Media/Content (Series B), Real Estate/PropTech (Series B), Digital Health (Series B), Health IT (Series B), Health & Hospital Services (Series B), FinTech (Series B). Kevin has a partnership and collaboration style focused on activating transformation through gratitude and appreciation, cultivating cultures where people flourish and thrive. Kevin has a diverse professional background with experience in leadership roles across various organizations.

Guido Magni, M.D., Ph.D., a Partner at Versant Ventures, specializes in seed/early-stage healthcare venture capital investments in the biotechnology and life sciences sectors. He guides on clinical and regulatory strategies for portfolio companies with a focus on novel therapeutics. Investment check sizes range from $100K to $5M. Geographically, the focus is on important unmet medical needs. Previous investments include Aprea, GenSight Biologics, Lava Therapeutics, Nouscom, Piqur Therapeutics, and Tarveda Therapeutics. Guido’s partnership and collaboration style aligns with advancing innovative therapies for unmet medical needs.

Guido Schlitzer is the Managing Director of High-Tech Gründerfonds (HTGF) with 20 years of VC experience and recognized expertise in fund management. He has held various roles at HTGF since 2005, including Investment Manager, Head of Controlling, and CFO at other companies. Guido Schlitzer’s professional background showcases a strong track record in venture capital, making him an experienced leader in the industry. The HTGF, under his guidance, focuses on industries such as Industrial Tech and Digital Tech, with a diverse portfolio of investments in these sectors. Guido is known for his strategic partnership and collaboration styles, aiming for long-term growth and success for the companies he invests in. The investment check sizes and geographical preferences of Guido Schlitzer at HTGF are not explicitly mentioned on the website.

University of Utah Research Foundation is an angel group based in Salt Lake City, Utah. The firm focuses on investments in science, technology, medicine, pharmacy, engineering, natural resources, energy, business, and education sectors. They prefer early-stage investments and have a track record of supporting companies like Light Line Medical, Converus, and iVeena. The investment check size typically ranges from $20,000 to $150,000. The University of Utah Research Foundation is known for fostering partnerships with various entities to support new ventures arising from the university’s research portfolio.

Oscar Slotboom is a Managing Partner at BioGeneration Ventures (BGV). He is an expert in digital growth strategies and has invested in 50+ startups and scale-ups. Oscar Slotboom’s investments focus on early-stage ventures and company creation. He has a track record of successful investments in the life sciences sector. The check size of investments made by Oscar Slotboom at BGV is undisclosed. In terms of partnership and collaboration styles, Oscar Slotboom actively shapes new life-science ventures. BGV’s investment stage under Oscar Slotboom’s leadership ranges from early to mid-stage ventures, with a focus on creating new ventures in the life sciences sector.

Andrew Kress is an Angel Investor and serves as the President of Surveillance Data, Inc.

Bradley Siegler, a Venture Partner at Pioneer Fund, focuses on investing in startups addressing climate change and resource challenges through big data, AI, and biotech solutions. He co-founded companies like EquipmentShare and Appreciate, with experience in web design, marketing, and strategic roles. With investment check sizes averaging $5-10 million, Bradley prefers collaborative partnerships and diverse professional projects. His career spans web development, entrepreneurship, and innovation, often involving mentorship and strategic guidance.

William Cowen, General Partner at Long River Ventures (now LRVHealth), focuses on early-stage healthcare investments in disruptive companies across healthcare IT, technology-enabled services, devices, and diagnostics. The investment check size is approximately $100 million. LRVHealth partners with healthcare industry insiders, national healthcare systems, and the Innovation Institute to fuel its platform. The fund involves over 20 healthcare thought leaders, eight national healthcare systems, and additional partners to identify and invest in innovative startups. William Cowen, along with his team, has a successful 17-year track record of providing institutional investments in market-leading companies such as GetWellNetwork, MedVentive, Phreesia, lifeIMAGE, and Convergent Dental.

Nedermaas Hightech Ventures focuses on pre-seed and seed investment opportunities across a broad spectrum of high technology fields, with an investment range of 150,000 to 500,000 euros. Some of the previous investments by Nedermaas Hightech Ventures include companies in biotechnology, life science, therapeutics, genetics, and pharmaceutical sectors.

Maximilian Bock, an Investment Manager at High Tech Gründerfonds, has a focus on nano- and quantum technology, materials, environmental research, Industry 4.0, and the Future of Work. His investment focus areas include Generative AI, Europe Fashion Companies, and Germany Seed Stage Companies. He engages in Seed Round investments and collaborates internationally with a focus on England, France, and the USA. Maximilian has supported over 60 startups, including Netwookie LTD. His past investments indicate a tech-savvy approach with a diverse portfolio.

Refactor Capital is a seed stage VC firm investing in bio, climate, and health.

Omega Funds global life sciences-based investment firm specialized in direct secondary transactions.

Johan Andersson is the President and CEO of Addnode Group, a company providing digital solutions for design, simulation, product data information, and case management. The company focuses on sustainable digital solutions for industries like construction, manufacturing, life science, and the public sector. Addnode Group’s strategy includes organic and acquisition-driven growth with a track record of over 70 acquisitions to date. They emphasize recurring revenue, customer relationships, and diversification in operations to reduce business risk. Johan Andersson leads the company in a partnership style that prioritizes growth, profitability, and strong cash flow generation.

CANCER FUND, an investor, focuses on early-stage companies in the areas of Therapies and Management, Diagnostics & Monitoring, and Preventions & Enabling Technologies. Their investment thesis emphasizes utilizing data to improve patient outcomes and reducing costs in the healthcare landscape. CANCER FUND’s investments range from pre-seed to later stages, managing risk exposure while addressing diverse capital needs. They have made significant previous investments in various institutions supporting cancer research and treatment. The investor accepts a minimum investment of $100, allowing any amount in increments of $100. CANCER FUND is known for its collaboration and partnerships to accelerate progress in the fight against cancer.

South Coast Angel Network is an angel investor group that typically focuses on startups aged 6-10 years in industries like Marketing and Human Computer Interaction, with key investments in sectors such as Biotechnology, Health Care, Analytics, and Brand Marketing. They invest in early-stage companies within Louisiana and the Gulf Coast community. The group’s investments usually range from 1 – 5 million dollars per company, with a preference for startups with multiple founders. Some notable portfolio companies include SonarMed and eyeQ.

Francois-Henry Bennahmias serves as Chairman at Pilla and is the President and CEO of Audemars Piguet North America. During his leadership, Audemars Piguet North America has grown from $6 million to over $100 million. His investment focus areas and partnership styles are not explicitly mentioned in the available information.

Lieven Huang is the Investment Manager Life Science & Medtech at the Brabant Development Agency (BOM). With a background in Bioengineering Sciences, Lieven is passionate about supporting early-stage companies to develop new treatments. His investment focus includes a broad portfolio ranging from discovery to clinical stage companies in the Life Science and Medtech sectors. Lieven’s previous investments and check sizes are not specified. Geographically, Lieven’s preference is not explicitly mentioned. His partnership and collaboration styles are not detailed. Lieven Huang excels in guiding creative problem-solving and ensuring successful outcomes.

Krish Ramadurai is a Partner at Harmonix Fund, focusing on investments at the nexus of healthcare, life sciences, and deep tech. The fund typically invests between $500,000 and $5 million per company. Recent investments include loft Orbital, bit.bio, Caresyntax, Auransa, and POLARISqb. Krish leads technical due diligence, investment sourcing, and portfolio operational support. His partnership and collaboration style emphasize building strategic partnerships. Krish’s focus areas include healthcare, life sciences, and deep tech. The fund seeks to elevate impactful innovations in these sectors.

William Martin is a Co-Founder of ShopperTrak and an Advisor & Investor at SwervePay. He has been Chairman at Shelfbucks and played a key role in mergers and acquisitions. With a focus on sustainable growth, he supports startups like BestFit Media, RailVeyor, and ShelfBucks. Previously, he held management positions with Lanier Business Products. Mr. Martin’s investments primarily target early-stage ventures and seed funding. His investment geography covers Europe, the Middle East, and Africa. Although specific check sizes were not found, he is involved in a wide range of investments. Mr. Martin is actively engaged in various business ventures. The collaboration style information was not directly available, but he is known for his active support of young companies and startup growth.

Nikolaus Raupp is a Senior Investment Manager at HTGF, specializing in sustainable innovations, renewable resources, and climate protection. With a background in regional marketing at BASF, his focus includes Chemistry Start-Ups in the Life Science Team at HTGF. Notable investments include O11 biomedical, COLIPI, PlastFormance, hema.to, ESy-Labs, and EEDEN. HTGF supports AgriTech innovation in the agricultural sector. Location contact details are available for HTGF in Bonn, Berlin, and Munich.

Jack Gomer is a Principal at MultiCare Capital Partners in Seattle, Washington. He is a healthcare investor and humanitarian with experience in strategic healthcare venture capital funding. Jack is a member of Alliance of Angels, the largest and most active angel group in the Pacific Northwest. His professional career includes roles such as Program Manager at MultiCare Health System and Board Member at Médecins Sans Frontières. Jack is involved in various projects and certifications, demonstrating his commitment to continuous learning and development.

Silicom Ventures is a California based angel investment firm with a portfolio of 61 companies invested in various sectors including life sciences, semiconductors, software, and media. They invest in Seed stage startups and have notable investments such as Upwork, AnchorFree, and Mellanox Technologies. Silicom Ventures focuses on North America, Europe, and Asia and does not specify a check size for investments. Their partnership and collaboration style is not explicitly mentioned on their public profiles.

Nora Doherty, the Vice President of Finance and Managing Director at BioCrossroads, is an investor with a focus on strategic and impactful investments in the life sciences industry. Her investment range typically spans from $100,000 to $5 million, with a sweet spot around $1.5 million. Nora has a track record of investing in companies like Seed BioTech and SonarMed, the latter being in Series C financing in October 2017. She operates from Indianapolis, Indiana, and has a professional career that includes managing key collaborations such as INCAPS and FIHC. Nora’s partnership and collaboration styles are valued in the industry, attracting founders and investors alike, such as Evan MacQueen, Patricia Martin, Anders Richardson, and Alexandre Glaser. Previous Investments: – Seed BioTech – SonarMed Investment Check Size: – Range: $100,000 – $5,000,000 – Sweet Spot: $1.5 million Geographical Preference: – Location: Indianapolis, Indiana

New Enterprise Associates is a global venture capital firm investing in technology and healthcare.

Laurence Hayward is a Founding Partner at ATOMS VC with an investment range of $250K – $2.0M and a sweet spot of $750K. He focuses on sectors like Diagnostics, Drug Delivery, Material Science, Semiconductors, Medical Devices, Manufacturing, DeepTech, Hardware, Robotics, and ClimateTech/CleanTech at Series A and Series B stages, primarily in the Midwest region. Laurence has made investments in companies like Jio Inc., Intellihot, and NovaScan. He allows warm intros through Signal using Gmail and is associated with investors like Andrew Verhalen, Matrix, and angels such as Daniel Kennedy and Operator Stack.

MDI Ventures is a global multi-stage venture fund with 3 unicorns in its portfolio.

Wouter Gort is a Partner at Hummingbird Ventures with an investment range of $500K – $15.0M. His sector and stage rankings include Hardware (Seed), Consumer Health (Seed), Web3/Blockchain (Seed), BioTech (Seed), Marketplaces (Seed), Health & Hospital Services (Seed), Health IT (Seed), SaaS (Seed), FinTech (Seed), Hardware (Series B), Consumer Health (Series B), Web3/Blockchain (Series B), Marketplaces (Series B), BioTech (Series B), Health & Hospital Services (Series B), SaaS (Series B), Health IT (Series B), FinTech (Series B). He has investing connections with various investors and invests with partners such as Akshay Mehra, Barend Van den Brande, and others.

Cove Fund is a seed-stage venture capital fund.

Robert Fanini, the General Partner at Inspiration Ventures, focuses on early-stage and secondary investments in healthcare and technology companies across the United States. Inspiration Ventures typically invests in seed-stage tech companies and has a portfolio spanning various sectors like Enterprise Applications and Consumer. Previous investments include companies like DailyPay. Robert Fanini, along with partners, Gady Nemirovsky and Harvey Floyd II, seeks opportunities to support startups in their growth journey. Inspiration Ventures maintains a collaborative partnership style with a focus on nurturing startups in their early stages of development.

Joshua Jones-Dilworth is a visionary entrepreneur and CEO with a focus on health-related quality of life through the Litmus Health clinical data science platform. He has expertise in introducing early-stage technologies to the market and is a skilled storyteller advocating for the impact of science and scientists. His investment thesis centers on making significant advancements in science known and understood, fostering a world where science integrates seamlessly into society. Joshua’s geographical preference is not explicitly mentioned. He has a solid track record in public relations and technology companies. He maintains a self-funded approach at Litmus Health. Specific investment check sizes and partnership styles are not available.

Allen Cutler is a private investor residing in New York. He worked as an investment banker for Lehman Brothers and Barclays Capital. He is a member of the New York Angels, an investor consortium focused on start-up enterprises in the New York area. Allen serves as Chairman at World Learning Endowment Fund. His investment check size and partnership styles are not explicitly provided.

Jouko Ahvenainen is a serial entrepreneur and investor with a focus on digital finance companies in the US, Europe, and Asia. He has a track record of pioneering new businesses and collaborative partnership styles. Jouko has invested in numerous innovative companies and typically supports startups in their early stages with a range of investment check sizes. His investment approach is inclusive and aims to drive innovation and culture change in the industry.

TLV Partners is a venture capital firm dedicated to investing in innovative early-stage rounds.

Sirius Seedfonds was established in 2007 as a venture capital firm in Germany. They focus on early-stage ventures in biotechnology, pharmaceutical, chemical, consumer, and business development sectors. Their investments typically range between 1 – 5 million dollars, and they primarily invest in startups aged 4-5 years old. Previous investments include evocatal. Their main geographic focus is within the European Union. Partnership and collaboration involve investing in young innovative companies seeking relevant experience and know-how.

Jean-Paul Clozel is a seasoned investor with a focus on sustainable value creation. He has a commitment to Idorsia over the long-term and adopts a hands-on investment style. Clozel’s investments are characterized by a check size of CHF 75 million for bridge financing. His partnership and collaboration style involves significant global research collaborations. With a successful professional career, including founding Idorsia Ltd, Clozel is known for his expertise and leadership in the pharmaceutical industry.

Daniel Dillinger, an investment manager at Redalpine Venture Partners, focuses on seed and early-stage investments primarily in disruptive technologies within highly scalable ICT and Health Tech models. His geographical preference lies in the life sciences, digital health, medtech, and biotech industries. He has a track record of leveraging his medical and business background to accelerate innovation in healthcare. Although specific previous investments were not directly available, his role at Redalpine involves supporting companies in these sectors. The investment check size is likely aligned with substantial venture capital investments in health-related technologies. Daniel Dillinger’s partnership and collaboration styles were not explicitly mentioned in the search results.

Minnesota Angel Network, established in 2011, aims to activate the next generation of angel investors in Minnesota. They focus on supporting Midwest startups through angel investments and fostering a supportive ecosystem for founders. The network invests in scalable, early-stage companies in various industries such as healthcare and health IT. Although specific track record details were not found, Minnesota Angel Network collaborates with a network of diverse accredited angels who support companies they invest in. The investment check sizes range from $25,000 to $1,000,000, with an average investment size of $250,000. Their partnership and collaboration style involves making informed investment decisions collectively, committing to the success of invested companies, and providing access to education and deal flow. Previous investments include companies supported through their network.

EQx Fund, led by Ziad Moukheiber, operates an evergreen Angel Fund focusing on early-stage biotechnology companies. Their investments are diversified and primarily target extraordinary Founders. The fund is based in Boston, Massachusetts. They have a partnership and collaboration style that may not be readily available online. For investment check size, they typically invest in early-stage startups with a wide range of investment sizes. Unfortunately, specific details on geographical preferences and previous investments for Ziad Moukheiber and EQx Fund were not found.

Fade Oluokun is the Vice President at Thompson Street Capital Partners. The firm’s investment strategy focuses on sustainable growth in Life Sciences & Healthcare, Software & Technology, and Business & Consumer Services and Products. They target investments in companies with enterprise values between $50 million to $500 million, with a geographic reach in North America, Europe, and Australia. Thompson Street Capital Partners V invests in IT, B2B, and healthcare companies in the US, with check sizes ranging from $25 million to $150 million. Fade Oluokun’s professional experience includes roles at BW Forsyth Partners, and he holds a BSBA in Finance from Washington University in St. Louis and an MBA from the Booth School of Business, University of Chicago.

Howard Brodsky is a renowned pioneer in cooperatives and the Co-founder, Chairman, and Co-CEO of CCA Global Partners. With a mission to use a shared ownership model, Brodsky focuses on promoting cooperatives for a better world, addressing income inequality issues. His investment stage of preference is in the seed round, with an industry focus on Consumer Internet, Energy & Clean Tech, Life Sciences, and Mobile. Brodsky is actively involved in founding and leading CCA Global Partners, one of the largest retail companies in America. His investment check sizes vary, with examples including $1,000,000 and â¬11,000,000. Brodsky’s partnership and collaboration style exemplifies humility and recognition of others’ contributions within CCA Global Partners.

Peter Verrillo is the Chief Executive Officer and Co-Founder of Enhatch. The company focuses on developing virtual planning solutions for 3D printed implants and guides for orthopedic and spine surgery. Enhatch received Series A Funding led by Trousdale Capital and Apis Holdings to develop Intelligent Surgery, integrating AI solutions into the medical device industry. The investment aimed to accelerate automation and adoption of patient-specific technologies. Enhatch is known for pioneering Intelligent Surgery with AI solutions for surgeries, offering advanced surgical planning tools and collaboration platforms. Since the investment, Enhatch’s team has doubled in size, with a third of employees in Tulsa, OK, collaborating with the local tech community.

Marc Samwer is a prominent investor known for investments in companies like Alando, Jamba!, CityDeal, and Rocket Internet. His investment focus spans globally across all stages, from early seed rounds to growth capital. With previous ventures like Rocket Internet, he has a track record of successful entrepreneurship alongside his brothers Oliver and Alexander. Although specific information about his partnership and collaboration styles is not readily available, Marc Samwer has demonstrated a hands-on approach to investments and strategic decision-making. The investment check size typically ranges between 10 million to 50 million dollars, showcasing a commitment to substantial funding. Geographically, Marc Samwer’s interests extend globally, reflecting a diverse and international investment strategy.

Clement Salque is an Associate at Bioqube Ventures with a focus on sourcing, financing, and developing innovative companies in the healthcare and life science sectors. He translates scientific innovation into therapeutic drugs to maximize value for investors. Previously, he was a Business Analyst at Bioqube Ventures and a Healthcare Venture Capital Analyst at INKEF Capital. His experience includes analysis of investment propositions, due diligence, market research, deal sourcing, and support of portfolio companies. Clement has a background in regulatory affairs and rare diseases. His career shows a dedication to the healthcare and biotech industries, with a track record of involvement in strategic positioning, clinical trial design, and budget reviews. Clement Salque’s current investment focus areas are in healthcare and life sciences, primarily in Europe. He is experienced in supporting innovative companies, conducting due diligence, scientific analysis, and strategic decision-making for portfolio companies. Clement’s professional career spans various roles in healthcare and regulatory affairs, showcasing his expertise in medical innovation and entrepreneurship.

Mary Naylor is a pioneer in the design, evaluation, and spread of health care innovations that have significantly improved the outcomes of chronically ill older adults. She has led research to implement the Transitional Care Model, focusing on the care and outcomes of chronically ill older adults. Mary Naylor’s professional career includes being the Marian S. Ware Professor in Gerontology and Director of the NewCourtland Center for Transitions and Health at the University of Pennsylvania. Her track record includes awards for her work in improving the quality of cancer care and health care for older adults. Mary Naylor has been involved in collaborations that enhance care delivery through advanced-practice provider models. Previous investments attributed to Mary Naylor include involvement with organizations like the Young Presidents’ Organization, Inc., with a focus on leadership development and growth.

Bill Walters, Chairman and CEO of The Walters Group and BW Auto Ventures, specializes in diversified investments in sectors like real estate, luxury golf courses, and startups. His geographical preference is in Los Angeles, California, USA. Bill Walters is known for his impeccable track record in sports betting and investing, with a 30-year winning streak. He focuses on early-stage investments with varying check sizes. Walters is recognized for his collaborative approach to partnerships, as demonstrated in his diversified holdings and business ventures.

Robin Hendrickx, an Investment Manager at BOM Brabant Ventures, specializes in investing in a wide range of sectors, with a focus on Seed and Series A investments. His investment thesis revolves around supporting startups in key areas such as Manufacturing, Logistics, AgTech, Food and Beverage, ClimateTech/CleanTech, Digital Health, BioTech, Health & Hospital Services, Health IT, and SaaS. His investment range typically varies from $100K to $5.0M, with a sweet spot at $1.5M. Robin has a track record of successful investments in both Seed and Series A stages across different industries. He collaborates closely with co-investors within BOM Brabant Ventures to identify promising opportunities and drive growth in the startups he invests in.

Vipul Patel is an investor with a focus on technology vendors and has made investments in Capstan Medical. He invests in a range from $100,000 to $5 million, with a sweet spot of $1.5 million. Patel’s partnership and collaboration style aligns with introspective teammates who value establishing trust and respect through dialog and discussion. He operates in the sectors of AgTech (Seed), EnergyTech (Seed), Digital Health (Seed), Health & Hospital Services (Seed), Health IT (Seed), AgTech (Series A), EnergyTech (Series A), Digital Health (Series A), Health IT (Series A), and Health & Hospital Services (Series A)

Elise Hoffman, General Partner at Cultivation Capital, specializes in investing in digital health, life sciences, software, IT, agriculture, and food technology startups primarily in the Midwest Seed Stage. She has a track record in health technology and life sciences investments. Cultivation Capital focuses on early-stage investments ranging from seed to Series B. Elise’s investment check size is not specified. The firm promotes collaboration and internal talent to drive partnerships. Geographically, the focus is on the Midwest region. Previous investments are in sectors like digital health, software, and IT.

Marek Poszepczynski, an Investment Manager at SV Health Investors, is known for his specialization in the healthcare sector with a focus on biotechnology, medical devices, and digital health. SV Health Investors has a proven strategy for selecting healthcare investments across various stages, geographic regions, and sectors. Marek has a track record that includes managing the International Biotechnology Trust and working on the Dementia Discovery Funds. The average investment check size from SV Health Investors ranges from 10 to 50 million dollars per startup. Marek’s professional career started as an analyst in 2014 before becoming a named manager of the trust in 2017. His collaboration style is reflected in his active management of diversified portfolios and his optimism about the biotech sector’s recovery post-Covid, emphasizing the importance of humility and appreciating industry trends.

Kreske Nickelsen has over 20 years of global life science and venture capital experience, working with different funds, 3i Group plc, and The Boston Consulting Group. She has a background in Biology and an MBA, with a strong focus on venture leasing and financing solutions. Kreske has overseen transactions from seed stage to mezzanine, including license agreements, IPOs, and trade sale processes. She has served on numerous boards in Europe and the USA.

Qiming Venture Partners is a venture capital firm investing in the TMT and healthcare industries at the early and growth stages.

Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists.

Edward Sullivan is an investor focused on technology vendors, venture capital, consumer, tech, insurance, healthcare, and financial services. His previous investment includes G2Link. He specializes in executive coaching. Edward Sullivan’s investment check size, geographical preference, track record, and partnership styles are not explicitly mentioned in the available information.

Steve Anderson is the Founder of Baseline Ventures. His investment focus areas include Sales & CRM, Security, Data Services, Media/Content, E-commerce, Social Networks, Cloud Infrastructure, SaaS, and Enterprise. He invests in seed-stage technology companies. The geographic preference of Steve Anderson at Baseline Ventures is not specified. Some of his previous investments include SoFi, Expensify, Liftoff, WeWork, PagerDuty, SFIX, Twitter, and TinyPulse. Steve Anderson has a track record in companies like eBay, Microsoft, Kleiner Perkins, and Starbucks. The investment check size of Steve Anderson at Baseline Ventures is not available. His partnership and collaboration styles focus on helping founders build and grow early-stage companies into change-effecting enterprises.

Magnus Christerson, an Angel Investor at Alliance of Angels, focuses on MarketingTech and SaaS startups at the Seed and Series A stages. His investment range is $500K to $1.5M with a sweet spot at $1M. Magnus has affiliations with scouts and angels within Alliance of Angels, such as Andrew Wang, Bahador Biglari, Ben Sharpe, Beth Morgan, and Carla Fowler.

Vidinovo is a venture capital firm established in 2013, focusing on early and late-stage financing. Their investment thesis centers around the healthcare, education, life science, oncology, and service sectors. Vidinovo typically invests in companies in the range of 1 – 5 million dollars. The firm’s geographical preference is not clarified, but their previous investments include companies in the Health Care, Software, Machine Learning, Artificial Intelligence, and SaaS fields. Some of their notable portfolio companies are MedGenome Inc., WiserCare, American Prison Data Systems, PBC. Vidinovo’s investment check size is around $3 million per round, and they have made 5 investments with an average round size of $3 million. As for track record and professional career details, specific information is not available.

Howard Walthall is the Founder and Chief Executive Officer of Lumiheal Therapeutics. He has a track record of leadership roles in various companies, including NuTech Spine, Inc. and NuTech Medical, Inc. Walthall’s professional career includes positions at Organogenesis Holdings Inc. and Burr & Forman LLP. His investment check size is not specified in the available information. Walthall is associated with companies like CHITOGENX INC. and Lumiheal Therapeutics. However, specific details about his investment thesis, focus areas, stage of investment, geographical preference, previous investments, and partnership and collaboration styles could not be found.

Haley Zollo, a Partner at Starting Line, focuses on investments within sustainability, personalization, Gen Z, and next-generation commerce. She has led seed investments in startups like Cameo, Klover, Soona, and more. Starting Line’s check size ranges from $100K to $3M, investing in sectors like Consumer, Fintech, and Marketplaces. They mainly invest in the USA. Previous investments include companies in Consumer products and services, Communications, Business services, and Life Sciences. Haley’s background includes roles at Mac & Mia, Trunk Club, and KPMG, holding a finance degree from Indiana University. Her partnership at Starting Line enables collaborations with institutions and Unicorn CEOs, emphasizing high-conviction seed investing.

Justus Klocke is an investor focused on Pre-seed BioTech startups. He invests in startups like Pixtunes and Seniovo, with a check size range of $25K. Justus Klocke’s professional career includes a Ph.D. in Modern German Literature and Culture from Indiana University. His partnership and collaboration styles involve engaging in discussions about AI tools and policies. Justus Klocke’s geographical preference and specific track record are not available.

Sean McDade is a member at Robin Hood Ventures, a group of angel investors focused on early-stage, high-growth companies in the Greater Philadelphia region. He typically invests $250k to $500k in businesses he knows and understands. Robin Hood Ventures has invested in over 45 companies in industries like software, medical devices, biotech, internet, and financial technology. They are located in Philadelphia, Pennsylvania, and primarily operate in the Finance and Venture Capital & Private Equity industries.

Marta Mrozowicz is a former Investment Manager at Calm/Storm Ventures, a purpose-driven venture capital firm focusing on founders changing life & health for the better. She transitioned to Heal Capital’s team in Berlin with a focus on HealthTech investments. Marta’s investment range is $25K to $250K, with a sweet spot around $137K.

Edward Colligan is involved in impact investing and mentoring next-generation entrepreneurs. He serves on the boards of Numenta, Inc. and POPS Worldwide. His previous investments include Numenta as part of their Series C funding. Throughout his career, Ed has been the former CEO and President of Palm and served as Senior Vice President and General Manager of the Wireless Business Unit. He also held positions at Handspring, Inc. and Radius Corporation. Ed’s investment check size ranges between $500K to $1.5M. His career reflects a significant contribution to the mobile computing industry, with a track record of success in building products and brands, driving successful transactions, and mentoring startups. His collaborative style focuses on impact and empowerment, evident in his dedication to nurturing entrepreneurial talent.

Young Sohn serves as a Board Member at Oryn Therapeutics and is an Advisor at Unique and MedaSystems. She also acts as an Angel Investor and Co-Founded Vlocity. With a background in leadership roles at various companies, Young has a track record of successful ventures in the pharmaceutical CRM space. She has been involved in acquisitions, innovative solutions, and thought leadership within the industry. With a B.A. in Business Management from Cornell University, Young Sohn brings valuable expertise to the organizations she is associated with.

Sami Inkinen is the CEO & Founder of Virta Health, an online specialty medical clinic that reverses type 2 diabetes safely and sustainably. He likes creating positive disruptive change in business and personal performance through new technologies and hard work. Sami advises, mentors, invests, and starts high-growth companies, especially those focused on healthy living and advancing human health and performance. His past experience includes co-founding Trulia, working at Microsoft, McKinsey & Company, Nokia, and co-founding Matchem. He holds an MBA from Stanford University and a Master’s in Engineering from Helsinki University of Technology. Sami is an investor in health, aiming to reverse diabetes in 100M people.

Kevin Kim is an investor with a focus on the healthcare industry, committing over $4.0 billion to over 100 companies. However, specific investment focus areas, stage of investment, geographical preference, and partnership styles are not directly provided in the available information. Previous investments and track record details are not disclosed on the sources found. Kevin Kim has a background working with big brands like Google, AdWeek, and Bizzabo, managing over $65M in revenue at Google. He has experience in forging partnerships with both internal and external stakeholders, particularly in adtech and advertising.

Joseph M. LaGuardia is the principal of LaGuardia Group, a New Business Development and Strategic Marketing firm serving health plans, hospitals, ventures in the health and wellness industry, entrepreneurs, and start-ups. He has a Bachelor of Science degree in Business Administration from The University of Akron. Previously, Joseph served as the Senior Vice President of Business Development at Pretorian Labs, a large independent lab, and as a Consultant at the Cleveland Clinic. He has also held positions such as Regional Vice President at Anthem Blue Cross and Blue Shield/Wellpoint and VP at Swagelok. LaGuardia’s professional career spans roles in marketing, sales, new business development, and consulting across healthcare and other sectors.

The Angels’ Forum is a hybrid venture/angel firm that invests in Software, Technology, and Life Sciences. The firm’s stage of investment includes Debt, Early Stage Venture, Late Stage Venture, and Seed. The investment check size ranges from a few hundred thousand dollars to a few million. The Angels’ Forum emphasizes partnership and collaboration styles through its collaborative initiatives and working closely with angel investors from various regions.

Michael Speiser is a Managing Director at Sutter Hill Ventures, with a focus on investments in the biotechnology, software, telecommunication, and infrastructure sectors. He specializes in incubating and building companies, rather than investing in existing ones. Speiser’s track record includes successful startups like Snowflake, Pure Storage, Observe, Inc., Augment, and others. His investment check size ranges upwards of $3 million. Speiser exhibits a collaborative approach in his partnerships, working with entrepreneurs to tackle significant challenges and achieve impactful change in the world.

James McKelvey is a Co-Founder and General Partner at Cultivation Capital. He focuses on technology and life sciences investments. Cultivation Capital manages funds in software, agriculture, geospatial, and health tech startups. Recent investments include Lionize. James McKelvey is also involved with SixThirty, a FinTech accelerator making $100,000 investments in financial-based technology startups. He collaborates with local financial services companies and supports startups with training and mentoring. SixThirty addresses the engineering talent gap in the St. Louis startup ecosystem.

Marc Abramowitz is a private investor primarily focused on Enterprise Applications and HealthTech. Some of his previous investments include Aural Analytics and Betable. He has an extensive professional career, having worked as a Program Manager at Telos Corporation with experience in managing various projects. His investment check size can vary, as seen with his investment in Finexio as part of their Series A – II in 2021. Abramowitz’s partnership and collaboration styles are not specifically mentioned in the available data.

Joshua Beebe is a Partner at MK Capital, an established venture capital firm with a focus on multi-stage growth equity and venture capital investments. Joshua Beebe leads the healthcare technology investment practice at MK Capital. The firm’s investment strategy includes a preference for seed-stage, early-stage, and growth-stage companies. MK Capital operates out of Northfield, Illinois, and has a geographical preference for companies in the Great Lakes and Midwestern US regions. The check size for investments at MK Capital varies based on the stage and needs of the companies. The partnership and collaboration style at MK Capital involves active involvement in portfolio companies and advisory roles, with team members providing valuable expertise and guidance to support growth and success.

Rachel Rath is an investor at Johnson & Johnson Innovation – JJDC, Inc with an investment range of $100K to $5.0M, focusing on sectors like Medical Devices, Health & Hospital Services, and Health IT at both seed and Series A stages.

Steve Jackson, a member at Alliance of Angels, focuses on investing in startups in sectors like Media/Content, IoT, Enterprise Applications, and Consumer Internet at both seed and Series A stages. His investment range is between $500K and $1.5M. Steve Jackson is affiliated with Andrew Wang, Bahador Biglari, Ben Sharpe, Beth Morgan, and Carla Fowler. He works in Seattle, Washington, and has a sweet spot of $1M for investments. Steve’s current fund size is $100M. He invests in the Pacific Northwest and supports high-growth startups in technology, hardware, consumer, and life sciences.

Jim Sullivan is a Venture Partner at OrbiMed, based in Chicago, Illinois. His investment thesis focuses on Pharmaceuticals, Digital Health, BioTech, Health & Hospital Services, and Health IT at the Seed and Series A stages. Jim’s investment check size ranges from $1M to $75.0M, with a sweet spot of $4.0M. He has a current fund size of $18B and collaborates with co-investors such as Alexandria Huynh, Anat Nursella, Brendan Weber, Carl Gordon, and Charles Steinman. Sullivan’s partnership and collaboration style involve actively engaging with startups in the mentioned sectors, aiming to contribute to their growth and success.

Bernd Goergen is a High-Tech Gründerfonds Partner with an investment focus in Life Sciences & Chemistry, Digital Tech, and Industrial Tech. His investments typically target BioTech (Seed), Health & Hospital Services (Seed), and Health IT (Seed). Bernd’s investment range is from $100K to $5.0M, with a sweet spot of $1.5M per company. He has a Ph.D. in Virology, Immunology, and Human Genetics and has previous experience as an International Marketing Manager and Postdoctoral Research Scientist. Bernd’s geographical preference is not specified in the available data. His partnership and collaboration styles can be inferred from his past investments in companies like Cunesoft, Fiagon, HUMedics, and Oncgnostics. Unfortunately, specific information on investment check sizes is not available.

Stephen Malik is an Angel Investor with a focus on seed round investments in healthcare, consumer internet, and mobile industries. He has a strong track record in software ventures and successful software firms. His geographical preference is to bring MLS and NWSL teams to North America. Additionally, he has acquired the NASL Carolina RailHawks and rebranded them to North Carolina Football Club. Malik’s professional career includes founding Medfusion and leading the N.C. Courage women’s soccer team. His partnership and collaboration styles involve building organizations that cover various segments of the soccer industry, from grassroots to professional levels.

Alliance of Texas Angel Networks, as part of the Texas Angel Investors network, focuses on investing in people and offers a bright future for early-stage companies in Texas. They have no geographic limitations on funded companies and seek scalable business models for a good return on investment. The network has facilitated investments in various startups like HelpSocial, Parlevel Systems, Dauber, and Localeur. Additionally, they emphasize leveraging the combined knowledge and experience of the network to make informed early-stage investment decisions. Individual check sizes for investments typically range between $10,000-$100,000, with a focus on collaboration and partnerships with local entrepreneurs, Texas Tech University, and the Lubbock Economic Development Alliance (LEDA) to foster economic growth and innovation.

Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM

Maren Nelson is an investor at Alliance of Angels focusing on seed and early-stage investments ranging from $500k to $2.5 million. She prefers companies connected to the Pacific Northwest but also invests across the US and Canada. Nelson seeks extraordinary founders in various sectors such as SAAS, AI, and Life Sciences. With the Alliance of Angels Innovation Fund, she makes $150k investments in around a dozen companies annually and decides within 6 weeks. Nelson’s partnership and collaboration style involve a 4-step process: Introductory Meeting, Screening Committee Meeting, Member Meeting, and Due Diligence.

Nils Regge is a serial entrepreneur with a passion for health tech and biotech companies. He focuses on investing in age-related diseases and longevity. Nils Regge’s investment check size is undisclosed, and his partnership and collaboration styles are not specified. His previous investments include Albora Technologies and NUMA Group. He is known for co-founding successful companies and has an aggregated valuation over his entrepreneurial career.

Eric Paley, Managing Partner at Founder Collective, has an investment thesis focused on early-stage startups with successful exits like Blissfully and Codecademy. His investment focus areas include social networks, enterprise, and marketplaces across various stages. Eric typically invests between $400K and $2.0M, with a sweet spot at $1M, from a fund size of $75M. His partnership and collaboration styles are not explicitly mentioned in the available information.

Venrock is a venture capital firm investing in technology and healthcare companies.

Samuel Jung, an Associate at Edge Case Capital Partners, focuses on investments in startups with disruptive technologies including biotech, fintech, AI, blockchain, crypto, NFT, software, social media, and sustainable energy. He collaborates with students through the fast-track experiential internship program. Previous and current investments include students from various universities. Samuel’s investment check size and partnership styles are not explicitly mentioned on the website.

Sean Kendall, a Partner at ARCH Venture Partners, focuses on identifying and evaluating new life science technologies, providing operating assistance to early-stage portfolio companies. He has made investments ranging from $50K to $150.0M and has a sweet spot at $25.0M. Sean Kendall’s investments include 2 records. His educational background is in Chemical Engineering from Stanford University. Based in Chicago, Illinois, he is known for his collaboration styles and active role in guiding portfolio companies.

Bluegrass Angels is an angel group investing in innovative Kentucky startup companies aiming for quick growth in large markets, providing strong financial returns and new jobs in the Kentucky economy. They focus on high-tech sectors like healthcare, agriculture, industrial chemicals, manufacturing, biotech, fintech, and media. Bluegrass Angels prefer to invest in companies with viable exit strategies. The group typically invests in early-stage startups and aims to fund 5-7 companies annually. Their geographical preference is Kentucky. The portfolio includes high-tech startups with long-term success goals. The organization consists of volunteer leaders who mentor startups and have a strong track record in funding and supporting Kentucky startups.

Jayde Crystal Wright is a VC Associate at Deerfield Management with a current investing position as an Associate. Their investment range is $10.0M – $50.0M with a sweet spot of $25.0M. Crystal Wright focuses on sectors such as Medical Devices, Pharmaceuticals, Digital Health, BioTech, Health & Hospital Services, and Health IT in both Seed and Series A stages. They have collaborated with various co-investors like Abraham Kometz, Adam Greene, Adam Grossman, Alexis Cazé, and Alison Stamas. Crystal Wright is based in New York, USA.

Alexander Packard is an investor with a focus on high-growth companies in health care and online education. He is the President at Iora Health and has previously worked as COO at Outside the Classroom. Alexander Packard’s track record includes leadership roles at various companies, including advisory and educational firms. His career includes a background in senior operating roles emphasizing innovation and service. While the specific investment focus areas and partnership styles were not available, his experience suggests a preference for innovative ventures in health care and education sectors. Alexander Packard has a history of contributing to ventures with a strong focus on public health. His investment check size and partnership styles were not explicitly mentioned on the sources accessed.

Unshackled Ventures is an early-stage venture capital fund for immigrant-founded startups.

Keno Gutierrez, a Partner at BGV (BioGeneration Ventures), has a background in biotech investments and life sciences. With over 20 years of experience, Keno was previously a Vice President at M Ventures. He holds a PhD in Genetics from University College London and an MBA from INSEAD. Keno has been involved in various biotech companies and research in lipid metabolism published in Nature. His portfolio includes companies like Brenig, Dualyx, Fibrocor, FundaMental Pharma, and Tessellate Bio.

Willemijn Verloop is an investor at Anterra Capital with a focus on Seed to Series B investments. Her investment thesis involves sectors like Supply Chain Tech, AgTech, Food and Beverage, and FinTech. She has a track record of advising companies like V-Ventures, Tony’s Chocolonely, and Rubio Impact Ventures. Willemijn typically invests between $1 million to $20 million, with a sweet spot at $5 million. Her partnership and collaboration styles are aligned with her roles on various boards, showcasing a commitment to impact investing and strategic guidance.

Dragonfly Capital Partners is investing in and supporting the promising opportunities in the cryptoasset class.

Neil Thanedar is an entrepreneur, investor, scientist, activist, and author. As the founder and chairman of LabDoor, he emphasizes the importance of having a diversified portfolio with at least 34 companies to achieve successful investments. Neil focuses on a seed-stage valuation approach. He has a geographical preference towards North America and has a track record of founding companies like Avomeen Analytical Services. His investment check size strategy outperforms large growth funds by investing in a larger number of startups for higher average returns. Neil Thanedar values partnership and collaboration, as seen in his ongoing work with LabDoor.

Oprah Winfrey is an investor with a successful track record and a focus on sustainability, inclusivity, empowerment, accessibility, and health and wellness. She manages her investments through a family office and has made investments primarily in Enterprise Applications and HealthTech sectors. She has a preference for investing in the United States and Sweden. Oprah’s previous investments include Maven, Apeel, Guild, Oatly, and Spanx. She has a net worth estimated at $2.5 – $2.8 billion and is known for her successful collaborations and partnerships, leveraging the power of endorsements to enhance impact.

Angela C. Angel Lowry is the founder of 37 Angels, an angel investment network and training bootcamp for women investors. She focuses on investing in startups with a specific thesis and guides entrepreneurs through their investment journey. Angela’s investment check size varies, and she has a track record of supporting startups. Her partnership and collaboration style are tailored to different collaboration styles to ensure effective working relationships.

Franz Salzer, Investment Manager at Bayern Kapital GmbH, focuses on software, bioscience, healthcare, and pharmaceutical sectors. Previous investments are in Series B. The investment check size typically targets the seed round. The partnership and collaboration style information is not available.

Markus Okumus is an investor focusing on Series A investments in Wellness & Fitness, Digital Health, and Health & Hospital Services, with a preference for Swiss and American regions. He has a track record as a Founding Partner at FORM Life Ventures with previous board positions at Baze Labs AG. Markus Okumus’s investment check size is detailed on Signal NFX. He engages in collaborative styles within the industry.

Zino Society is an investor with a focus on Life Sciences, Consumer, and other sectors. They have invested in companies like Healionics and have a Check Size that can reach up to $3M. Zino Society has a professional career track record that includes roles like Fractional CTO at SeekMake, Lecturer of Game Development at Estonian Entrepreneurship University, and Entrepreneur in Residence at Antler. Their previous investments include Healionics and LatiPay. Zino Society’s partnership and collaboration styles are not specified.

Ero Carrez is an investor focused on successful, robust, family-owned small and medium-sized businesses in the private equity and venture capital sectors. His geographical preference aligns with companies in Europe, the United States, and Asia. Ero Carrez’s investment check size typically ranges between $500K to $1.5M per company. He has a track record of investing in companies like Patriarche, Manufactors Invest, and u201cProjet Etoileu201d. Ero Carrez’s stage of investment is primarily in companies in the digital, smart cities, and healthcare sectors, supporting visionary entrepreneurs to create the champions of tomorrow.

Marc Hirshman, General Partner at Cultivation Capital LLC, focuses on Real Estate/PropTech investments in the Midwest region with an investment range of $100K – $3.5M and a sweet spot at $1.8M. He has a track record as a General Partner with a current fund size of $74.2M. Previous investments include Series B Real Estate startups. Marc Hirshman’s partnership and collaboration style are not explicitly mentioned on the available sources. Cultivation Capital aims to invest in companies with transformative potential, but there is no specific mention of Marc Hirshman’s geographical preference on their website.

Kristina Barrett is the Principal at Cultivation Capital LLC, focusing on investments in sectors like Education (Seed), ClimateTech/CleanTech (Seed), Education (Series A), and ClimateTech/CleanTech (Series A). She operates in the investment range of $100K to $3.5M with a sweet spot at $1.8M. Kristina’s previous investments include areas such as Marketing, Agriculture Tech, and AI. In her professional career, she has worked on launching 3 venture capital funds and led end-to-end investment activities with a current fund size of $74.2M. Kristina Barrett holds a Bachelor of Arts from Harvard University and is pursuing a Doctor of Law degree from Loyola University Chicago School of Law. Her investment check size ranges from $100K to $3.5M. Kristina emphasizes trust, collaboration, and synergy in her partnership and collaboration styles.

Rishi U. Shah, the founder of Outcome Health, is a visionary entrepreneur with an estimated net worth of $3.6 billion. His investment focus areas include healthcare technology, with a stage of investment ranging from early to mid-stage startups. Shah’s geographical preference has been prominent in Champaign, Illinois. His professional career showcases a track record of success in data architecture, research, and collaboration styles focused on building strong relationships. Overall, Rishi U. Shah is a pioneering figure in healthcare technology.

Oliver Roskopf is an Angel Investor with a Chief Marketing Officer background. He has invested in companies like Packmatic, Rausgegangen, Synctive, ChefCoco, academa, xolo, deineStudienfinanzierung, and OWWN. Roskopf focuses on Business/Productivity Software and Food Products industries with investment ranges typically between $5K to $50K, with a sweet spot at $25K. His career includes roles in Groupon, eDarling, and Zalando. He prefers early-stage investments and has a geographical focus on Europe and the US. Roskopf values collaboration and has collaborated with investors like Christian Weiss and Robert Maier.

Jonas Bergman is the Investment Director at Chalmers Ventures with an investment focus in MarketingTech (Seed), Medical Devices (Seed), Pharmaceuticals (Seed), BioTech (Seed), and FinTech (Seed) sectors. His recent investment includes Embedl AB in the seed stage. Some of his previous investments include companies like Swedish Algae Factory, Metry, Evispot, Micvac AB, and Mevia AB. Jonas has a track record of serving on the board of various companies and has a background in CEO roles, management consulting, and extensive experience in sales and marketing. His investments typically range from $100K to $5.0M, with a sweet spot at $1.5M. Jonas Bergman is an alumni of Chalmers School of Entrepreneurship and Chalmers University of Technology.

Scooter Braun is an active investor with a focus on companies in the Business/Productivity Software, Pharmaceuticals and Biotechnology, and Financial Software industries. He invests in gaming/esports, social commerce, health & hospital services, health IT, consumer internet, and fintech sectors. His investment check size ranges from $250K to $5.0M, with a sweet spot of $1M. Scooter Braun has made 48 investments and partners with other investors such as Lior Shiff, Marlinspike, Larry Marcus, and more. He engages in partnerships and collaborations to support companies at various stages, including seed and Series A.

Kerim Baran is an investor who advises and sits on the board of early-stage startups in healthcare, education, and greentech companies. Some of his favorite private investments include SelectMinds, Chart.io, PresenceLearning, DoktorSitesi, Humantelligence, Atolye Istanbul, Bodhi, Ivy Energy, and Complete Solar. He focuses on sectors like education, healthcare, and clean tech. Kerim Baran has a track record as a successful CEO in the solar industry and he engages in partnership and collaboration with new partners and collaborators to meet his projects’ energy needs.

NELSA, through the North of England Life Science Accelerator (Nelsa), selects and supports startups focusing on life sciences and drug delivery, including companies such as Lightox, Horizon: Therapeutic Microbubbles, StrataStem, and others. NELSA has a background in marketing and digital strategy roles and holds a Bachelor’s degree in International Marketing and a Master’s degree in New Media. NELSA has been involved in various companies such as hellomarketing.ai, HelloMaaS, and Popwallet. The investment check size of NELSA in startups is varied, with previous investments ranging from $64m fund to undisclosed businesses focused on drug delivery. NELSA’s partnership and collaboration styles involve various roles like Co-Founder, CEO, and Advisor & Investor, showcasing a diverse and active involvement in the startup ecosystem.

George Goognin invests in science and tech that produce abundant resources like housing, food, energy, and healthcare. His previous investments include Karma, a cross-border p2p loans ecosystem that raised $10 million in 2017. The typical check size for investments is $100k. George Goognin’s partnership style involves joining forces with companies to revolutionize B2B cross-border trade and manage compliance efficiently.

Falk F. Strascheg is an investor focused on venture capital investments. Operating through Falk Strascheg Holding, the firm’s investment thesis encompasses sectors like healthcare, engineering, technology, medicine, 3D, and science. Their family office, Extorel GmbH, specializes in venture capital investments in electronics, laser, semiconductor, and information technology. Falk F. Strascheg’s professional career and track record include founding TECHNOLOGIEHOLDING, a leading venture capital company in Germany. While specific details on the stage of investment, geographical preference, previous investments, investment check size, and partnership styles were not readily available, Falk F. Strascheg has a history of success and expertise in the venture capital industry.

Geert-Jan Mulder is an experienced life sciences investor who co-founded Forbion in 2006. He has led successful investments in various portfolio companies, including those in the biopharmaceutical and therapeutic sectors such as AM-Pharma, ARMGO Pharma, Complement Therapeutics, Enterprise Therapeutics, Mariana Oncology, NeRRe Therapeutics, and Prilenia Therapeutics.

Martin Velasco is an entrepreneur and Business Angel with extensive experience in the IT, medical, and biotech sectors. He serves on the board of Anecova SA. His previous investments are related to raising capital in companies like Acimmune and Sumerian. Martin Velasco focuses on Pelton turbines performance improvement using reverse engineering, parametric design, and CFD analysis. The specific investment check size for Martin Velasco is not available, and his partnership and collaboration style may involve elements of cooperative, competitive, and directive collaboration.

Impact America Fund is an investment company that funds market opportunities which use technology to enhance the lives.

Tijen Onaran is an angel investor focused on supporting female founders, with a track record of investments in startups such as Logga, FreeMOM, Pumpkin Organics, and more. Tijen’s collaboration style includes being added as an angel investor in companies like Pumpkin Organics to support and nurture their growth.

Tacoma Angel Network is an angel investing group founded in 2006 and based in Tacoma, United States. They focus on backing early-stage tech companies in the Life Sciences sector. With a portfolio of 2 companies, their latest investment was in DesignMedix in a Series A round in July 2014. The team comprises John B. Dimmer and Larry S. Kopp. Tacoma Angel Network collaborates with other investors, with 15 co-investors in their portfolio companies over 18 years. They primarily invest in Series A and Series B stages, with a geographical focus on the United States.

Clifford Holekamp is the Cofounder, Managing Director, and General Partner at Cultivation Capital. He focuses on investments in software & IT, agriculture & food tech, and geospatial tech. His previous investments include companies like Decide, Benchmark Email, and ScopeStack. Cliff has a solid track record with experience in enterprise sales and founding businesses. The typical investment check size ranges from $0 to $10M. He is known for his collaborative approach and active involvement with the companies he invests in.

Harbor Street Ventures is a family office based in Chicago, Illinois, founded in 2014. They specialize in early-stage investments in the healthcare sector.

Joshua Siegel, General Partner at Acronym VC, has extensive experience and connections in software, technology, real estate, luxury lifestyle brands, digital media, and CPG. He oversees the day-to-day activities and operations, evaluating early-stage software, technology, and consumer companies seeking funding. Joshua sourced and led investments into companies like Daily Harvest, Super Coffee, Superhuman, Penny, Confiant, Easyknock, Todaytix, Easyship, and Bespoke Post. He was previously the General Partner of Rubicon Venture Capital and has a track record in top performing US VC firms, as well as experience at Citicorp Debt Capital Markets and Citibank. Joshua’s partnership and collaboration styles involve assisting current portfolio companies with corporate development, revenue generation, building professional networks, and leading LP relationships.

Christopher Miller is a senior portfolio manager and team leader at Allspring Global Investments, with 21 years of experience in the investment industry. He focuses on the Select Equity team and holds a bachelor’s degree in business administration. His investment focus areas include Life Sciences Transactions, Health Care, Technology, Mergers + Acquisitions, Private Equity, and Emerging Companies + Venture Capital. Christoph Miller’s previous investments include Goodbytz, Your Super, and Stenon. He has been involved in Series A, Series B, and Seed rounds with total amounts raised ranging from $1M to $13M.

Rajbir Minhas is an investor at Angel Physicians Fund, focusing on healthcare startups. His investments remain undisclosed. Rajbir’s professional career and track record are not publicly available. The investment check size is unknown, and his partnership and collaboration styles are not detailed in the sources found.

Gillian Sandler is the Managing Partner at Galapont Capital, focusing on investments in healthcare and life sciences with a primary therapeutic focus on autoimmune and neurodegenerative disorders. She has a track record of 25 years as an entrepreneur, CEO, Chairman, investor, and research analyst, among other roles. Gillian’s previous investments include leading roles in companies like Invicro and Molecular Neuro Imaging. While her investment check size is not specified, she has a hands-on approach and collaborates closely with the companies she invests in, aiming to drive transformation in the healthcare sector.

Anterra Capital is a venture capital fund which invests in fast growing companies that are transforming the global food system.

Michael Fisher is known for leading ElephantDrive, a cloud-based storage company. His investment focus areas have not been specified. ElephantDrive is a cloud backup solutions provider founded by Michael Fisher in 2015. The stage of investment and geographical preference of Michael Fisher are undisclosed. Previous investments include the acquisition of ElephantDrive by Jungle Disk. The specific investment check size and partnership styles are not publicly available.

Sean Brecker serves as the Chief Financial Officer at Oura, a health technology company. He has a background in investment banking and holds a Bachelors degree in Mathematics/Economics from Wesleyan University and an MBA from The Wharton School. His previous investments include Headspace Health, ÅURA, CoachArt, Lehman Brothers, Citibank, Nomura, and Nomura Holdings. The geographical preference of his investments covers Canada, United States, South America, and Europe. Sean Brecker’s check size investments are not explicitly stated on available sources. He demonstrates a collaborative and strategic partnership style in his leadership roles.

Piva is a venture capital firm that primarily invests in disruptive energy and industrial startups.

Lina Wenner is a Partner at firstminute capital, with a focus on health tech, gaming, B2B SaaS, and verticalised AI/ML. She covers the DACH and Nordic regions, leading investments into companies like Clockwork Labs, Engflow, Taktile, Xata, Infraspeak, and more. Lina’s professional career includes work at the Boston Consulting Group. Her partnership and collaboration styles are not explicitly mentioned in the available data.

Heiko Schmidt, a seasoned music industry executive and serial entrepreneur, has a strong investment thesis focused on applying AI technologies to create, find, and invest in longevity technologies and services. He leverages his expertise in AI monetization and healthcare to support business owners on their longevity journey. Schmidt’s career highlights include founding and selling businesses in the music, media, and tech industries, writing and producing hit songs, building proprietary systems for music monetization, and creating a breakthrough system to increase brand recognition. He has a track record of success in various ventures, contributing to the growth and innovation in the industries he operates in.

David Shriner is an Angel investor and a member at Alliance of Angels based in Spokane, Washington. He typically invests in Seed and Series A stages focusing on Diagnostics, Retail, Analytics, Data Services, BioTech, AI, and FinTech sectors. David’s investment range is $500K – $1.5M with a sweet spot of $1M. His recent investment includes Inherent Biosciences in the Seed stage. David works with co-investors like Jordan S. Ryan and Nola Masterson. Affiliated scouts and angels include Andrew Wang, Bahador Biglari, Ben Sharpe, Beth Morgan, and Carla Fowler. The current fund size he operates with is $100M. David Shriner’s collaborative style involves actively participating with co-investors and angel groups to support startup growth.

Daniel Bach is a Board Certified Internal Medicine-Dermatology Physician at Cedars Sinai, with experience as a Dermatologist at Cedars-Sinai and Assistant Professor of Dermatology at UCLA Health. He holds a Doctor of Medicine (MD) from Northwestern University and a Master of Public Health (MPH) from The Graduate School at Northwestern University. Daniel Bach’s previous investments are not available. His investment thesis, focus areas, check size, and partnership styles are not publicly documented.

Kristen Wong is a Principal at Altitude Life Science Ventures, based in Seattle, Washington, USA. Altitude Life Science Ventures is a venture capital firm that focuses on early-stage life science companies. Kristen Wong’s track record includes a philosophy to invest in life science markets with strong demand and growth potential, specializing in the life sciences, biotech, oncology, and digital health sectors. Altitude’s geographical preference for investments aligns with its base in the United States and particularly Kirkland, WA. The firm’s investment check size is in early-stage life science companies. Kristen Wong’s partnership and collaboration style emphasize backing the highest-quality entrepreneurs in the industry. Kristen Wong’s previous investments and specific investment focus areas were not explicitly stated but are in line with the firm’s focus on life sciences with high growth potential and strong demand.

Anges Quebec is a venture capital investor focusing on pre-seed and seed stage companies. They emphasize the quality of entrepreneurs, sector preferences include ICT B2B, DEEPTECH, and BIOTECHNOLOGY, with an investment check size ranging from $250k to $1.5M. They prefer projects headquartered in Quebec or in joint ventures with angel groups outside Quebec.

Chen Zhu, Investment Manager at Aqua Spark, focuses on investments in Food and Beverage (Pre-seed), EnergyTech (Pre-seed), AgTech (Pre-seed), BioTech (Pre-seed), and Consumer Internet (Pre-seed). Previously, Chen co-founded Mana Impact in 2017 and has a professional background at JPMorgan, CICC, and Morgan Stanley. Chen’s investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Chen Zhu’s partnership and collaboration style involves working with co-investors such as Amy Novogratz, Frank van Roest, Jan Slootweg, John Mairlot, and Josien Bakker at Aqua Spark.

Alister Coleman, the founder and Managing Partner at Tempus Partners, focuses on investments in software and information technology sectors. He has been involved in notable deals with investment check sizes reaching $4M. Alister’s geographical preference is in Sydney, Australia. His professional career is highlighted by a commitment to building a firm of operators and investors, aiming to support tomorrow’s greatest ventures. Previous investments by Alister at Tempus Partners include Swoop Aero. His investment style emphasizes co-leading funding rounds and collaborating with established partners like Right Click Capital.

Evan Jaysane-Darr is a Principal at Valor Equity Partners with a managing background at Invesco. With experience in venture and growth funds, he has invested in LifeX. His investment check size is around â¬7.5M. Evan holds a B.A. in History from Washington and Lee University and an M.B.A. from INSEAD in France. He is a CFA charter holder.

Todd Davis is an angel investor focusing on Enterprise Applications and HealthTech. He primarily invests in the United States in sectors such as Enterprise Applications and HealthTech. Todd Davis has made investments in Pyx Health, with a check size offering up to $1,088,300. His professional career includes co-founding LifeLock and serving as its CEO. Todd Davis has a track record of successful ventures and has been involved in philanthropic activities, serving on various boards and contributing to causes like the Sam Schmidt Paralysis Foundation and the Boys & Girls Club. In addition, Todd Davis does not have a strong geographic preference for investments and is willing to travel anywhere in the U.S. for the right opportunity.

Pia Ghosh is focused on clinical and translational studies in Bronchiectasis. She collaborates with organizations to address strategic alliances and constructive partnerships.

Ketan Yerneni is a Principal at KdT Ventures, an early-stage venture firm focusing on frontier computational technologies and science. He has previous experience in Business Development at Rhaeos, a company developing non-invasive diagnostics for hydrocephalus patients, and Surgical Innovation Associates, which was acquired by Integra. Ketan Yerneni’s track record includes bettering patient outcomes in reconstructive surgery and the development of diagnostic solutions. His investment focus areas include frontier computational technologies and science. Ketan Yerneni’s partnership and collaboration styles reflect a hands-on approach to driving innovation and improving patient outcomes. The investment check size and geographical preferences are not specified in the available information.

NueCura Partners is an angel investment company specializing in healthcare investments, with a portfolio of 16 companies including Babyscripts, Trilliant Health, and Bivarus. They focus on early-stage healthcare ventures and have made 2 exits. The investor operates in seed-stage round financing and has a geographical preference for healthcare investments. The check size for investments made by NueCura Partners remains undisclosed.

Jan Adams is a partner at Apollo focusing on company creation. His career spans venture investing, company building, strategy consulting, and basic research in the life sciences. Jan previously headed commercial activities at the Merck KGaA Innovation Center and was a Managing Director with EMBL Ventures. He has a trained biochemist background with degrees from Tübingen University, University of Cambridge, ESSEC (Paris), and Mannheim University. Jan Adams is a Class 11 Kauffman Fellow and a recipient of a Boehringer Ingelheim PhD and an Ernst-Schering Post-doctoral Research Fellowship. The geographical locations mentioned are Berlin, Germany, and Cambridge, MA, United States.

Quyen Nguyen is a VC Investor at Antler based in Sweden with an investment range between $100K to $5.0M. His sweet spot for investments is around $1.5M. Quyen focuses on various sectors and stages, including Pre-seed investments in Health & Hospital Services, Marketplaces, Health IT, E-commerce, AI, SaaS, and FinTech, and Seed investments in Marketplaces, E-commerce, Health & Hospital Services, AI, SaaS, and Health IT. His collaboration includes investing with several other investors like Adele Moynihan, Ahmed Bilal, and Ainaya Tama.

Federico Maroli invests in marketplaces and businesses with network effects across various countries in Europe and the MENA region. His check size for investments is not specified. Federico is an early stage investor at Dutch Founders Fund, specializing in B2B marketplaces and vSaaS solutions. He has a strong track record in venture capital, having held positions in various companies such as Secfi and PROfounders Capital. Federico’s partnership and collaboration style involve providing funding, hands-on support, and organizing engaging events for the startup community. He holds a Master’s degree in Finance and Investments and has a background in international economics and economics from Rotterdam School of Management, Erasmus University, Erasmus University Rotterdam, and Maastricht University School of Business and Economics.

Osman Mardin is the Managing Director of Sardis Capital with over 30 years of experience serving multiple Corporations, Investors, and Entrepreneurs in the US and Europe. His investment focus areas include corporate strategy, growth vectors, customer/market extension, shareholder expansion, corporate finance, M&A, and IPO planning in sectors like semiconductors, software, and life sciences. Osman specializes in strategic advisory, M&A, and private financings, with a strong emphasis on Life Sciences and Information Technology. He holds a BA from Trinity College, Cambridge, and an MBA from Harvard Business School.

Boralis is an angel fund with a focus on transforming healthcare through new therapies, digital innovation, and other technologies, specifically in Life Science platforms and Digital Health. They invest in middle market, seed, and early-stage capital. Their geographical preference is not specified, but they have previous investments in Education & Health sectors. Boralis has made 2 investments, with the latest being in The Social Handshake in May 2022, with an investment amount of $1.17M. Their partnership and collaboration styles involve working with co-investors like Golden Egg Check Capital, JEX, and others to provide resources and support to their portfolio companies.

Peter Weiderman is an individual angel investor based in Stockholm, Sweden. He focuses on seed-stage investments and has a preference for investments in the European Union. He has made investments in companies like Fenix Begravning. His investment check sizes vary based on the specific opportunity. In partnerships, he maintains an individual investor style.

Kajsa Gustafsson, Head of Exits & Portfolio Management at Almi Invest, is part of a venture capital firm that invests nationwide and has a GreenTech fund focusing on CO2-reducing investments. Almi Invest offers financing through loans, a Verification Fund, and supports small and medium-sized enterprises in business development. They have a large investor network and a portfolio of approximately 350 companies in various industries.

Patrick Sullivan is a Managing Partner, Chairman, and Co-Founder at ATON Partners, a Boston-based private management advisory and investment firm focused on healthcare sector-related companies and technologies. ATON Partners invests in companies involved in the development and commercialization of medical devices and in vitro diagnostics. Some of the portfolio companies of ATON Partners include Dune Medical, CereVasc, and Insulet Corporation. Patrick Sullivan’s investment check size is not explicitly mentioned in the available information. The geographical preference of ATON Partners is not specified. The current focus and specific investment thesis of Patrick Sullivan and ATON Partners are on healthcare sector-related companies and technologies.

Mark Kingdon, the founder of Kingdon Capital Management, has a strong focus on healthcare investments. One of his recent funds, Kingdon Healthcare Fund, emphasizes investments in the healthcare sector. His past investments include companies like Xoma Corp and Heron Therapeutics Inc. Kingdon Capital is a New York-based macro and long/short hedge fund that was founded in 1983. Mark Kingdon is known for his expertise in the hedge fund industry and has a track record of successful investments in healthcare companies.

Frist Cressey Ventures is focused on accelerating the growth of high potential healthcare enterprises through value-added partnerships.

Nathan Harrell, Managing Director and Head of Portfolio Group at Monroe Capital, focuses on responsible investing with a commitment to fostering ESG practices. Monroe Capital specializes in private credit markets, offering direct lending, asset-based lending, specialty finance, and more. The firm prioritizes responsible environmental, social, and corporate governance in its investments. Monroe’s due diligence process ensures thorough risk assessment and opportunity evaluation. Nathan Harrell leads a team dedicated to diversity, equity, and inclusion, promoting a culture of equality and respect. Additionally, Monroe Capital actively engages in community support through volunteer opportunities and partnerships with local organizations. The firm’s commitment to responsible investing and community involvement under Nathan Harrell’s leadership reflects a strong dedication to ethical investment practices and social responsibility.

Joseph Walder is the founder of Walder Ventures, established in 2020 to provide mission-driven investments. The focus is on science innovation, environmental sustainability, and supporting the Chicago region. Walder Ventures has invested in companies like Grove Biopharma. Joseph Walder’s track record includes being a professor of biochemistry and founder of Integrated DNA Technologies. The investment check size averages around $4M. Partnership and collaboration styles involve providing capital, infrastructure, and expertise to early-stage life sciences companies. Contact Walder Ventures at Hello@portalinnovations.com or 773.498.5643.

Correlation Ventures finances early, seed, and later stage venture, and debt financing investments and is based in California.

Michael Wortsman is a private venture investor focused on media, technology, and healthcare. His investment check size and partnership & collaboration styles are not specified.

Vivek Garipalli is a Co-Founder of Clover Health and CarePoint Health, with an investment thesis focused on innovating healthcare access and patient outcomes. His investments typically center around Health & Fintech sectors, targeting companies like Clover Health and Ensemble Health Partners. Vivek prefers to engage in pre-seed and seed funding stages, actively participating in the growth of his portfolio companies. His geographical interests span North America, Europe, and MENA. Notable investments include Clover Health, CarePoint Health, and Ensemble Health Partners. Vivek’s professional career showcases a history in healthcare entrepreneurship and financial roles at prestigious firms. As a top shareholder in Clover Health, his partnership and collaboration style emphasize leveraging data and innovation for healthcare improvement.

Corey Ritter is a Principal at ARCH Venture Partners, focusing on Biotechnology, Life Science Tools, Instruments, Medical Diagnostics & Devices, Quantum Technologies, Materials, Nanotechnology, and Semiconductors. His key investments include Vizgen. Corey has supported companies like Slingshot Biosciences and Singleron Biotechnologies and has been involved in ARCH’s investments in various innovative ventures.

Daan van Lange is a financial savvy professional with experience in Venture Capital and Private Equity. His focus has been on Deeptech ventures, including hardware, software, and hybrid technologies. Daan is passionate about creating impact and investing in ventures, technologies, and funds that shape the future. His recent investments include Manufacturing, Logistics, AgTech, ClimateTech/CleanTech, BioTech, Health & Hospital Services, SaaS, and FinTech. Daan’s investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. He has an educational background in Finance and Strategic Management, holding a Master of Science degree and a Bachelor of Science degree.

Kilian von Berlichingen is a Senior Investment Manager at HTGF since April 2020, specializing in venture capital and investments in Digital Tech startups. With a background in Business Administration & Finance and consulting at PwC and goetzpartners, Kilian has a track record in the startup ecosystem. Although his specific investment thesis is not provided, his focus areas include Industrial Tech, Life Sciences & Chemistry, and Digital Tech. Kilian von Berlichingen has a passion for tennis and art, open to discussions. While his investment check size is not specified, he entered the investing realm through Project A and Global Founders Capital. His geographical preference and partnership/collaboration styles are not explicitly detailed on the HTGF webpage.

Casper Bruens is the Managing Partner of Brightlands Venture Partners, with a diverse investment focus in materials, electronics, medtech, biotech, and nutrition. Brightlands Venture Partners’ funds include Limburg Ventures, Chemelot Ventures, Brightlands Agrifood Fund, and BVP Fund IV, with a fund size of â¬45 million at first closing. Casper Bruens has invested in companies like Grassa, Neuroplast, Vacis, and Hy2Care. He collaborates with other organizations and investors to fuel sustainable startups, as seen in the partnership with ReSolved Technologies for a circular material supply.

Sozo Ventures is a cross-border venture fund focusing on assisting US-based technology start-ups in global expansion.

Hannes Klöpper is a prominent investor with a focus on the digitalization & AI, HealthTech, and Sustainability sectors. He typically invests in companies with revenues ranging from â¬1 to â¬10 million and a proven product-market fit. Klöpper emphasizes impact alongside returns and provides support to entrepreneurs in scaling from $1 million to $100 million in revenue. His investment check size varies based on the company’s growth potential. Klöpper values collaboration and offers not just capital but also his extensive network and experience gained from investing in over 70 private technology companies. His current investment portfolio showcases a diverse range of sectors and countries, highlighting his strategic approach to investing.

Ditlev Bredahl, the seasoned investor, focuses on redefining the boundaries of human longevity through Lifespan Ventures. His investment style revolves around the longevity market, aiming to enhance quality of life, transform healthcare systems, and revolutionize medical technologies. Bredahl’s approach integrates foresight, expertise, and belief in the transformative power of the sector. Lifespan Ventures actively engages in the multidisciplinary field of longevity, intersecting with healthcare, pharmaceuticals, wellness, technology, and insurance. The fund embraces technological disruption, investing in biotech advancements, AI-driven health platforms, and the convergence of technology and biology. Bredahl and Lifespan Ventures seek investments that promise not only financial returns but also profound societal impact, shaping a future where longevity equates to vitality, productivity, and happiness.

Joel B. Braunstein is the Co-Founder of C2N Diagnostics and Tivorsan Pharmaceuticals. He serves as an angel investor with a track record of investments in health-related startups such as C2N Diagnostics and Tivorsan Pharmaceuticals. His investments range from â¬11.6m to â¬47.5m. He has a geographical preference for health-related ventures. Braunstein’s partnership style involves providing early commercial guidance to life sciences discoveries. He has a professional career in the healthcare and investment sectors, demonstrating a specific focus on fostering innovation in the health industry.

Evaristo Babe, known for co-founding SinDelantal.Mx and having a successful exit, focuses on making Angel and Pre-Seed investments in startups based in Spain. His average check size per round is $880.8k USD, with a specific focus on Ecommerce. He has a track record in investing in companies like Reveni and shows a preference for startups with global appeal targeting a global audience. Evaristo Babe’s investment thesis revolves around ideas with global potential and initial paying customers where his experience adds unique value. Additionally, Babe’s partnership and collaboration style may align with investors like Julián Recuenco Bernal and Marek Fodor, who share similar investment profiles and interests in Ecommerce.

Trevor Cox is an Angel investor based in Seattle, Washington, and a member at Alliance of Angels. His investment range is $500K – $1.5M with a sweet spot at $1M. Trevor’s focus areas include Hardware, Retail, Cloud Infrastructure, BioTech, and AI at both seed and Series A stages. He prefers investments in the Seattle/Portland region. Some of Trevor’s affiliated partners include Andrew Wang, Bahador Biglari, Ben Sharpe, Beth Morgan, and Carla Fowler. He is known for his collaboration with Alliance of Angels in nurturing startup investments.

Susan Preston, Managing Member at SeaChange Fund, is a globally recognized author, consultant, and speaker on angel and venture financing with nearly 20 years of experience. SeaChange Fund focuses on investments in the Pacific Northwest, typically investing between $250k-$1M in 10-12 companies annually. Susan Preston is known for her leadership in the field and collaborates closely with the SeaChange team to provide hands-on post-investment support, including executive members, board observers, industry experts, and talent sourcing.

Kevin Hrusovsky is a Venture Partner at ARCH Venture Partners with a 30-year career leading life sciences companies. He is the Chairman of 908 Devices, with previous roles at Quanterix, Caliper Life Sciences, Zymark Corp. Additionally, he created the Powering Precision Health foundation. Kevin Hrusovsky has a track record of over 25 years in commercializing disruptive technologies in the life science industry, focusing on teamwork and transparency. He has played a key role in building Quanterix into a successful public entity with substantial growth. Kevin Hrusovsky has received recognition for innovation and entrepreneurship awards.

John Dyett, Co-Founder of Salem Partners, heads the firm’s efforts in the Life Sciences. Mr. Dyett has raised over $500 million of equity and completed multiple merger and acquisition assignments. Notable previous investments include Adams Respiratory Therapeutics and ZS Pharma. He played a key role in investments raising several rounds of venture capital. His partnership and collaboration styles involve active involvement in the investment committee. John Dyett’s track record includes successful IPOs and investment committee roles at Salem Partners. The specific geographical preference is not mentioned.

Christa Alport is a commercially focused finance and operations leader with a passion for shaping the future of data and customer centricity. Specializing in technology startups, real estate, sports, and entertainment, Christa has expertise in financial management, market entry playbooks, working capital management, statutory and tax compliance, and capital raising. Previous roles include Financial Controller at Hambro Perks, head of various financial positions at Data Republic, and Head of Finance at DesignCrowd. Christa’s investment focus areas include technology start-ups, real estate, sports & entertainment, and pharmaceuticals. Additionally, Christa has been involved in collaborative initiatives in the real estate and consumer services sectors with innovative financing products such as Doorsteps Mover. Partnerships and collaboration styles emphasize transparency and trust in the real estate industry.

McCall McIntyre leads identity partnerships at Google Cloud focusing on building out Google’s strategic partner ecosystem in the IDaaS, UEM, and Endpoint Security spaces. Previous investment roles included leading early stage venture investments in health tech, adtech, and consumer identity for Samsung Electronics.

Christian Mordowicz is an Investment Manager at TGFS and MBG Mittelst�ndische Beteiligungsgesellschaft Sachsen mbH. His investment focus areas include EnergyTech (Series B), Insurance (Series B), BioTech (Series B), and more. Christian Mordowicz typically invests in the range of $100K to $5.6M, with a sweet spot of $2.9M. Some of his previous investments involve Alexander Witt, Andreas Muller, and Birthe Ross. He has a professional career background with past positions at Volksbank Dresden-Bautzen eG and B�rgschaftsbank Sachsen GmbH. Christian Mordowicz holds a Bachelor’s degree in Business Administration and a Master’s degree with a focus on Banks and Insurances. His partnership and collaboration style is exemplified by his work within the TGFS and MBG Mittelst�ndische Beteiligungsgesellschaft Sachsen mbH.

Dr. Marianne Mertens focuses on high-tech start-ups in digital tech, industrial tech, life sciences, chemistry, and related business areas. She has been involved in investments in companies like Memo Therapeutics, BioVersys, ADC Therapeutics, Mariana Oncology, and more. Apollo Health Ventures, where she is a Partner, has recently closed a $180 million fund. Marianne’s investment check size is not specified. Her geographical preference is not explicitly mentioned.

Julie Vaughan Murchinson is a healthcare enthusiast with a focus on transforming the industry. With a background in Healthcare and Operations Management, she serves as a Partner at Transformation Capital. Her career includes leadership roles in health IT consulting, investment firms, and non-profits. Julie’s geographical preference is in Seattle, WA, where she is actively involved with healthcare-related organizations. While specific investment areas are not detailed, her investments align with the passion for healthcare improvement. Julie’s partnership and collaboration style are not explicitly defined on the available sources.

Petar Tsachev is a VC at LAUNCHub Ventures, with a focus on structuring pricing, sales funnel optimization, storytelling in fundraising, and fostering collaboration. His investment thesis includes agility in the enterprise, with a special interest in GlycanAge’s innovative technology measuring chronic inflammation and biological age. Petar invests in Seed and Series A funding stages, supporting startups like Colossyan and health tech companies addressing chronic diseases. His previous investments include supporting rounds led by Lakestar. With a background in GTM & Operations leadership, Petar brings expertise in commercial team development and content marketing strategies. He engages with founders as partners on a journey to success, emphasizing alignment and collaboration for mutual growth.

Hub Angels is one of the oldest angel groups in the Boston area, investing in young tech and life science companies since March 2000. They focus on industries such as healthcare/life sciences, IT/Internet/communications, and technology. The investment ranges from $250K to $750K, with investments in over 40 companies totaling over $40 million. Their investment stage is 12+ month-old companies, with a geographical preference for Massachusetts, other Northeastern states, and Eastern Canada. Among their previous investments are LifeHarbor, Raven360, Brixton Biosciences, and others. The management team includes Charles Cameron and David Verrill. Hub Angels invests in early-stage technology companies and is led by Mike Krasner, an entrepreneur known for creating and growing innovative businesses in advanced technology markets. The check size of their investments is typically around $250K to $750K. Hub Angels’ collaboration style involves entering due diligence on about 15 companies annually and investing in 3 or 4 of them.

Brian Valentine, a retired investor and board member, has a diverse professional background. Previously, Brian served as Senior Vice President of Windows Engineering at Microsoft, where he led the teams delivering Windows Vista. Later, he transitioned to Amazon as Senior Vice President, managing the eCommerce platform globally. Notably, Brian was also the CEO, Board Member, and Lead Investor at WISErg, a bio-clean technology company focusing on converting food waste into organic fertilizer. Additionally, Brian has experience as a Managing Principal at Ivy Softworks, where he enhanced the engineering discipline and execution processes.

Tony Petrucciani is a Managing Partner at VisionTech Partners. He serves as Chief Financial Officer and Partner at Boomerang Ventures, with a focus on healthcare, information technology, and life science sectors. Boomerang VC Fund I, managed by Boomerang Ventures, makes early-stage investments ranging from USD 0.25 to USD 1.5 million in the Midwest, Great Lakes, and select states in the USA. Tony Petrucciani’s career highlights include founding Single Source Systems Inc., successful exits, and recognized leadership. He has extensive experience in technology, sales, and management, serving on several boards. Tony’s investment style includes mentorship, technology-focused investments, and being actively involved in the growth of startups.

A principal investment firm specializing in Agriculture, Agtech, Biogreentech, Food & Nutrition.

Greg Ennis is the Managing Director at Peninsula Ventures, a venture capital firm specializing in early-stage technology and healthcare companies. The firm was founded in 1991 and focuses on software, infrastructure, services, and healthcare IT. Peninsula Ventures prefers companies headquartered in the Western U.S. The investment team includes Greg Ennis as Managing Director and Ryan Keating as General Partner. Previous investments include Boatsetter, Claravine, Flint Mobile, Pramata, Redeam, Scifiniti, and Soci. The firm follows a collaborative approach, evidenced by funding rounds for various companies like Bumped, Claravine, CloudApp, CoinTracker, Crowd Factory, and Axcient.

Mark Birzell is an angel investor associated with Alliance of Angels focusing on seed and early stage investments in sectors like hardware, retail, bioTech, and consumer internet. He has invested in companies with a check size range of $500K to $1.5M, preferring a sweet spot of $1M. With more than 25 years of consulting and industry experience, Mark specializes in strategy, organizational design, and operational excellence. Notable affiliations in the industry include working with ProCogia, Sia Partners, Point B, Accenture, and General Electric. He is known for driving growth and enhancing operational management. Mark works collaboratively with scouts and angels at Alliance of Angels, demonstrating a partnership-focused approach in his investments.

Andreas Bechtolsheim is an Angel Investor known for smartly investing US$ 100,000 in Google, which became worth $1.7 billion by March 2010. He has made numerous investments in companies like Cresta, Volt Active Data, and Cerebras within the Business/Productivity Software and Application Specific Semiconductors industries.

Edgar Jannotta is an experienced investor with over 25 years in private equity business, serving as Managing Principal and Co-Manager of the Healthcare Group at GTCR. With a track record of over $7.5 billion in investments in 100 companies, he has a strong background in leading private equity investments. Mr. Jannotta has been actively investing personal funds in private healthcare companies since 2011 and serves on the board of multiple companies. His investment check size varies, with recent investments including Alcyone Therapeutics at $3.64M. His partnership style involves forging strategic partnerships, fundraising, and building world-class teams in the biotech and biopharma sectors.

Lex Westbroek, an Investment Manager at Brightlands Venture Partners, focuses on investments in the chemistry, healthcare, regenerative medicine, and agri-food sectors. Brightlands Venture Partners typically targets ESG and impact investments in 15 to 20 companies. Geographically, they are based in the south of the Netherlands and align their investments with the Brightlands campusses ecosystem. Previous investments include companies like ReSolved Technologies, Aliform, Circularise, and more. Lex Westbroek’s partnership and collaboration style involves supporting innovative companies like ReSolved Technologies with a circular material supply mission to reduce the environmental footprint through investments and industry partnerships.

Michael Burcham is an experienced executive coach, entrepreneur, investor, and strategist with over 30 years of experience. He has successfully scaled and exited three private equity-backed businesses and helped over 100 firms realize their full potential. Michael has a strong background in healthcare innovation, entrepreneurship, and startup venture coaching. He is the President and CEO of Narus Health and serves as a Special Investment Partner at Galen Partners. Michael’s previous positions include President of ParadigmHealth, Professor at Vanderbilt University, and Vice President of Managed Care at HCA Centennial Medical Center. His academic achievements include a Ph.D. in Health Administration, an MBA, and a bachelor’s degree in Physical Therapy. Michael’s leadership and expertise make him a valuable asset in guiding businesses towards success.

Mercedes Tuin, Senior Investment Manager in Life Sciences & MedTech at BOM Brabant Ventures, focuses on investing in healthtech startups primarily at the seed stage. With a track record of successful investments, including contributions to RiboPro’s funding round of â¬1.2 million for mRNA technology advancements. Mercedes has been involved in notable investments like brain health startup Mendi.io, psychologist booking platform Ahum, and drug developer Galecto. Her collaborative style emphasizes finding solutions collectively, leveraging her extensive network and experience to support founders. Mercedes Tuin’s partnership approach includes active involvement in scaling businesses, as seen in supporting RiboPro to expand their high-performance RNA products globally.

Ilya Spitalnik is a British entrepreneur known as the founder of Powtoon, a cloud-based video creation platform. His professional career includes leadership roles at Powtoon and GreenWave. His investment check size and specific investment thesis were not found in the available sources. Ilya’s track record showcases his expertise and thought leadership in visual communication technologies. While his investment focus areas were not explicitly mentioned, his previous investments include Powtoon and involvement in GreenWave. Geographically, Ilya has engaged in activities in locations like Tanzania. Partnership and collaboration styles emphasize the importance of communication and alignment in business decisions. Ilya’s stage of investment focuses on seed-stage companies within the video industry. He has shown a commitment to innovation and engagement through his ventures.

Tawanda Mays Jolly is known for focusing on investment areas such as building businesses, workforce ecosystems, addressing substance use disorder, community infrastructure, transportation in Appalachia, regional culture, and community leaders. His previous work experience includes roles like FICC Analyst at Citigroup Global Markets, Senior Associate at JPMorgan Chase, and MBS Allocator at Salomon Brothers. Specific investments made by Tawanda Mays Jolly include Jolly Nicks LLC and Anytime Fitness. Tawanda has a strong background in the financial sector with experience in prime brokerage, asset allocation, and maintaining daily positions for various products.

Shane Johnson, as the Managing Director of Coast to Crest Fund, specializes in providing business advisory services to companies in the biotechnology and healthcare sectors. His investments focus on strategic guidance in regulatory strategy, product development, and launch strategies. Geographically, his preferences align with investing in the U.S., notably in Arlington, Virginia. Previous investments have been in local startups from Lane County. The investment check size for the Coast to Crest Fund is not explicitly mentioned in the available data.

Oliver Reuss is the Executive Director and Investment Manager of the Boehringer Ingelheim Venture Fund. With a background in Molecular Biology and a focus on Infectious Diseases, he spent 5 years in academic research before joining Boehringer Ingelheim in 2008. Oliver has held various roles, including business analytics, business development, strategy, and healthcare innovation, before joining the Venture Fund in 2018. His past investments include companies like Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics, Actyme, TheRNA immunotherapies, and STAT-Dx. The investment check size and partnership and collaboration styles were not explicitly mentioned in the search results.

Dietmar Hopp, through dievini Hopp BioTech Holding & Co., focuses on oncology, CNS, cell-based therapies, and personalized medicine. Previous investments include Curevac and investments in various minor companies. Notable investments in sports teams include TSG 1899 Hoffenheim soccer club, the Adler Mannheim hockey team, and the Rhine-Neckar Lowen handball team. He has estimatedly invested over â¬350 million into TSG 1899 Hoffenheim. Dietmar Hopp’s investments have also reached around â¬80 million ($105 million) in CureVac. His partnership and collaboration style are entrepreneurially driven, aiming for organizational synergy in therapeutic and personalized medicine approaches.

Matthew De Silva is a Venture Partner at Builders VC, with an investment range of $100K to $5.0M, focusing on areas like Digital Health (Series A), BioTech (Series A), Health & Hospital Services (Series A), and Health IT (Series A). Recent investments include Eigen Therapeutics, Arpeggio Bio, and Enveda Biosciences. His sweet spot for investments is $1.5M, and he collaborates with various co-investors. His partners include Ludwig Schulze, Josh Kopelman, Milad Alucozai, Kevin Mahaffey, and more. Matthew’s investments are in collaboration with investors like Alison Sunstrum, Jim Kim, and others.

Dr. Robert Pelberg is a new entrant to entrepreneurship and early-stage investing. He is affiliated with Cardioventure Partners LLC and is an angel investor in Foldax Inc. and Atria CV Inc. Dr. Pelberg is an experienced cardiologist and a Fellow of prestigious medical associations. His investments are in the medical and healthcare sectors. Drawing on his medical background, he focuses on early-stage startups related to cardiovascular health. Geographically, his investments align with the US market. Known for his partnerships in medical startups, Dr. Pelberg is likely to collaborate closely with founders to propel their growth. The size of his investment checks may vary based on the specific startup needs.

Kent Novak, CEO of Valencell Inc., focuses on investments in biometric sensor technology, specializing in wearable biometrics for chronic disease management. His investment check size aligns with funding for companies like Valencell, which develop innovative solutions in electronic equipment and instruments. Kent Novak’s collaboration style emphasizes partnership-driven innovation, as seen in his role fostering collaboration for innovative solutions at Valencell. His track record includes serving as the CEO of Valencell, demonstrating leadership and expertise in the technology sector. While specific details on his investment thesis were not found, his focus areas likely include technology, innovation, and healthcare based on his role and investments.

Nina Neumann is an investor at Picus Capital with an investment range of $250K – $750K, focusing on Human Capital/HRTech, TransportationTech, EnergyTech, Insurance, E-commerce, Real Estate/PropTech, Health IT, and FinTech at Series B stage.

Lucy Wang is an experienced early stage emerging technology investor and operator, serving as the Co-Founder and General Partner at Divergent Capital. She focuses on backing deeply technical founders creating impact through innovative technologies, with a preference for investments in ML/AI, blockchain, robotics/autonomous systems, aerospace, AR/VR, computational life sciences, synthetic bio, new materials, and energy-related solutions. Lucy typically invests in the range of $500K – $2.0M, with a sweet spot of $1M per investment. Her notable previous investments include companies like Immuta and Wayfinder Biosciences. With a background in machine learning and experience at firms like 11.2 Capital and Greycroft Partners, Lucy brings a diverse track record and professional career in the investment landscape. She actively engages in partnerships and collaborations to support the growth of the startups she invests in.

Agate Freimane is the General Partner at Norrsken VC, a â¬320M fund with a focus on impact startups. The fund aims to back over 30 startups in climate tech, energy, biotech AI, and health tech, linked to UN Sustainable Development Goals. Agate has invested in Sunsave, Granular Energy, Lun, and Material Exchange. Her professional career includes being the Head of Investment at BrickVest and she holds a degree from the University of Warwick. Norrsken VC invests in startups with clear environmental or social impact objectives, and Agate’s investments usually range in the millions.

Max Herzberg is a Postdoctoral Research Scholar at Washington University School of Medicine with experience in roles such as Graduate Research Fellow, Graduate Research Assistant, and Evaluation Specialist. He holds a Ph.D. in Child Psychology – Neuroscience from the University of Minnesota and a Bachelor of Arts in Psychology from Grinnell College. Max has a track record of involvement in various research and evaluation positions, demonstrating a collaborative and detail-oriented work style.

Flávia Andrade, a native of Rio de Janeiro, Brazil, has over 20 years of experience living in Chicago, Illinois. She is the CEO and Co-founder of IDL Ventures, an internationalization platform focused on supporting the expansion of deep technologies globally. Flávia has designed IDL’s fund and model, collaborating with various stakeholders to make the internationalization process sustainable and beneficial to all ecosystems involved. Her career highlights include strategies for national and international pilots, curriculum expansions, technology co-creations, and digital transformations. Before IDL, Flávia was a Professor at DeVry University, where she contributed significantly to curriculum design and pioneered international exchange programs. She also played a key role in the CS4ALL program, promoting STEM education in Chicago Public Schools. Flávia Andrade’s professional journey is characterized by a passion for innovation, venture capital investment strategies, business internationalization, and higher education management.

Nicole Junkermann, a German-born investor and entrepreneur based in London, founded NJF Capital, the venture capital arm of NJF Holdings. She specializes in transformative technologies and bridges the gap between traditional business and innovative technologies. With an investment focus on content, media, technology, genomics, virtual reality, and artificial intelligence, Junkermann values strategic insights to make impactful investments. Her geographical preference is international, with notable investments in Swarm Technologies, Bolt, Really Sports, Carbyne, and Gordian Biotechnology. Nicole’s successful career includes founding and selling businesses, co-founding Infront Sports and Media, and leading private equity fund United in Sports. Her investment check sizes range vary based on the stage, with an emphasis on early to late-stage ventures. Nicole Junkermann’s partnership and collaboration styles focus on fostering clear vision, collaboration, openness to different perspectives, practicality, reliability, and investing in people behind businesses.

Louis Beryl is an investor with a focus on Life Sciences & Healthcare (23%), Consumer Products & Services (21%), and Business Services (16%). His recent investments include companies like Payabli, Kona, and meez, with a check size range that includes Seed and Series A rounds. Louis Beryl’s collaboration style involves investing in startups with potential to address crucial societal challenges, as seen in investments such as Payabli. He actively participates in seed funding rounds, with a recent involvement in Payabli’s $12M seed funding led by TTV Capital, Fika Ventures, and Bling Capital.

Dreamers VC is a venture capital fund for startups that are addressing social problems.

Owen Lozman is the Managing Director of M Ventures, leading the Technology Investments in Electronics, Frontier Tech, and Sustainability. With a background in R&D, he has successfully led projects from concept to commercialization and holds a PhD in Physical Organic Chemistry. Owen has previously worked at Merck KGaA, Darmstadt, and has industry experience with FujiFilm, Avecia, and the University of Leeds. He has published over 50 scientific papers and 15 patents. Based in Amsterdam, Owen focuses on investments in companies like Electroninks, Mosa Meat, and Pacific Light & Hologram within the technology sector. His career showcases a track record of bringing disruptive technologies to market through collaboration with customers and partners.

Blue Leaf Ventures is an early-stage venture capital investment group that partners with startups in industries like Financial Services, Education, Life Sciences, and Industrial Sectors. Their experienced team provides advisory services to help entrepreneurs grow their innovative ideas into successful businesses. The team comprises seasoned executives with deep experience and diverse networks. Blue Leaf Ventures has made investments in companies such as Bookelicious and has a portfolio of two companies. For more information, contact them at contact@blueleafventures.net.

Satel Naik is a seasoned investor with a focus on the communications, media, information, and business services industries in North America and Europe. Naik’s investment strategy targets profitable middle-market companies with recurring revenues, high barriers to entry, and high free cash flow. He invests in companies with operating leverage and multiple opportunities for value creation, with investment sizes ranging from $20 million to $200 million. Naik has a successful track record in these sectors and collaborates closely with a diverse team of professionals. His previous investments align with Abry’s thematic investment approach in various sectors, including Business Services, Communications, Healthcare IT, and more.

Manuel Grossmann is a Partner at Amino Collective with a current investing position. His investment range is $5.0M to $10.0M, with a sweet spot at $7.5M. He has 18 investments on record across various sectors and stages, including Pre-seed Digital Health, BioTech, Health IT, and Health & Hospital Services. Manuel collaborates with co-investors like Friedrich A. Neuman, Peter Thiel, Christian Reber, Filip Dames, and Florian Otto.

Humboldt Fund is an investment firm that seeks to invests in bio revolution companies.

Wally Wang, a seasoned investor and Managing Partner at Scale Asia Ventures, focuses on AI-powered biotech and health tech startups in the healthcare sector. His investments primarily target Food and Agriculture Tech and Enterprise Applications. Wally Wang invests in early to mid-stage startups, particularly in the Seed stage. His geographic preference includes the United States, with a location in Menlo Park. Notable previous investments include Ceres Imaging and Speedscale. With over 10 years of IT experience and a track record of leading IT and telecom projects, Wally brings a wealth of expertise to his investment strategy. He has been involved in ventures such as InfStones, 8×8, Huawei Technologies, Alcatel-Lucent Enterprise, Avaya, and Nortel Networks, showcasing his diverse professional career in technology and DevOps Cloud engineering.

Martin R. Felsenthal is a venture capital and growth-stage investor who focuses exclusively on innovative healthcare software and services businesses. His previous investments include the healthcare sector, and he has a track record as a professional journalist. The check size of his investments can be further explored through the PitchBook Platform. Collaboration and partnership styles are not explicitly mentioned, but he focuses on investing in healthcare, suggesting a collaborative approach within the health tech industry.

Juan Pinilla focuses on investment areas in Therapeutics, DeepTech, BioTech, Web3/Blockchain, Web3/Crypto, and ClimateTech/CleanTech at pre-seed and seed stages. His typical investment check size ranges from $500K to $3.0M with a sweet spot around $2.0M. Some of his known investments include Creasallis, Expression Edits, and Zafrens. He collaborates with co-investors such as Hiroki Takai, Jason Whitmire, and Wasim Malik.

Andrew Ferguson is the Managing Director at Webster’s Wealth Partners. He focuses on investments in wealth creation, estate planning, tax implications, and retirement planning. The check size for investments has been observed to be around $3 million. Unfortunately, specific details regarding previous investments, track record, stage of investment, and partnership styles were not found.

Tom Demery is a Principal on the Investor Relations Team at Valor Equity Partners. His background includes roles at Monroe Capital, Evanston Capital Management, Fox River Partners, and Putnam Investments. Tom holds an M.B.A. from Kellogg School of Management and a B.A. in History from Hobart College. He is a member of The Economic Club of Chicago and serves on the boards of Metrosquash and The Brinson Foundation.

Felix von Laffert is passionate about exchanging ideas with founders and topics that will shape the future. He focuses on investing in companies that create real value, become established employers, and values analyzing business models. His career background includes previous positions at Bencis Capital Partners, Digital+ Partners, Henkel Tech Ventures, FTI-Andersch, and Hermes-OTTO International. Felix has a BSc. in International Business Administration from WHU – Otto Beisheim School of Management and The University of British Columbia (UBC).

Julianne Roseman is currently a Senior Associate at Plug and Play Tech Center focusing on Health & Hospital Services (Seed) and Health IT (Seed) investments in the Midwest region. Some of her previous investments include Helium Health and Rapicare. She has a track record in leadership, commercial litigation, market research, and analysis. Julianne has experience from previous roles at Plug and Play Tech Center and Harrington Discovery Institute at University Hospitals. Her partnership and collaboration style involve contributing valuable insights to the industry, with a keen focus on innovative healthcare solutions.

Cheryl Zimberlin, Investment Director at M Ventures (Merck), is known for her focus on Digital Health, BioTech, Health & Hospital Services, and Health IT sectors. She typically invests in the Seed to Series B stages with an investment range of $100K to $5.0M and a sweet spot of $1.5M. Her recent investments include ImmuneBridge in the Seed stage, with a total of $12M raised. Cheryl collaborates with co-investors such as Dylan Morris from Insight Partners and other investors like Anique ter Braake, Bauke Anninga, Christian Patze, Christian Uhrich, and Daniel Franke. Her track record showcases a strategic approach to biopharmaceutical investments within these sectors.

Ondrej Smolek is an investor with a focus on Material Science (Series B), SMB Software (Series B), BioTech (Series B), and Health IT (Series B). He typically invests between $100K to $5.0M with a sweet spot at $1.5M. His geographical preference and partnership and collaboration styles are not specifically mentioned in the available data. Ondrej Smolek’s current fund size is â¬24M, reflecting a successful track record in investing.

Jakob Loven, Ph.D., a Managing Partner at Nextech Invest Ltd, is an accomplished oncology-focused entrepreneur with extensive experience in creating, launching, and building early-stage therapeutic-based platform biotechnology companies. His previous board seats include A2 Biotherapeutics, Arrakis, IconOVir, Hexagon, Boundless, Laronde, and Scorpion Therapeutics. With a Ph.D. in medical sciences focused on oncology, Jakob has a multicultural background and a successful track record in the life sciences sector. His investment focus areas include creating early-stage therapeutic companies. Check size and partnership style details are not available on the website.

Michael L. Mark is a successful entrepreneur with a background in technology companies. He has a strategic focus on investments in the biopharmaceutical and medical device sectors. Michael prefers late-stage growth investments in market-leading companies. His geographical preference spans North America, Europe, and Southeast Asia. Some of his previous entrepreneurial ventures include American Energy Services, Inc., Intercomp USA, Inc., and Cadmus Computer Systems, Inc. Michael’s investment check sizes vary, and he is known for his partnership and collaboration styles that focus on strategic alignment and mutual trust.

Bolt is a pre-seed venture firm investing where the digital and physical world intersect.

Marcel Zijp, Investment Manager Agrifood & Health at Brightlands Venture Partners, focuses on smart and sustainable farming, green biotech, circular economy, alternative protein, and personalized nutrition for healthy and sustainable diets. Associated with the Brightlands Agrifood Fund targeting investments in agriculture, chemical, and gas sectors in Geleen, Netherlands.

Bernhard Koehler is a Senior Investment Manager at Bayern Kapital, involved in funding startups in sectors like Medical Devices (Series B) and SMB Software (Series B). His investment range typically falls between $100K and $5.0M, with a sweet spot at $1.5M. Currently, he operates within a fund size of â¬24M, collaborating with other investors to support ventures at various stages. Bernhard’s investment approach seems focused on specific sectors and stages, indicating a strategic and diversified portfolio.

Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.

Jacopo Leonardi is a Partner at Agent Capital, a biopharmaceutical investment firm. With a 25-year track record, his expertise lies in global commercial operations, focusing on orphan and rare diseases, immunology, and neurology, aligning with Agent Capital’s investment focus. The firm supports disruptive healthcare companies with novel therapeutics, aiming for high returns. Jacopo’s career spans roles at prominent companies like Baxter and Baxalta. Agent Capital’s previous investments include 14 healthcare companies, with four going public. Jacopo’s track record showcases sustainable growth in new ventures. Though specific check sizes are not listed, collaborations align with diverse management teams for superior returns and fostering healthcare innovations.

Mr. Ethan Beard, a tech entrepreneur and innovative leader, is an experienced investor with a diverse investment portfolio. Known for his role as an Entrepreneur in Residence at Greylock Partners and his previous positions at Facebook and Google, Beard brings a wealth of experience and expertise to the table. His investment focus areas include startups like Cosmology, Arkive, and BeetsDAO. These investments span across various stages, from seed to Series A, with significant check sizes, demonstrating his commitment to supporting early-stage ventures. Ethan’s collaborative style is evident in his co-investors and partnerships with notable firms like Tuesday Capital and Color Capital. With a strong track record in the tech industry, Ethan Beard strategically guides companies towards growth and success, leveraging his vast network and industry insights.

Subrah Iyar is an investor with a varied portfolio, focusing on ventures in the VC stage. He has made investments in companies like Zoom, American Cricket Enterprises, and Musely. His professional career includes roles at Webex, Cisco, and Apple. Subrah’s investment check size is not publicly disclosed. His partnership and collaboration styles are highlighted through his involvement as an Investor, Co-Founder & CEO at Moxo, and his advisory roles at Tact.ai and Zoom.

Madeleine Magnerius, Vice President at EQT Partners, possesses a robust investment background with a strategic focus on transformative ventures. With a track record spanning impactful investments, including roles as a Seed Investor in innovative startups like **OCON Therapeutics** and **Fika**, Madeleine demonstrates a keen eye for groundbreaking solutions. Her commitment to sustainability is evident through investments in companies such as **Circulate**, a B2B marketplace driving sustainable packaging solutions. Madeleine’s professional journey includes pivotal experiences at **Goldman Sachs** as an Investment Banking Analyst, shaping her expertise in the financial sector. In her current role at EQT Partners, Madeleine continues to excel in shaping the future of investment landscapes. Her investment check size and partnership approach underline a dedication to fostering entrepreneurial success and propelling forward-thinking initiatives.

Jessica Li is a Venture Partner at Predictive VC, with a focus on Series B Data Services, Marketplaces, BioTech, Data Services (Seed), Data Services (Series A), and Digital Health (Series B). Her investment check size typically ranges from $100K to $5.0M, with a sweet spot at $1.5M. Jessica has a track record of delivering large-scale transformation projects and has 15+ years of industry experience. She specializes in Data Architecture, Information Management, and customer data in Finance, Telecom, and Marketing spaces. Her current role is as a Solution Architect at Macquarie Group. Jessica prioritizes building long-term, broad relationships in venture capital and values well-rounded founder teams with a focus on process orientation.

Edward Zuckerberg is known for investing through partnerships and collaborations, aligning with the principles of commitment and value generation. His investment check size has been notable, with successful investments in various enterprises. His track record and professional career showcase his expertise in digital marketing and social media utilization. Edward’s geographical preference and stage of investment remain understated, focusing on strategic investments that yield substantial returns. Previous investments testify to his acumen in selecting promising ventures. His investment focus areas include healthcare technology systems and business/productivity solutions.

The Angel Capital Group is an angel investor and venture capital firm investing in seed/startup and early growth stage companies, focusing on social media, medical devices, and movies/entertainment. The firm does not have a specified geographical preference and invests domestically. They have a track record of successful achievements and the CEO job announcement indicates a distinguished professional career. The investment check size varies between $500,000 to $2 million per round. The partnership and collaboration style involve keeping the angel investor updated on the company’s progress to maximize the partnership.

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

Elad Gil is a technology entrepreneur, investor, and future optimist, involved in investments, incubations, and operating companies focusing on the technology future. His investment focus areas include AI, longevity research, societal beauty, inspiration, and human capital movements. Elad typically invests at late-stage funding sources. He has made notable investments in companies like Airbnb, Airtable, Anduril, and Coinbase. Elad’s professional career includes significant contributions to major tech companies, founding and investing in startups, and successful entrepreneurial projects. While specific check sizes may vary, he is known for individual check sizes of up to $50 million in a single round, often from a growth fund. Elad Gil’s partnership and collaboration styles emphasize coordination, collaboration, and relationship-building for mutual success.

Sapan Shah is a Managing Partner at Alera Group, Inc., and a Board Director at HPA. He has been involved in various board director roles and has a background in healthcare acquisitions. Sapan Shah’s career showcases experience in healthcare and investment roles, with a focus on board memberships in Chicago-based organizations.

Radhika Ramachandran is a seasoned professional with extensive experience in various roles across digital marketing, communications, strategic partnerships, and fundraising. She has served in key positions such as Digital/Strategic Marketing & Communications Consultant, Inbound/Digital Marketing & Social Media strategist, and Chief Marketing Officer. With a track record of successful collaborations, Radhika has worked with a diverse range of organizations and tech startups globally. Her expertise includes driving innovative marketing campaigns, managing digital initiatives, and fostering strong partnerships. Radhika holds advanced certifications in Inbound Marketing and Frictionless Sales, coupled with an MBA and MS in Information Science with a focus on Artificial Intelligence/Expert Systems.

Marcus Wallén is an Angel Investor with a focus on seed round investments. His investment check size and partnership style are undisclosed.

Beril Kocadereli, Portfolio Associate at Antler, focuses on pre-seed investments in sectors such as Cybersecurity, ClimateTech/CleanTech, Web3/Crypto, Health IT, and more. With an investment range of $100K to $5.0M and a sweet spot at $1.5M, Beril collaborates with various investors. Beril’s track record and professional career at Antler show a specialization in investing in diverse sectors at the pre-seed stage. The partnership and collaboration style of Beril at Antler involve working with a range of investors to support startups globally.

Pradeep Bekal is an Angel Investor at Angel Physicians Fund, a venture capital firm based in Powell, Ohio. The fund focuses on life science and healthcare investments at the seed stage. While specific investment thesis or partnership styles were not found, the fund’s investment check size and stage indicate a focus on supporting early-stage companies in those industries. The geographical preference and track record of previous investments are not available. Pradeep Bekal is associated with medical centers in Cincinnati, Ohio, and is known for his work in treating GI issues.

Farzad Nazem is an angel investor focused on pre-seed investments in areas such as Hardware, Medical Devices, Analytics, Education, BioTech, Marketplaces, Health & Hospital Services, Health IT, AI, and SaaS. He is based in the San Francisco Bay Area. His investment check size ranges and geographical preference are not specified. Farzad Nazem has a strong track record with 54 investments recorded, including companies like Ceevra, Inc., TigerGraph, Emailage, Luminist, and Tubi. With a background as the former CTO of Yahoo!, he brings extensive experience to his investments. His partnership and collaboration style involves engagement through partnerships and collaborations to drive innovation.

Gregory D. Wasson is the Co-Founder of Wasson Enterprise, a family office that partners to build sustainable, high-growth businesses aiming to do well by doing good. He collaborates to create disruptive businesses with a lasting impact in industries such as healthcare data analysis platforms, medical waste management, therapies, e-commerce, money transfers, and energy storage systems. Wasson’s investments align with his focus on sustainability and purpose-driven entrepreneurship. He has a wealth of experience in leadership, operations, and governance, contributing to the success of ventures he supports. Wasson’s partnership and collaboration styles involve building legacy businesses, and he serves in leadership roles across various organizations, including the board member at Cooler Screens, Performance Health Systems, and Innovation Associates, among others.

Romulus Capital is an American seed- and early-stage venture capital fund that invests in technology companies.

Affinity Capital Management is a Minnesota-based investment company that funds healthcare technology companies.

Melinda Gloriosa, Investment Associate at Rev1 Ventures, focuses on seed-stage investments in Ohio software companies, health diagnostics startups, and life science early-stage companies in the Midwest. Some of her previous investments include Trace, a Columbus AR startup. Melinda emphasizes collaborative leadership and supports industry disruptors in her investments. Although specific investment check sizes are not available, she is known for providing funding that aligns with the learning and execution curve of the team and market opportunities. Her track record includes successful support for startups and active involvement in driving innovation and growth.

Vivien Ho, a Partner at Pear VC located in the San Francisco Bay Area, specializes in investing in health, focusing on human and planet health. With a broad investment range, Vivien seeks opportunities in the early-stage healthcare and life sciences sector, aiming to support innovative solutions that address significant healthcare challenges. Vivien values founders with industry expertise and solutions that have the potential to make a substantial impact in the healthcare space. In her career, Vivien has demonstrated a dynamic track record of leadership and strategic investments.

Dr. Frank Hensel at HTGF focuses on drug development companies, particularly those in the clinical stage. His professional background includes a Ph.D. in biology and experience as an entrepreneur in a startup developing antibodies for cancer treatment. He has successfully exited companies with deals reaching up to 425 million euros, emphasizing the importance of partnerships in the drug development sector.

John Racine is an experienced senior executive and former CEO from the payment processing industry, specializing in buyouts and growth equity investments in the healthcare, manufacturing, business services, and technology sectors in the U.S. and Canada. His investment check size is undisclosed. He focuses on commercial real estate investments and possesses a wealth of experience in managing Core Solutions business units. He is known for his expertise in facilitating private mortgage investments as a real estate alternative. Racine’s partnership and collaboration styles align with the three common collaboration styles: introspective, relational, and expressive.

Edward Michael, Managing Partner at LionBird, focuses on early-stage technology startups in healthcare, commerce, and enterprise. The investment check size ranges from $200K to $1.5M. Edward Michael has a professional background of 25 years at Abbott Laboratories, serving as Executive Vice President of Diagnostic Products. Specific previous investments are not available. LionBird’s partnership and collaboration styles involve digital health-focused activities. For more details, visit LionBird’s website at https://www.lionbird.com/

Oliver Heine is an angel investor with a focus on HealthTech, Consumer, and other areas. Known for past investments like WorkGenius, his investment check size varies. Oliver Heine embraces genuine partnerships and collaboration, complementing tasks performed in interfirm collaborations.

Garri Zmudze is an investor and advisor for cutting-edge deeptech companies, focusing on longevity. He supports projects towards a longer and healthier human life. As a seasoned business angel, Garri has an extensive track record in building tech businesses and investing in early-stage ventures. Previous investments include Profi. His investment focus areas include longevity research. Garri’s professional career showcases technology expertise, innovative leadership, and client relations. LongeVC, where Garri is a funding partner, discusses plans for funding sci-fi longevity tech. Collaboration for longevity investments involves joint efforts from VCs, startups, investors, and nonprofits.

Tullis Health Investors is a private equity group that invests primarily in the healthcare sector.

Josh Linkner is the Managing Partner and co-founder of MuditÄ Venture Partners, an early-stage venture capital fund focusing on companies in Healthcare & Biotech, Financial Services, Auto & Manufacturing, Tech & Entrepreneurship, CPG, Real Estate, Travel & Hospitality, and Retail. The fund aims to raise $40 million and primarily invests in pre-revenue companies and companies before a Series A fundraising round. Track record and professional career details are not available at the moment.

Startup Florida is an angel group based in Florida, United States, focusing primarily on companies in the healthcare and information technology sectors. They have a track record of investments in various technology firms, targeting early-stage businesses. Startup Florida has made investments in education technology, fintech, wireless technology, machine-sensor technology, and health tech companies, showcasing their diverse portfolio. The group has demonstrated an interest in innovative startups, particularly in technology-driven fields. Their investment check sizes vary depending on the specific company and opportunity, with a preference for companies with high growth potential. Startup Florida is known for its collaborative partnership style, supporting entrepreneurs with not just funding but also guidance and expertise to help startups succeed. Previous investments by Startup Florida include various technology firms, indicating a commitment to cutting-edge and transformative technologies. With a focus on early-stage ventures and a diverse portfolio, Startup Florida offers strategic investments to drive innovation and growth in the healthcare and information technology sectors.

Todd Kimball is a senior accounting professional with over 15 years of experience in the non-profit and government sectors, excelling in finance and accounting solutions. He leads the non-profit practice in Oregon and SW Washington and is the Accounting Solutions Partners practice leader in the same area. With a track record at Mercy Corps and expertise in not-for-profit accounting, he is known for creating process efficiencies, implementing internal controls, and providing technical expertise. Todd has worked with over 20 non-profits as a fractional CFO. His investment check size and partnership and collaboration styles were not explicitly mentioned in the available information.

Roman Huber is the Managing Director of Bayern Kapital, a venture capital firm that focuses on deep tech startups in the software, bioscience, healthcare, and pharmaceutical sectors. The firm invests from â¬250,000 to â¬25 million Euro and partners with startups offering new technical developments. Bayern Kapital’s investments in software startups include Wealthpilot, Daypaio, and Cliniserve. They emphasize on B2B business models with a clearly defined benefit for customers and require a comprehensive business plan with a technical roadmap. Roman Huber predicts growth in machine learning, AI, AR, robotics, and green technology.

Robert Slay is an angel investor specializing in emergency medicine. He is the owner of ROBERT D SLAY, MD, INC. As an investor, Robert focuses on Pre-seed FinTech companies. His investment check size ranges between $250K to $5M. Robert’s professional career includes being Chief of Staff and Chief of Emergency Medicine at Marina del Rey Hospital. He has been actively involved in writing nutrition books, hosting medical television shows, and doing stand-up comedy as a hobby. Robert’s partnership and collaboration styles are not explicitly mentioned in available sources.

Lightspeed China Partners is a leading venture capital focusing on early-stage investments in China.

Daniel Bertholet is the founder of 4See Ventures, a venture capital firm founded in 2019 that focuses on the health tech sector. The firm invests primarily in Enterprise Applications and Life Sciences, with a preference for investments in Switzerland. 4See Ventures typically enters at the seed round stage, followed by Series A rounds. The firm has invested in 14 companies in the last four years, with notable investments such as KeePAP. Daniel Bertholet’s investment check size ranges based on the round of investment, and the partnership and collaboration styles emphasize open dialogue with investors to empower decision-making.

Capnamic is a venture capital firm from Berlin/Cologne doing early-stage investments in outstanding teams in Germany/Austria/Switzerland.

Christian Schuetz is a Partner at b2venture, one of the most active investors in Europe, passionate about venture investing in life sciences, medtech, and health-AI sectors. His investment focus areas include managing the firm’s Industrial Technologies Fund, biotech, and health-related investments. Christian works with angel investors and has a track record of previous investments in various sectors.

Ron Garret is a Venture Partner at Funk Ventures with experience in engineering, filmmaking, and investing. He was involved in the development of Google’s Adwords platform and worked at NASA’s Jet Propulsion Lab. Ron has a track record in angel investing since 2003, emphasizing mentorship and full-time commitment. He suggests a minimum investment of $1M for serious angel investing. However, specific information on his investment focus areas, previous investments, investment check size, and partnership styles was not found.

Sven Gabor Janszky is a visionary futurologist and Chairman of the largest independent futurology institute in Europe. His investment approach focuses on early-stage ventures in sectors like consulting, information technology, biotechnology, education, and computer technologies. Janszky prefers seed and early-stage investments with an average round size of $934K. His portfolio includes 11 startups, with a track record of 20 investments and 1 exit. Janszky’s partnership style emphasizes collaboration with lead investors and similar-focus funds for mutual growth and success.

Mike Lebus is an angel investor and co-founder of Angel Investment Network Ltd. He has invested in multiple UK startups, including Sweatcoin and What3words. With 40 networks across 90 countries and nearly 2 million users, Angel Investment Network is the largest global angel investment community. Mike Lebus is known for supporting startups and providing valuable funding opportunities through his network.

Sabity Abdillah Tsara is the CEO of SIMEX – SABITY IMPORT EXPORT, an import-export company specializing in collecting local products for export and importing various goods. Tsara has experience in the import-export industry since 2013 and has worked in Ambanja, Madagascar. Additionally, Tsara previously served as Chef d’Agence at PAMF in Port Bergé, Madagascar.

Julie Wukelic is an Angel Investor and Member at Alliance of Angels based in Spokane, Washington. Her investment thesis focuses on Hardware (Seed), Retail (Seed), and BioTech (Seed) sectors, along with Hardware (Series A), Retail (Series A), and BioTech (Series A) stages. Julie’s geographical preference includes Seattle and Portland. She has a successful track record in investing in startups with a check size ranging from $500K to $1.5M, with a sweet spot of $1M. Julie Wukelic is known for her collaborative and partnership-oriented investment approach.

Brad Charchut is a Partner in the Private Credit Group at Bain Capital, based in the Chicago office. He is responsible for capital markets and originations in North America. He joined Bain Capital in 2011 and previously worked at Cerberus and Heller Financial. Brad Charchut’s previous investments include acquiring Merchants Fleet, a high-growth fleet management company, alongside the Merchants leadership team.

Digital Health Angels is a prominent investor in the Digital Health sector, focusing on seed-stage investments in companies with live MVPs or products in the market. Their investment strategy emphasizes technologies that drive healthcare innovation and transformation. While specific details about their investment thesis, focus areas, check size, geographical preference, and partnership style are not available, Digital Health Angels has a track record of consistent investments in digital health ventures over the years. Their investments are strategically aimed at supporting startups in the Digital Health space, contributing to the advancement of healthcare technologies. The precise size of their investments, previous investment portfolio, and partnership approaches remain undisclosed. This investor plays a vital role in fostering innovation and growth in the Digital Health industry.

Bob Dunn is the Managing Partner at Thompson Street Capital Partners, a private equity firm based in St. Louis. He focuses on companies in Life Sciences & Healthcare, Software & Technology, and Business & Consumer Services and Products with investments between $50 million and $500 million. Some of his previous investments include TA Associates, Hambrecht & Quist, Echosat, BioIVT, Global Software, TierPoint, FocusVision, and Iracore International. The Investment Check Size of the fund managed by Thompson Street Capital Partners is between USD 4 million and USD 15 million.

Michael Oschmann is the CEO of Mueller Medien since 2000, focusing on New Media. His investment focus spans across various sectors like Health Care, Biotech, Community, Marketplace, FinTech, Impact, Proptech, Media, and EdTech. While his geographical preferences are not specified, he has made past investments in Phonedeck and Salonmeister. His partnership and collaboration style emphasizes fruitful collaborations for mutual success.

Aditya Agarwal is actively investing with a focus on sectors like Cloud, Fintech, Biotech, and CPG. His investment check size ranges from $250K to $1.5M, with a sweet spot of $750K. Aditya prefers to invest in early-stage startups and has a track record of investing in companies like PlanetScale, Hypernet, Awecom, Sparks, Vamo, Gusto, and Asana. He collaborates with and lends a helping hand to startup founders in Silicon Valley, leveraging his experience as the CTO and VP of Engineering at Dropbox and as a co-founder of Cove. Aditya has a successful track record in the tech industry, serving on the boards of FlipKart, Carnegie Mellon’s School of Computer Science, and the Anita Borg Institute. His educational background includes a bachelor’s and master’s degree in Computer Science from Carnegie Mellon University.

Eli Cole, a Partner at Hyperlink Ventures, focuses on investments in venture capital funds, along with occasional direct investments in technology and healthcare startups. With a background in creating value through venture investing programs, his primary focus areas include technology and healthcare sectors. Eli holds an M.B.A. from UCLA Anderson, a J.D. cum laude from UC Hastings College of the Law, and a B.A. in Mathematics from TCU.

Mai Ho is a Venture Partner at Hustle Fund and has led investments in companies like Fonos and DatBike. She manages a family office’s portfolio in healthcare and renewable energy. Mai Ho was featured in Forbes’ 30 Under 30 – Asia – Finance & VC (2021)

Lee Zapis is the Founder and President of Zapis Capital Group, investing in early-stage technology companies with a focus on Life Sciences & Healthcare, Media & Digital Media, and Software & Internet. Zapis Capital Group prefers investing in the Great Lakes and Midwestern US regions. Previous investments include Axuall and Scout RFP. Mr. Zapis boasts a successful radio executive career and has served on various boards and advisory roles. The investment check size of Zapis Capital Group can range, exemplified by a $500,000 investment in a Cleveland technology business. Collaboration and partnership styles can be seen in Mr. Zapis’ involvement with various organizations and director positions.

Yury Melnichek is the founder of Melnichek Investments, an investment company focusing on early-stage, high-tech IT startups in the field of computer vision and machine learning. The investment thesis revolves around AI being the future that can transform industries and improve people’s lives. The company invests in AI startups in their pre-seed, seed, and Series A rounds, with investment ranging from $200,000 to several million. Yury Melnichek has a technological background and expertise in technology, along with successful experience in business. Melnichek Investments aims to provide not just financial support but also mentorship and guidance to AI startups for their success. The company has successfully invested in startups like Gero Startup, OneSoil, and Rainbow.ai. Melnichek Investments is actively seeking new investment opportunities in AI startups dedicated to developing technologies for the betterment of mankind.

Kevin Cook is an Angel Investor specializing in the Healthcare Sector. He has a track record of serving in various finance and investor relations roles at companies like Cloudera, RBC Capital Markets, and Barracuda Networks. His professional career includes positions such as CFO and VP of Finance. Kevin Cook has a successful stock coverage history and focuses on the Consumer Goods sector. His investment check size, geographical preferences, and partnership styles were not explicitly mentioned in the search results.

Lukas Erbguth is a Principal at Atlantic Labs with a focus on climatetech, digital health, future of work, AI & data, mobility & logistics, industrial automation, fintech, and proptech. He leads investments in early-stage startups and has made previous investments in companies like Purpose Green, Apryl, and Aeditive. Lukas has a professional background at Atlantic Labs and is known for his collaboration styles in the investment field. His investment check sizes typically range from $100k to $5.0M.

Steven Conine is the co-founder and co-chairman of Wayfair, a $3.3 billion e-commerce company. His investment focus areas include AI/ML, Biotech, Consumer, Enterprise, and University Spinouts. He has a strategic approach to scaling a business, maintaining company culture, and providing advice to startups. Conine’s geographical preference is not specified. His previous investments include Wayfair Inc Class A. Known for his professional career at Wayfair, he has grown the company to $7.3 billion in net revenue. The investment check size is undisclosed. Conine emphasizes collaboration, innovation, and creating a culture of innovation in his partnership style.

Toba Spiegel is an Investment Manager at Trill Impact focusing on Impact Ventures. His investment focus areas include Digital Health, Health IT, and Health & Hospital Services for both Series A and Seed stages. Toba Spiegel’s previous investments include companies like Open Cosmos and Autovio. He maintains partnerships and collaborates with investors such as Christian Schulte, Felix von Laffert, and others. Unfortunately, details on Toba Spiegel’s track record, geographical preference, stage of investment, and investment check size were not found.

Lateral Capital Management invests in owner-operated companies at critical moments, focusing on technology and business services sectors such as B2B software, industrial technology, and managed solutions. They provide capital for organic growth, M&A pursuits, and minority recapitalizations. Some of their previous investments include Niron Magnetics, Spintech Holdings, and Steelhead Composites. Lateral typically invests between $15-75 million in customized private equity solutions aimed at enabling business owners to build durable businesses without continuous venture capital or premature exits. They approach investments as a ‘buy in’ to accelerate a business owner’s vision and target ambitious yet sensible and profitable businesses, which they refer to as ‘PANTHERs’.

Dirk Ploss is a venture capitalist with a focus on skin care and beauty startups. His investment thesis revolves around breakthrough ideas in sustainability, life science, biotech, digital solutions, and new business models. Dirk primarily invests in Series A companies with check sizes ranging from 0.5 to 5.0 million euros, taking up to a 20% minority share. His geographic focus includes Europe, North America, Korea, and Israel. Dirk has invested in startups like Dermanostic, Salvalco, LYCL INC., S-Biomedic, and Depoly. With a background in innovation and marketing, Dirk’s professional career includes roles at Beiersdorf, where he served as Senior Early Innovation Manager and held positions in digital technologies scouting, e-commerce, and brand management. Dirk is also known for his involvement in mission-one GmbH and Startup Grind as a board member and Chapter Director, respectively.

Reinhard Ambros served as the global head of the Novartis Venture Fund from 2005-2017, building a billion-dollar corporate Biotechnology Venture Fund. He led numerous investments, exits, IPOs, and M&A deals, with a focus on the biotech industry. Reinhard has a track record in international leadership in venture capital, corporate strategy, and pharmaceutical product development. His geographical preference includes Europe and the US, where he serves on various biotech company boards. His investment check sizes are significant, given his role in managing a billion-dollar fund. Reinhard is known for his partnership and collaboration styles, having established key networks with finance syndicates and pharma organizations.

Borealis Ventures partners with early-stage entrepreneurs to build market-defining companies in information technology and life sciences.

Yinebeb Atel is a Partner and Data Scientist at Tribe Capital based in Seattle, Washington, USA. Tribe Capital is a $1.6B+ AUM venture capital firm with a focus on capturing a perpetual edge in venture and crypto using data science. Yinebeb’s investment range is $25K – $40.0M, with a sweet spot of $6.0M. He has previous investments in the Web3/Blockchain and Crypto sectors across various stages. Yinebeb collaborates with investors like Ailbhe Dempsey, Alexander Chee, Anirudh Pandit, Apolo Ohno, and Arielle Kogut. His partnership and collaboration style involve investing in various sectors and stages, including Seed and Series B, supporting startups in Web3, Crypto, Consumer Internet, Enterprise, and FinTech.

Michael Berman is a Venture Partner at RiverVest Ventures, specializing in medical device investments. His investment focus is on pre-seed to Series B stages, with a range from $100K to $5.0M and a sweet spot at $1.5M. Berman has a track record of investing in companies like BridgePoint Medical, Apnex Medical, and Prospex Medical. His geographical preference includes Israel and the Midwest region. With a current fund size of $184.4M, Berman collaborates with co-investors such as Brian Chee (Polaris Partners). His professional career includes roles as a Board Member at multiple medical device companies, Chairman at Rebiotix, and President at Boston Scientific Cardiology. Berman’s investing strategy involves partnerships with investors like Andrew Kleiboeker, Derek Rapp, Isaac Zike, Jay Schmelter, and John McKearn.

Dr. Martin Pfister was a Principal and an expert for venture capital and investments in Life Science & Chemie startups at HTGF. His unfortunate passing in October 2023 marked the end of his impactful career. During his tenure, he focused on investments in Life Science & Chemie startups and contributed significantly to the growth of the sector. One of the notable successes under his guidance was the acquisition of the biosensor company lino Biotech by Miltenyi Biotec, showcasing his strategic acumen in investment decisions. His legacy includes a strong track record of successful investments and a profound impact on the startups he supported. His partnership and collaboration style emphasized fostering meaningful relationships with portfolio companies to drive mutual success.

Alfred Scheidegger is the Founder and Board Member of Nextech Invest Ltd, focusing on oncology therapeutics, diagnostics, and devices. He has a track record of investing in companies like Agensys, Ganymed Pharmaceuticals, MacroGenics, Sunesis Pharmaceuticals, TetraLogic Pharmaceuticals, and Tracon Pharmaceuticals. Alfred’s investments are known to be substantial, and the check size is not explicitly mentioned on the website.

Dr. Priscilla Chan is a Co-founder and Advisor at The Breakthrough Energy Coalition. She also founded Startup:Education. Chan Zuckerberg Initiative focuses on Science, Education, and Justice and Opportunity, with a keen interest in housing affordability, criminal justice reform, and immigration reform. Priscilla Chan’s investments are in K-12 education, biomedicine, and artificial intelligence, providing grants from $40,000 to $14 million, with notable projects receiving up to $100 million. She has a background in real estate and mortgage financing, currently serving as a Mortgage Loan Officer and Realtor, demonstrating a diversified expertise in both philanthropy and business. The investments by Chan Zuckerberg Initiative aim to advance human health over 10-15 years, showcasing a commitment to long-term impact. The organization collaborates with large organizations in education and science, presenting a hands-on approach to fostering innovation and social change.

Castle Island Ventures is a venture capital firm,

Shana Fisher, Co-Founder and Managing Partner at Third Kind Venture Capital, focuses on investments in software, financial services, digital media, information technology, life sciences, and education sectors. The fund targets early-stage investments and operates in the Greater New York Area and East Coast of the US. Investment check sizes vary based on the stage of investment. Collaborative investing style with a focus on seed to series A rounds.

Louis Lucido is the Interim President of BioCorRx Inc. and a former Senior Advisor and Chief Operating Officer of DoubleLine Group, LP. He has invested in BioCorRx and has experience in the investment and capital markets. Louis Lucido’s previous investments include rounds in BioCorRx, particularly in the Post IPO Round in 2019. He is known for his collaboration styles focusing on introspective, relational, and expressive approaches to enhance teamwork and productivity.

Keiretsu Forum South-East is a part of the global investment community of Keiretsu Forum, known for its diverse investment opportunities in emerging technologies, healthcare/life sciences, consumer products, real estate, and other high-growth segments. Keiretsu Forum members aim to provide quality deal flow for angel investors globally, having invested over $1 billion in 950+ companies across different industries. With a network of over 1,850 members in North American and international chapters, Keiretsu Forum stands out for its collegial screening process, direct investments in presenting companies, and extensive networking opportunities. This investor emphasizes a mission of ‘Great Association With Quality Deal Flow’ and has a track record of supporting innovative ventures in various sectors to foster growth and success.

Andrew Rudd is a seasoned investor with a strong academic background in asset allocation, modern portfolio theory, risk management, and performance measurement. He is the Co-Founder, CEO & Chairman of Advisor Software and a Co-Founder of Advisor Partners. His investment focus areas are aligned with modern portfolio theory principles.

Mikael Ahlström founded Procuritas in 1986. He is the Chairman of Procuritas Investment Committee. Prior to founding Procuritas, Mikael was…

Martin Redl is the Investment Director at Bayern Kapital, overseeing the early-stage sector since 2007. He focuses on software, bioscience, healthcare, and pharmaceutical sectors. Previous investments include Shore GmbH, United Maps, and casavi GmbH. Martin holds a track record of successful early-stage investments. His check sizes vary based on the project. With a collaborative and hands-on approach, he positions Bayern Kapital at the forefront of innovative funding strategies.

Thanos Triant is an individual angel investor with a diverse portfolio. He focuses on investing in Seed stage companies, primarily in the San Francisco Bay Area and Silicon Valley. Thanos Triant has made investments in companies such as Fleksy Inc., Weengs, Pollfish, Mist.io, and Transifex. His professional career includes successful ventures in building financial data products on Wall Street and managing IT organizations. As an angel investor, he has a track record of investing in early stage software companies. Thanos Triant’s check size for investments ranges across various seed rounds, with a partnership and collaboration style that aligns with individual angel investing strategies.

Naveen Jain is a Co-Founder and Chief Executive Officer at Viome Life Sciences, Board Member of XPRIZE, Advisor at Pegasus Tech Ventures, and involved in various other ventures. His investment focus areas include companies like Particle Network and Proprio. Jain has been active in investments at both pre-seed and seed stages. Some of his previous investments include LS Digital and Onmove. His professional career is marked by a dedication to solving global challenges through innovation, with a particular focus on empowering women and promoting entrepreneurship. The investment check size for Naveen Jain’s active investments is significant, reflecting his commitment to impactful ventures.

Kevin Harvey, General Partner at Benchmark Capital, focuses on investments in CloudPassage, Upwork, Eucalyptus Systems, Boku, RightScale, and Red Hat. His investment thesis centers on equal partnership, no growth fund, and picking the next partner. Kevin’s interests span mobile computing, consumer internet, and computing infrastructure. He invests in various stages from seed to late stages and primarily collaborates in social commerce, biotech, social networks, cloud infrastructure, marketplaces, and SaaS sectors.

John Prendergass is an investor who focuses on early-stage digital health, biotech, and medical device companies in the greater Philadelphia area. He seeks solutions that fill unmet medical needs, with investments ranging from $50K to $500K and a sweet spot of $300K. His previous investments include OneForty in a Series A funding round. John Prendergass’s partnership and collaboration style involve investing in startups with specific healthcare objectives and avoiding basic R&D or cost-increasing solutions in the healthcare system.

Btov Partners is a venture capital firm focused on early-stage investments in digital and industrial technology companies.

Innovate Mississippi/MS Angel Network is an early-stage VC investor focusing on Education, Software, E-Commerce, and Construction startups. They predominantly invest in the Seed and Early Stage Venture rounds. Their investments are geographically centered in Mississippi. Some of their previous investments include South Mississippi Angel Fund I. The network is known for its support of minority and women-led firms. Innovate Mississippi/MS Angel Network maintains an active role in the tech ecosystem, collaborating with local organizations like the Oxford Chamber for tech initiatives.

Soner Casur is an investor based in Istanbul, Turkey. He has a keen interest in disrupting various industries with technology, focusing on areas such as Health Technology, Messaging, Disrupting consumer verticals, and Fintech. Soner has made investments in Lokum Games and collaborates with co-investors like APY Ventures and Bogazici Ventures. His investment style reflects a preference for deep work, meaningful connections, and creative freedom. While Soner’s track record and professional career details were not accessible, his investment check size typically ranges from $250K to $5M. Through his investments, Soner aims to disrupt traditional sectors and contribute to innovative advancements.

Michael Baum is the founder of FOUNDER.org, a non-profit foundation that invests in student entrepreneurs solving big problems. The organization focuses on industries such as sensors, sanitation, influencer marketing, biotechnology, health, and transportation. FOUNDER.org provides early-stage funding and seed grants to support student entrepreneurs in building great companies. Baum’s track record includes six successful exits, including Splunk. The organization hosts an annual contest awarding $100,000 in grant funding to top student teams. FOUNDER.org works closely with student founders from universities globally, providing hands-on mentorship and support for high-impact companies.

Jonathan Bill is an experienced investor with a focus on enterprise applications and consumer sectors. His investment thesis includes supporting startups like On Device Research and Kawa Space. Jonathan has a track record of success, having founded BillBachao and co-founded Fintech Venture. His investment check size ranges and his geographical preference includes investments in India and Singapore. Jonathan’s professional career spans roles at Vodafone and Reuters, showcasing his expertise in internet services and business development. He values collaboration and has engaged in partnerships across various sectors.

Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies.

Andy Solomon is an Angel Investor with a focus on comprehensive intellectual property, regulatory, and commercial strategies for pharmaceutical products. His previous investments include SoleSociety. He has a track record of creating impactful communication strategies, and his typical investment check size ranges from $5.0M to $50.0M. Andy Solomon’s partnership and collaboration styles involve respect, equity, and empowerment.

Ámür Filiz is the founder and CEO of Technolera, a venture builder based in Istanbul, Turkey, focusing on the software sector.

Ann Crawford is a Certified Master Life Coach at Crawford Coaching, LLC, where she helps professionals navigate the corporate world, define and pursue career goals, strengthen relationships, boost confidence, and explore new career paths. She has a background in Organizational Change Management Consulting, Principal Consulting, Workforce Readiness Management, and Leadership and Learning Development. With a Ph.D. in Applied Organizational Psychology from Hofstra University, Ann has a track record of successfully aiding organizations in talent alignment, leadership development, and change management. Her collaboration style involves providing tailored solutions, developing internal programs, and supporting strategic initiatives with a focus on trainings, employee engagement, and organizational development.

Beth Morgan is an Angel Investor and a Member at Alliance of Angels based in Seattle, Washington, with a typical investment range of $500K to $1.5M. Her sweet spot investment is around $1M, and she operates within the Sector & Stage Rankings including Fashion, Wellness & Fitness, Advertising, Food and Beverage, Education, Consumer Health, Real Estate/PropTech, Consumer Internet, and FinTech both in Seed and Series A stages. Beth is affiliated with various scouts and angels. Her investment thesis emphasizes coaching for effective leadership.

Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.

Heather Redman is the Co-Founder and Managing Partner of Flying Fish Partners, a venture firm funding tech companies in the Pacific Northwest. Her investment thesis involves a focus on corporate development, finance, M&A, business development, and intellectual property strategy. She has invested in companies like Armoire and prefers to engage actively in pre-seed and seed investments. With a JD from Stanford and a BA from Reed, Heather brings a wealth of experience in early-stage and high-growth companies, showcasing a hands-on partnership approach with a deep commitment to community service. She has a diverse board presence and is known as a consummate networker and advocate for various industries.

Jim O’Connell serves as Principal at Safeguard Scientifics with over 20 years of operational, financial, and entrepreneurial experience in the life sciences. He has been involved in sourcing and leading investments in companies like Syapse, Quantia Communications, and Alverix. His focus areas include healthcare/foodtech startups, and he typically invests in early to mid-stage companies. While his specific stage of investment is not specified, his check size varies based on the opportunity. Geographically, his investments are not limited to specific regions, with a broad scope of interests. Jim’s partnership and collaboration styles involve working closely with industry experts, guiding portfolio companies, and fostering collaborations between different partners.

Alex Arnold focuses on investing in startups primarily in the pre-seed and seed stages in the health tech, fintech, and sustainability sectors.

Christine Hao, known for her work in various projects including EcoLogistics, demonstrates expertise in entrepreneurial activities. Her investments are multifaceted, focusing on high-tech and bio-tech ventures backed by venture capital. Christine has a notable track record in the industry, showcasing a commitment to fostering innovative ideas. While her investment thesis is not explicitly stated, her investments reflect a keen interest in transformative technologies and entrepreneurial ventures. She has engaged in early to mid-stage investments, with check sizes typically around $250,000. Christine’s previous investments include projects like FURREAL, emphasizing geographical information utilization for volunteer opportunities. Her partnership and collaboration styles revolve around enhancing synergies in the entrepreneurial ecosystem, promoting effective and sustainable performance. The details of her geographical preferences and specific investment focus areas require further exploration for a comprehensive understanding of her investment strategy.

Lasse Chor is an investor with a diverse investment thesis, focusing on B2B SaaS, health tech, fintech, and gaming sectors. He typically invests in early-stage startups across various sectors, with previous investments averaging N/A USD. Lasse Chor has a track record as a successful Danish businessman with global recognition. His investment check size is not specified, and his partnership and collaboration styles are not explicitly defined.

Bill Gates, co-founder of Microsoft Corporation, is an entrepreneur and philanthropist. He is heavily invested in climate tech through Breakthrough Energy Ventures, participating in 45 deals in the past year across energy, food, and construction. Gates focuses on late-stage life sciences investments and Series A+ venture funding, providing flexible debt solutions. His investments spread globally, fostering partnerships with visionary entrepreneurs for societal progress. Gates has a successful track record, amassing a fortune from Microsoft and leading charitable initiatives through the Bill & Melinda Gates Foundation. His investment check sizes vary based on unique needs, supporting companies committed to long-term impact. Gates promotes gender equality and forms long-term strategic partnerships, offering expertise and add-on project funding for impact evaluations. He advocates for public-private partnerships and collaboration to drive energy innovation and address global challenges.

Shaheen Shamsavari serves as Principal at Xandex Ventures and is also an Angel Investor. He has expertise in business development in Xandex’s Semiconductor, Solar, and Investment Divisions, with a focus on managing Xandex Investments’ portfolio. He is a member and active investor at the Life Science Angels, Keiretsu Forum, North Bay Angels, and HealthTech Capital. Previously, he worked at Gilead Sciences in Formulations and Process Development, specializing in HIV and Hepatitis C therapeutics. Shaheen is a graduate of the University of California at Berkeley in Molecular and Cell Biology with a Neurobiology emphasis. Additionally, he is the Founding member at HealthTech Capital.

Okan Erol is an experienced entrepreneur and investor with a focus on technology startups. He co-founded Wordego and is actively involved as the Chairman and CEO. Okan has invested in startups such as Wordego, MD Research & Development, and Nanomik Biotechnology. With a background in Business Development and General Management, Okan has a track record of success in executive roles. He holds a Master’s degree in Business Administration and a PhD in Finance and Banking. Okan Erol’s investment check size varies based on the startup and round, as seen in his investments across different rounds. As an Angel investor, his partnership and collaboration style involves mentoring young entrepreneurs and offering MBA courses at various universities.

eCoast Angels is an angel group that seeks early-stage companies with significant market opportunities, a compelling business plan, an unfair competitive advantage, defensible intellectual property, and a believable exit strategy. They are focused on nascent technologies and dynamic startup teams, with a long track record of providing financial and intellectual capital to early-stage entrepreneurs. They have been lead investors in twelve deals, raising over $17 million for startups. The members have participated in over $1 billion of M&A activity. Their investment focus areas include a cooperative relationship between candidate firms and angel investors, a good fit with e-Coast Angels’ mission, skills, and interests, and a thorough understanding of the dynamics of the marketplace.

Flatley Venture Capital focuses on investing in medical companies, particularly in areas related to cystic fibrosis. Their investment stages may include seed funding, startup capital, early stage, expansion, and later stage. Previous investments include Illumina. The check sizes of their investments vary, possibly ranging from under $300,000 to under $10,000,000. Their partnership and collaboration styles may involve setting up joint ventures and launching companies around interesting technologies.

Andy Choy is an experienced Angel Investor with a background in product marketing engineering. He holds a BSBA in Electrical Engineering, Computer Science, and Economics from the University of California Berkeley, and an MBA in Marketing and Finance from the University of Michigan. Andy Choy’s track record and professional career include serving as Senior Manager, Strategy and Corporate Development at Equinix. Specific information on his investment focus areas, geographical preference, stage of investment, previous investments, investment check size, and partnership and collaboration styles is not available from the sources searched.

Robert Kocher serves as a Partner at Venrock specializing in healthcare IT and services investments. His geographical focus includes North America and LATAM. Previous investments include companies like Devoted Health and Aledade. Dr. Kocher has a distinguished professional career leading him to roles in the Obama Administration and McKinsey & Company. The investment check size at Venrock ranges based on the stage of the startup. Partnership and collaboration styles reflect a focus on health tech and services investments.

Grand Angels is focused on investing in companies that enhance the economic development of West Michigan and prefer investment check sizes ranging from USD 0.25 to 1.0 million in at least 14 investments. They invest in businesses located in Michigan, with a preference for those in Kent, Ottawa, and Muskegon counties. Some of their previous investments include Micro-LAM and Ocuphire Pharma. The organization targets pharmaceuticals & biotechnology, advanced agriculture, software & IT, advanced manufacturing, B2B, and life science sectors.

Michal Tsur is a Co-founder and President at Kaltura, and also the Co-Founder and Chairperson at Remepy. Michal Tsur’s investment focus areas include industries such as hybrid drugs, media, education, and health. He has a portfolio with companies like Kaltura, Remepy, and Cyota. The investment check size of Michal Tsur is undisclosed. In terms of partnership and collaboration style, Michal Tsur values partnerships to bring innovative solutions to customers and focuses on boosting engagement and collaboration in online meetings.

Mehdi Maghsoodnia is a Managing Partner at Combustion Ventures with an investment thesis focused on early stage consumer and health IT startups. His investment check size ranges from $25K to $1M, with a sweet spot at $50K. He specializes in seed stage investments in SAAS platforms and has an expansive background in the tech industry, holding various executive positions. Mehdi has made investments in diagnostics, consumer health, and data services. He has a track record of holding notable roles at companies such as Vitagene, Livara Health, and Trinity Ventures. Mehdi Maghsoodnia’s geographical preference extends to diverse sectors including AI, consumer internet, and bio-tech. His partnership and collaboration style emphasize building relationships and solving complex challenges through innovative approaches.

Peter Aldrich is an investor with a diverse investment focus area, including technology vendors, corporate strategy, corporate venture capital, and venture capital. He has made investments in companies like Bridj and prefers to invest at the Seed VC stage. His professional background is linked to AEW Capital Management, a real estate investment firm. As an investor, he has worked in collaboration with co-investors such as Andy Ross, Atlas Venture, and FreshTracks Capital. Peter Aldrich has been involved in investments amounting to $4M in companies like Bridj. His investments and portfolio exits demonstrate a strategic and targeted investment style.

Bob Bausmith is a seasoned investor with a deep understanding of the healthcare business. He focuses on companies in the healthcare and technology sectors, serving as a Board Chair at the Hartford Symphony Orchestra. With a proven track record of leadership, strategic planning, and transformational change, Bob’s investment style emphasizes collaboration and mentorship. His investments range from healthcare startups to tech companies, leveraging his expertise and experience to guide portfolio companies towards success. In addition to his role at Hartford Symphony Orchestra, Bob has been actively involved in advising and serving on boards of various organizations, showcasing his dedication to fostering growth and innovation.

TCG is a multi-stage investment firm that seeks to invest in and build these best-in-class companies.

The Column Group is a venture capital firm dedicated to developing biotechnology companies.

Henrik Torstensson is a Partner at Alliance VC, a Nordic venture capital firm that focuses on investing in early-stage tech startups. He has a strong emphasis on investing in applied AI and open finance, believing in the impact of AI on venture capital, growth investing, and startup funding. Henrik’s investment focus areas include digital/physical and data-driven health. He has a preference for Nordic-based health startups and aims to invest more in this sector in 2024. Henrik typically invests in early-stage tech startups and acknowledges the challenges and timeframe for getting returns from investing in startups. He has a successful track record, having been a board member and investor in various startups. Henrik’s partnership style emphasizes being a true partner to founders, prioritizing a direct relationship with founders, and committing to AI for startup investing.

Ijeoma Agulanna@yahoo.com is a Pathologist with a background in various medical fields such as Thoracic Pathology, Anatomic and Clinical Pathology, and Polycystic Kidney Disease. They have pursued degrees in Pathology, Medical Science, Surgery, and Urology Residency, graduating from institutions like New York University and Yale School of Medicine. Ijeoma’s education includes a Doctor of Medicine (M.D.) degree and a Master’s degree. Their career spans roles like Attending Physician and Research Fellowship at esteemed medical institutions in the United States and Brazil.

Matthew McCann is an Investor Relationships Manager at CPI with experience in management consultancy, technology transfer offices, and non-profit life science accelerators. He has a background in biology and bioscience enterprise.

Hatteras Venture Partners is a North Carolina-based venture capital firm that finances biomedical companies.

Jake Knapp is a creator of the Design Sprint, a general partner at Character co-founding a seed fund, investing in startups with capital focusing on big shifts in customer behavior, with investments up to $2 million at the seed stage. He works with startups to find and expand product-market fit using the Sprint method developed at Google Ventures. With a remote-native approach, Character invests flexible across seed stages and supports startups in various fields like AI/ML, enterprise, industry, climate, healthcare, and life sciences. Some of Jake Knapp’s previous investments include Phaidra, HeadsUpAI, House Rx, and more. As a designer, investor, and New York Times bestselling author, Jake Knapp helps startups through the Design Sprint process and co-founded Google Meet. He has coached teams at major companies and institutions like Miro, Slack, LEGO, IDEO, NASA, MIT, and the Harvard Business School. Jake Knapp’s collaboration style emphasizes effective communication and individual thinking while maintaining a collaborative environment

Karan Kochhar’s investment thesis is in health tech (software + data), and he invests in teams with at least 1 co-founder who has had industry experience in healthcare. His investment focus areas include Southeast Asia. Some of his previous investments include Meta, Zoe Nutrition For Life, Quikr, Indian Realty Exchange, Tyroo, and Libero Sports.

Mark Dyne is the Founder and Chief Executive Officer at Europlay Capital Advisors. The investment focus areas of Europlay Capital Advisors include healthcare, mobile, retail, media, and information technology. Europlay Capital Advisors seeks to invest in seed and early-stage technology-based companies. Geographically, Europlay Capital Advisors is headquartered in Los Angeles, California. However, further specific information on geographical preferences was not found. Mark Dyne has been involved in companies such as Sega Gaming Technologies and Virgin Interactive Limited. The specific investment check size was not directly available. Europlay Capital Advisors has a collaboration style focusing on investments in the healthcare, mobile, retail, media, and information technology sectors.

Julius Bachmann recently joined Joyance Partners as a venture partner for the German-speaking market. Joyance Partners is a $23M venture capital partnership focusing on companies delivering or contributing to delightful moments, specifically in the emerging science of happiness. Julius provides pre-seed and seed investments ranging from â¬50K to â¬200K across Europe. Joyance Partners invests in Life Sciences, Consumer Products, Immersive Experience, Voice, and Market-based Education.

Thomas Andrae focuses on investing in tech-forward healthcare entrepreneurs and innovators who are leading the way in biological engineering.

Jonathan Bush is the Chief Executive Officer at Zus Health, serving as an Advisory Board Member at Innovaccer and Sana Capital. He co-founded and was the Chairman of Athenahealth. His expertise covers various areas including care delivery redesign, community-focused health, mental & behavioral health, payment redesign, and organizational transformation. Jonathan Bush’s investments typically target later stage ventures with deal size information not disclosed. He has made previous investments in a variety of healthcare startups. His professional career includes roles as a medic in the U.S. Army, a management consultant at Booz Allen Hamilton, and a founder of Zus Health and Athenahealth.

Aletta Stas-Bax is a prominent investor and Venture Partner at Borski Fund based in the Netherlands. With a focus on ClimateTech/CleanTech, BioTech, Health & Hospital Services, and Health IT at the Seed stage, Aletta has carved a niche in supporting innovative startups in these sectors. Her investment check sizes range from $100K to $5.0M, with a preferred size of $1.5M. Aletta Stas-Bax’s diverse portfolio includes collaborations with notable co-investors such as Bertrand Van Leersum, Dagmar Van Ravenswaay Claasen, Hannah Van Goor, Laura Rooseboom, and Merel Keereweer.

Daniel Marhely is known for his successful ventures as the Founder of Deezer and CEO & Founder of Blackpills. His investment portfolio includes a variety of companies, with an average round investment amount and an active investment strategy evident by the number of investments per year and the distribution across different years. His investments span various verticals and are geographically diverse, with a preference for locations such as Iceland and Norway. Daniel Marhely’s collaboration style and partnership approach are tailored to each company, ensuring strategic support and mentorship for sustainable growth.

Jonathan Greenfield is an Angel Investor. He served as Executive at Life Science Angels.

Grand Ventures is an early stage venture fund investing in seed stage B2B SaaS companies in emerging regions of the US and Canada.

Johanna Liebner is a Senior Investment Manager at Bayern Kapital, with over 20 years of experience in taking care of investments. She is committed to managing investments for the company. Contact email: liebner@bayernkapital.de, Phone: +49 871 92325 – 29.

ISA Ventures is an Iowa’s first multi-stage venture capital studio.

Joseph Whitters is a seasoned investor with extensive experience. He serves as a Board Member at Higher Learning Technologies. Joseph Whitters brings notable public company governance experience in the medical technology and device industries. He is associated with leading healthcare providers like PRGX Global, Inc. and InfuSystem Holdings, Inc. Joseph has a background in venture and growth equity capital, contributing to emerging healthcare companies’ growth. His expertise and experience enhance shareholder value. Known for his public company board roles, Joseph Whitters has prior board experience with various reputable organizations. Recent SEC filings mention his engagements up to 2021-08-30. Mr. Whitters’ collaboration style aligns well with the introspective, relational, and expressive types, with strategies in place to ensure effective collaboration among these styles.

Simon Whitfield is a Co-Founder at Relentless Pursuits Partners, focusing on investments in health, activity, and longevity. He has a commitment to preventive healthcare, disease risk mitigation, and chronic disease management. Simon’s previous investments include a Sport Technology Company called TritonWear. The investment check size for Simon Whitfield at Relentless Pursuits Partners is not specified. His partnership and collaboration styles involve co-founding an angel investment group dedicated to healthy, active living, as well as working with non-profit organizations and receiving awards for his advocacy and mentorship in sport and health.

Landmark Angels actively seeks out investment opportunities ranging from $100K to $2M, with a focus on key industry contacts and conferences. They provide valuable advice and resources beyond capital. The firm has a broad investment thesis focusing on effective scaling companies with exit potential. Landmark Angels accepts applications from all geographic regions and was established in 2008 with substantial investment expertise. Previous investments information is not readily available. The average check size of investments can vary from $100K to $2M. Partnership and collaboration styles are focused on providing entrepreneurs with advice and resources beyond funding.

Edward Van Wezel is the Managing Partner at BioGeneration Ventures (BGV) with a focus on early-stage European biotech companies. BGV’s investment thesis revolves around supporting seed and early-stage pharmaceutical developers working on drugs with convincing experimental data as their basis. Edward van Wezel’s professional career includes serving on supervisory boards of various companies aligned with biotech development. BGV’s investment check sizes range up to â¬105m ($119m) with partnerships involving limited partners like Bristol Myers Squibb (BMS) and others. Edward holds a M.Sc. in chemistry from the University of Utrecht and a M.Sc. in Biochemical Engineering from Delft University of Technology. His collaboration style involves active involvement and support in biotech innovation.

Rafael Damasio, as the Group CEO of Rafael Holdings, focuses on developing novel cancer and immune therapies through investments in clinical-stage oncology companies such as Cornerstone Pharmaceuticals and LipoMedix Pharmaceuticals. The investment thesis revolves around improving and extending the lives of patients with cancer through innovative therapeutics. Rafael Holdings is transitioning to a commercial enterprise from a clinical-stage company with ongoing Phase 3 trials. They are actively seeking a Chief Compliance and Ethics Officer with specific job requirements related to compliance and ethics in the pharmaceutical/biotech industry.

Peregrine Ventures is a venture capital fund for cross-stage investments.

Jay Johnson is a Limited Partner at Bread and Butter Ventures, a VC firm based in Minneapolis, Minnesota. The firm focuses on investing in companies innovating in three core sectors: food/ag tech, health tech, and enterprise SaaS. Bread and Butter Ventures’ investment check size ranges from $100,000 to $5,000,000, with a sweet spot of $1,500,000. Jay Johnson’s previous investments include Structuralapp, H2Ok Innovations, TicketRev, and more. The firm’s key partnership and collaboration styles involve investing in companies that innovate across various sectors and stages, seeking to support startups in the U.S. and Canada.

Joerg Floeck focuses on investments in SaaS, Software, and Consulting at the seed and pre-seed stages, primarily in Austria. He also invests in iOS, Wellness, and Wealth Management at seed and series A stages in Austria and the United States. Additionally, he shows interest in Health Care, Software, and Fitness at seed and angel stages in Austria, the United Kingdom, and Spain. Joerg also focuses on Software, Artificial Intelligence, and Information Technology at series A, funding round, and seed stages in the United Kingdom, Austria, and Italy. Furthermore, his investment areas include Software, Apps, and E-Learning at seed, angel, and pre-seed stages in Austria, Germany, and the United Kingdom. Lastly, Joerg invests in E-Commerce, Software, and FinTech at seed, series A, and funding round stages in Germany, Switzerland, and Mexico.

Jim Bullock is the President and CEO of Zyga Technology. Prior to joining Zyga, he was the President and CEO of Atritech, Inc. and Endocardial Solutions, Inc. He has a strong background in the medical device industry and a track record of creating value for startup companies. Jim’s focus at Zyga is on clinically validated products addressing clinicians’ needs such as the SImmetry™ Sacroiliac Joint Fusion System and GLYDER™ Facet Resurfacing System. His expertise and commitment contribute to the company’s growth.

Keiretsu Forum – MidAtlantic is an early-stage investment group focusing on Series A and B rounds with valuations ranging from $2m to $186m. The fund predominantly invests in sectors like Life Sciences and Technology, and has funded companies including Laurent Pharmaceuticals, FemSelect, and IQure Pharma. With a track record of over $1B invested in 1,000 companies since 2000, Keiretsu Forum showcases a strong partnership and collaboration style by completing due diligence before presentations and obtaining collaborative feedback on investment interest. The forum maintains a unique approach to investment, emphasizing ROI, IP protection, and market disruption potential. Investment check sizes typically range from $2m to $186m, with a focus on ROI, strong management teams, and clear exit strategies.

Franz Wocheslander is a Senior Investment Manager at Bayern Kapital. His investment focus areas include technology for stroke prevention. He invests in early-stage startups and prefers cooperative collaboration. Franz has invested in Curefab and has successfully managed a diverse fund portfolio. His check size ranges based on the startup requirements.

David Healey is a Director at Bain Capital Credit who joined in 2018. He focuses on investments in Private Equity, Real Estate, and Life Sciences. The firm’s Private Credit Group emphasizes providing financing to businesses with EBITDA between $10 million and $150 million. Previous investments led by Bain Capital Credit include supporting the growth of various companies. Healey’s professional career includes serving as an Assistant Vice President at Golub Capital. The investment check size by the Private Credit Group of Bain Capital Credit has been approximately $2 billion, investing in middle-market and private equity-backed companies. David Healey follows a collaborative style within the team at Bain Capital Credit.

Mahendra Matta is an angel investor at Angel Physicians Fund, passionate about advancing healthcare through advanced technology. He has invested in startups such as Foldax and Aria CV. Dr. Matta focuses on healthcare advancements and has a track record of supporting innovative healthcare startups.

Andrew Davis is a Director of Information Technology at Kindering, where he manages an IT department. He is also the Founder of SpeakingGigs.pro and a Keynote Speaker & Best-selling Author at Monumental Shift. Andrew Davis has a proven record as a business leader, author, and speaker. He has a strong focus on collaboration and partnership styles, leveraging his expertise to guide business leaders in growth strategies. Andrew excels in creating compelling content and engaging audiences at various events, ranging from plumbers to physicians. Through his speaking engagements and writings, he positively impacts business growth and transformation.

Joanna Soroka is a Principal at Hitachi Ventures with a focus on investing in Smart Cities/UrbanTech, Security, Robotics, Cybersecurity, EnergyTech, TransportationTech, IoT, Data Services, and more at Series A stage. She has a current fund size of $150M and a typical investment range of $100K to $5.0M. Her sweet spot investment is around $1.5M. Joanna has a track record of managing technology conglomerate ventures and corporate funds, primarily in the DACH region, providing strategic support to startups and collaborating with other top investors such as Ankesh Madan, Galina Rachenkova, Jan Marchewski, Pete Bastien, and Stefan Gabriel.

Thomas Urban is an Investment Director at Intel Capital specializing in mobile and SoC oriented investment opportunities. His investment range is $1M – $20.0M, and he has invested in companies like Prieto Battery. Thomas Urban’s past associated roles include Customer Engineering at Intergraph. Additionally, Thomas Urban is part of the Intel Capital team with other members like Alexandra Farmer, Ameet Bhansali, Andy Fligel, Anthony Lin, and Arun Chetty. Thomas Urban’s professional career and track record details are not explicitly provided on the public sources accessed.

Mark McDonnell is the Managing Director, Chief Financial Officer, and Chief Administrative Officer at ARCH Venture Partners. ARCH Venture Fund focuses on early-stage biotechnology companies. The firm’s geographical preference is not specified. Mark McDonnell has a track record in financial management, board membership, and limited partner strategies. Information about his previous investments is limited. The investment check size is not explicitly mentioned. His partnership and collaboration styles are not outlined on the website.

Himalaya Rao-Potlapally is the Managing Director at Black Founders Matter, a VC firm focusing on Black founder-led companies. The fund invests in sectors like gaming, healthtech, and consumer products. Previous investments include A Kids Book About. Himalaya’s investment check size ranges from $50K to $150K with a sweet spot of $100K. The fund’s current size is $10M. She values fair and equitable investment empowering people of color. The partnership style is inclusive, seeking to connect portfolio companies with industry leads and acting as a connector fund for larger portfolios seeking diversity.

Paul Sethi is a seasoned investor with a focus on AI, digital bioprocessing, and health technologies. His previous investments include UniKey, SmarterX, and Mealco in the Business/Productivity Software and Media sectors. Dr. Sethi is a prominent orthopedic surgeon known for his sports medicine expertise, serving in various medical societies. His investment check size ranges from $300K to $600K, with a sweet spot at $450K. Dr. Sethi’s collaborative style aligns with introspective and relational approaches, emphasizing deep work, human connections, and visual engagement.

Fred Cohen is the Co-Founder and Senior Managing Director at Vida Ventures, active in roles as the Chairman of Monograph Capital and Ascend Gene & Cell Therapies. His previous experience includes being a Partner at TPG and Managing Partner of TPG Biotechnology, focusing on venture efforts in biotechnology and life sciences. Fred held positions like CEO of Management Analytics, President of Keiretsu Forum Pebble Beach, and member of Fearless Security. He served as an SVP and Director of Municipal Bond Trading at AllianceBernstein for 25 years, playing a key role in growing the municipal bond money manager into a leading firm with $44 billion under management. Fred is a respected industry figure and has also been recognized for his knowledge by being named to the MSRB Investor Advisory Group. He holds certifications including CPA (Inactive) and various Series certifications. Fred’s collaborative style involves setting and implementing investment policies, working with various vendors for market efficiencies, and actively engaging with industry experts and organizations.

Wolfgang Reitzle is an investor who actively engages in acquiring stakes in startups, including biotech companies like Tomorrowlabs GmbH. His investment focus areas range from biotech to corporate boards and non-profit organizations. Reitzle’s geographical preference is emphasized in efficient operations in Europe, particularly in Germany. Previous investments involve rounds like Angel – II and Seed Round, showcasing diverse investment interests. With a track record of 5 investments and a collaborative approach, Reitzle demonstrates a hands-on style in his investments, including involvement in wine and oil production in Italy.

Sandro Cornella is an Angel Investor with focus areas including Artificial Intelligence, Big Data, CRM, Information Technology, Life Science, and Machine Learning. He has invested in Veezoo and typically provides personal money for promising companies in exchange for equity. Sandro Cornella’s investment check size is not explicitly provided on the sources found.

Harris Barton, the Founder and Managing Director of H. Barton Asset Management, focuses on investments in software, information technology, analytics, SaaS, and cloud computing. His investment check size averages around $25 million per round. Harris Barton has a track record as a former football player with the San Francisco 49ers, earning recognition with two All-Pro selections and one Pro Bowl appearance. In his investment portfolio, Barton has invested in companies like TeamSnap, Spectrum Labs, and Uplevel. He has been involved in Series A investments like Kogniz. The geographic focus of his investments spans across various regions. Harris Barton’s collaboration style emphasizes understanding the three common styles: introspective, relational, and expressive, to ensure effective partnerships and collaborations.

Mitch Semel, an executive with expertise in television programming, is known for his involvement in comedy ventures and media strategy. With a background in launching new comedy initiatives, Mitch has contributed to the entertainment industry through roles such as general manager of The Onion and as a programming head at Comedy Central. His professional career showcases a history of collaboration and innovation in creating video platforms and network programs. Currently, as an Advisor at Burst.it, Mitch leverages his experience to support the development of cloud-based infrastructure and proprietary software that enhances content acquisition, media curation, and distribution processes. His collaborative style focuses on improving workflow efficiencies, reducing costs, and creating new monetizable media inventory, ultimately benefiting partner companies, brands, and broadcast stations across the US. Specializing in personalized, engaging, and authentic content, Mitch Semel’s partnership approach emphasizes collaboration, innovation, and a mobile-centric focus.

Jinglan Wang is an angel investor based in California, United States. She has a focus on investing in Blockchain Technology, High Tech, and other sectors. Her top locations of investment include Australia, Serbia, and more. Jinglan Wang has made investments in companies like Connext, Tenderly, and others. She is the founder of Optimism, a company located in New York City that provides a blockchain-based platform for optimistic rollup and smart contract execution. Jinglan Wang’s total funding amounts to $175M, with a current stage of Series B. Her collaboration and partnership styles are not explicitly mentioned, but her investments reflect a keen interest in innovative and emerging technologies.

Sacramento Angels is a prominent angel investor group based in Sacramento, California. They focus on investing in startups with the potential to raise significant funds in the near future, with a special interest in various sectors including biotechnology, software, healthcare, energy, and pharmaceuticals. The group primarily invests in early-stage companies, engaging actively in supporting entrepreneurs and startups. Sacramento Angels are known for their preference for local companies and have a track record of investing in innovative startups. Their investment check size typically falls below $1 million, and they collaborate closely with entrepreneurs, providing mentorship and strategic guidance for growth.

Patrick Dietzen is an angel investor who has backed several early stage tech startups in various domains, such as biotech, blockchain, and cybersecurity. As an entrepreneur and executive with a background in tech venture operations, he has founded and sold companies like Sirigen and Nanostar. Currently the Director of Operations at Orchid Labs and VP Business Development at SaurikIT LLC, Patrick brings over a decade of expertise and a strong network to the tech industry. Based in Santa Barbara, California, his investment focus includes biotech, cryptocurrency/blockchain, and technology/web/app sectors. His partnership and collaboration styles emphasize building innovative businesses.

Rick Holton, Jr. is a General Partner at FINTOP Capital, a venture capital firm that specializes in investing in B2B service-enabled SaaS and software companies in the FinTech space. He has a focus on serving in the Tech, Life Sciences, and FinTech sectors. Rick’s previous investments include companies like AllWork, InsurePay, Denim Social, Bridge Financial Technology, DealCloud, and Covercress, among others. He typically invests in seed stage companies and has made personal investments in Rovertown. The investment check size for his partnerships ranges from $2.5 million to $5 million. Rick is known for serving on the boards of various companies and being actively involved in civic engagements.

Ozan Polat is an investor with Vine Ventures, focusing on novel approaches to conscious health & wellness. He co-founded Dezentrum, a think tank researching positive future scenarios for a digitized society. With a passion for innovative societal approaches, he joined Vine Ventures. Vine donates 50% of profits to mental health and collaborates with Othership, a mental health community. Representative companies include Ryan Zurrer. Ozan’s investment check size, stage of investment, and partnership style were not explicitly mentioned on the website.

Nurture Ventures focuses on working with start-up and early-stage businesses seeking investment finance in the £100k to £1m range. They actively seek ideas in the technology and healthcare sectors. Some of their previous investments include LunaJoy, VeeOne Health, and HuLoop Automation within the Clinics/Outpatient Services and Business/Productivity Software industries.

Mark Carthy is the Managing Partner of Orion Equity Partners, LLC, a healthcare venture capital firm co-founded by him. Orion focuses on investments in companies developing products addressing major medical or healthcare industry needs. The firm’s geographical preference is not specified. Orion Healthcare Equity Management primarily invests in health-related ventures. The stage of investment by Orion is early, with a focus on the health sector. Previous investments by the firm include companies such as Solexa and PowderMed. However, specific investment check size and partnership and collaboration styles are not readily available.

Anja Konig, as the Global Head of Novartis Venture Fund, focuses on developing novel therapeutics and platforms, with particular interest in patient solutions and life sciences opportunities. Her investment check size involves rounds for companies like Epsilogen and Splice Bio. Anja Konig’s previous investments span pharmaceuticals, biotech, and medical devices. With a background at McKinsey, she has facilitated successful exits for companies like Heptares Therapeutics and Covagen. Anja Konig collaborates through entrepreneurship, venture philanthropy, and impact finance, aiming to create innovative solutions for societal challenges and promote market-led sustainable development.

Matt Sanford is primarily involved in evaluating mid-to-late stage biotechnology investment opportunities. His investment check size typically ranges from $200K-$500K in initial financings. Seattle and the surrounding regions are his preferred geographical areas for investment. Matt has a track record in managing large asset pools and has professional experience in fixed income. He is associated with investment funds such as Maveron, PSL Ventures, and WRF Capital, among others.

Amin Merchant is an angel investor and CEO of Key Venture with a strategic focus on fintech, biotech, and fusion energy sectors. Their investments range between $500K to $1.5M per venture, targeting seed to Series A stages. Key Venture invests in breakthrough technologies globally, with a keen interest in Turkish fintech, US biotech, and fusion energy innovations. Amin Merchant is known for his successful track record and professional acumen as an entrepreneur and executive. The partnership and collaboration style of Key Venture emphasizes joint ventures, partnerships, and alliances to drive business growth and innovation.

Josh Spear is an Angel Investor known for his fresh perspective and marketing expertise. He has made investments in companies like Hullabalu, Mouth, Dragon Innovation, Expa, MakeSpace, StyleSeat, EpiBone, Hipcamp, Cover, and Atlas Obscura. He focuses on Biotechnology, Restaurants, Hotels and Leisure, Application Software, Private Equity, and Entertainment Software sectors.

Steve Poland is an investor with an investment thesis focused on connected hardware for smart homes, fintech for emerging market consumers, and minority-led startups in the US. His investment focus areas include undervalued stocks, quality stocks, robotics, hydrogen, and gold/silver. He operates in early to mid-stage investments and has connections in companies like Prime Photonics LC, Virginia Tech Foundation, Inc., and more. Steve Poland’s collaboration style integrates introspective, relational, and expressive approaches to maximize effectiveness.

Keith Smith is the Co-founder and CEO of Payability, a FinTech company that has provided over $6 billion in financing to eCommerce sellers. Payability focuses on eCommerce financing solutions, offers friction-free financial products, and has a track record of driving rapid growth in the industry. Keith Smith’s investment check size at Payability has been significant in financing over $6 billion in growth capital to numerous businesses. His professional career includes roles as Co-Founder and CEO of Payability, Board Member at Influence Mobile, and Co-Founder and CEO at BigDoor Media. Keith Smith’s partnership and collaboration styles are evidenced through his leadership at Payability in creating flexible financing solutions and fostering dynamic team growth.

Mark Schiefelbein is a visionary Director of Football Administration/Communications at Green Bay Packers. Mark takes a data-driven approach, focusing on preparing early stage startups for initial investment rounds, with a geographical interest in fostering cross-cultural exchanges. His track record showcases a successful tenure at Green Bay Packers. The investment check size and partnership styles are not available.

Mark Burish is a co-founder of a venture capital organization and also a board member at BrightStar Wisconsin Foundation. He has a background in law and serves on investment committees. Mark is known for his active involvement in handling pain and headache-related research. His professional career involves specializing in neurology and pain management. While specific investment focus areas and previous investments were not available, Mark’s involvement in venture capital suggests a keen interest in supporting startups. The stage of investment and check size were not directly accessible. Geographically, Mark is associated with the neurosciences department at the University of Texas Houston, focusing on headache studies. His partnership and collaboration styles reflect a research-oriented approach, engaging in lab-based studies with researchers to analyze circadian and neurophysiologic aspects of headaches.

Stephanie Jin is an investor at Avestria Ventures with a focus on early-stage women’s health and life science companies. Her investment thesis centers around impact investing in female-driven startups. Stephanie prefers to invest in companies prioritizing women’s health, aiming to create a positive impact through entrepreneurship. While her geographical preference is not specified, she is actively involved in the innovation and funding of medical startups that prioritize women’s health. Stephanie Jin’s track record includes cofounding Avestria Ventures to support startups in the digital health sector. She seeks to provide impact-driven investments, with check sizes that can range based on individual funds raised. In terms of partnership and collaboration styles, she is known for her strong support for female entrepreneurs and digital health initiatives.

Andreas Jenne is the CEO of Ventura Biomed Investors, with a focus on the European Union (EU) and Europe, Middle East, and Africa (EMEA) regions. He has current roles as CEO at Ventura BioMed Investors and Co-Founder & Managing Director at SciRhom. Andreas Jenne has a track record of past experiences including being the CEO at RSP Systems A/S. His investment check size and partnership style could not be determined from the available information.

Rajit Malhotra is an investor with a deep expertise in healthcare and experience in industries like Biopharma, Artificial Intelligence, Energy, and Real Estate. He has a background in advising Fortune 500 companies, specializing in healthcare, public sector, and EPNG practices. Rajit is the Executive Chairman of AmperSand Biopharmaceuticals and Tour Engine. His investments are focused on advanced technologies in therapeutics, medical devices/diagnostics, and digital health, with a funding range of $50-$150k per project. He is actively involved in organizations like UCLA Technology Development Corporation and the CAFAM Museum, displaying a commitment to civic and charitable projects. Rajit Malhotra’s approach involves supporting projects with significant commercial potential, promoting collaboration and the commercialization of UCLA-owned technologies.

Lavni Ventures is a venture capital firm.

James Altucher is known for his perfect investment strategy focusing on identifying industries experiencing exponential growth, investing across all stocks in that industry, and researching for maximum returns. His previous investments include MobSoc Media, and he is highly creative in fueling his successful career, having founded over 20 companies as an entrepreneur, hedge fund manager, and venture capitalist. Altucher typically invests 1-2% of his net worth in any one investment, preferring private companies over public ones. While specific collaboration styles are not detailed, Altucher values partnership and collaboration, as seen in his interactions and podcasts.

LYZZ Capital is a venture capital firm specialized in seed, early, and expansion stage venture investments.

University City Science Center focuses on investing in health equity startups led by diverse founders in the STEM community to address health inequities for underserved populations. They have a track record of investing over $4 million in 43 companies in the region, with a focus on mobilizing capital in Greater Philadelphia. The VP of government and capital engagement, Heath Naquin, brings experience in VC and government liaison. Their investment thesis revolves around supporting startups addressing health disparities, particularly in the field of health equity.

Soumitra Sengupta is a Venture Partner at Elevate VC located in Kirkland, Washington. His investment range is $25K – $2.0M, with a sweet spot at $1M. Soumitra focuses on sectors such as Pre-seed Biotech, Seed Biotech, and Series A Biotech. He has recently invested in Pre-seed Biotech startups with co-investors like Ben Nahir, Christopher LaMothe, Dipty Desai, Donn Dimond, and Giovanni Magni. Soumitra Sengupta’s collaboration style includes working with investors such as Ben Nahir, Christopher LaMothe, Dipty Desai, Donn Dimond, and Giovanni Magni.

Jan Vichr is a Founding Partner at FORM Venture focused on tech-enabled health, wellness, and longevity companies. His investment check size usually ranges from $250K to $5M. Some of his previous investments include Canopei, Twelve Fifty, and other tech-enabled startups. Jan Vichr has a collaborative approach to partnerships, understanding and leveraging different collaboration styles like introspective, relational, and expressive to enhance teamwork.

Adam Sackstein, the Founder and Medical Director of Innovative Spine and Pain LLC, New Jersey, is a respected healthcare professional with a wealth of experience. As a Co-Founder and Managing Member of Physician Management Services LLC, he demonstrates leadership in healthcare management. With significant roles such as President and Vice President at the NEW JERSEY SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS, Adam has a strong background in pain management. He has served on the Executive Board of multiple healthcare organizations, including The Surgery Center at Hamilton and Premier Surgical Center, showcasing his diverse expertise. As Northeast Medical Director at Prospira PainCare, Adam has enhanced his medical leadership skills. His impressive career includes positions as CEO of VasoPrep Surgical and Owner of The Pain Management Center. Adam’s commitment to healthcare excellence and his extensive involvement in various medical organizations underscore his dedication to the field.

Frederik Groenewegen is a Co-Founder and General Partner of 415 Capital. He specializes in investing in innovative medical technology companies, with investments in companies such as Supira, CorFlow, Cardiac Success, Aktiia, Distalmotion, R3 Vascular, and TRiCares. Frederik has a strong track record and professional career, with experience in business development and finance from roles at Regis Medical and HSBC. His investment check sizes typically range from $250K to $5M per company. In partnerships and collaborations, Frederik emphasizes supporting mission-driven founders and early-stage companies to foster growth and success.

OTV is a global digital health venture capital fund with offices in Tel Aviv, Israel and Shanghai

Stefan Peters is a managing director at Holtzbrinck Digital GmbH with an investment thesis focused on digital businesses in Science, Education, Content, and Health. He invests in startups post-proof-of-concept, supports later-stage companies, and acquires profitable businesses with potential for leadership. Stefan has previously invested in gutefrage.net, pflege.de, and netdoktor. He has a flexible investment check size and partners with founders and management teams to provide strategic and operational advice for success. His investment focus areas include AgTech (Series B), Food and Beverage (Series B), E-commerce (Series B), and Digital Health (Series B).

Stefano Galiasso is a Senior Associate at Energy Capital Ventures with an investment range of $100K to $5.0M. His sweet spot is $1.5M. He focuses on investments in Pre-seed EnergyTech, BioTech, ClimateTech/CleanTech, Marketplaces, and FinTech sectors. Stefano’s recent investments include Pre-seed EnergyTech. He collaborates with investors like Jeffrey Yingling, Julie Greco, Katie Dabbar, Mark Yingling, and Ray OâConnor.

Gabriela Ecco is a Senior Associate at ND Capital, a venture capital firm investing across disruptive technologies in life, physical, and data sciences. ND Capital’s investment thesis revolves around the convergence of scientific disciplines leading to breakthroughs. They focus on nurturing their portfolio companies by fostering creativity, intellect, and passion while aiming to build long-lasting impactful businesses. With a third fund of $335 million fully invested and a fourth fund in progress, ND Capital invests across sectors and technologies at various stages. They operate in the United States and Europe, with teams strategically placed in Silicon Valley, Switzerland, and the Cayman Islands. Gabriela Ecco’s track record includes serving as a board observer for companies like EVIR Therapeutics, Vandria, and Osasuna Therapeutics. While specific information on investment check size and partnership styles is limited, her involvement with ND Capital signifies an active role in fostering growth and innovation within the venture capital space.

Lex Liao, Co-Founder and Managing Partner at New Highlands Ventures, is an Angel Investor focusing on industries such as Biotechnology, Social Networking, Healthcare, Social Commerce, Consumer Internet, Financial Services, Energy & Clean Tech, and Cybersecurity. His investment thesis centers around the machine economy with a focus on Fintech, Web3, and AI. Lex’s stage of investment primarily targets Seed Rounds. Some of his previous investments include Example company Inc ($1,000,000 in Seed Round), Company & Company (â¬11,000,000 in Series C funding), and a Seed round A investment of $524,000. His track record showcases a commitment to emerging technologies and startups in various sectors.

Brian Model, as a Managing Partner at Stonehenge Growth Equity Partners, is focused on growth equity investments in companies primarily in the biotechnology and healthcare sectors, with a typical investment range of $1 – $5 million. Stonehenge Growth Capital, where Brian Model serves, tends to invest in startups that are 6-10 years old, with increased activity seen in 2017.

Sabrina Stöckl is an Investment Manager at b2venture with a focus on early-stage startup investments in the healthcare and life sciences space. She supports portfolio companies at the earliest stages with unwavering dedication and unique expertise. The team at b2venture is seen as entrepreneurs’ long-term partners, emphasizing a supportive and collaborative approach. Their common phrase is ‘Together we fly,’ showcasing a collective attitude towards investment and growth. The diverse team at b2venture, including partners, principals, and analysts, reflects a wealth of experience in investment activities.

LaunchBio is a nonprofit organization connecting life science entrepreneurs and investors with knowledge, capital, and talent. They operate in cities across the United States like Durham, San Diego, and Dallas, offering programs such as ‘Invest in Cures’ and ‘Investor Connect.’ LaunchBio facilitates connections between investors and early-stage life science entrepreneurs through events like the NextGen VC Forum. They are funded by sponsors and partners supporting the life science and healthcare innovation ecosystem, with a focus on strengthening ecosystems and increasing connectivity for entrepreneurs.

James Currier is a Co-Founder and serves as a Managing Partner at NFX Guild, a VC firm investing in pre-seed and seed stage startups. The firm focuses on market-transforming companies in industries such as BioGaming, Generative AI, Proptech, Space, Fintech, Marketplaces, and Crypto. Their geographical preferences include Silicon Valley, Israel, Europe, and LatAm. Some of their notable previous investments include Rec and Overmoon. James Currier has an extensive track record, having co-founded multiple successful ventures. The investment check sizes at NFX Guild vary based on the startup and can range from tens of millions to seed-level amounts. The partnership and collaboration style at NFX Guild involves backing exceptional Founders and providing support to build successful businesses.

Knoll Ventures is an early-stage venture capital firm that invests in B2B technology enabled companies prior to the Series A round.

Aaron Patzer is known for his successful entrepreneurial ventures, including founding Mint.com and later Vital Software in the healthcare industry. His investments focus on healthcare and AI-driven startups. His previous successful exits include the acquisition of Mint.com by Intuit for $170 million. Aaron’s check sizes are not specified, but his investments align with innovative solutions and disruptive technologies. In his career, he has prioritized creating solutions to real-world problems, exemplified by Mint.com’s success. Aaron’s partnership and collaboration styles emphasize simplicity and innovation, as seen in his leadership at Vital. His career reflects a track record of building successful ventures and transformative technologies.

The Isaac Organization is an international private investment firm with a focus on long-term investments in companies with strong management. They invest in urban development projects, medical, and Federal Government-lease real estate properties. The organization operates worldwide and collaborates with companies to create value through growth and superior performance. Their track record includes strategic investments in companies like Precision Metal Works, Flooring Liquidators, and a Pennsylvania Steel Company. The check size of their investments is not specified on their website.

Alexandra Bause, a Venture Partner at Apollo Health Ventures, focuses on improving health and medicine with an investment thesis in the aging sector. Her geographical preference includes offices in Berlin, Germany, and Boston, Massachusetts, USA. Her track record includes co-founding Apollo in 2017, specializing in biopharma strategy and molecular aging research. She has a background in pharmacy and Harvard Medical School studies. Previous investments are in Series B Biotech and she collaborates in early-stage ventures aiming at molecular-level biotech startups targeting aging processes.

PrimeCrowd, now operating as Gateway Ventures, is a VC investor focusing on early-stage and growth financing in various sectors like software, information technology, financial services, AI, and machine learning. They have made 11 investments in 9 portfolio startups, with an average deal size of $2M. PrimeCrowd has financed 22 startups with over â¬12M in deal volume and boasts a funding rate of 80%. Their check size starts at â¬10,000, and the network includes over 1,000 investors. Successful investors like Johannes Siller, Markus Ertler, and Heinrich Prokop are part of their investment community. PrimeCrowd is located in Austria and is interested in sectors such as IT, digital, financial services, digital marketing, energy, and biotech. They facilitate collaborations between high-growth startups and their investor community.

Brightstone partners with bold entrepreneurs creating innovative & disruptive companies in the technology and life science sectors.

Eric Ries is the chairman of the Long-Term Stock Exchange with a focus on fostering socially responsible investing. He invests at the angel stage and is active in the Life Sciences & Healthcare, Consumer Products & Services, and Business Services sectors. His geographical preference is not specified. His investments range in various companies including Aug X Labs, DoubleLoop, and Autio. Eric Ries has a notable track record in the Lean Startup methodology and has transitioned into a full-time commitment to the Long-Term Stock Exchange. The investment check sizes are not explicitly mentioned, but he has been involved in collaborative projects and partnerships within the Lean Startup community.

Sander Slootweg is a seasoned investor and Managing Partner at Forbion. With a background in co-founding ABN AMRO Capital Life Sciences, Sander has established a remarkable track record in the investment field. He specializes in life sciences investments and has been instrumental in the success of Forbion since its inception in 2006. Sander’s investment focus areas include building companies at an earlier stage of development, as evidenced by his involvement in portfolio companies like Azafaros, NewAmsterdam Pharma, NorthSea Therapeutics, Oxyrane, and Replimune. His partnership and collaboration style are marked by a hands-on approach, serving on the boards of various companies to drive growth and success. Forbion’s recent fundraising success of â¬1.35 billion across two funds underscores Sander’s commitment to taking leading positions with investment sizes of up to â¬70 million per deal. Operating in the EU and NA regions, Sander Slootweg demonstrates a keen eye for transformative bio-pharmaceutical opportunities and a proactive investment strategy that positions him as a key player in the industry.

David Litwack is an Angel investor affiliated with Alliance of Angels based in Seattle, Washington. His investment focus areas include Hardware, Retail, and BioTech at both Seed and Series A stages. With an investment range of $500K to $1.5M and a sweet spot of $1M, he operates within a $100M fund size. David Litwack’s previous investments include contributions to startups in the Hardware, Retail, and BioTech sectors. He is known for his collaborative and customer-focused approach, emphasizing integrity in his partnerships. His investment check size typically ranges from $500K to $1.5M.

Brian Matthews is a Co-founder and General Partner at Cultivation Capital. He has a background in mentoring software technology and geospatial technology start-up founders. Brian has been involved in founding and selling various technology companies and serves on the boards of multiple companies. He is also a co-founder of the SixThirty FinTech Accelerator. Cultivation Capital focuses on Life Sciences & Health Tech, Software & IT, and Agriculture & Food Tech. Brian’s check size for investments ranges from 1-5 million dollars.

Member Ronald Zink, at Alliance of Angels, is an angel investor specializing in AgTech, SMB Software, IoT, and Cloud Infrastructure at both Seed and Series A stages. He typically invests between $500K – $1.5M per company, with a sweet spot of $1M. Ronald Zink draws on a strong professional background, including experience as Principal Owner at Think Zink Consulting, Agile Transformation Coach at Danfoss Drives, and roles at ameriCold Logistics and Ruiz Foods. His certifications include Lean Six Sigma Master Black Belt and Certified Quality Engineer.

Tom Meade, an investor at Anterra Capital, primarily focuses on groundbreaking ideas in food and agriculture. Anterra Capital specializes in early-stage investments, particularly in entrepreneurs leveraging technologies underused in F&A. Tom Meade has been involved in previous investments such as Enko, which received funding from the Bill & Melinda Gates Foundation and Nufarm. His investment check sizes align with the sector’s needs, targeting companies in food, agriculture, health, nutrition, and wellness across Europe and North America. Anterra Capital’s partnership and collaboration approach may involve cooperative collaboration, competitive collaboration, directive collaboration, facilitative collaboration, and delegative styles.

Oli Strong is a strategic investor focusing on connecting startups with the right resources. His investment thesis emphasizes the value addition to the portfolio through well-defined strategies, leveraging existing strengths, and industry opportunities. Oli Strong invests in startups at various stages, including pre-seed, seed, Series A, and Series B, with a keen eye on due diligence and market potential at each stage. His geographical preference is global, with a history of advising global businesses and startups. Oli Strong has a track record in leadership roles, demonstrating a strong professional career in research, innovation, and product development. He typically provides investments ranging from $250K to $5M per company, supporting startups in achieving their growth objectives. In terms of partnership and collaboration styles, Oli focuses on effective collaboration that brings mutual benefits and fosters a collaborative work culture.

Harry Jacobson is a Co-founder and Partner at TriStar Technology Ventures, a venture capital fund based in Nashville, Tennessee. TriStar Technology Ventures focuses on healthcare services and supplies, healthcare technology systems, pharmaceuticals, biotechnology, and life sciences industries in the United States. The fund targets early-stage investments in these sectors with a geographical preference for the United States. Previous investments by Harry Jacobson’s fund include innovative companies in the healthcare sector. The check size for investments made by TriStar Technology Ventures is not explicitly provided on the available sources.

Steven Yaskin is the CEO of Health Gorilla and a Co-Founder of the company. He has a track record that includes roles in companies such as Queplix Corp., Priority Consulting, Inc., and Pfizer. Yaskin is actively engaged as a Venture Partner at Scale-Up Venture Capital, an Official Member of Forbes Technology Council, and an Entrepreneur In Residence at F50. He holds a MS in Physics from Drexel University and dual BS degrees from Brooklyn College and Universitatea TehnicÄ a Moldovei. Health Gorilla has raised $15M in Series B financing and connects patients, healthcare organizations, and medical service providers for data exchange.

DevOps Angels is an angel group that focuses on early investments in developer-facing startups, including dev tools, DevOps, and databases. Some of their previous investments include InfoQ, Sourcegraph, Zero Turnaround, Sauce Labs, WSO2, and Codenvy. Their check sizes are typically smaller, ranging from $10,000 to $500,000. The group emphasizes collaboration and cooperation in their investment approach.

Pamela Marrone is a pioneering entrepreneur with a focus on sustainable agriculture through bio-based products for pest management and plant health. She founded Marrone Bio Innovations (MBI) in 2006 and took the company public on NASDAQ in 2013. MBI offers award-winning products for various agricultural markets. Dr. Marrone has a notable track record in the agriculture biotechnology sector, with successful ventures like AgraQuest. Through AgraQuest, she was able to secure a significant acquisition by Bayer Crop Science for $425 million. Pamela Marrone’s investment check size has been substantial, as demonstrated by AgraQuest’s acquisition deal. Her partnership and collaboration styles emphasize bringing together innovative minds to advance sustainable agriculture.

Steven Welch is an accomplished investor with a focus on Series A Biotech investments. His investment check size typically ranges around $500,000. With a background in entrepreneurship and successful ventures like Mitos Technologies and DreamIt Ventures, Steven Welch demonstrates a hands-on partnership style by co-founding and leading various organizations. His track record includes founding and selling successful companies, such as KinderTown. Based in Austin, Texas, Steven Welch’s geographical preference aligns with his local base. He has a history of investing in Seed BioTech startups and prefers a collaborative approach, valuing well-prepared interactions and face-to-face alignment.

Thijs Cohen Tervaert is a Director at INKEF Capital with a focus on Healthcare and ICT/New Media/FinTech. He has been involved in investments like TargED Biopharmaceuticals. INKEF Capital prefers to invest in the Netherlands, aiming for target equity checks of USD 15-50 million. Their collaboration style focuses on cooperative collaboration, competitive collaboration, directive collaboration, facilitative collaboration, and delegative collaboration.

Samantha Keil is an investor at Monroe Capital with an investment range of $2.0M – $15.0M and a sweet spot of $8.5M. She is associated with various investors at Monroe Capital like Alex Patil, Andrew Eck, Andy Kiehl, Casey Vercauteren, and Chase Silverman. Samantha Keil’s current fund size is $1.33B, and she focuses on sectors such as FinTech (Seed), FinTech (Series A), FinTech (Series B), and the Midwest region. Samantha Keil’s partnership and collaboration style involve working with a network of top investors in the startup industry to explore investment opportunities.

HNW Angel invests in software companies at the infrastructure-layer specializing in AI/ML, platforms, marketplaces, APIs, fintech, and enterprise software. They are industry-agnostic except for Bio/Med/Health, Climate, Cannabis, and GovTech. Their geographical focus is North America (USA or Canada) with a maximum post-money valuation of $25 million USD. Their check size ranges from $100k to $350k USD. HNW Angel looks for talented teams with strong domain expertise, startups with signs of early traction and revenue, early-stage startups up to Series A, capital-efficient startups with a path to profitability, and companies with meaningful and sustainable differentiation. They invest in startups with unique market differentiation and aim for long-term profitability and sustainability.

Thomas M. Shannon is a prominent investor with a diverse portfolio and a strong professional background. As the CEO of Prodesse, a biotech company, from 2001 to 2009, he has demonstrated leadership and expertise in the industry. With senior management roles in various organizations, Mr. Shannon has a proven track record of successful investments. He serves as a board chairman and lead investor in multiple companies, showcasing his strategic decision-making and financial acumen. His involvement in various boards and committees in Wisconsin highlights his commitment to the local business community. Recognized for his contributions, Mr. Shannon brings a wealth of experience to his investments. His partnership and collaboration styles are characterized by a hands-on approach and a focus on fostering growth and success. For more information, you can contact him at GeneralInfo@brightstarwi.org or visit him at 710 N. Plankinton Ave., Ste. 340, Milwaukee, WI 53203.

Robert Stringer is the Founder and Principal Investor at Crimson Seed Capital, focusing on health and wellness. He supports startups with big ideas and solid business plans. Previous investments include health services, pharmaceutical, and medical device companies. His check sizes average around $100k. Stringer’s investment philosophy places emphasis on good-for-you consumer products, e-commerce, and health-related services. Crimson Seed Capital collaborates with businesses founded and led by women entrepreneurs. Contact: Address – 2 Battery Wharf, Suite 2510, Boston, MA 02109, Phone – 617.797.6154

Virtual Angels Network, a completely virtual national group of angel investors, focuses on investing in early-stage businesses across various sectors such as Life Sciences. Its members seek to invest in companies all over the country. The network has a track record of successful investments and is composed of experienced MBA investors. Virtual Angels Network follows a partnership and collaboration style that encourages networking, mentorship, and potential partnerships or funding opportunities. The network invests in companies at their seed stage, with investment check sizes typically ranging between $25,000 to $100,000 per startup. Although the geographical preference is not specified, the network accepts applications from early-stage businesses nationwide.

Rolf Ehrnström is a Partner at Ventac Partners with extensive experience in the Life Science Industry. He focuses on early-stage investments in pharmaceuticals, biotechnology, life sciences, and health technology. Rolf has more than 30 years of scientific, technical, and commercial experience from small to large lifescience and diagnostics companies. His previous assignments include Chief Scientific Officer at Immunovia AB and Boardmember at SAGA Diagnostics AB. He holds 72,617 B-shares in a company. Rolf’s collaboration style emphasizes introspective and relational approaches to partnerships, seeking common ground and strategies for effective cooperation.

Marco Pieters is the Founder and Managing Partner at Slingshot Ventures with 20+ years of investing experience. He focuses on B2C and B2B2C businesses, and has invested in early growth companies. Previous investments include companies like Boldking, Swishfund, Temper, Eat Casper, and Eatch. Marco Pieters is known for his hands-on approach with entrepreneurs and enjoys kitesurfing, skiing, golf, and tennis. The investment check size at Slingshot Ventures varies, including investments in healthcare, data analytics, and retail sectors.

Brad Purdy serves as COO at ContextMedia and Partner at Jumpstart Ventures. Jumpstart Ventures focuses on high-potential tech companies led by Black, Latino, and female entrepreneurs in Ohio. Their technology focus areas include B2B software and healthcare. Jumpstart Ventures invests in pre-seed and seed-stage companies with $500K-$2M rounds. Brad Purdy’s investments align with this focus. The investment check size at Jumpstart Ventures ranges from $1,000,000 to $5,000,000. They invest at the Seed and Series A stages. Jumpstart Ventures also partners with corporate innovation partners to source and vet emerging technologies, aiding in their innovation efforts.

Split Rock Partners invests in emerging healthcare, software and Internet services companies in the Upper Midwest and West Coast.

Sam Palmisano is known for managing Wall Street, not being managed by it. His investment focus areas include Tech and Health with an interest in early and seed stage investments. He has made 10 investments with a portfolio exit in Expanse in 2020. Palmisano is the Chairman of the Center for Global Enterprise and had a successful career at IBM. His investment check size ranges from $100,000 to $1 million. Palmisano’s partnership and collaboration style involves a focus on worldwide collaboration, redefining the global corporation. He succeeded Lou Gerstner at IBM and is credited with setting a new standard for corporate leadership.

Guy Giuffredi is an investor at Serpentine Ventures. Serpentine Ventures focuses on investing in healthcare and information technology industries. They are constantly looking for new founding teams to invest in and leave no stones unturned when evaluating new opportunities. Their previous investments include Cleveron, a smart solution to optimize energy use and reduce CO2 emissions. The investment check size is not specified on the website. Serpentine Ventures emphasizes leveraging their experiences to support founders and investors, bringing wide entrepreneurial and venture experience to their partnerships.

John Caldwell is an investor with a focus on stock selection and equity strategy, leading the Life Sciences & Healthcare Practice at Caldwell. His investment preferences and geographical focus are not available. John is known for his extensive track record in the Diversified Stock Income Plan (DSIP) List, with 30 years of performance. Information about the stage of investment, previous investments, investment check size, and partnership collaboration styles of John Caldwell is not readily available.

Wouter Verhoeven is a venture partner at BGV since 2021. With over 15 years of Biotech experience, he primarily focuses on Pharmaceuticals, Consumer Health, Digital Health, BioTech, and Health & Hospital Services. His investment check size ranges from $100K to $1M, with a sweet spot at $500K. Geographically, his preference is in the Netherlands. Wouter’s professional career includes roles at Dualyx, Berna Biotech, Crucell, Rabo Private Equity, Mabxience, and NBE Therapeutics, with a background in business development. He holds a MSc in Technical Management from Delft University of Technology.

Martien van Osch, the Managing Partner at Forbion, has a strong track record in the life sciences industry, with notable exits such as PneumRx, Circulite, Pathway, Impella, and Flowmedica. He leads the medical device-related activities at Forbion, chairs Staten Biotechnology, and has a degree in Econometrics from Rijksuniversiteit Groningen. Martien’s investment style is hands-on, focusing on transformative therapies for cardio-metabolic diseases. His expertise and experience make him a valuable partner for entrepreneurs in fostering healthcare innovation.

Peter Sands is the Executive Director of The Global Fund to Fight AIDS, Tuberculosis, and Malaria since March 2018. He has a diverse professional career, previously serving as the Group CEO of Standard Chartered PLC and a Research Fellow at Harvard University. While details about his investment thesis and focus areas are not explicitly mentioned, his professional background suggests a focus on global health initiatives. Peter Sands has a strategic partnership and collaboration style, evidenced by his leadership at The Global Fund. His investment check size is not specified, but his involvement in significant fund allocations indicates a capacity for substantial investments. Geographically, his work spans worldwide in healthcare. Previous investments and specific investment stages are not directly provided. Additionally, his track record includes successful initiatives at The Global Fund, emphasizing progress and collaboration in the fight against infectious diseases.

Matt O’Dore is involved in investments related to Roofing, Siding, Windows, and Gutters.

Business Angels Frankfurt Rhein-Main, founded in 2000, is an angel network based in Frankfurt, Germany. The firm focuses on technology, nanotechnology, radiolocation in renewable energy, agricultural topics, and new hedge fund concepts. They specialize in seed round investments within the Technology, Media, and Telecom (TMT) industry. The investor network’s active portfolio includes a diverse range of investments in these areas. Their partnership and collaboration styles aim to foster growth and success in the startups they support.

Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and business services industries.

Sujal Patel, strategic director at Madrona Venture Group, is a seasoned entrepreneur and investor with a focus on tech startups. With a background in founding successful companies like Isilon Systems and Nautilus Biotechnology, Patel brings a wealth of experience to the table. He has backed over 85 startups and shares valuable insights on product-market fit, recruiting, hiring, and perseverance. Patel’s investments span life sciences and technology sectors, with a strong emphasis on creating platform technologies for quantifying and unlocking potential. His collaborative style and strategic guidance benefit startups as they navigate the challenges of growth and market expansion.

Fabian Wawro is a Senior Associate at FORM Life Ventures, investing in the field of healthcare. His investment focus lies in Digital Health, Health & Hospital Services, and Health IT, with a preference for Series B and Series A stages. Fabian’s investment range typically spans from $500K to $2.0M, with a sweet spot of $1.3M. He has a track record of investing in innovative startups in the healthcare sector, particularly in later-stage opportunities. Fabian is known for his partnership and collaboration style, actively engaging with companies to foster growth and success. Located in Zurich, with a focus on the EU region, Fabian Wawro brings a wealth of experience and expertise to his investments in the healthcare industry.

Compound is a venture capital firm that invests in bleeding-edge technology built by outliers.

Ramu Sunkara is the Co-Founder and CEO of Alan AI, with a total of ten years of experience. He has a strong background in technology and entrepreneurship, having co-founded and served in various leadership roles at companies like Skyline Labs, Synqq, Qik, and Oracle. Ramu Sunkara holds an MBA from Boston University, an MS in Computer Science from the University of Wisconsin-Madison, and a Bachelor’s degree in Engineering from the Indian Institute of Technology, Madras. He is currently based in Sunnyvale, CA, USA, and his investment check size typically ranges between $100,000 and $500,000. Ramu Sunkara’s partnership and collaboration style are highlighted by his involvement in successful partnerships with companies like Ramco Systems and Alan AI. He has a professional track record of leading innovative technologies and a strong educational background, making him a prominent figure in the tech and investment space.

George Ribaroff is a Partner at Meridian Street Capital, a venture capital firm focused on early-stage investments in healthcare and technology-related companies across the United States. The firm’s investment focus areas include HealthTech and Enterprise Applications. Meridian Street Capital primarily invests in startups from the seed to series-A stages, with lead rounds in companies such as Isaac Health and Ounce. The check sizes for investments made by Meridian Street Capital range from seed to series-A rounds. George Ribaroff is known for supporting founders from the early stages, often from day one, with a concentrated and steadfast approach.

Neil Vangala is a seasoned investor with over seven years of experience in investing and acquisitions. His investment focus areas include healthcare, healthcare technology, and tech-enabled services. He primarily invests in early to mid-stage startups. Neil’s geographical preference is not clearly defined. His professional career showcases a consistent track record of success. However, specific details on his investment check size and partnership and collaboration styles are not readily available in the search results.

NXT Ventures is an angel group that drives disruptive startup companies, focusing on sectors like software, enterprise software, manufacturing, machine learning, and information services. They primarily invest in seed and Series A rounds, with a geographical preference in North America. With a total of 59 investments and 6 lead investments, they have made 13 diversity investments. Some of their previous investments include Lionano, Intarcia Therapeutics, Clinical Research IO, and Luminopia. The team at NXT Ventures, led by managing directors Raymond Chang and Barry Turkanis, has a professional background in successful entrepreneurship and investment management. Their investment check size averages around $6 million, showcasing a commitment to funding innovative startups through their strategic collaboration and partnership styles.

Tim Roe, Director at Rev1 Ventures, focuses on investing in enterprise software, data analytics, digital health, healthcare IT, life sciences, food tech, ag-tech, advanced materials, and alternative energy sectors. Rev1 Ventures specializes in early-stage investments, primarily in seed and series A rounds. The firm’s geographical preference is for startups located in Ohio, particularly Columbus, with emphasis on healthcare, biotechnology, software, cybersecurity, data analytics, and enterprise software. Previous investments by Rev1 Ventures include Trace, Champ, and Redi. Tim Roe’s career history shows his current role as Director at Empactful Capital LLC. The investment check size at Rev1 Ventures involves funds like Rev1 Fund II, a $20MM corporate-backed fund. Rev1 Ventures follows a collaborative approach, providing resources and education tailored to each startup’s needs.

BIP Capital is a venture capital firm that seeks early-stage and growth investments.

Ohio TechAngel Funds, through their investment arm, focuses on providing capital for the commercialization of innovations in IT and life sciences, with a specific emphasis on Ohio-based technology ventures. They have a history of investing in high-growth technology-driven businesses in Ohio, particularly in software, advanced materials, sensors and instruments, and life sciences. Their typical investment check size ranges from $375,000 to $500,000 for each new venture, and they prefer companies where members’ coaching and expertise can directly impact success. Ohio TechAngel Funds prioritize supporting entrepreneurs and innovation, with a collaborative approach involving public and private entities and additional investments from private investors.

Investing with conviction in visionary, technical founders inventing the future.

Beacon Angels is a Boston-based angel group that invests in early-stage, fast-growing companies in the $50,000 to $400,000 range. Since their founding in 2006, they have facilitated the growth of successful New England-based startups, resulting in significant returns to member investors. The group focuses on investments in industries such as health care, biotechnology, software, and therapeutics. They have a geographic preference for New England-based companies. Beacon Angels members are accredited investors who actively seek, assist, and benefit from the success of rapid-growth startups. The group encourages collaboration and partnership among investors to enhance portfolio value through shared capital, experiences, and strategic relationships. Meetings are held monthly to engage with company presentations and discuss investment opportunities.

Steffen Roehn believes that the European market has seen trillions of euros of investments over five years with almost no return, indicating that something is wrong.

Yifang Cui is an Investment Manager at Boehringer Ingelheim Venture Fund, with a focus on early-stage therapeutics and digital health companies. The fund’s investment philosophy includes activating success, adding value expertise, and ongoing investments. They are open to investing worldwide and have a commitment of â¬300 million, offering investments up to â¬3 million per venture and up to â¬15 million per venture over its life. Specific areas of investment include immunomodulation, tissue regeneration, and digital therapy. Regarding previous investments, no specific data is available on the website. The partnership and collaboration style information is not provided on the website.

Julie Whytock is a venture capitalist with a stage-agnostic approach, investing in seed to late-stage technology companies across various sectors. She is interested in bio and healthcare, consumer, and crypto investments. Julie’s investment check size and geographical preferences are not disclosed. There is no specific information available about her previous investments, track record, or partnership and collaboration styles.

Cuthbert Simpkins invests in a clinical stage biotechnology company focused on creating products that utilize nanoparticle technology.

Dominique Burgauer is an Angel investor with a focus on Enterprise Software, Mobile, Healthcare, Synthetic Biology, Big Data, Personal Health, Mobile Health, Health Care Information Technology, Robotics, Artificial Intelligence, and Education markets. His previous investments include Archilogic, Cambrian Genomics, FELFEL, and HealthCrowd. The check size of his investments is not specified, and no data was found on partnership and collaboration styles.

Lucanus Polagnoli is the Founder & Managing Partner at Calm/Storm Ventures, a venture capital firm with a focus on supporting purpose-driven founders in the digital health space across Europe. His investment thesis revolves around backing founders changing life, health, and well-being for the better. Lucanus Polagnoli’s investment focus areas include digital health companies such as ThinkSono, Foundation Health, Bea Fertility, Doctorly, and more. He has a notable track record in early-stage investments, with investments ranging from Pre-Seed to Series A rounds with a check size of around $137K. Some of his previous investments include organizations like ThinkSono, Foundation Health, Bea Fertility, Nolea Health, and Doctorly. Lucanus Polagnoli’s professional career includes roles as a Kauffman Fellow, a Startup Mentor at EIT Health, and previous positions at Speedinvest and KPMG Australia, showcasing his diverse expertise in financial and advisory fields.

Björn von Siemens, a seasoned investor, has been deeply involved in the digital healthcare technology space since 2007. He is the co-founder of surgical.ai, a healthcare investment group with $150 million in assets under management. Additionally, Björn is the visionary behind Caresyntax, a global leader in surgical analytics and automation, revolutionizing surgeries in 4,000 operating rooms globally annually. His educational background includes studies at the London School of Economics, EBS Oestrich-Winkel, and research in behavioral psychology and entrepreneurship at the University of St. Gallen and Harvard University. Björn has a track record of strategic investments, with a recent notable investment in Lillian Care amounting to $2.92 million in their Pre-Seed round, showcasing his commitment to innovative healthcare solutions. Björn’s collaboration with prominent co-investors in Lillian Care highlights his partnership style and focus on advancing breakthrough healthcare technologies.

Paul Vernooij is an Investment Manager at BOM Brabant Ventures. The investment thesis focuses on RNA technology and related fields. BOM Brabant Ventures invests in scalable startups and scaleups with growth potential, with investments typically ranging between 150k and 5M EUR. Previous investments include Flindr Therapeutics, Onera Health, and Tidal Control, mainly in the Netherlands. Paul Vernooij has a professional track record in promoting advancements in mRNA, RNAi, and nucleic acids. The partnership and collaboration styles of BOM Brabant Ventures involve facilitating startups with unique knowledge and capital for mutual growth and success.

Anthony Vickers is an experienced investor focusing on customer needs, customer value, and double-down strategy in venture investments. Vickers Venture Partners, led by Anthony, invests in companies with high growth potential sourced globally. The average investment check size is not specified. Previous investments include Kimberwalli, Yarpa NSW Indigenous Business & Employment Hub, Aboriginal Affairs NSW, and Lean Enterprise Institute.

Boulder Ventures invests in early stage information technology and life science companies in Colorado and the Mid-Atlantic.

Marcel Kloosterman, Managing Partner at Brightlands Venture Partners, focuses on investment in life sciences and cleantech. His previous investments include Hy2Care, Health Value Creation, FABPulous, and Q Chip. He typically invests in Series A and Series B funding rounds. Marcel’s investment check sizes range from â¬1 million to â¬6 million. He has a Ph.D. in organic chemistry from Leiden University and holds various board positions in portfolio companies.

Ms. Irena Goloschokin serves as Chief Executive Officer at Copper Mountain Technologies. With over 15 years of experience in the tech industry, she was previously the Chief Strategy Officer at T2 Systems, a leading provider of IoT solutions for the parking sector. Her expertise includes managing software and hardware product development, marketing, managed services, product management, and M&A activities. Holding an MBA from Indiana University, she has made significant contributions in the industry. Ms. Goloschokin is dedicated to driving the strategic direction of Copper Mountain Technologies and has been actively involved in various industry initiatives, serving on the IPI Board of Directors since 2014. She continues to demonstrate a deep commitment to research and innovation in the parking industry.

Purdue Angel Network is a part of the P3 Alliance, providing first looks at companies commercializing technologies from Purdue University. They aim to bring innovative products and processes from Purdue laboratories to the marketplace quickly. The network requires a $500 annual membership fee for participation. Previous investments include Pluto Aerospace, Verility, Insignum AgTech, Adipo Therapeutics, and Skyepack. Unfortunately, specific information about their investment check size could not be found. Purdue Angel Network’s partnership and collaboration styles involve leveraging university resources to solve societal challenges and collaborating with external partners in various sectors such as community and economic development, education, government, and healthcare.

Bobby Sandage, Jr., Ph.D., General Partner at Cultivation Capital LLC, has over 30 years of experience in the pharmaceutical industry. Cultivation Capital focuses on investment in Life Sciences & Health Tech, Software & IT, and Agriculture & Food Tech sectors. Bobby Sandage led a $20 million Series B funding round in 2013. The investment check size and partnership and collaboration styles were not specified on the available sources.

VentureSouth is an early-stage venture firm with a focus on providing risk capital to Southeastern startups. Their investment thesis centers on achieving positive returns without follow-on rounds. The firm typically invests in a diverse range of industries, including software, information technology, life science, and healthcare. VentureSouth’s geographical preference is the Southeastern United States, supporting promising ventures in the region. Some of their previous investments include 6AM City, Case Status, and Emrgy. Their investment check size ranges from $150,000 to $750,000, and they prioritize partnership and collaboration styles through member-led angel groups. VentureSouth has a proven track record of investing in early-stage startups and fostering growth in the region.

Dr. Brad Weinberg, Founding Partner at Blueprint Health, focuses on investing in healthcare startups. Blueprint Health’s investment focus areas include Health Care, Medical, Information Technology, Software, and mHealth. Brad Weinberg typically invests in early-stage companies, providing initial funding within the range of $100,000 to $1 million. He has made 87 investments in 79 portfolio companies. Brad Weinberg’s partnership and collaboration style at Blueprint Health involve launching the Blueprint Health Collective to accelerate the development and adoption of new healthcare technology through collaboration with prominent healthcare organizations.

Julia Bernstein is a seasoned healthcare leader, known for her experience in digital health leadership and advisory roles. She serves as the Chief Operations Officer at Brightside Health, setting strategy and scaling operations. Julia has held leadership positions at Thirty Madison, Tempest, Beacon Health Options, and Ginger. As an active angel investor and board member of PharmaCCX, she participates in investment and advisory roles in startups like Care + Wear, Coral Care, Untether Labs, Violet, and VivorCare. Julia’s investment check size and partnership details were not specified on her LinkedIn profile.

Sımon Saneback is a Founding Partner at Wellstreet with a focus on sectors like health technology, messaging, disrupting old consumer verticals, and fintech. Some of his previous investments include Web3/Blockchain and cryptocurrencies at different stages. His investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Sımon Saneback collaborates within a team of 17 at Wellstreet, where he is one of the 7 Partners. His partnership and collaboration style within the team is not extensively detailed in the available information. For more details, you can visit the Wellstreet team page.

Julien de Salaberry is a healthcare venture investor and founder of The Propell Group, focusing on seed investments in HealthTech startups. With a career in healthcare since 1997, he has a diverse track record, including leading brands like Natixis and AXA. His portfolio includes investments in companies such as Proteus, Glooko, Healint, Omada Health, and more. Julien’s geographical preference encompasses regions like Asia-Pacific, with a specific focus on IoT’s impact on the healthcare value chain. While specifics on investment check size are not found, his emphasis on HealthTech suggests investments likely vary based on startup needs. His partnership and collaboration style appear dynamic, leveraging technology efficiency gains in healthcare and navigating challenges for HealthTech devices to become mainstream in Asia.

Westway Capital, founded by John Levinson, focuses on investments in early-stage technology and healthcare companies. Their investment check size is not specified, but the firm is actively seeking opportunities in the healthcare industry. Westway Capital facilitates collaborations, partnerships, and strategic discussions.

Maria Tell is an Investment Manager at Almi Invest, focusing on Life Science investments. With a Master of Science degree in Molecular Biology from Uppsala University, Maria has a strong educational background. She has held board positions in various companies such as Navinci Diagnostics, CytaCoat, and ReSitu Medical AB. Maria’s expertise lies in finding, investing in, and developing companies with growth potential. Her recent role as Chief Operating Officer & Investment Director at Segulah Medical Acceleration showcases her leadership in the field. Maria has a track record of supporting startups and implementing successful exit strategies.

Daniar Betancourt (LION) bdaniar@gmail.com is a Grocery Team Member at Whole Foods Market with experience in the United States Marine Corps. They hold a Bachelor of Science (B.S.) in Accounting and Business Management. Their previous investments and partnership and collaboration styles are not available from the sources searched.

Varun Gupta is an angel investor with a focus on Health-Tech, Media, and Entertainment. He typically invests in early-stage companies, with a particular interest in biopharma. Varun Gupta’s investment check size ranges from $300K to $500K, with a sweet spot at $400K. His geographical preference is in California, United States. He has a track record of successful investments and has made notable investments in companies like Boult and Pesto. Varun Gupta’s professional career includes serving as a Partner at Caffeinated Capital in San Francisco. He has a Master’s degree in Computer Science from Stanford University.

Jonathan M. Aberman is a seasoned investor and innovation consultant with over 30 years of experience. As a Partner at Ruxton Ventures, he specializes in the intersection of innovation, entrepreneurship, and policies. Jonathan’s expertise extends to structuring complex business transactions and leading diverse organizations. He has a strong track record as a venture capitalist, lawyer, trader, and investment banker. With a background in law, corporate law, and international economics, Jonathan is known for his influential voice in the Greater Washington region’s innovation and entrepreneurship sector.

Danial Braund is an investor focused on private equity with a clear investment thesis of achieving high returns through a relentless focus on management disciplines. His investment focus areas include impact investing in sectors like food, bioscience, community development, and place-based initiatives. With a successful track record in the industry, Danial has previous investments in impact investing and economic development. His investment check size typically ranges from $250k to $1.5M, and he is known for his partnership and collaboration styles that prioritize market-oriented solutions, expertise expansion, and achieving equity. Danial Braund’s career showcases a background in finance, bioscience investing, impact investing, real estate, and social entrepreneurship.

Sanne Weijzen is the Vice President and Head of Corporate Strategy and Global Operations at Neogene Therapeutics. She has over 20 years of experience in the academic and biotech industry. Dr. Weijzen previously worked at Scenic Biotech as COO and Aglaia Biomedical Ventures as a partner. She holds a master’s degree in Biomedical Sciences and completed her Ph.D. research in Tumor Immunology. Neogene Therapeutics is headquartered in the US and EU. Sanne Weijzen’s professional career has been focused on strategic operations and corporate growth within biotech companies.

Balderton Capital is a Early-Stage Venture Capital Investor.

Investing in Great Entrepreneurs Solving the World’s Biggest Challenges

John Troiano is the founder and managing partner of The Beekman Group, a private equity firm that focuses on middle market investments in sectors such as healthcare services, consumer, and business and industrial companies. The firm’s investment strategy involves partnering with management teams of lower middle-market services companies with enterprise values ranging from $15 million to $75 million. The geographical preference for investments includes regions across the United States. The track record of The Beekman Group demonstrates successful partnerships with management teams to support the growth initiatives of middle-market companies. The check size of investments by The Beekman Group typically ranges between $20 million and $150 million. The partnership and collaboration styles involve working closely with management teams to create long-term, sustainable value.

Ray Wagner is the Managing Director at Thompson Street Capital Partners. The firm focuses on a thesis-driven approach, investing in various key industry verticals such as Life Sciences & Healthcare, B2B services, technology solutions, and software providers across cloud services, insurtech, non-profit software, and supply chain software. Ray Wagner’s investment stage ranges from Series B in sectors like Medical Devices, Pharmaceuticals, AI, Health IT, and more. Thompson Street Capital Partners has a geographical preference for the Midwest. With a track record of nearly $200 million in transactions, Ray Wagner brings extensive experience in due diligence, valuation analysis, and business development. The fund’s investment check size is between $50 million to $250 million, targeting companies with EBITDA between $5 million to $50 million in sectors like healthcare, life sciences, software, IT services, and business products. Thompson Street Capital Partners’ partnership approach is focused on actively working with companies to make a significant impact in their respective industries.

Five Star Bank is a dedicated investor supporting affordable housing and economic development. They invest in technology to enhance customer experience and drive growth in the small business segment. Five Star Bank has previous investments from The Cities of Rocklin, Sacramento, Roseville, Rancho Cordova, Elk Grove, and SMUD. The bank has a great depth of knowledge and experience with over 30 years in banking, emphasizing stellar client service and collaborations with organizations like URMC and Autobooks.

Nicholas Grouf is the Co-Founder and Managing Member at Alpha Edison, a venture firm with a knowledge-driven approach investing in various sectors including Mobility, Blockchain, Fintech, Proptech, Virtual Reality, Artificial Intelligence, Biotech, Climate Technology, and Electric Vehicles. The firm focuses on building trust and intimacy, avoiding reactive VC practices. As a serial entrepreneur, Grouf has had a successful career with leading companies such as Spot Runner and PeoplePC. His investment check size is not specified, and he emphasizes building successful teams, cornering markets, and maintaining a competitive edge. Grouf’s collaborative style involves selecting strong team members, valuing co-workers, and staying focused on deals while analyzing potential pitfalls.

Holger Hengstler is an Angel Investor who is a co-founder of dress-for-less. He has made investments in companies like TextCortex AI, Hedoine, and Idagio. His investment focus areas include technology, consumer, insurance, healthcare, industrials, and financial services. Holger Hengstler typically invests in early-stage ventures, particularly at the Series A stage. While his geographical preference is not explicitly mentioned, his involvement in expanding Privalia in Europe suggests a focus on the European market. Some of his previous investments include TextCortex AI and Privalia. Holger Hengstler’s professional career includes co-founding dress-for-less and holding positions on various supervisory boards. The specific investment check size and partnership/collaboration styles are not available in the search results.

Oliver Abert is an Angel Investor focusing on investments in various sectors including consumer technology, SaaS, enterprise tech, healthcare, deep tech, fintech, biotech, climate tech, and AI. His investment check sizes range from $250K to $5M. Dr. Oliver Abert was a Co-Founder and served as Chief Technology Officer & Chief Executive Officer at Numenus. He is also a Senior Software Development Manager at Autodesk and an Investor at Spintop Investment Partners.

Zia Uddin is the President and Co-Portfolio Manager at Monroe Capital with an investment thesis focused on the private credit landscape, emphasizing technology, software, and healthcare. His stage of investment ranges from Series B to later stage growth equity financing. Zia Uddin’s geographical preference is the Midwest, mainly Chicago, Illinois. Some of his previous investments include Snowden Lane Partners and Amelia in debt financing rounds. He collaborates with a variety of partners and co-investors from Monroe Capital. Zia Uddin’s investment check size ranges from $2.0M to $15.0M, with a sweet spot of $8.5M. His partnership and collaboration style involve driving global sales certification and nurturing a performance-driven culture. Throughout his career, Zia Uddin has managed complex projects internationally with various organizations like Marubeni Corporation and Ericsson.

North Country Angels is an angel group that focuses on invests in Enterprise Applications, Life Sciences, and more. They primarily invest in Series A and Angel stages in the United States, with a partnership style that involves early-stage ventures and seed investments.

Golden Angels Investors is an angel investment group founded in 2002 with a focus on capital formation for entrepreneurs in the Midwest. They invest across a wide range of industries, including healthtech, edtech, and B2B services. Some of their previous investments include Abre, Fiveable, EdSurge, Dynamis Software, and Transportant. Golden Angels Investors typically invests in startups in the financial technology sector with a check size of around $1 million. The group consists of approximately 100 investors, including founders, CEOs, venture capitalists, and business leaders, and operates as a single entity with a member-led assessment process. They have an Established Angel Group certification and collaborate with various sponsors like First Business Bank, Godfrey & Kahn, and Quandt Berndt & Company.

Thomas Lips is a General Partner at Nextech Invest specializing in BioTech investments at Series A and Seed stages with an investment range of $100K – $5.0M. He has a sweet spot investment size of $1.5M and has experience as the Chief Investment Officer at AIG Private Bank. Thomas Lips’ geographic focus is not specified. He is known to invest in companies with a strong track record and maintains a partnership and collaboration style that aims to work with others to identify solutions that satisfy everyone involved.

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

Phillip Chambers is an investor with a background in technology and startups. He serves as the Chief Executive Officer at Orbex Space and has been involved with companies like Tonsser and Peakon. With a focus on data analytics in the HR market, he brings his expertise in communication products to the table. His investment check size and partnership styles reflect a hands-on approach to building successful ventures.

Kent Johnson, an investor who served as Board Member at DimensionalMechanics, has a professional background as the Chief Financial Officer at various biotech companies. He holds an MBA from Harvard Business School and has a track record of successful financial management. Kent’s investment focus includes early-stage companies like DimensionalMechanics, where he led a $4.7 million funding round. His previous investments include companies in the artificial intelligence and biotech sectors. Kent’s check size for investments ranges based on the company’s needs. He brings a wealth of experience and expertise to collaborations, emphasizing strategic partnerships and hands-on involvement in the growth of startups.

BlueYard seeks to invest in founders with transforming ideas that decentralize markets.

Colin George is an Angel Investor with a focus on building in healthcare and software innovation in the healthcare sector. He serves as a Director of Enterprise Sales and Business Development at EverString and has a track record of investment activities in North America, Europe, and Asia. Colin George has been actively involved in various firms including Delphix and Summit Partners, where he held a senior associate position. His educational background includes a BS in accounting and a BA in philosophy with Honors from the University of Southern California.

Thies Sander is a General Partner at Project A, specializing in investments in Payments, Digital Health, Health & Hospital Services, and Enterprise at Series A and Seed stages. His previous investments include Kry, Spryker Systems, and Barzahlen. Thies has an extensive track record, having co-founded Project A and worked as a CEO at a German online comparison startup. With a focus on early-stage investing, his investment check size ranges from $200K to $10.0M, with a sweet spot of $5.0M. Thies values human connection and enjoys meaningful work in smaller groups. He co-founded Project A in 2012 and holds a double master’s degree from WHU and Kellogg Graduate School of Management.

Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.

Lukas Scherzenlehner’s investment thesis focuses on Health Care, Software, and Fitness. He has previously invested in Record Bird on Feb 10, 2016. The investment check size is not specified.

David Weisburd, the Managing Director at Growth Technology Partners, is known for his investments through 10X Capital. He focuses on innovative markets and factors affecting LPs’ decisions. Weisburd co-founded 10X Capital and his recent pre-seed investment in Zurp highlights his involvement in early-stage funding. With a professional background in criminology and as a Distinguished Professor at George Mason University, he brings expertise in research methods and place-based criminology. Weisburd’s investment check size aligns with emerging manager funds and venture capital landscapes. He emphasizes not overlooking emerging managers in the venture ecosystem. His partnership and collaboration styles are reflected in fostering relationships of trust and implementing impactful police practices.

Lasse Lehtinen is a General Partner at Icebreaker.vc, an investor focusing on early-stage tech companies. His investment focus areas include Consumer Goods, Energy & Greentech, Fintech, and Healthcare & Life Science among others. He has invested in companies like Flowhaven, HoxHunt, Valpas, Logmore Oy, Aibidia, and Cerenion. Lasse Lehtinen’s track record includes chairmanship and partnerships at Nord Growth and Frontier. Icebreaker.vc typically invests between â¬100,000 – â¬500,000 and in countries like Finland and Sweden. The fund has a community of over 1,000 professionals with 5+ years of industry experience. Lasse Lehtinen’s approach involves initial investments varying between â¬150,000 – â¬800,000 with follow-on investments. The fund’s primary markets include Consumer, Companies, and Marketplace, and they have a hands-on approach to helping companies succeed.

David Selverian is an experienced investor with a focus on Human Capital/HRTech, Health & Hospital Services, Health IT, and Enterprise sectors. He evaluates early-stage startups with an investment check size in the Pre-Seed, Seed, and Series A stages, specializing in areas like AI/ML and B2B. David shows a preference for female and underrepresented founders and has a track record in successful acquisitions. His collaboration style is marked by a commitment to partnership and patient care, evident in his involvement in healthcare startups. With a background in investing and healthcare, David engages in a broad range of investments, aiming to support and grow promising ventures.

Robert Wiesenthal, the Founder and CEO of Fly BLADE, has a diverse investment portfolio that includes companies like Secret, Fundera, Splice, and Activate. With an emphasis on healthcare and technology sectors, he maintains a strategic partnership approach focused on early-stage investments. His investment check size varies per company but is substantial, as shown in the public sale of shares of Blade Air Mobility Inc. Wiesenthal’s professional career is marked by successful ventures such as Blade, showcasing his expertise in transforming businesses. While specific details on stage of investment and partnership styles are not available, his track record and involvement with high-profile companies demonstrate a hands-on and innovative approach to investing.

Markus Enzelberger is a Partner at Versant Ventures with a current fund size of $102.2M. His investment range is $100K – $5.0M, focusing on Pharmaceuticals (Seed), Pharmaceuticals (Series A), BioTech (Series A), and BioTech (Seed) sectors. He has co-invested with Alexander Mayweg, Beckie Robertson, Bill Link, Brad Bolzon, and Brian Atwood. Markus Enzelberger’s professional career includes a role as Chief Scientific Officer at MorphoSys and involvement in a Series A funding round for Vector BioPharma. He collaborates with entrepreneurs, industry, and academics to create and operate innovative biotech companies in Basel, Switzerland through Versant Ventures. Ridgeline, a Versant Ventures Discovery Engine, works closely with Markus Enzelberger in company building, with a focus on biotechnology companies discovering and developing novel therapeutics.

Steve Papa is a Co-Founder and serves as the Chairman & Chief Executive Officer at Parallel Wireless. He has a strong background as a successful serial entrepreneur, with previous experiences at Endeca, Akamai, Inktomi, Teradata, and Venrock. Steve reimagined the technology landscape for over 20 years, leading companies to successful acquisitions and growth. His investment focus areas include companies like Toast, Kandou, Reflektion, Ombud, and Desktop Capital. He guides his companies towards broad commercialization and growth, bringing his expertise in strategic direction setting. Steve’s track record includes Oracle’s 6th largest acquisition ever with Endeca. He reimagined the database landscape, internet content distribution, and network caching, showing a strong ability to innovate and lead successful ventures. Steve Papa holds a BS from Princeton University and an MBA from Harvard Business School.

Scott & Cyan, seasoned investors, have a track record of success, focusing on Silicon Valley, San Francisco, and Southern California. With over 275 investments, they back startups in various markets like Mobile, SaaS, Bitcoin, and Medical Devices. They prefer larger check sizes of 500K+, targeting growth and later-stage funding. Their investment thesis evolves towards proactive investing and expanding geographically. Previous successful investments include Uber, Thumbtack, and SpaceX. Collaborative and hands-on, they seek to impact and guide portfolio companies towards success.

Hiren Shah is an investor associated with Alliance of Angels, the largest and most active angel group in the Pacific Northwest. The group focuses on financing high-growth startups in technology, hardware, consumer, and life sciences. Hiren Shah has made two investments, with a recent investment in Sanfe during a Series A round in April 2022. The check size for investments typically ranges from $500k to $2.5 million for their first investment round. His partnership and collaboration styles align with investments in sectors like retail and consumer, primarily focusing on locations in India.

Joe Amadio, the Managing Director at Thompson Street Capital Partners, specializes in Series B investments with a focus on Pharmaceuticals, Medical Devices, Consumer Health, Digital Health, BioTech, AI, Health IT, and more. He has a sweet spot investment range around $25.0M, and a current fund size of $1.2B. Joe’s track record includes successful investments in the Midwest region. He collaborates with investors like Alex Mace, Alison Schulte, and others. With a background as a Private Equity Investor, his partnership style is characterized by a strategic and collaborative approach, leveraging his vast experience in the industry.

Reno Seed Fund is a venture capital firm and angel group founded in 2019, based in Reno, Nevada. They primarily invest in early-stage companies in sectors like SaaS, fintech, blockchain, life sciences, IoT, advanced manufacturing, cybersecurity, and hospitality across Northern Nevada. Their partnership and collaboration styles were not explicitly found in the search results.

Tom Lopez is a seasoned investor with a background as the CIO of the Los Angeles Fire & Police Pensions fund. He has overseen significant growth in assets and diversified investments across various asset classes. While specific investment focus areas are not specified, he has experience in private equity investments. His professional career includes decades in guiding startups to successful exits. The geographic preference for investments is not clearly defined. Additionally, previous investments are associated with Green Theme Technologies. The investment check size remains undisclosed, but he demonstrates a collaborative and partnership-oriented style in his engagements.

Jefferson Corner Group focuses on providing investment capital to U.Va. faculty spin-off companies and other technology businesses in the region. Their preferred industries include Biotechnology, Business Products, Clean Technology, Computers and Peripherals. They are based in Charlottesville, VA, USA.

Sciety is the Nordic region’s leading life science investment company, investing in unlisted life science and health tech companies. They focus on biotechnology, medical technology, pharmacology, diagnostics, ICT in healthcare, and health tech. Their investments range from the product development phase to expansion phase. In pharmaceuticals and biotech, they invest from late preclinical phase to Phase II, whereas in health tech and medtech, they invest in late development phases or companies with market traction.

Gary P. Pisano focuses on investing in science and technology-based industries such as aerospace, biotechnology, pharmaceuticals, specialty chemicals, healthcare, nutrition, computers, software, telecommunications, and semiconductors. His investment strategy includes early-stage funding in the biotech industry. Gary P. Pisano’s geographical preference is evident in his contributions to European co-inventorship location and co-patenting networks. His past work has involved nearly 100 articles and case studies on leading corporations like Amazon, BMW, IBM, Merck, Pfizer, and Virgin Group. While details on his investment check size are not specific, he emphasizes the importance of strategic investment decisions in SMEs. Pisano promotes strategic collaborations and partnerships, recommending an understanding of the four basic collaboration modes in business relationships.

Roger Sippl, as the managing partner of Sippl Investments, focuses on early-stage venture capital investments, especially in software and medical technology companies. The firm has a history of investing primarily in Silicon Valley-based enterprises but is expanding internationally, particularly in Asia. Sippl Investments works collaboratively with larger venture capital firms and offers expertise in technology and biotech. Roger Sippl’s partnership and collaboration style involve providing guidance, advisory support, and investment activities with a wide range of high technology companies. His background includes founding successful software companies like Informix and Visigenic, showcasing a track record of innovative contributions to the enterprise software industry.

Andy Ziolkowski is a Managing Partner at Cultivian Sandbox Ventures, based in Chicago, Illinois. He has made investments in sectors such as Food and Beverage (Seed), AgTech (Seed), Health & Hospital Services (Seed), Digital Health (Seed), BioTech (Seed), Health IT (Seed), Food and Beverage (Series A), AgTech (Series A), BioTech (Series A), Digital Health (Series A), Health & Hospital Services (Series A), and Health IT (Series A). One of his notable investments is Descartes Labs. Andy typically invests in the range of $1M to $10.0M, with a sweet spot at $5.5M. He has a track record of 2 total investments on record and is connected to investors like Rob Trice, Ludovic Copéré, and Phil Boyer. Co-investors in Descartes Labs include Eric Chin, Venky Harinarayan, Collin West, and Omar El-Ayat.

Juliette Audet is a Partner at Forbion, with an investment focus on Pharmaceuticals and BioTech sectors at seed and Series A stages. Her investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Some investors who collaborate with her at Forbion include Antoine Boulanger Piette, Audrey Cacaly, Dirk Kersten, Dmitrij Hristodorov, and Geert-Jan Mulder.

Andrew Thierry is known for making investments in a wide range of areas including Retail, MarketingTech, BioTech, E-commerce, ClimateTech/CleanTech, Web3/Blockchain, Web3/Crypto, SaaS, AI, and FinTech. His investments span across various stages including Pre-seed, Seed, Series A, and Series B. Thierry’s investment range typically falls between $100K and $5.0M, with a sweet spot at $1.5M. Some of his notable investments include Feve, La Solive, mobee travel, Jolimoi, Each One, Vendredi, Lyanne, and Javelot. Thierry’s track record and professional career include experiences in consumer-facing businesses and involvement in healthcare and impact investments. His partnership and collaboration style involve understanding and leveraging the three common collaboration styles: introspective, relational, and expressive, to ensure effective teamwork and successful investments.

Vera Mehler has a scientific background in regenerative medicine and stem cell therapy. She focuses on life science companies at Coparion. Vera Mehler invests in early-stage companies in software and biotechnology sectors across Germany. Her track record includes representing Coparion in eight portfolio companies and serving as an Investment Manager. While specific investment check sizes were not found, her partnership and collaboration style involves conducting research, projects, and reform initiatives in partnership with officials. Geographic focus was not specified in the search results.

Sean Soole focuses on evaluating businesses for attractiveness to investors by minimizing risk, implementing systems, structures, and building a solid team. He emphasizes the importance of great people in the leadership team and advisory board. Investors seek assurance of return on their investment, timeline for returns, and the rate of return. Sean Soole advocates building systems and processes to attract investors and create a ‘freedom business’ that allows for a smooth transition for potential investors. The tools provided by Sean Soole aim to help businesses achieve sustainable success through strategic mentorship and execution.

Dr. Jonathan De Pass is an Angel Investor who founded Evaluate and served as Board Member at Advera Health Analytics. He is known for market intelligence and analysis in the life science sector, setting new industry standards. Jonathan De Pass has a strong track record in guiding investments and created EvaluatePharma in 1996. His investments include Evaluate Ltd. where he secured additional funding from HgCapital for growth. Jonathan De Pass has a collaboration style that involves leveraging new technology and unparalleled information assets to bring innovation to clients. He prefers a partnership approach that focuses on building on unique business offerings with new capabilities.

Will Anderson, an Associate at Possible Ventures, leads sourcing, due diligence, and the investment process for early-stage investments across Europe, the US, and Australia. With a focus on mission-driven teams using frontier tech, Will backs startups in Europe and Australia. His previous investments include Sorare. Will’s professional career includes roles in business development for a health and education consultancy and working with startups in multiple regions. At Possible Ventures, he supports deal flow, research, and marketing. Investment check size ranges based on startup needs.

Lennaert Jonkers is a Venture Partner at Social Impact Capital. He focuses on sectors such as AgTech, Consumer Health, ClimateTech/CleanTech, Digital Health, BioTech, Health IT, and FinTech. His investment range is $100K to $5.0M, with a sweet spot of $1.5M. Lennaert’s geographical preference is Amsterdam, Netherlands. He has a strong track record in seed and Series A investments in various sectors, collaborating with co-investors like Aaron Hurst, Jason Paragas, Julie Majorelle, Laura-Marie Töpfer, and Lauryn N. Nwankpa.

New Science Ventures is a venture capital firm focused on investments in life sciences and information technology companies.

Patrick Brunel is an Angel/Individual investor based in Switzerland with a focus on Agriculture, Biotechnology, Business Development, and Professional Services. His past investments include Comet Biorefining. Patrick Newberry has recently been appointed as a Non-Executive Director at Brunel Pension Partnership, where he will also chair the Audit Risk and Compliance Committee. Patrick Brunel’s geographical preference and stage of investment are not explicitly specified. His investment check size and partnership/collaboration styles are not readily available.

Alpha Edison is a venture capital firm that focuses on technology-driven innovation.

David Lee is the Chairman of Refactor Capital, a $50M early-stage venture capital firm that invests in areas such as applied biology, healthcare, crypto, food, wellness, transportation, and aerospace. The average check size for investments is around $500,000, with a portfolio typically consisting of 40 to 50 companies. Refactor Capital primarily focuses on seed-stage companies in various sectors, including healthcare, life sciences, agriculture, financial, and legal services. Some of the previous investments by Refactor Capital include Headspace, Tempest, Lucy, Kin Euphorics, Cambridge Cancer Genomics, Cofactor Genomics, Notable Labs, Verge Genomics, and more. David Lee has a background in venture capital and startups, having co-founded and served as Chairman of Refactor Capital. He has a professional career that includes previous roles at SV Angel, Google, and StumbleUpon. Refactor Capital’s partnership and collaboration style involves active engagement and support for early-stage ventures, particularly in healthcare, life sciences, and technology sectors.

Kay G. Balster is a Principal / Prokurist at HTGF, specializing in venture capital and investments in Life Science & Chemistry startups. With a focus on biotechnology and medical technology sectors since 2009, he brings 20 years of experience in advising technology startups. Kay’s background in economics and training as a banker complements his daily interactions with founders in the HTGF portfolio. Contact information: HTGF Bonn, SchlegelstraÁe 2, 53113 Bonn, Telephone: +49 228 823 00 â 100.

Lukas Speiser is an individual angel investor known for his investments in various startups. His investment focus includes health care, medical devices, and biotechnology. Lukas Speiser prefers to invest in companies in the EU and MENA regions. Some of his previous investments include dunatura, Cleveron, Findependent, Sleepiz, and Testmate Health. With a track record in finance and founding Amorana, Lukas Speiser maintains a collaborative approach in his investments, engaging in partnerships to propel startup growth. He typically invests in the seed stage with check sizes that vary based on the company’s needs.

Marie Rocha focuses on investing in groundbreaking startups with diverse teams that build modern solutions to modern problems in the biotech and software industries.

Next Floor is a venture capital firm based in Salzburg, Austria, founded in 2015. The firm focuses on investments in the med tech, health care, and social impact sectors. They prefer to invest in Convertible Note and Seed stage startups. Next Floor’s geographical preference is Salzburg, Austria. Some of their previous investments include RateBoard, Seasy.com, and AVISIO. The firm has invested in 6 companies since 2016 and led 2 rounds as the lead investor. For more information, you can visit [Next Floor Website](http://tacc.next-floor.at/).

Chicago ArchAngels is a preferred provider of risk capital focusing on early and seed-stage companies in the Midwest and nationally. They engage with a wide range of industries, including medical devices, healthcare, digital technology, manufacturing, green technology, and more. Their investment focus is on innovative companies aiming for technological proof of concept and market dominance. Chicago ArchAngels seek companies looking to raise between $500,000 and $3 million in their current round. Members bring valuable business and entrepreneurial experience, collaborating with various angel groups and accelerators. They host monthly meetings with presentations from companies with global potential and are affiliated with Washington DC ArchAngels, operating since February 2012.

Tobias Teuber is an investor with a focus on personalized nutrition concepts based on blood and DNA tests. He invests in health tech startups, with a check size ranging around early-stage VC funding. Tobias Teuber’s investments have primarily been in companies like Thiocyn and Lykon. He is the Co-Founder and CEO of Lykon, a company offering personalized nutrition products and services. Tobias Teuber’s collaboration style involves seeking community partners to support the shared vision of the companies he invests in.

Duke Angel Network is dedicated to supporting the global Duke entrepreneurial community with an angel investing platform and a co-investment fund. They actively engage and match Duke alumni network expertise with portfolio companies to support growth and success. The network provides a powerful opportunity for networking and guidance from industry experts and successful entrepreneurial leaders. DAN members collaborate to connect DAN portfolio companies with the Duke network to foster further success. They typically invest between $500K-$2M in early-stage rounds, with a focus on sectors like Life Sciences and High Tech. Notable previous investments include Baebies, Superb AI, and Xilis. Key collaborations involve supporting Duke alumni founders raising seed or Series A equity capital of $300,000 to $3 million.

Sasha Saberi, as an investor at LOUD Capital, focuses on Seed and Series A investments in sectors like Lodging/Hospitality, AutoTech, Digital Health, Health IT, and Health & Hospital Services. Notable co-investors include Blake Overlock, Brian Penick, Chase Petrie, Darshan Vyas, and David Hunegnaw. His investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Sasha Saberi has a diverse professional background, including roles at companies like Zigabyte, LOUDX Studio, The Venture Atlas, HYPEBEARS NFT, and One Identity. He holds certifications in Agile Foundations, Project Management, Scrum, Design Sprint Facilitation, and Enterprise Design Thinking.

Lee Shapiro is a Managing Partner at 7wire Ventures, with a focus on building collaborative partnerships to achieve health moonshots. He has a background in commercial law and is dedicated to supporting startups with a mission beyond monetary success. Lee’s investment check size and specific geographical preferences were not available, but he has been involved in strategic partnerships to ignite the growth of Israeli digital health companies. Lee Shapiro’s past investments include Livongo Health and Allscripts, where he held positions such as Chief Financial Officer and President. His partnership and collaboration style emphasize shared values, complimentary skills, and a long-term commitment to realizing a company’s vision.

AMV is a venture capital firm investing in early-stage digital health, tech, and life sciences companies.

Jasper Bos is a General Partner at Forbion, focusing on the firm’s Growth Fund. He has been involved in notable transactions including the sale of Prexton Therapeutics and Epitherapeutics, as well as the IPOs of Translate bio and Progny. With a background as a former Merck executive, Jasper Bos holds a PhD in Pharmacy from the University of Groningen. His investment check size, geographical preference, and partnership styles were not explicitly mentioned in the available information.

Dave Sachse is a Co-Founder and Partner at Sachse Family Fund, a family office investment firm based in Milwaukee, Wisconsin, established in 2017. The fund specializes in investing in various sectors, including medical devices, virtual reality, augmented reality, biotechnology, life sciences, pharmaceuticals, CPG, and hardware. Dave Sachse’s investment focus areas are broad and diverse, covering a range of innovative industries. The fund actively seeks opportunities in early-stage companies in these sectors. While specific details about the stage of investment were not available, the firm is known for its interest in cutting-edge technologies. Dave Sachse’s approach reflects a commitment to social consciousness and community-oriented investments. The fund’s partnership and collaboration styles emphasize creating a sense of community and adapting to the evolving needs of different demographics. In the dynamic landscape of the apartment market, Sachse Family Fund recognizes the importance of smart technology, energy efficiency, and community-building events to meet the preferences of modern consumers.

Lina Behrens, CEO of Flying Health, is focused on investing in Nordic Health Tech companies. She has a background in healthcare and consumer goods, with experience at Boston Consulting Group and Polymath Ventures. Lina supports startups in digital healthcare and is actively involved in industry associations and advisory boards. Her investments target Nordic Health Tech and FemTech sectors. Lina Behrens has a track record of supporting companies in medtech and consumer goods sectors, demonstrating a hands-on approach to investment.

James Bachman is the COO of SynerZ Medical, a company developing an alternative to gastric bypass surgery for obesity and Type 2 diabetes patients. He has a track record of leading innovative medical device solutions, securing investments to support research and development efforts aiming for safer and less intrusive solutions in the healthcare industry.

Richard Easton is a venture capitalist with a focus on healthcare and life sciences. His investment thesis revolves around improving healthcare services and reducing costs. Easton Capital, where he is a key figure, has a history of investing in healthcare and currently concentrates solely on this sector. The firm aims to maximize returns by financing companies with capital-efficient models. Richard Easton’s geographical preference leans towards West Wales, where he has significant experience in commercial and corporate banking. He invests in various stages, including early stage, development capital, and succession and acquisition. His professional career spans 31 years in banking, with roles in credit risk assessment, portfolio management, and mentorship for local businesses. Richard Easton’s investment style focuses on maximizing returns while minimizing risks on a reasonable capital base.

David Meister is an angel investor with diverse investments. His investment focus areas include technology, corporate strategy, corporate venture capital, venture capital, and various industries like IT, healthcare, and financial services. He typically invests during the Seed to Series A stages with a check size ranging between $150,000 to $400,000. David Meister has previously invested in Powder. With a background in fashion design and a track record of dressing celebrities for red carpet events, he has demonstrated a strong professional career. Geographically, David Meister is based in Los Angeles, California.

Cat Catherine Kennedy is an active Angel Investor at Alliance of Angels, with a focus on seed and early-stage investments ranging between $500k to $2.5 million. She seeks extraordinary founders in various sectors, including SAAS, AI, Life Sciences, and other industries like manufacturing and retail. Preference is given to companies with a connection to the Pacific Northwest, but Cat also considers investments across the US and Canada. She has a hands-on partnership style, participating actively in the investment process. Cat has a proven track record within the investment community and is known for making quick decisions within approximately 6 weeks of the screening meeting. Additionally, she is involved in the Alliance of Angels Innovation Fund, making $150k investments in about a dozen companies annually, emphasizing a sector-agnostic approach towards early-stage ventures.

SOSV is a global VC firm with $1B AUM and 1,000+ investments, that operates HAX, IndieBio, Chinaccelerator, MOX, and dlab.

Alex Bard is an entrepreneur and investor who believes values and people are crucial for building great companies. He has been part of starting 4 technology companies in the enterprise software space. His investment focus areas include healthcare, applications, fintech, consumer services, infrastructure, and blockchain. Geographically, his preference aligns with San Francisco Bay Area and Austin, Texas. Some of his previous investments include Hims, Kustomer, AppZen, Coder, and NorthOne, spanning various stages from Seed to Series A. Alex Bard’s partnership and collaboration style involve working closely with entrepreneurs, providing mentorship, and leveraging his expertise to foster growth and success.

Andrew Schwab is the Co-Founder and Managing Partner at 5AM Ventures, a venture capital firm specializing in seed and early-stage life sciences companies. The firm focuses on building next-generation life science companies and has a geographic preference for Canada, Mexico, and the United States. 5AM Ventures typically invests in companies in the early seed stages within the life sciences category, including therapeutics, tools, and technologies like genomics and proteomics. Andrew Schwab has an impressive track record of leading investments in companies such as Biodesy, Cleave, Flexion, Ilypsa (acquired by Amgen), Panomics (acquired by Affymetrix), Precision NanoSystems, and Synosia (acquired by Biotie). The firm is known for being entrepreneur-friendly and building long-lasting relationships with entrepreneurs to achieve success.

Dr. Robert Lufrano served as Chairman and Chief Executive Officer of Blue Cross and Blue Shield of Florida and has been an Advisor at RubiconMD. His investment focus areas include healthcare and technology, with a particular interest in companies driving change in the healthcare industry. He has been involved in Series A funding rounds, as demonstrated by his $4M investment in RubiconMD in 2016. Robert Lufrano’s geographical preference and previous investments are not explicitly stated. His professional career involves leadership roles in healthcare organizations, showcasing his extensive experience. The investment check size and partnership/collaboration styles of Robert Lufrano are not specified.

Berkeley Angel Network is a group of angel investors associated with UC Berkeley. They focus on investing in companies primarily belonging to sectors like Health Care, Medical Device, E-Commerce, and Food and Beverage. Some of their previous investments include Alpaca Securities, HealthCrowd, and Bone Health Technologies. Berkeley Angel Network invests in startups at the Seed and Series A stages, with a check size usually ranging between 1 to 5 million dollars per deal. Their geographical preference is not limited to a specific region, aiming to connect global entrepreneurs with industry experts and professionals.

Jonathan Ozeran is a Vice President of Generative AI at Tempus, an investor, and advisor. His current investments include companies in various sectors such as Hardware, Pharmaceuticals, IoT, Consumer Health, BioTech, Health IT, AI, Consumer Internet, and Enterprise at Seed and Series A stages. His investment check size ranges from $5,000 to $20,000 with a sweet spot at $10,000. One of his recent investments is in Tribe XR. As a Venture Partner at Good Growth Capital, Jonathan Ozeran is involved in supporting startups and has a track record of making impactful investments.

C. Victor Brick is the CEO of Ohana Growth Partners, LLC (OGP) which owns 100 Planet Fitness health clubs throughout the United States and Australia. He is also the founder of the John W. Brick Mental Health Foundation, advocating for mental wellness integration in the fitness industry. Victor Brick is involved in promoting research for wellness integration into healthcare and active collaboration for industry improvement.

Robert Fabbio is a venture capitalist with a primary focus on digital health, health services, and health IT in seed to Series B stages. His investment range is $100K to $5.0M, with a sweet spot at $1.5M. Geographically, he is active in Austin, Texas. Some of his previous investments include WhiteGlove Health, Ventix Systems, Agere Systems, and DAZEL Corporation. Fabbio is known to collaborate with partners such as Bart Robertson, Bernie Brenner, and Courteney Real, among others. He has a strong track record in founding companies and working in the technology and healthcare industries.

Vertex Ventures is a global network of operator-investors that manage portfolios.

Ralph Kunz, an experienced entrepreneur and business angel with over 20 years in top-level management and strategy consulting, focuses on investing in industries like life science, information technology, and telecommunication companies. He operates in the early-stage venture and seed investments, with previous investments in companies like Tripod GmbH and Envion. With a track record in the aerospace industry, including roles at Greenwich AeroGroup and Summit Aviation, Ralph Kunz brings a wealth of experience. His partnership and collaboration styles emphasize collaborative approaches for successful investments.

Carla Fowler is an Angel Investor affiliated with Alliance of Angels based in Seattle, Washington. She focuses on Digital Health, BioTech, and Health IT at both Seed and Series A stages. Carla’s typical investment check size ranges from $500K to $1.5M with a sweet spot at $1M. Her previous investments include a diverse portfolio in the healthcare technology sector. With a fund size of $100M, Carla actively collaborates with other investors within Alliance of Angels, demonstrating a strong commitment to fostering startup growth through strategic partnerships. Her track record reflects a successful career in supporting over a dozen startups in the MedTech and biotech fields.

Angie Willmott is an Angel Investor at Angel Physicians Fund based in Cincinnati, Ohio, USA. With 14 years of experience in the field of medical research, Angie brings valuable expertise to the table. Her professional career includes working at Ethicon Endo-Surgery, a Johnson & Johnson company, which demonstrates her deep industry knowledge. While details about her investment focus areas, previous investments, and investment check size are not readily available, her background in medical research and real estate investments suggests a diverse investment approach. Angie’s successful track record may indicate a strategic investment style, potentially focusing on opportunities that align with her industry experience and interests.

Barak Diskin is an angel investor focusing on healthcare, fashion, consumer internet, real estate, and more. He has made investments in companies like FabFitFun and MeUndies. Barak’s professional career includes being the Co-Founder of MeUndies and the Global Head of Real Estate at CloudKitchens. He has a background in real estate development and internet ventures. With a track record in building and investing in companies, Barak’s investment check size varies based on the round. His geographic focus is in the United States, particularly California, and he has a background in real estate and technology. Barak Diskin is known for his seed round investments and seeks collaboration opportunities for investment opportunities.

Charles Boorady is the Founder and Managing Partner of Health Catalyst Capital Management. The firm focuses on investing in growth-stage healthcare technology and technology-enabled services businesses in an effort to improve healthcare outcomes. Mr. Boorady’s investment thesis is centered on promoting value-based care and enhancing the human condition through innovative healthcare solutions. Some of the previous investments made by Health Catalyst Capital Management include Insightin Health, Clearsense, and Vivante Health. The investment check size typically varies based on the specific opportunity and growth stage of the company. Additionally, the partnership and collaboration style at Health Catalyst Capital involves leveraging a deep network of C-level executives from healthcare organizations to support portfolio companies, aiming to create long-term value.

7wire ventures focuses on investing in early and growth-stage companies focused on healthcare IT, digital healtcare and mobile health.

Jos Feijen is a VC and Investment Manager at BOM Brabant Ventures in the Netherlands. He focuses on EnergyTech startups at Seed, Series A, and Series B stages. Jos has a diverse portfolio with co-investors like Bart Mul and Bart van den Heuvel. His investment range varies from $100K to $5.0M, with a sweet spot at $1.5M.

Drew Volpe, a Partner at Procyon Ventures, focuses on investing in entrepreneurs with deep technology at the frontier of AI, computational biotech, connected sensors, AR/VR, and blockchain. Drew’s previous investments include Jellyfish, Sia, Plex Research, Feature Labs, Seven Bridges Genomics, Upskill, Smarking, Oculii, Resilinc, and others. His professional career includes roles as Founder/Managing Partner at First Star Ventures, Founding Investor at Salient Predictions, Investor/Board Director at Brink, and investments in multiple startups like Oort, Jellyfish, Plex Research, and more. Drew is an experienced founder and CTO/VP Eng in database systems and AI, holding an A.B. in Computer Science from Harvard University, and is dedicated to backing visionary founders shaping the future with new computing technologies.

New Era Capital Partners is a venture capital firm that invests in technology-focused and global enterprises.

Timothy Young is a Co-Founding General Partner at Eniac Ventures, leading in strategic seed-stage investments. Eniac Ventures has a focus on companies in areas such as AI, consumer, deep tech, fintech, healthcare, SaaS, sustainability, and Web3. The average check size for investments is around $1.5 million. Timothy Young collaborates closely with co-founder Tim Young and plays a significant role in managing and tracking new investment opportunities, conducting market research and due diligence, and supporting Eniac’s portfolio companies. Eniac Ventures emphasizes partnering with bold founders who utilize technology to drive transformational change.

Nils Winkler is an investor with a focus on creating value from societal externalities through startup investments. His investment portfolio includes ventures in ELUXR, ShareIQ, and Semasio. Nils operates mainly in the European Union and has a track record of exits in ShareIQ and Semasio. His investments span across HealthCare, Identity, Infrastructure, and The Digital Commons. Nils Winkler’s check sizes vary, with the Semasio investment amounting to â¬600K. He has a collaborative relationship with startups, aiming to drive innovation by capturing market externalities for societal growth.

Eric Dobkin is a New York-based angel investor serving as Board Member at Strategic Growth Banking. He has invested in companies like OROS, Ready4, Shareaholic, and Searchable.ai. Eric Dobkin is known for his significant contributions to the IPO market and has a track record in the capital markets division. His investment check size and partnership styles align with strategic collaborations focusing on the healthcare sector. He plays a key role in the newly formed private equity firm by Whistler Capital Partners.

Adam Anders is the Managing Partner at Anterra Capital with a focus on companies leveraging biotechnology and digital solutions. His investment range is $1M to $20M, with a sweet spot at $5M. He specializes in sectors like Supply Chain Tech, Food and Beverage, AgTech, and FinTech across various stages. Adam has made investments in companies like Salus and Smartwyre. With a total fund size of $260M, he brings a wealth of experience from his roles at Anterra Capital, CELINE, Rabo Ventures, and other organizations. Adam collaborates with investors like Andrew Calabrese, Andrew Plant, and Anneke Stelte.

Civilization Ventures is a venture capital firm focused on cutting edge innovations in exponential health tech and biology.

David Ebsworth is an experienced investor with a diverse portfolio. He has made investments in companies like Small Pharma. David Ebsworth’s investment focus areas include Biotechnology, Pharmaceutical, Therapeutics, Biopharma, and Health Care. His investment check size varies based on the opportunity. He has a track record of over 35 years in the global pharmaceutical industry and currently serves in leadership roles at Verona Pharma Plc. David Ebsworth’s geographical preference is not explicitly stated, but his investments indicate an international focus. He has a partnership and collaboration style that emphasizes connecting with other companies.

Ben Sharpe is a member at Alliance of Angels, the largest and most active angel group in the Pacific Northwest. Alliance of Angels focuses on financing and supporting high-growth startups in technology, hardware, consumer, and the life sciences. They have made seed and early stage investments totaling over $100M in 200+ portfolio companies, with 40+ successful exits. Ben Sharpe and the group prefer companies connected to the Pacific Northwest but also invest across the US and Canada. Their investments range from $500k to $2.5 million for the first investment. They are sector agnostic but have a majority in SAAS, AI, and Life Sciences. The partnership style involves an investment process from introductory meetings to due diligence, with decisions typically made within 6 weeks.

Mark Suster is the Managing Partner at Upfront Ventures, a venture capital firm that invests in early-stage technology companies. Upfront Ventures focuses on a variety of sectors including healthcare, defense technologies, computer vision, ag tech & sustainability, fintech, consumerization of enterprise software, and gaming infrastructure. They invest approximately $3 million per company at the earliest stages of formation. Upfront Ventures returns investments to LPs and has a history of substantial funding rounds. The team consists of 10 partners and maintains a strong presence in both Los Angeles and San Francisco. Collaboration and partnership styles at Upfront Ventures prioritize diversity of thought, experiences, and dedication to funding founders across different backgrounds.

Peter Pham is known for primarily investing in HealthTech, Enterprise Applications, and other sectors. His investments are focused on early-stage startups such as Mate Fertility and theMednet. Peter Pham has experience leading series D rounds and follows a barbell approach in his investment strategy. While there is no specific data on his geographical preference, Peter Pham’s past investments and experience indicate a strong focus on the United States market.

Monte Cahn is an Angel Investor with a successful track record in the domain industry.

Founders Capital Partners is a venture capital firm and an angel group founded in 1988. They specialize in early-stage technology-based businesses focusing on industrial products and services. The firm primarily engages in follow-on rounds with occasional new startup investments.

Oguzhan Ozer, an Associate at Earlybird Venture Capital, focuses on investments in various sectors including Medical Devices, SMB Software, IoT, BioTech, Health & Hospital Services, Health IT, SaaS, and Consumer Internet at both Seed and Series A stages. His investment range typically falls between $100K and $5.0M, with a sweet spot at $1.5M. Earlybird Venture Capital, where Oguzhan Ozer works, is known for its expertise in enterprise software companies, with a specific focus on developer, data, and productivity tools, alongside AI-centric products and robotics. They invest in all development and growth phases of technology companies. Oguzhan Ozer is part of the team that leads the tech team and the development of the data-driven sourcing platform ‘Eagle Eye.’ The firm has over EUR 1.5 billion under management, seven IPOs, and 22 trade sales, establishing itself as one of the most successful venture capital firms in Europe. His geographical preference is not explicitly mentioned in the available data.

Michael Braun is a seasoned Senior Venture Partner at 415C, actively involved in technical evaluations of new portfolio prospects. With a professional background as the CEO of CoRRect Medical GmbH and founder of Symedrix GmbH, Mr. Braun has co-founded successful medical device distribution and consulting companies, offering support to multiple startups. His career began at Rüsch AG / Teleflex, where he invented the Polyflex™ stent. Holding a B.Sc. in Biomedical Engineering, Michael Braun demonstrates a hands-on approach to partnerships and collaboration, ensuring strategic guidance and support to emerging ventures.

STOAF is a seed and early stage life sciences and tech-focused venture capital firm in Sweden. With a portfolio of 23 companies, STOAF has made notable investments in sectors like Enterprise Applications, Life Sciences, and more. Their investments include companies such as Limina, Percepio, Ilya Pharma, and SweGaN. STOAF has a team of 17 partners and their investment check size varies across Seed and Series A stages. They have collaborated with 22 investors and focus on funding Swedish companies in the mentioned sectors.

Alexander Mayweg, Ph.D., is a Managing Director at Versant Ventures and the head of Ridgeline Therapeutics, the Basel-based Discovery Engine of Versant. He excels in drug discovery and medicinal chemistry, drawing on his experience at Roche Pharma Research. Mayweg’s investment focus areas at Versant Ventures are in early biotech investment and company creation, with a keen interest in sourcing innovative opportunities globally within the healthcare industry. His geographical preference spans Europe, the U.S., and Asia. Since 2016, Alexander has been involved in launching and investing in companies like Black Diamond, Monte Rosa, Bright Peak, Enterprise, T-knife, and Matterhorn. With a Ph.D. in organic chemistry from Oxford University, Alexander brings deep operating capabilities and a strong track record to his role, reflecting his commitment to fostering partnerships and collaborations within the industry.

Ashok Krishnamurthi, a serial entrepreneur and investor, focuses on enterprise IT and the intersection of computer science and life sciences. He has a check size range of $3 million to $10 million, typically investing in Seed, Series A, and Series B+ rounds. Ashok’s investment style is hands-on, actively engaging with startups to foster growth. Some of his notable investments include GoEuro, Robin Systems, and Veradocs. With a strong background in the industry, Ashok brings a wealth of experience to his investments, supporting startups at various stages. He is known for his partnership and collaboration styles that emphasize teamwork and strategic guidance. Ashok Krishnamurthi’s track record showcases a successful career in identifying promising ventures and supporting them through to fruition.

Amy Gu, Founder and Managing Partner of Hemi Ventures, leads investments in cutting-edge technology companies focused on autonomous vehicles, AI applications, and biotech. The firm primarily invests in early-stage companies. Amy Gu’s geographical preference includes Silicon Valley and the San Francisco Bay Area. Hemi Ventures has made investments in companies like Smart Radar System, Tensorflight, and Alcatraz AI. Amy Gu has a track record of supporting startups like Evernote and Udacity. The investment check size by Hemi Ventures is not specified. Partnership and collaboration styles focus on nurturing visionary startups to the next stage of growth.

Samantha Fernandez Keys is an angel investor and operator with a focus on maximizing human potential and livelihoods. She supports startups in various industries including health, autism, financial inclusion, and education for underrepresented markets in the US and Latin America. Samantha funds seed to growth stage companies through angel groups and syndicates, has a background in product, operations, and strategy roles, and holds an MBA with a focus on technology, marketing, and impact investing. She has previously worked at Adobe, The Bridgespan Group, Root Capital, Acumen, and the U.S. Social Innovation Fund. Samantha is passionate about the intersection of tech, business, and impact.

Jeanette Welsh, Partner & COO at Telegraph Hill Partners, has a focus on private equity investments in the life sciences and healthcare sectors. She specializes in early-stage investments ranging from $2-8 million. Jeanette has a background in private equity, mergers & acquisitions, and securities law. She has been involved in companies such as Three Cities Research and has represented THP on the boards of various firms like Interface Associates and AngioScore. As a Partner at THP, she collaborates with professionals in advancing human health through life science and technology, fostering innovation in the healthcare sector.

Pär Svärdson is known for basing investment decisions on team, timing, and technology, emphasizing a strong technological core and good timing in investment opportunities. His collaboration style may relate to the introspective, relational, and expressive styles, with an affinity for deep work, human connection, and visual engagement in brainstorming.

Franklin Johnson is a venture capital pioneer, known for founding Asset Management Ventures in 1965. The firm focuses on early-stage investments in digital health, technology, and life sciences. Previous investments include companies like basys.ai and SubjectWell. Franklin Johnson’s investment check size ranges from $200,000 to $2,000,000, with a sweet spot of $1 million. He has a diverse portfolio of over 200 tech startups, displaying a strong track record in the industry. Johnson’s partnership and collaboration style emphasize value-added relationships with firms offering broader investment capabilities.

Coyote Ventures is a venture capital company that invests in early-stage companies focused on women’s health and wellness.

Alastair Rampell is a General Partner at Andreessen Horowitz where he focuses on investing in financial services. His investment focus areas include sectors like AI / Devtools, Cybersecurity, Web3, Deeptech, Biotech, Digital Health, Consumer, Fintech, and Gaming/VR. He invests in Seed, Series A, and Series B+ stages with check sizes ranging from $500,000 to $50 million. Alastair has a track record of co-founding Affirm, Inc. and serving on the board of various companies such as Rocket Companies, Loft, Descript, Wise, and Propel, Inc. He is known for his partnership and collaboration styles focusing on long-term relationships and mutual success.

Mike Collett, the Founder and Managing Partner at Promus Ventures, focuses on investing in early-stage DeepTech companies run by visionary and tenacious founding teams. Promus Ventures’ previous investments include Rocket Lab, ICEYE, Halter, and Gauss Surgical. The investment check size ranges from seed rounds like Halter’s in 2017 to later-stage investments like Iceye’s Series D of $136 million. Mike Collett’s partnership and collaboration style involve supporting innovative technologies for sustainable farming, human spaceflight, AI mapping, and healthcare innovations.

Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage.

Oren Tversky is an angel investor focusing on investments in the mobile, music, social media, and video sectors. He has previously invested in Eyegroove, which was acquired by Meta. Oren has a track record of investing in startups in San Francisco, United States. His investment check size and partnership styles are not disclosed on the available sources.

Go Beyond invests in European startups that generate positive impact for people or the planet. They focus on companies in the environment, health, education, food, housing, services, medtech, biotech, technology, and luxury sectors. Go Beyond invests in the seed stage or later, with smaller angel tickets, aiming to support founders in fundraising for seed rounds or later. The founding team includes Kart Siilats and Kadri Harnak. They seek commitments from eligible professional investors for private limited partnership funds. Previous investments information is not available, but they have a track record in investing. Check sizes and partnership styles are not specified on the website.

Robert Schier is a Senior Investment Director at Zürcher Kantonalbank Asset Management (Swisscanto Private Equity) with a background in pharmacy and biotechnology. He has significant experience in investing in healthcare and life sciences sectors, managing investments in private start-ups, and serving on the boards of numerous life sciences companies. Robert’s investment focus areas include healthcare and life sciences. He has been involved in investments in over 20 start-ups and 25 companies as part of an investment committee. His check sizes for investments range from CHF 8 million to CHF 16 million. Dr. Schier is known for his hands-on partnership and collaboration styles, bringing expertise and strategic insights to his portfolio companies.

Russell Hinds, an Angel Investor with a dual background in technology and real estate investment, was the Managing Director of RSH Ventures. His investment focus areas include biotechnology, life sciences, software, semiconductors, and wireless sectors. Mr. Hinds is engaged in early-stage investments and is actively involved in angel investor groups like the Band of Angels, Keiretsu Forum, and Central Texas Angel Network (CTAN). He serves on the boards of various companies and is based in Austin, Texas, where he also manages a Real Estate investment and land development partnership.

DU Angels, an accredited angel group based in Denver, CO, USA, focuses on investing in industries such as Aerospace, Agriculture, Biotechnology, Business Products, Business Services, and more. They have a ‘Founder-First’ mentality and are interested in startups with a track record of sales and revenue generation. Their preferred investment range is $0 to $3,000,000, with a valuation up to $10,000,000. DU Angels prefer startups in the United States and aim to leverage the extensive network of alumni, students, faculty, and community partners at the University of Denver.

Michasl Deherrera is an investor affiliated with the Colorado Competitive Council, with involvement from organizations like Comcast, Xcel Energy, Amazon, Google, Wells Fargo, and others. Michael Sapp and Elizabeth Peetz are key members of the Investor Committee. The specific investment focus areas, stage of investment, geographical preference, previous investments, track record, investment check size, and partnership/collaboration styles are not explicitly provided.

Sean Lauber is a founding partner at Korify Capital, a venture capital fund focused on investing in innovative and visionary companies in the biotechnology sector, specifically in cutting-edge technologies in longevity, mental health, and regenerative medicine. The investment thesis of Korify Capital revolves around three core focus areas: Distributed development companies, Enabling technologies, and Domain-specific platforms. They invest in the biotech sector in the US, Europe, and Israel, selectively in fintech and blockchain opportunities. Korify Capital targets late-stage/pre-IPO venture opportunities as well as event-driven investments in smaller public companies.

Gene Matsutani is known for his investments in gene therapy and targeted toxins for glioma. His investment focus areas are related to these medical advancements. The stage of his investments is not specified. Gene Matsutani’s geographical preference is not readily available. He has a professional career background in IT and helpdesk administration. Unfortunately, details about his previous investments, investment check size, and partnership collaboration styles are not currently accessible.

Selin Anil, an analyst at Earlybird Venture Capital, focuses on making venture capital investments in global category leaders across a wide range of sectors. The investment process at Earlybird involves initial calls, partner evaluations, term sheet negotiations, and due diligence processes to confirm all material facts. The geographical preference is in European technology companies. Selin Anil’s investment check size, partnership, and collaboration styles were not explicitly mentioned in the available information.

Fred Khosravi is a seasoned medical device entrepreneur with a focus on the healthcare industry. He is involved in Imperative Care and Tulavi Therapeutics as Chairman & CEO and Executive Chairman, respectively. He has directed organizations like Instylla Medical and Ostial Corp. Fred’s geographical preference centers around California, particularly Campbell and Santa Cruz. His professional career spans over several successful ventures in the medical technology space, showcasing a solid track record. While specific investment focus areas are not detailed, Fred Khosravi’s leadership style emphasizes collaboration and innovation, evident in his various chairmanship roles and involvement in cutting-edge medical advancements.

John Daly, an angel investor with Alliance of Angels, focuses on investments ranging from $500K to $1.5M, with a sweet spot at $1M. His investment thesis includes sectors like Hardware (Seed), Energy, Tech (Seed), Cloud Infrastructure (Seed), SaaS (Seed), and specific focus on Hardware (Series A), Energy, Tech (Series A), Cloud Infrastructure (Series A), SaaS (Series A). John Daly’s recent investments include Seed rounds in various sectors. His professional career is based in New York, New York, where he has made notable investments, with TMRW Sports being one of his latest Seed VC investments.

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies.

Amit Tiwari, Managing Partner at Tiger Iron Capital, boasts over 17 years of private equity experience. Specializing in Biotechnology, Informatics, and Clinical Services, he oversees operations with a focus on Strategy, Business Development, and Operational Excellence. Amit holds an MBA from the University of Michigan and is a Certified Professional in Healthcare Information and Management Systems. His investments remain undisclosed publicly, emphasizing a long-term partnership and collaboration style with a track record of innovation and excellence.

Zhou Zang is a Senior Associate at Corazon Capital, focusing on investments in early-stage companies spanning health and wellness, consumer-facing tech, and urban tech. Zhou Zang’s professional career includes previous positions at Polsky Holdings, L.E.K. Consulting, and Home Partners of America, with an MBA from The University of Chicago Booth. Corazon Capital’s investment check size has expanded with its recent fund raises, and Zhou Zang is known for collaboration and partnership styles that support portfolio companies at various stages.

Anne Wojcicki is an angel investor with a focus on Diagnostics, Human Capital/HRTech, BioTech, Digital Health, and Health IT. She invests at the seed stage in companies like Brightside Health, Ezra AI, Orchid, Eureka Health, Calypso AI, Helium Health, Nest Genomics, and Wisdo Health. Previous investments include Freenome, Doctor On Demand, and SpoonfulOne. Anne is the CEO and Co-Founder of 23andMe, with a track record in healthcare and biotechnology investing. She takes initiatives to disrupt the healthcare experience and prefers collaboration with partners. Anne’s check sizes vary based on the round of investment, and she is open to partnerships and evolving leadership styles.

Jack Oliver is an investor with a focus on business services, industrials, software, technology, digital infrastructure, education, and healthcare sectors. He has made investments in Juristat. His investment check sizes range from $20 million to $40 million in equity size. His professional career includes being a Senior Policy Advisor and Team Leader at Bryan Cave Leighton Paisner. Jack’s investment approach is industry agnostic, with a particular interest in startups at the seed stage. His geographic preference and partnership styles could not be determined from the available information.

Cliff Hinrichs is an Angel Investor with a focus on seed investments in industries like Big Data, Marketplaces, Brand Marketing, and Biotechnology. His geographical preference includes the United States, Europe, and the United Kingdom, with previous investments in companies like VetPronto. He is recognized for his top quartile investment performance since 2012. Cliff has a diverse professional background with experience in venture capital and advisory services. His investment check size ranges around $1,000,000 for seed rounds. Cliff’s collaboration style emphasizes partnerships with companies in sectors like Digital Media, Kids, Mobile Advertising, and more.

Floris Rost van Tonningen is an investor with a focus on Seed and Angel rounds, having invested in companies like Billy Grace, Zazzy, and Springest. His investment check size, partnership and collaboration styles, track record, and professional career details are not available on the reference page.

Robert Paul focuses on determining fund size, investment stage, specifying location and geographic focus, defining sector focus, establishing a unique selling point, refining the Thesis, and next steps in starting a venture capital firm.

Dominik Lohle, a Senior Investment Manager at HTGF, thrives in the dynamic startup and venture capital scene. With experience in German venture capital companies and a focus on sectors like Industrial Tech, Life Sciences & Chemistry, and Digital Tech, Dominik has made investments in companies such as graswald.ai, SKY ENGINE AI, Tokenize.it, and GlassDollar. His check size for investments includes a $3.3 million seed round for graswald.ai, $7 million raised by SKY ENGINE AI, and a â¬2.5 million investment in oculai among others. Dominik’s geographical preference includes investments in various regions, showcasing partnerships with funds like Lakestar, Supernode Global, FOV Ventures, and Cogito Capital Partners. His collaboration style involves leading funding rounds and engaging with other investors to support startups’ growth. With a track record of over 700 investments and successful exits, Dominik Lohle is a strategic and dedicated investor with a wide range of professional expertise.

Joost Holthuis is a Venture Partner at BGV (BioGeneration Ventures) with a focus on Seed and Series A investments in Pharmaceuticals, Consumer Health, Digital Health, BioTech, and Health & Hospital Services sectors. His investment range is from $100K to $1M, with a sweet spot at $500K. Joost has a geographical preference for investments in the Netherlands. BGV has a strong track record of successful divestments, including Dezima Pharma to Amgen for up to USD 1.55 billion and Acerta Pharma for up to USD 7 billion. Joost’s background includes founding OctoPlus and serving as the CEO for 14 years, leading to a successful listing on Euronext and acquisition by Dr. Reddy’s in 2013. He holds a PhD from the University of Utrecht.

Ron Theis is an investor and member at Alliance of Angels, the largest and most active angel group in the Pacific Northwest. The firm focuses on seed and early-stage investments in industries like software-as-a-service, artificial intelligence, life sciences, manufacturing, retail, and food across the United States and Canada. Since 1997, they have invested over $100 million in 200+ portfolio companies, celebrating 40+ exits generating more than a billion dollars in returns. The Alliance of Angels network consists of 140+ active angel investors and is further supported by a $6.6 million seed fund. Ron Theis is part of this dynamic group with a strong focus on entrepreneurship, angel investing, venture capital, and start-ups.

Norman Meisner, the Founder of Beta Fund, is a Principal focusing on emerging high tech and biotech companies in the early stages of Series B and Seed investments primarily in the US. His portfolio includes companies like Fetchnotes and Loop. His check size ranges from $250,000 to $750,000, with a track record of successful exits through acquisitions. Norman Meisner’s investment thesis is centered around supporting startups in life sciences, enterprise applications, and other sectors. He maintains collaborative partnerships in his investments, typically investing with other co-investors like Keiretsu Forum.

Martin Huber is a dedicated investor with a strong focus on sustainable energy solutions. With a track record in finance and controlling, Martin has led successful ventures like ARYZTA. His investments reflect a commitment to algorithmic enterprise solutions that impact performance positively. While specific check sizes were not found, his investments target sustainable technologies and aim to drive value creation. He combines quantitative expertise with a hands-on partnership style, evident in his role as CFO and in maximizing team performance. Martin’s investments include MERSANA THERAPEUTICS INC, demonstrating a knack for growth and strategic leadership. His professional journey highlights a keen eye for building teams and a commitment to creating change alpha through collaboration and operational leverage.

Mattias Söderhielm is an investor known for his involvement with Red Flag. He has a focus on investments in companies like Bokio. Previous investments include Red Flag, with undisclosed amounts raised. His partnership and collaboration styles involve working closely with co-founders and other investors. Geographically, his investments have been in Sweden and potentially in other regions in Europe. The investment check sizes he participates in are variable, depending on the opportunity. His track record and professional career details are not readily available in the search results.

Lokman KURIS is an investor with a focus on Seed Round investments in areas such as Big Data, Marketplaces, and Healthcare. He has made previous investments in Logan Wood Technologies and held positions like International Expansion Manager at UberEATS. While his investment check size is not specified, he operates in locations like London, United Kingdom, and has a partnership style focusing on cooperative collaboration.

Brian Rawlings is a Partner at Back Porch Group, Co-Founder of Exile, and Chief Executive Officer at Endorsee. His professional career includes roles as a Business Development Executive at Workstand and Dealer Store Manager at Sears. He holds a Bachelor of Business Administration in Computer Information Systems. Brian’s past investments include Back Porch Group, Bandposters, and Endorsee, focusing on markets like Consumer Internet, Mobile, Music, Music Services, Cloud-Based Music, and Social Commerce. He has experience in project management and operations in various industries. Brian’s investment check size and specific partnership and collaboration styles were not explicitly mentioned in the available sources.

Rachel Zoe Ventures is an early stage venture capital firm focused on disruptive consumer technology platforms and solutions.

Spandan Innovators is an innovative startup that designs R&D based projects focusing on Power Electronics, Solar field, and Agricultural automation products to address the needs of Indian farmers. Their previous investment, the ‘Spandan’ portable ECG device, received international recognition for detecting early heart attack symptoms. The investment stage, geographical preference, investment check size, and partnership styles are not explicitly mentioned in the available information.

Alsace Business Angels is a French angel investment firm that offers business development services and provides early stage investments in high growth potential companies. The firm is an active member of France Angels, the body federating the French network of business angels. It is an association of individuals who invest a part of their personal assets in startups. The firm was established in 2007 and is based in Strasbourg, France with an additional office in Mulhouse, France. Alsace Business Angels invests in biotechnology, health care, software, medical, and agriculture startups within the EU region. They focus on early stage investments ranging from prototype to scaling stages, with check sizes varying from $60,000 to $200,000 per company. Their partnership and collaboration styles involve strategic partnerships with major organizations to support entrepreneurship and provide personalized services for business managers and entrepreneurs.

Emeka Alozie is a Venture Partner at Interlock Capital in Seattle, Washington. His investment focus areas include Seed BioTech and FinTech (Seed & Series A). Emeka has a track record as a Banking Professional with degrees in MISM and MBA from Keller Graduate School of Management and Technology jobs update. He has previous investments in BioTech and FinTech sectors. Emeka prefers investments in the range of $80K – $930K, with a sweet spot at $160K. Interlock Partners, where Emeka is a Venture Partner, is focused on redesigning the future through investment, partnership, and collaboration.

Harry Welten is a life science entrepreneur and business angel with over 15 years of experience, specializing in seed-stage financing for life science startups. His investment areas include biotechnology and health sciences, focusing on early-stage companies with high growth potential. Harry Welten’s investments have primarily been in Europe and involve IPOs, mergers, and acquisitions. He has a track record of raising significant funds from private and public investors, with a preferred check size in the range of CHF 100K to CHF 500K. Harry Welten’s partnership and collaboration styles are characterized by strategic alliances and business combinations to drive innovation and market expansion in the life science sector.

Euan Guttridge is the Founder and General Partner of Reinforced Ventures, an early stage investment firm specializing in robotics, autonomous systems, and biotechnology. The check sizes for investments range from $500K to $1.5MM, focusing on early-stage B2B SaaS opportunities. The firm’s portfolio includes companies in the autonomous systems, robotics, and biotechnology sectors. Reinforced Ventures was recognized as one of the 2022 Top 50 Emerging Managers by Weekend Fund.

John Fein is a Managing Partner at Firebrand Ventures, with a focus on healthcare, IT, and startups. He served as a Managing Director for Techstars, running three accelerator programs and investing in 30 startups. John’s average first check size is around $150,000. His partnership and collaboration styles involve fostering entrepreneurship through partnerships with universities and communities, aiming to help ventures accelerate their growth. His professional background includes managing large-scale projects in the healthcare sector.

Joel Mezistrano, a member at Alliance of Angels, focuses on seed and Series A investments in sectors like Data Services, Enterprise Applications, Real Estate/PropTech, Digital Health, Health IT, Health & Hospital Services, Enterprise, and FinTech. His investment range is $500K to $1.5M with a sweet spot at $1M. Joel’s partnership and collaboration styles involve working with various scouts and angels, including Andrew Wang, Bahador Biglari, Ben Sharpe, Beth Morgan, and Carla Fowler.

Sinan Güler focuses his investments primarily in the Consumer and HealthTech sectors with a geographic preference for Turkey and the United States. He has made investments in companies such as Meditopia and Monument. His investment check size is around 250,000 Tl or 50,000 US Dollars. Sinan Güler’s collaboration and partnership styles were not explicitly mentioned in the available sources.

Frank Groenewegen is a Co-Founder and General Partner of 415 Capital with almost 40 years of experience in investing, management, sales & marketing in the medical technology space. He has funded over 40 companies and founded successful European medical device distribution companies. His companies established new clinical standards of care in Europe. As an investor, Frank has a stage of interest in early to mid-stage startups. His geographical preference is Europe. Previous investments include CoRRect Medical, Regis Medical GmbH, and more. Frank’s investment check size can be obtained by contacting info@415capital.com or calling +49 (0)89 628 346 116.

James Cheng is an experienced investor with a diverse portfolio. He has invested in over 40 startups across various industries and is actively involved in advising startup companies. His investments span multiple sectors, and he has a focus on fostering successful exits. James prefers to invest in startups with scalable potential and is known for his collaboration and strategic guidance to portfolio companies. While his check size is not specified, his track record includes successful investments and partnerships, contributing to the growth of startups. Geographically, his preference seems broad, with a focus on finding opportunities with high growth potential.

Walter Jin is the Chairman and CEO of Pager+Onlife, with a background in private equity and venture capital, investing over $1 billion across more than 40 healthcare companies. He is a Co-Founder and General Partner of Three Fields Capital, specializing in mezzanine debt, distressed debt, and public equity investments in healthcare, life science, and health tech sectors. Previous investments indicate a focus on Pager with a Series B investment of $22M. Walter Jin’s investment check size aligns with mezzanine debt and distressed debt investments.

Kevin Fox is a Vice President at Thompson Street Capital Partners. The investment thesis at Thompson Street Capital Partners is focused on sustainable growth across Life Sciences & Healthcare, Software & Technology, and Business & Consumer Services and Products. The investment focus areas include these industries. The firm targets investments ranging between $50 million and $500 million in enterprise value. Thompson Street Capital Partners seeks partnerships globally and has successfully partnered with companies in North America, Europe, and Australia. Kevin Fox’s previous investments include Sabai Global. The partnership and collaboration styles at TSCP emphasize adding value to management teams. The investment check size for Thompson Street Capital Partners V is $1.15 billion.

Niels Sharman is a Senior Investment Manager at HTGF with a focus on Life Sciences and Chemie. He supports high-tech start-ups in digital tech, industrial tech, life sciences, and chemistry. His educational background includes a Biology Bachelor’s from Ludwig-Maximilians-Universität München and a Management Master’s from Technische Universität München. Niels has experience in the pharmaceutical industry and biotech startups. His investments reflect a strong interest in Digital Health.

Tripti Thakur is a VC Investor and Limited Partner at Emmeline Ventures. Her investment focus areas include Consumer Health, Digital Health, BioTech, Health & Hospital Services, and Health IT at both Seed and Series A stages. She prefers investments with check sizes ranging from $100K to $5.0M, with a sweet spot at $1.5M. Tripti Thakur is geographically focused on Los Angeles/Southern California and the San Francisco Bay Area. Her previous investments include Seed Digital Health and collaboration with investors like Azin Radsan van Alebeek, Hayal Koc, La Keisha Landrum Pierre, Mary Zoumas, Naseem Sayani. Her investment style involves partnering with individuals from Emmeline Ventures and other key co-investors.

John Mairlot is an Investment Manager at Aqua-Spark with an investment range of $100K – $5.0M. His sweet spot is $1.5M, with a current fund size of â¬275M. He focuses on Food and Beverage, AgTech, EnergyTech, and BioTech at pre-seed and seed stages. John Mairlot’s previous investments include michroma, Elyos Energy, SAPI, Billdr Renovation, Lixon, Oceano Fresco, Proteon Pharmaceuticals, and more. He is known for his partnership with Aqua-Spark and his role as a mentor at StartLife. John Mairlot is actively involved in diverse ventures across various industries and regions.

Alex Kopelyan is a focused investor with interests in the Deep Tech sector. He has experience in guiding over 117 IPOs and 200 acquisitions. Some of his notable investments include Allozymes, Beeflow, Carbix, and NovoNutrients. Alex values collaboration and partnerships to accelerate the formation of innovative solutions. His work involves a hands-on approach based on the effect of metabolites produced by soil bacteria, aiming to drive progress in the biotech industry.

Michela Grimaldi, a Former Investment Associate at Calm/Storm, a venture capital firm focused on purpose-driven founders, has a background that includes operational experience at a digital startup in Berlin and a market research firm in Buenos Aires. She also has experience at a company builder focused on healthcare. With a Master’s Degree in Finance and IoT from ESCP, Michela has studied and worked in six countries. Her investment focus areas align with purpose-driven founders who are changing life and health for the better. Michela has transitioned to a fund in Italy focused on agritech after her role at Calm/Storm. Her previous investments cover a wide range of sectors such as mental health, reproductive healthcare, chronic conditions, digital therapeutics, and healthcare access. Michela’s professional career embodies a unique blend of social interactions and analytical skills, showcasing a diverse and impactful track record in the venture capital landscape. The partnership and collaboration styles at Calm/Storm emphasize an exclusive founder network and a boutique venture capital approach, indicating a strategic and hands-on investment strategy.

William Banks is an angel investor with a focus on High Tech and HealthTech sectors. His previous investments include Luna Lights. He prefers investing in startups in the United States and has made a significant investment in Luna Lights in a Seed Round in 2016 that resulted in an acquisition in 2020. William Banks’ partnership and collaboration styles are not explicitly mentioned in the available information.

Larry Sonsini is the Founder and Managing Director at WS Investments, a venture capital firm located in Palo Alto. The firm’s investment focus areas include Health Care, Software, Biotechnology, E-Commerce, and Enterprise Software. WS Investments typically invests in startups in the Medical and Marketplace fields that are around 2-3 years old. Some of its notable investments include Alias Technologies, Smartlens, Holocron Technologies, Crowdz, and Driveroo. Larry Sonsini’s partnership and collaboration style involves co-investing with funds like Next Coast Ventures, Maveron, Khosla Ventures, and Stanford University. WS Investments’ portfolio companies are often funded by TCV, Wayra, and Sequoia Capital in subsequent rounds. The fund is mostly active in the United States with a geographical focus similar to Benchmark, Canaan Partners, Menlo Ventures, RRE Ventures, and Tech Coast Angels.

Emelie Agnvall is focused on early-stage investments with a particular interest in GreenTech ventures aimed at reducing CO2 emissions. She has a professional background as a Venture Business Analyst and Project Manager at Scania Group, demonstrating her experience in project management. Emelie’s geographical preference includes regions like Ástersund, Jämtland, Södertälje, and Áre in Sweden. She has a track record of working with organizations like Naturvårdsverket and Scania Group, showing her dedication to environmental and sustainable initiatives. Emelie’s investment check sizes typically align with early-stage funding requirements, and her partnership and collaboration styles indicate a hands-on approach with a focus on impactful climate-smart investments.

Camille Hunt PT, CSM is an impact investor with a focus on healthcare, venture fundraising, and food. She prioritizes investments that positively impact women and the underprivileged. Camille serves as the Director of CYH Consulting, supporting clients in raising capital, business strategy, and operations. Her strong collaboration style emphasizes working with the right people to bring about positive change. As the Vancouver Chapter President at Valhalla Private Capital, she facilitated investments and mentorship for startups, showing a track record of $71+ million invested across 238+ deals. Camille’s investment check sizes are aligned with impact investing, with a strategic and futuristic approach to creating a better world through her investments.

Hakan Goker, Managing Director at M Ventures, heads the Biotechnology Investments covering Healthcare and Life Sciences. He has invested in several companies such as Asceneuron, F-Star Therapeutics, Ribometrix, and Storm Therapeutics. His expertise spans 18 years in the sector, with previous experience at Aescap Venture and Atlas Venture. The investment check size for M Ventures is â¬600 million, and Hakan Goker’s collaboration style focuses on innovation in drug discovery. He is known for active participation and guidance in portfolio companies.

Launchpad Venture Group, LLC is a nationally-recognized leader among angel networks, providing human and financial capital to entrepreneurs. They focus primarily on high tech and life sciences startups. They have invested over $125 million in more than 150 startups since 2001, with investments ranging from 1 to 5 million dollars per company. Some of their previous investments include 7AC, 3Play Media, and Boston Heart Diagnostics. Launchpad Venture Group fosters a culture of respect and professionalism in the startup ecosystem, aiming to build long-term relationships with startups. The group supports its capital investments with advice and mentorship.

Pegasus Tech Ventures is a Silicon Valley-based global venture capital firm.